Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZB1,Marginal zone B- and B1-cell-specific protein,16106,-0.0941544956869808,0.0176004083524475,-0.128651296057778,-0.0596576953161837,8.93726858842889e-08
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL17,C-X-C motif chemokine 17,16249,-0.0704056177430296,0.0144506672678281,-0.0987289255879727,-0.0420823098980864,1.11439315044589e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,13577,-0.0642907080791983,0.0137847877090205,-0.0913088919888785,-0.0372725241695182,3.13251793050743e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM3,Intercellular adhesion molecule 3,16254,-0.0407505441833814,0.00900290794178403,-0.0583962437492781,-0.0231048446174847,6.0429932959652e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL5,Fc receptor-like protein 5,16074,-0.0881401472062213,0.0194746238219026,-0.12631040989715,-0.0499698845152922,6.05714554616601e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEG1,Protein HEG homolog 1,13703,-0.0425230842661923,0.0094234734394515,-0.0609930922075173,-0.0240530763248674,6.46125634281285e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL20,C-C motif chemokine 20,16249,-0.133418733820143,0.0301273459626599,-0.192468331906956,-0.0743691357333296,9.55137294018426e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16254,-0.0432317800513078,0.00994972356740737,-0.0627332382434263,-0.0237303218591894,1.40106396745737e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPCAM,Epithelial cell adhesion molecule,16044,0.137833621931923,0.0331677888024526,0.0728247558791161,0.20284248798473,3.26051478793834e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELE,E-selectin,16254,-0.0716403525844607,0.017272186463459,-0.10549383805284,-0.037786867116081,3.37496618182016e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARCO,Macrophage receptor MARCO,16063,-0.0366905321833527,0.0090110380461452,-0.0543521667537973,-0.0190288976129081,4.68886517405271e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11D,Transmembrane protease serine 11D,13904,-0.0534781186383368,0.0131402551059306,-0.0792330186459607,-0.0277232186307128,4.73152729495674e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB4A_DEFB4B,Beta-defensin 4A,15819,-0.204993234801868,0.0505932904145098,-0.304156084014307,-0.105830385589429,5.10709011063266e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMG,Oligodendrocyte-myelin glycoprotein,15973,0.0911610349739849,0.0228210363480784,0.0464318037317514,0.135890266216219,6.50927551591951e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPA33,Cell surface A33 antigen,15973,0.183980223720856,0.046385362536908,0.0930649131485159,0.274895534293195,7.33027112088382e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC6A,C-type lectin domain family 6 member A,15725,-0.0636656398118838,0.0163010205510325,-0.0956156400919075,-0.0317156395318602,9.43761648556997e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPE,Carboxypeptidase E,16058,0.0511154274474607,0.0131540913980021,0.0253334083073765,0.0768974465875449,0.000102363030040898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM1,Intercellular adhesion molecule 1,16011,-0.0386080450304903,0.00996919797692239,-0.0581476730652581,-0.0190684169957224,0.000108049861878627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC2,WAP four-disulfide core domain protein 2,15200,-0.0517733830204751,0.0134533302272417,-0.0781419102658688,-0.0254048557750813,0.00011939347192664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WARS,"Tryptophan--tRNA ligase, cytoplasmic",16074,-0.0492531119896407,0.0129630389630018,-0.0746606683571242,-0.0238455556221571,0.000145521025531483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR15L,Protein GPR15L,13936,-0.0811378869279354,0.0214745886076295,-0.123228080598889,-0.0390476932569816,0.000158547247523811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WDR46,WD repeat-containing protein 46,13913,-0.0484772916746731,0.0131286086333025,-0.0742093645959461,-0.0227452187534002,0.00022291677630291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP3,Lysosome-associated membrane glycoprotein 3,16227,-0.0644103453610532,0.0175211203564301,-0.0987517412596561,-0.0300689494624503,0.00023754019896144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY96,Lymphocyte antigen 96,15918,-0.0448608706852584,0.0123811278554319,-0.069127881281905,-0.0205938600886118,0.000291744291634238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APLP1,Amyloid-like protein 1,16063,0.0630320240728589,0.0174852667308615,0.0287609012803703,0.0973031468653474,0.000313261356567813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF15,Growth/differentiation factor 15,16254,-0.0528918510665514,0.0147488799772214,-0.0817996558219054,-0.0239840463111975,0.000336567552337082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5L,CD5 antigen-like,13949,-0.0587702292287222,0.0163928979716748,-0.0909003092532048,-0.0266401492042396,0.000338096711144821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAN,Brevican core protein,15918,0.0417047086827087,0.0117294262196473,0.0187150332921999,0.0646943840732175,0.000378266115321042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST2,Bone marrow stromal antigen 2,16208,-0.0640198782393246,0.0180142951948358,-0.0993278968212028,-0.0287118596574463,0.000380734101761905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,13913,-0.0460721278646611,0.0131271407880244,-0.071801323809189,-0.0203429319201332,0.000450057852154805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,13703,-0.0495095160105771,0.0141191447709182,-0.0771830397615768,-0.0218359922595774,0.000455406521999006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBI,Transforming growth factor-beta-induced protein ig-h3,15996,-0.0324276994126009,0.00925249658100869,-0.0505625927113779,-0.0142928061138239,0.000458285156776509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT16,U8 snoRNA-decapping enzyme,13910,-0.10634693200053,0.0303804607336656,-0.165892635038515,-0.0468012289625454,0.000465834505228807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR1,Hepatitis A virus cellular receptor 1,16170,-0.0746638600229619,0.0213480270013531,-0.116505992945614,-0.0328217271003097,0.000470974154992609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON2,Serum paraoxonase/arylesterase 2,15821,-0.0416255270447095,0.0119565615607161,-0.0650603877037131,-0.0181906663857058,0.00050015382806105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMH,Granzyme H,15821,-0.0924160485833933,0.0265598300201117,-0.144473315422812,-0.0403587817439743,0.000503624585683582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF7,SLAM family member 7,16054,-0.0692643727442043,0.02005277225657,-0.108567806367082,-0.0299609391213271,0.00055354959941927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRCP,Lysosomal Pro-X carboxypeptidase,16159,-0.0371837320733962,0.0107672008886023,-0.0582874458150567,-0.0160800183317358,0.000554933678822617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LF,CMRF35-like molecule 1,16195,-0.0714051402080244,0.0208482638104504,-0.112267737276507,-0.0305425431395417,0.000616342805176181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16043,-0.0376631688111325,0.0110230445778981,-0.0592683361838128,-0.0160580014384521,0.00063526947892238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAR,Immunoglobulin alpha Fc receptor,16054,-0.0555442842103567,0.0164086394852414,-0.0877052176014299,-0.0233833508192836,0.000713323649526573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL10,C-X-C motif chemokine 10,16133,-0.0775026219000657,0.02293221416312,-0.122449761659781,-0.0325554821403505,0.000727529608506589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK1,SLIT and NTRK-like protein 1,13568,0.037684264012101,0.0112432746244933,0.0156474457480941,0.0597210822761079,0.000805319181263678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP5,Tartrate-resistant acid phosphatase type 5,16132,-0.0374117829464794,0.0111646571744489,-0.0592945110083991,-0.0155290548845596,0.000807309046266485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGCR6,Protein DGCR6,13528,-0.0494231537260805,0.0147751580357731,-0.0783824634761957,-0.0204638439759652,0.000825014909727258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENG,Endoglin,16254,-0.0195732026502132,0.00587291127490991,-0.0310841087490366,-0.00806229655138974,0.000861707004741138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM2,Inactive carboxypeptidase-like protein X2,13965,-0.0292809039362039,0.00881494291019876,-0.0465581920401935,-0.0120036158322144,0.000896894549884366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHI3L1,Chitinase-3-like protein 1,15727,-0.0894618484120639,0.0272075886249742,-0.142788722117013,-0.0361349747071145,0.00101079944004122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMNDC1,Survival of motor neuron-related-splicing factor 30,13936,-0.0727323732441783,0.0221586841347313,-0.116163394148252,-0.0293013523401049,0.00103202338146064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP3,Latent-transforming growth factor beta-binding protein 3,15725,-0.0603910937089645,0.0185176737026987,-0.0966857341662539,-0.0240964532516751,0.00111151583880008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC7,Sialic acid-binding Ig-like lectin 7,16063,-0.0316574257027987,0.0097302917176668,-0.0507287974694257,-0.0125860539361718,0.00114231680639535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP7,Insulin-like growth factor-binding protein 7,16254,-0.0331997553377385,0.0102180058592593,-0.0532270468218869,-0.0131724638535902,0.00115988919237508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPL,N-acetylneuraminate lyase,13965,-0.0505723373465198,0.0156144506352876,-0.0811766605916836,-0.0199680141013561,0.00120307661772038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAP18,Chromatin complexes subunit BAP18,13938,-0.0781378052538915,0.0241820384507542,-0.12553460061737,-0.0307410098904133,0.00123543776614696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22,Interleukin-22,13913,-0.0757322178459404,0.0234674230474594,-0.121728367018961,-0.02973606867292,0.0012533223891789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1R,Huntingtin-interacting protein 1-related protein,13915,-0.0499417729594721,0.0155506213117259,-0.0804209907304549,-0.0194625551884894,0.00132316272384112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMA,Granzyme A,16249,-0.0378966221375606,0.0118408160829565,-0.0611046216601553,-0.0146886226149659,0.00137449669103422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2,Ribonucleoside-diphosphate reductase subunit M2,15725,-0.0559798781769516,0.0175052476880187,-0.0902901636454682,-0.021669592708435,0.00138710876860498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESR1,Estrogen receptor,13568,0.0637300530383022,0.0199628114151797,0.02460294266455,0.102857163412054,0.00141398977805414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RA,Interleukin-2 receptor subunit alpha,15944,-0.0444841279882779,0.0139399260502928,-0.0718063830468518,-0.017161872929704,0.00141991964325717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS8,Regulator of G-protein signaling 8,15797,0.070090288261931,0.0222029160296831,0.0265725728437522,0.11360800368011,0.0015980775879459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,15797,-0.0462396611049403,0.0146552802506495,-0.0749640103962133,-0.0175153118136673,0.0016071479641004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD27,CD27 antigen,16091,-0.044090285764399,0.0140848294543868,-0.071696551494997,-0.0164840200338009,0.00174917535391131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL1,Interleukin-1 receptor-like 1,16203,-0.0497132678823623,0.0158860776777192,-0.080849980130692,-0.0185765556340326,0.0017549823702208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB2,Integrin beta-2,15969,-0.030421132754348,0.00974179912358992,-0.0495150590365842,-0.0113272064721117,0.00179494668853163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POMC,Pro-opiomelanocortin,13643,-0.0760468590922792,0.024635539912996,-0.124332517321751,-0.0277612008628071,0.00202677777707838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGF,Hepatocyte growth factor,16249,-0.0366739925752574,0.0118974121621625,-0.0599929204130959,-0.0133550647374188,0.00205600945164884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP8,GTPase IMAP family member 8,13506,-0.054895649952799,0.0178668647423516,-0.0899147048478082,-0.0198765950577897,0.00212708450013622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK6,Kallikrein-6,16069,0.0317172637958823,0.0103617963781492,0.0114081428947098,0.0520263846970548,0.00220977292386023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G2A,"Phospholipase A2, membrane associated",16039,-0.0587118072871138,0.0193288601956674,-0.0965963732706218,-0.0208272413036058,0.00238916962853777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17C,Interleukin-17C,15797,-0.0724729259974581,0.0240100668587518,-0.119532657040612,-0.0254131949543046,0.00254485949920367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCA2A,Guanylin,15992,0.0344937727815076,0.0114550477349373,0.0120418792210306,0.0569456663419847,0.00260599130155325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM3,Junctional adhesion molecule C,13703,-0.0515442545681565,0.0173332986845955,-0.0855175199899637,-0.0175709891463494,0.00294732933420087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTXR,Neuronal pentraxin receptor,16063,0.0347619255194235,0.0116980144714271,0.0118338171554264,0.0576900338834205,0.00296682853690307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16011,-0.0617985617390002,0.0208910989240551,-0.102745115630148,-0.0208520078478522,0.0030996554429284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN15,Lipocalin-15,13946,-0.0629662096317103,0.0213050961578678,-0.104724198101131,-0.0212082211622895,0.00312733037234683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRSF1,G-rich sequence factor 1,13430,-0.0828730892990524,0.0281056431568431,-0.137960149886465,-0.0277860287116398,0.00319738155034556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",13528,0.0557726699301762,0.0190264382036335,0.0184808510510545,0.0930644888092979,0.003380851759368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL17,C-C motif chemokine 17,16027,-0.0921069203306233,0.0314478206227558,-0.153744648751225,-0.030469191910022,0.00340664276901199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAP1,Proline-rich acidic protein 1,13983,-0.0407353670405074,0.0139635967802433,-0.0681040167297842,-0.0133667173512306,0.00353689808719069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL11,C-X-C motif chemokine 11,16208,-0.0798720693711229,0.0274989047950276,-0.133769922769377,-0.0259742159728688,0.00368273389229935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY9,T-lymphocyte surface antigen Ly-9,15883,-0.0293117126478627,0.0101038309299978,-0.0491152212706585,-0.00950820402506691,0.00372426191262697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL19,Interleukin-19,15663,-0.0708083817355755,0.0244197584945619,-0.118671108384917,-0.0229456550862342,0.00374117210529126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WIF1,Wnt inhibitory factor 1,16195,-0.0338878296820809,0.0117034762835273,-0.0568266431977944,-0.0109490161663675,0.00379018826310556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JUN,Transcription factor AP-1,15797,0.0503542328597498,0.0174136230490717,0.0162235316835692,0.0844849340359304,0.0038373866505068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCY2C,Heat-stable enterotoxin receptor,13751,-0.0838891419058079,0.0290227924815318,-0.14077381516961,-0.0270044686420055,0.00385284295264054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACVRL1,Serine/threonine-protein kinase receptor R3,15888,-0.0241850999103644,0.00837976071348151,-0.0406094309087881,-0.00776076891194061,0.00390533606904013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLM2,Protein GOLM2,16208,-0.0220382553383599,0.00764387822054262,-0.0370202566506234,-0.00705625402609634,0.00394269626942116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAB2,Stabilin-2,13983,-0.0282152421137156,0.00980963061015845,-0.0474421181096262,-0.00898836611780507,0.00403001676533456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13501,-0.0682993171747279,0.0238170262900483,-0.114980688703222,-0.0216179456462333,0.00414150561555153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP12,Macrophage metalloelastase,16079,-0.0520313641329483,0.0181555308521245,-0.0876162046031124,-0.0164465236627842,0.00416406864107918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL18A1,Collagen alpha-1(XVIII) chain,16139,-0.0224905280944661,0.00790804801555593,-0.0379903022049557,-0.00699075398397646,0.00446063974001985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH3,Neurexophilin-3,13568,0.0294902376569021,0.0103954860418962,0.00911508501478558,0.0498653902990187,0.00456312947962429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",13568,0.0470087144754068,0.0166182071825885,0.0144370283975333,0.0795804005532803,0.00467991299561212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLC2,Immunoglobulin lambda constant 2,13995,-0.0246551493619422,0.00872664426212727,-0.0417593721157116,-0.00755092660817273,0.00473073302054839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT1,Glutathione hydrolase 1 proenzyme,16050,-0.0483740540475644,0.0172275550380405,-0.0821400619221237,-0.0146080461730051,0.00499187300412586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCLY,Selenocysteine lyase,16148,-0.046277261315282,0.0164893096455147,-0.0785963082204908,-0.0139582144100731,0.00501428055528214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",13983,-0.0611285049390941,0.0217885244973274,-0.103834012953856,-0.0184229969243324,0.00503023123667126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGLN1,Egl nine homolog 1,16054,-0.0542158678967267,0.0194611376363527,-0.0923596976639779,-0.0160720381294754,0.00534497486980225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP7,Retinoid-binding protein 7,13936,-0.0593243809210569,0.021366026874516,-0.101201793595108,-0.0174469682470055,0.00550083287278575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2D1A,SH2 domain-containing protein 1A,16054,-0.0554298739422395,0.0199726263500532,-0.0945762215883438,-0.0162835262961352,0.00552159905962539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPC2,NPC intracellular cholesterol transporter 2,13746,-0.0298914509409565,0.0108633661332971,-0.0511836485622188,-0.00859925331969417,0.0059385806601749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE5,Adhesion G protein-coupled receptor E5,16179,-0.0285606134766511,0.0103814773925064,-0.0489083091659637,-0.00821291778733845,0.00594593399489991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REN,Renin,16063,-0.0711090151894571,0.0258705724049264,-0.121815337103113,-0.0204026932758014,0.00599090750554675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A2,Secretoglobin family 3A member 2,16103,-0.0756215332407442,0.0276919793684404,-0.129897812802887,-0.021345253678601,0.0063247699293577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSA,Arylsulfatase A,16074,-0.04184047733957,0.015325145611721,-0.0718777627385431,-0.0118031919405969,0.00633678674721865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA5,Integrin alpha-5,16074,-0.0234374244017599,0.00860027981848112,-0.0402939728459829,-0.00658087595753693,0.00643334638099531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD80,T-lymphocyte activation antigen CD80,13965,-0.0316122474291793,0.0116119644773532,-0.0543716978047916,-0.00885279705356698,0.00648929365495789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL9,C-X-C motif chemokine 9,16133,-0.0618258744785049,0.0228315455953774,-0.106575703845445,-0.0170760451115651,0.00677788654385689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX6B1,Cytochrome c oxidase subunit 6B1,13965,-0.0301237136306415,0.0111261604062894,-0.0519309880269687,-0.00831643923431428,0.00678813587585926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAG3,Lymphocyte activation gene 3 protein,15973,-0.0376021625206534,0.0139481226413022,-0.0649404828976057,-0.010263842143701,0.00702811253948089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM17,Splicing factor 45,13946,-0.0712525514524474,0.0264667568061917,-0.123127394792583,-0.0193777081123116,0.00710772669822679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTIF3,"Translation initiation factor IF-3, mitochondrial",13936,-0.0812676877208279,0.0301960539566711,-0.140451953475903,-0.0220834219657525,0.00712517734799297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16208,-0.0416698340734184,0.0155016329960541,-0.0720530347456844,-0.0112866334011524,0.00719348200869049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SART1,U4/U6.U5 tri-snRNP-associated protein 1,13501,-0.0349222229227052,0.0130336389969706,-0.0604681553567676,-0.00937629048864276,0.00738455935223236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDCP1,CUB domain-containing protein 1,15918,-0.046745165033862,0.0175605203308963,-0.0811637848824188,-0.0123265451853052,0.00777683429068771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFB,Vascular endothelial growth factor B,13568,-0.026742170052116,0.010086056000803,-0.0465108398136898,-0.00697350029054212,0.00802520538185904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES2,Retinoic acid receptor responder protein 2,16157,-0.0428726478462042,0.01619710912403,-0.0746189817293029,-0.0111263139631054,0.00813045080543802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT18,"Keratin, type I cytoskeletal 18",15973,-0.0738145983651469,0.028001637621346,-0.128697808102985,-0.0189313886273087,0.00839507401409215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL22,C-C motif chemokine 22,15867,-0.0467444574594819,0.0177363163805499,-0.0815076375653596,-0.0119812773536042,0.0084089669979777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMMT,MICOS complex subunit MIC60,13913,-0.0411728403507204,0.0156447285688343,-0.0718365083456356,-0.0105091723558052,0.00850429526240819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HHEX,Hematopoietically-expressed homeobox protein HHEX,13938,-0.0689750215758693,0.0262545573420166,-0.120433953966222,-0.0175160891855167,0.00861942264389497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL24A1,Collagen alpha-1(XXIV) chain,13936,-0.0509715647445285,0.0194192903131161,-0.089033373758236,-0.012909755730821,0.00867970557968622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NACC1,Nucleus accumbens-associated protein 1,13913,-0.0506301372353124,0.01931669946178,-0.0884908681804012,-0.0127694062902236,0.00877534690745773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRHR,Growth hormone-releasing hormone receptor,15667,-0.0504026521936535,0.019256726004632,-0.0881458351627323,-0.0126594692245748,0.0088686346336485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI3,Elafin,15850,-0.0487142721376546,0.0186230783375411,-0.0852155056792352,-0.0122130385960741,0.00891027922271833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,13946,-0.0706583847922094,0.0270396148744844,-0.123656029946199,-0.01766073963822,0.00898100988854943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1,Allograft inflammatory factor 1,15725,-0.0468590526905874,0.017972022674069,-0.0820842171317628,-0.0116338882494121,0.00913367445433138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPL,Lipoprotein lipase,16063,0.0417946187208892,0.0160425833106224,0.0103511554320692,0.0732380820097091,0.00918973212189044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST7,Cystatin-F,16084,-0.0844890322082357,0.0324318705180804,-0.148055498423673,-0.0209225659927981,0.00919257245391604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR4,Proline-rich protein 4,13599,-0.0629206827520944,0.024192167721879,-0.110337331486977,-0.0155040340172115,0.00930884417612217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL13,C-X-C motif chemokine 13,16208,-0.0539441369481022,0.0207467866422762,-0.0946078387669635,-0.0132804351292409,0.00932757543765204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HJV,Hemojuvelin,13946,-0.0392351201683959,0.0151091929187107,-0.0688491382890688,-0.00962110204772299,0.00942033933332632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD74,HLA class II histocompatibility antigen gamma chain,16208,-0.0305642675972911,0.0118489322166031,-0.0537881747418331,-0.00734036045274913,0.00990320710688502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOA,Elongin-A,15973,-0.0489329171526839,0.0189837225334783,-0.0861410133183013,-0.0117248209870664,0.00995707706419189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,13938,-0.0411962054824383,0.0160081340833931,-0.0725721482858888,-0.00982026267898775,0.0100791373571944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",13643,-0.0513535593267494,0.0199556164605652,-0.0904665675894573,-0.0122405510640415,0.0100812744009703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB2,BPI fold-containing family B member 2,13938,-0.0580443683883817,0.0225741056395642,-0.102289615441928,-0.0137991213348358,0.0101425922823131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NHLRC3,NHL repeat-containing protein 3,13368,-0.028453385111859,0.0110741923571205,-0.0501588021318152,-0.00674796809190283,0.0101999451723686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPP1,Tripeptidyl-peptidase 1,15944,-0.0403992695692022,0.0157549146806817,-0.0712789023433383,-0.00951963679506612,0.0103494994680594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LZTFL1,Leucine zipper transcription factor-like protein 1,13703,-0.0630940265732909,0.0246222490854099,-0.111353634780694,-0.0148344183658874,0.0104033498877578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,13965,-0.0239417141585191,0.00936552969393257,-0.0422981523586269,-0.00558527595841123,0.0105877001608647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF6,SLAM family member 6,15725,-0.0334597311166388,0.0130976804054328,-0.0591311847112871,-0.0077882775219905,0.0106394074932105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSNA1,Sjoegren syndrome nuclear autoantigen 1,13936,-0.0456466682010392,0.0178681477569107,-0.0806682378045843,-0.0106250985974942,0.0106403405218915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMB,Granzyme B,16054,-0.0581716366544993,0.0227865367472493,-0.102833248679108,-0.0135100246298907,0.0106923440613026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN2,Vascular non-inflammatory molecule 2,15973,-0.0408528349066975,0.0160062876816586,-0.0722251587627484,-0.0094805110506466,0.0107106885436912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT2,Angiopoietin-2,16195,-0.0333356134781488,0.0130743484934499,-0.0589613365253105,-0.007709890430987,0.0107908289288449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA2,Adenosine deaminase 2,15982,-0.0373664276366024,0.0146965670754865,-0.066171699104556,-0.00856115616864885,0.0110147494280082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTR1,Endosome-associated-trafficking regulator 1,13643,-0.0520041921167131,0.0204794883927903,-0.092143989366582,-0.0118643948668442,0.0111174977807043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRL,Prolactin,16208,0.0647593409988545,0.025638053834537,0.0145087554831621,0.115009926514547,0.0115494552755399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",13936,-0.0887776411038637,0.0352403862515523,-0.157848798156906,-0.0197064840508211,0.0117732299789902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPX,Sushi repeat-containing protein SRPX,13965,-0.0307919787110121,0.0122351105294454,-0.0547727953487251,-0.00681116207329914,0.011857426574348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN2,Calsyntenin-2,16249,-0.0339782918647639,0.0135059108113772,-0.0604498770550633,-0.00750670667446462,0.0118855210943048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGFR,Tumor necrosis factor receptor superfamily member 16,13965,-0.0258103353464968,0.0102622512512739,-0.0459243477989937,-0.00569632289399987,0.0119118410541862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSPN,Persephin,16054,0.0812254138840956,0.0324266248559289,0.017669229166475,0.144781598601716,0.0122584797358869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A14,Protein S100-A14,13946,0.0449649632873343,0.0179849375143203,0.00971448575926651,0.0802154408154022,0.012425627076554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",13723,-0.0558176022032721,0.0223306038956056,-0.099585585838659,-0.0120496185678851,0.0124449173572148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSP1,Lymphocyte-specific protein 1,16054,-0.0348991573220541,0.0139666060439803,-0.0622737051682556,-0.0075246094758527,0.0124728892128998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,15918,-0.0479751826964638,0.0192161467936719,-0.0856388304120607,-0.0103115349808669,0.0125487911791899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELP,P-selectin,16138,-0.0485233724475189,0.0194563728217973,-0.0866578631782416,-0.0103888817167962,0.0126426941486684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2,Ataxin-2,13528,-0.0941417978278085,0.037815003504423,-0.168259204696478,-0.0200243909591394,0.0128029408716083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCF2,Neutrophil cytosol factor 2,16027,-0.0732038907080214,0.0294775449672081,-0.130979878843749,-0.0154279025722936,0.0130244404737084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16054,-0.0329103585630083,0.013274695096213,-0.0589287609515858,-0.00689195617443087,0.0131786802676794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL23,C-C motif chemokine 23,16133,-0.0350781632136731,0.0141545292698748,-0.0628210405826278,-0.00733528584471842,0.0132138018829533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5RA,Interleukin-5 receptor subunit alpha,16054,-0.0473955794774381,0.0191262095884604,-0.0848829502708204,-0.00990820868405577,0.0132207165439593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",13643,-0.0595631454282952,0.0240472320309844,-0.106695720209024,-0.0124305706475658,0.013264082266697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6,Interleukin-6,15973,-0.0617366467081325,0.0249377689102885,-0.110614673772298,-0.0128586196439672,0.0133104951701462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAUR,Urokinase plasminogen activator surface receptor,15942,-0.0233025092438843,0.00942685834293056,-0.0417791515960282,-0.0048258668917404,0.0134490529260613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDM3A,Lysine-specific demethylase 3A,13568,0.0774459827694927,0.0313427835714509,0.0160141269694489,0.138877838569536,0.0134882340692075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP1G2,AP-1 complex subunit gamma-like 2,13913,-0.0686851654147723,0.0278223543320805,-0.12321697990565,-0.0141533509238945,0.0135722612366588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRP,Agouti-related protein,16249,-0.0443289539646176,0.0179733460150608,-0.0795567121541368,-0.00910119577509844,0.0136592104927443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP7,Matrilysin,15793,-0.0414297476107387,0.0168248393727621,-0.0744064327813526,-0.00845306244012493,0.0138110698933178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BATF,Basic leucine zipper transcriptional factor ATF-like,13605,-0.0727371787349196,0.0295421742888529,-0.130639840341071,-0.0148345171287679,0.013823119879704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG2,Desmoglein-2,16074,0.0226810346061762,0.00921680297145636,0.0046161007821217,0.0407459684302306,0.0138718393694756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,13965,-0.0541171305401986,0.0219928041249521,-0.0972230266251048,-0.0110112344552925,0.0138796395855721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL1,Protein kinase C-binding protein NELL1,16091,0.0354241069893225,0.0144295945749884,0.00714210162234528,0.0637061123562998,0.0141004618969895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LONP1,"Lon protease homolog, mitochondrial",13643,-0.0734605544355276,0.0299259065660163,-0.13211533130492,-0.0148057775661356,0.0141107525124081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDO1,"Indoleamine 2,3-dioxygenase 1",13643,-0.054695114651663,0.022295021407335,-0.0983933566100397,-0.0109968726932863,0.0141698829807169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN3A2,Butyrophilin subfamily 3 member A2,16054,-0.0312501361380965,0.0127632767345378,-0.0562661585377906,-0.00623411373840245,0.0143582060793901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFI,Complement factor I,14020,-0.0169307805342552,0.0069248684327072,-0.0305035226623613,-0.00335803840614909,0.0145004807463883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP1,Metalloproteinase inhibitor 1,15882,-0.0238071419432799,0.00973917735972432,-0.0428959295683396,-0.00471835431822028,0.0145172572367712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL2,ADAMTS-like protein 2,13983,-0.0277348173413843,0.011415644663807,-0.050109480882446,-0.00536015380032259,0.0151303256248361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGA,Alpha-N-acetylgalactosaminidase,13540,0.0494421285836984,0.0203882162521999,0.0094812247293866,0.0894030324380102,0.0153199361457635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS3,"Nitric oxide synthase, endothelial",15667,-0.0430797745709437,0.0177887100579836,-0.0779456462845916,-0.00821390285729584,0.0154573403635363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART3,Ecto-ADP-ribosyltransferase 3,16138,0.0285803281791071,0.0118073599731748,0.00543790263168456,0.0517227537265297,0.0155079387876981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10,V-set and immunoglobulin domain-containing protein 10,13913,-0.0296618623842997,0.0122860887116209,-0.0537425962590768,-0.0055811285095227,0.0157798661228795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB10,Ras-related protein Rab-10,13965,-0.0446810346460184,0.0185243621129754,-0.0809887843874503,-0.00837328490458659,0.0158774641584244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF1,Pigment epithelium-derived factor,13818,-0.0219710963604624,0.00910965480489431,-0.0398260197780553,-0.00411617294286956,0.015884891159203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF1,Scavenger receptor class F member 1,16254,-0.0350002828632587,0.0145455117215437,-0.0635094858374843,-0.00649107988903313,0.0161278888134532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL21,C-C motif chemokine 21,16133,-0.0340187371538217,0.0141451937461722,-0.0617433168963191,-0.0062941574113242,0.0161850858928327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UMOD,Uromodulin,16208,0.0438422252966333,0.0182405686919878,0.0080907106603372,0.0795937399329294,0.0162476559206353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPO,Myeloperoxidase,16074,-0.0390260467772612,0.0162610940922162,-0.070897791198005,-0.00715430235651739,0.01640798028216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP1,Guanylate-binding protein 1,13911,-0.0539604502215448,0.0225448517295643,-0.0981483596114909,-0.0097725408315988,0.0167029805278228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,15918,-0.0333776143997202,0.0139483417137904,-0.0607163641587495,-0.00603886464069097,0.016725273447397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLNK,B-cell linker protein,13568,-0.0333704607531739,0.0139482041748689,-0.060708940935917,-0.00603198057043086,0.0167495814965118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AREG,Amphiregulin,15973,-0.0368176329781429,0.0153919543025838,-0.0669858634112072,-0.00664940254507865,0.0167681106670195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR4,Fibroblast growth factor receptor 4,13703,0.0437518141603241,0.0182956770391362,0.00789228716361715,0.0796113411570311,0.0167988434386239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDO2,"Tryptophan 2,3-dioxygenase",13605,-0.0325217561513835,0.0136009736818755,-0.0591796645678595,-0.00586384773490745,0.0168099220463766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECI2,Enoyl-CoA delta isomerase 2,13501,-0.0509722059268792,0.0213189705071445,-0.0927573881208825,-0.0091870237328759,0.0168192984385407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC8,Histone deacetylase 8,13568,0.0510469326110762,0.0213520039844815,0.00919700480149238,0.09289686042066,0.0168283562473544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON1,Spondin-1,16076,-0.0264647414644824,0.0110996558070087,-0.0482200668462195,-0.00470941608274531,0.0171238879096504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD244,Natural killer cell receptor 2B4,16249,-0.0221808362449425,0.00930696554535472,-0.0404224887138377,-0.00393918377604723,0.0171719127238237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP5,Retinol-binding protein 5,15973,-0.046027090139643,0.0193175316206251,-0.0838894521160681,-0.00816472816321785,0.0171997448818164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHISA5,Protein shisa-5,13983,-0.0206964617011,0.00870916403524519,-0.0377664232101806,-0.00362650019201946,0.0174958741869606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MME,Neprilysin,15973,-0.0655748701876292,0.0276038028365852,-0.119678323747336,-0.0114714166279222,0.0175334284504818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB118,Beta-defensin 118,13528,-0.0475441794038779,0.0200352176516282,-0.0868132060010692,-0.00827515280668662,0.0176567216614659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16188,-0.0234102435086521,0.00987348212211104,-0.0427622684679897,-0.00405821854931442,0.0177506228407292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSMB,Beta-microseminoprotein,16016,-0.0557660524355579,0.0235500564109405,-0.101924163001001,-0.00960794187011448,0.0178973414716291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD7,FERM domain-containing protein 7,13605,-0.026569400586591,0.0112287848289381,-0.0485778188513096,-0.00456098232187234,0.0179863270662712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16082,-0.0401974159491889,0.0169908642565544,-0.0734995098920355,-0.00689532200634235,0.0180017333666418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECAM1,Platelet endothelial cell adhesion molecule,16074,-0.0244189606442665,0.0103216796823804,-0.0446494528217322,-0.00418846846680085,0.0180032929330106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYTL4,Synaptotagmin-like protein 4,13965,-0.0595389725378521,0.0251697597503384,-0.108871701648515,-0.0102062434271888,0.0180195221096437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE1,Adhesion G protein-coupled receptor E1,13936,-0.0448855931744716,0.0189802899517995,-0.0820869614799987,-0.00768422486894461,0.0180508710250415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16138,-0.0343940622142785,0.0145480635620762,-0.0629082667959478,-0.00587985763260911,0.0180824131903537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,13643,-0.0432658477744496,0.0183509941660242,-0.0792337963398571,-0.00729789920904217,0.0184033842198498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAC1,Cartilage acidic protein 1,16254,-0.0242153395047036,0.0102752350403948,-0.0443548001838775,-0.0040758788255297,0.0184514254138113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTAG1A_CTAG1B,Cancer/testis antigen 1,13720,-0.0406735321466923,0.0172691421279321,-0.0745210507174393,-0.00682601357594536,0.0185231500897201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",13946,-0.0348776595599668,0.0148206080660284,-0.0639260513693825,-0.00582926775055113,0.0186203441367648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP1,Peptidoglycan recognition protein 1,16179,-0.0340519480520827,0.0144869256732462,-0.0624463223716453,-0.00565757373252007,0.0187586647457841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARP1,Poly [ADP-ribose] polymerase 1,16054,-0.0471813630357307,0.020121034874919,-0.0866185913905719,-0.00774413468088957,0.0190454540287198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPO,Lactoperoxidase,15507,-0.0482478531664256,0.0205772754664742,-0.088579313080715,-0.00791639325213618,0.0190541673077762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNC,Tenascin,16138,-0.0386769981196007,0.0165075061881236,-0.0710317102483229,-0.00632228599087844,0.0191417480178125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP2B,DNA topoisomerase 2-beta,13568,-0.0645496459512806,0.027632082900023,-0.118708528435326,-0.0103907634672355,0.019503667048372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO1,Roundabout homolog 1,16076,-0.0191677590401602,0.00821323108999658,-0.0352656919765535,-0.00306982610376687,0.0196202500082843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSN,Gelsolin,13934,0.0148874145327166,0.00638583370785095,0.00237118046532869,0.0274036486001044,0.0197507510423249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRB,Paired immunoglobulin-like type 2 receptor beta,16063,-0.045679896950203,0.0196588375346452,-0.0842112185181076,-0.00714857538229827,0.0201576711465339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPESP1,Sperm equatorial segment protein 1,13965,-0.0240864244737441,0.0103779722067115,-0.0444272499988986,-0.00374559894858952,0.02030559988432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM19,Probable RNA-binding protein 19,13501,-0.0377209570269257,0.0162627318917635,-0.0695959115347822,-0.00584600251906912,0.0203842970807978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEG1,Protein LEG1 homolog,13225,-0.0553019752399447,0.0238479228713285,-0.102043904067749,-0.0085600464121408,0.0204133023311204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCPEP1,Retinoid-inducible serine carboxypeptidase,13593,-0.040166746337516,0.0173311634628432,-0.0741358267246888,-0.00619766595034331,0.0204857287002234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLH1,Glutamate carboxypeptidase 2,13568,0.0858460698047794,0.0370561378396659,0.0132160396390342,0.158476099970525,0.0205376859178739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,13965,-0.0580032280376077,0.0250599531173512,-0.107120736147616,-0.00888571992759932,0.0206504580576997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAM,Basal cell adhesion molecule,16074,0.0192051085970142,0.00831402869372783,0.00290961235730763,0.0355006048367207,0.0209027520768682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD79B,B-cell antigen receptor complex-associated protein beta chain,16249,-0.0353226978689964,0.0153020811896828,-0.0653147770007746,-0.00533061873721806,0.0209916762078356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRA,Paired immunoglobulin-like type 2 receptor alpha,16074,-0.033108580197561,0.0143930137765968,-0.0613188871996907,-0.00489827319543132,0.021442684383418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNF,Tumor necrosis factor,15797,-0.0302097941547485,0.0131400395765266,-0.0559642717247407,-0.00445531658475635,0.0215142933580136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOP56,Nucleolar protein 56,13501,-0.0888827688614712,0.0387263943674519,-0.164786501821677,-0.0129790359012654,0.0217399777297408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHC1,SHC-transforming protein 1,13506,-0.0914024704988238,0.0398603255385422,-0.169528708554367,-0.013276232443281,0.0218593498874104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC9,DnaJ homolog subfamily C member 9,13936,-0.0610994172604765,0.0267486374769749,-0.113526746715347,-0.00867208780560567,0.0223743680732326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFC1,Cryptic protein,15725,0.0370536148372653,0.0162407350684493,0.00522177410310465,0.068885455571426,0.0225308179932895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC8,Sialic acid-binding Ig-like lectin 8,13643,-0.0361296009828747,0.0158368585362364,-0.0671698437138979,-0.00508935825185142,0.0225424114518013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPLX2,Complexin-2,13506,-0.0245529686523534,0.0107734274277721,-0.0456688864107866,-0.00343705089392013,0.0226808073109476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAPPA,Pappalysin-1,15797,-0.0365598788964896,0.0160431154841399,-0.0680043852454038,-0.00511537254757538,0.0226891847891333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIM,Vimentin,15821,-0.0917690879313658,0.040322574088107,-0.170801333144056,-0.0127368427186761,0.0228668850118514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3S2,AP-3 complex subunit sigma-2,13938,-0.0369139151606775,0.0162401859730529,-0.0687446796678611,-0.0050831506534939,0.0230414492470358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH9,Myosin-9,13983,-0.0882456194761834,0.0388510864993339,-0.164393749014878,-0.012097489937489,0.0231390689176791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFL4,Insulin growth factor-like family member 4,13568,0.058444408354625,0.025744621906784,0.00798494941732824,0.108903867291922,0.0232135124686398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN4,Cerebellin-4,16195,-0.0245582041944657,0.0108196488227706,-0.045764715887096,-0.00335169250183534,0.0232341347101448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL7,C-C motif chemokine 7,16054,-0.0459723135078734,0.0202732622730479,-0.0857079075630473,-0.00623671945269942,0.0233648431629519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPY30,Protein dpy-30 homolog,16146,-0.0468801059715632,0.0207146427309872,-0.0874808057242982,-0.00627940621882817,0.0236403836602274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSM,Oncostatin-M,15979,-0.0554236033647623,0.0244951596906644,-0.103434116358464,-0.00741309037106006,0.0236715824038746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MST1,Hepatocyte growth factor-like protein,13767,-0.0501290718325234,0.0221603693605866,-0.0935633957792731,-0.00669474788577377,0.0237064847473079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN1,Ficolin-1,13965,-0.0436211527342332,0.0193453461678159,-0.0815380312231523,-0.00570427424531415,0.0241572132491812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRD1,Natural killer cells antigen CD94,16249,-0.0360301823614867,0.0159893607519534,-0.0673693294353153,-0.00469103528765814,0.0242481843765235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GASK1A,Golgi-associated kinase 1A,13501,-0.0335187389058665,0.0148962704890407,-0.0627154290643864,-0.00432204874734672,0.0244559182752944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EREG,Proepiregulin,15900,-0.0614040347282031,0.0272964488101389,-0.114905074396075,-0.00790299506033083,0.0244927703970721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",13938,-0.0314212986929207,0.0139727694833303,-0.0588079268802482,-0.00403467050559326,0.0245438231798451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13410,-0.0248865337045559,0.0110751417178655,-0.0465938114715723,-0.00317925593753955,0.0246522558046978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP9,Matrix metalloproteinase-9,16052,-0.0466255712574844,0.02081582679616,-0.0874245917779581,-0.00582655073701079,0.0251104324366876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCNE1,G1/S-specific cyclin-E1,13568,0.0725416091120208,0.0324153611551405,0.00900750124794555,0.136075716976096,0.0252452193943428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA12,Carbonic anhydrase 12,15973,0.0244017423292179,0.0109152204818048,0.00300791018488052,0.0457955744735554,0.0253937073964417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRC,Receptor-type tyrosine-protein phosphatase C,13983,-0.0175644471847843,0.00785711846684174,-0.0329643993797941,-0.00216449498977449,0.0254014565386729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,13936,-0.03756912317399,0.0168063499083878,-0.07050956899443,-0.00462867735354989,0.0254060771517923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7,Complement component C7,13692,-0.0251911289283443,0.0112705930614135,-0.0472814913287148,-0.00310076652797382,0.025425543798729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,15725,-0.0597725682540483,0.0267489165000711,-0.112200444594188,-0.00734469191390894,0.0254590029120513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",13936,-0.0788967243887775,0.0353163824096209,-0.148116833911634,-0.00967661486592047,0.0254990251553853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELT,Tumor necrosis factor receptor superfamily member 19L,16074,-0.0214253976680433,0.00959247569889015,-0.040226650037868,-0.00262414529821859,0.0255255636238689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,15797,-0.0324279657140094,0.0145186055224749,-0.0608844325380602,-0.00397149888995858,0.0255269508801613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",13965,-0.058103125914874,0.0260140951835027,-0.109090752474539,-0.00711549935520871,0.0255301481314476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300A,CMRF35-like molecule 8,13703,-0.0230379534417844,0.0103156832072402,-0.0432566925279751,-0.00281921435559369,0.0255456581079804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB14,EF-hand calcium-binding domain-containing protein 14,13936,-0.0214667776235604,0.00961722361808429,-0.0403165359150056,-0.0026170193321152,0.0256230126026589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G1B,Phospholipase A2,16230,0.0327787288267052,0.0146858782754836,0.00399440740675738,0.061563050246653,0.0256292500711034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,15918,0.0269612070400176,0.012086052229045,0.0032725446710893,0.0506498694089459,0.025710234341423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASC3,Protein CASC3,13605,-0.032680075391013,0.0146535484868128,-0.0614010304251661,-0.00395912035685987,0.0257516477756984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16146,-0.045286404368136,0.0203161886442188,-0.0851061341108049,-0.00546667462546706,0.0258223176171767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40LG,CD40 ligand,16249,-0.0598826816431005,0.0268702761399699,-0.112548422877441,-0.0072169404087595,0.0258551989521927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL15,C-C motif chemokine 15,16254,-0.032850466682783,0.0148059798672719,-0.061870187222636,-0.00383074614293008,0.02651889363232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",13965,-0.0239724944391365,0.010807865931249,-0.0451559116643844,-0.00278907721388849,0.0265667883440477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300C,CMRF35-like molecule 6,16208,-0.0259868452882223,0.011722396585434,-0.048962742595673,-0.00301094798077156,0.0266468866902546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EEF1D,Elongation factor 1-delta,13965,-0.0703412659461609,0.0317308709619656,-0.132533773031613,-0.00814875886070839,0.0266522400968255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL27,C-C motif chemokine 27,16063,-0.046668956312283,0.0210617922043812,-0.0879500690328702,-0.00538784359169582,0.0267184080645644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",13501,-0.0331263713524077,0.0149803662422194,-0.0624878891871578,-0.00376485351765766,0.0270304494325479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,13751,-0.0544291242001689,0.0246253495717779,-0.102694809360854,-0.00616343903948414,0.0271015750536292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSD,Cathepsin D,15058,-0.030386091332131,0.0137483684421398,-0.0573328934787251,-0.00343928918553694,0.0271090696283533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UHRF2,E3 ubiquitin-protein ligase UHRF2,13501,-0.0267516104561936,0.0121044777217893,-0.0504763867909006,-0.00302683412148657,0.0271177941280822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMPER,BMP-binding endothelial regulator protein,13703,-0.0178964020919152,0.00810577348641599,-0.0337837181252905,-0.00200908605853983,0.0272706471133782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC1,SPARC-related modular calcium-binding protein 1,16195,-0.0248466991177311,0.0112632548687334,-0.0469226786604486,-0.0027707195750137,0.0273982561218868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC2,Mucin-2,13983,0.0697333487794165,0.0316588750342476,0.00768195371229118,0.131784743846542,0.0276358602909728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1,Programmed cell death protein 1,16171,-0.0317878257785535,0.0144354807076065,-0.0600813679654622,-0.00349428359164482,0.0276749948909617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE2,Angiotensin-converting enzyme 2,15821,-0.0385665297231487,0.0175457231469803,-0.0729561470912302,-0.00417691235506729,0.0279593675369357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD1,Protein disulfide isomerase CRELD1,13703,-0.0282933111925845,0.0128839230145668,-0.0535458003011354,-0.00304082208403364,0.0281074566181286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGR,Progesterone receptor,13568,0.0781558261711542,0.0356511533719996,0.00827956556203502,0.148032086780273,0.028379243528665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LETM1,Mitochondrial proton/calcium exchanger protein,13946,-0.0399283523712404,0.0182167622899567,-0.0756332064595555,-0.00422349828292539,0.0284070600918648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP2,Neuropilin-2,16074,-0.0218811732417741,0.00998613311333929,-0.0414539941439191,-0.00230835233962908,0.0284548367053861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16074,-0.0276328760018042,0.0126132820212437,-0.0523549087634419,-0.00291084324016652,0.0284823238337143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA4,Ephrin-A4,15888,-0.0223918844172519,0.0102280253846484,-0.0424388141711629,-0.00234495466334097,0.0285919065329806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYNU,Kynureninase,16249,-0.0343525305524121,0.0156951409032874,-0.0651150067228554,-0.00359005438196868,0.0286301787397797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL5,C-C motif chemokine 5,16138,-0.076177966860697,0.0348199412225878,-0.144425051656969,-0.00793088206442487,0.0287007827091006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BP1,SH3 domain-binding protein 1,13936,-0.0373793583671444,0.0170885727333351,-0.0708729609244812,-0.00388575580980768,0.0287307028587996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTDH,Protein LYRIC,13568,-0.0698659427080156,0.0319704606058903,-0.132528045495561,-0.0072038399204707,0.0288818644240115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAT,Tissue-type plasminogen activator,16203,-0.0379909418167384,0.0173902658539637,-0.0720758628905073,-0.00390602074296961,0.0289317748856381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB1,DnaJ homolog subfamily B member 1,15973,-0.065487360784003,0.0300268233745256,-0.124339934598073,-0.00663478696993278,0.0292007762078779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFA,Protransforming growth factor alpha,16054,-0.034506207763423,0.0158252463209188,-0.0655236905524239,-0.00348872497442216,0.029238372669001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2,Low-density lipoprotein receptor-related protein 2,13605,-0.0285051002629006,0.0130761614538794,-0.0541343767125042,-0.00287582381329706,0.0292798447433528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,15866,-0.0377783637997176,0.0173715754217319,-0.0718266516263122,-0.00373007597312301,0.0296656190141332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM5,Intercellular adhesion molecule 5,16063,-0.0336242325068381,0.0154844947973892,-0.063973842309721,-0.00327462270395524,0.0299096933711503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGER,Advanced glycosylation end product-specific receptor,16019,0.0301221192394494,0.0138739123241479,0.00292925108411958,0.0573149873947792,0.0299357081303563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSS,Cathepsin S,12602,-0.018219400113718,0.00839296660914246,-0.0346696146676372,-0.00176918555979879,0.0299653865859809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GLB2,Endophilin-B2,13938,-0.0503103640064814,0.0232246408833137,-0.0958306601377763,-0.00479006787518649,0.030309046477317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIA,Melanoma-derived growth regulatory protein,16091,-0.0273276633221173,0.0126278721860993,-0.0520782928068718,-0.00257703383736273,0.0304732652228344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA14,Carbonic anhydrase 14,16195,0.0263214403008207,0.0121794894948743,0.00244964089086708,0.0501932397107742,0.0307000469086052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA,Lymphotoxin-alpha,16054,0.0297444144063205,0.0137655104296134,0.00276401396427823,0.0567248148483628,0.0307261120500306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18R1,Interleukin-18 receptor 1,16249,-0.0244045575860391,0.0112958216090848,-0.0465443679398454,-0.00226474723223281,0.0307490110106753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAC3,Ras-related C3 botulinum toxin substrate 3,13605,-0.0505324155722923,0.0234069777080277,-0.0964100918800267,-0.00465473926455794,0.030878384224898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2L,Ataxin-2-like protein,13946,-0.0349312300758082,0.0162032664378129,-0.0666896322939216,-0.0031728278576949,0.0311152522347802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL28A1,Collagen alpha-1(XXVIII) chain,13605,-0.0571285755285059,0.0265026346109139,-0.109073739365897,-0.00518341169111453,0.0311338971278982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,13936,-0.0660525022919249,0.0306604847803142,-0.126147052461341,-0.00595795212250914,0.0312321715910745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,13501,-0.051159292432199,0.0237502185255846,-0.0977097207423447,-0.00460886412205326,0.0312534671724736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBI3_IL27,Interleukin-27,16173,-0.0225831824852599,0.0104963287310775,-0.0431559867981718,-0.00201037817234803,0.0314490413210809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF168,E3 ubiquitin-protein ligase RNF168,13568,0.0306872474865181,0.0142701124505897,0.00271782708336236,0.0586566678896738,0.0315368013379425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB6,Integrin beta-6,15797,0.0223635113190115,0.0104055325258512,0.00196866756834327,0.0427583550696798,0.0316341579727304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYAP1,Synapse-associated protein 1,13703,-0.04227179458283,0.0197239508456767,-0.0809307382403562,-0.00361285092530377,0.0321169632105704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD6,MICOS complex subunit MIC25,13913,-0.0214795399766193,0.0100278010839917,-0.041134030101243,-0.00182504985199563,0.0322108881259315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRG1,Scrapie-responsive protein 1,13965,-0.0204058497443737,0.00953059193957376,-0.0390858099459383,-0.00172588954280914,0.0322841021827897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRK1,Protein BRICK1,15667,-0.0327968687010261,0.0153228048351654,-0.0628295661779503,-0.00276417122410187,0.0323381923700407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16254,-0.0202678145613479,0.0094703330674197,-0.0388296673734905,-0.00170596174920527,0.0323585131120179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SWAP70,Switch-associated protein 70,13936,-0.0268234715823228,0.0125340474863927,-0.0513902046556525,-0.00225673850899304,0.0323681624159588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR1,Asialoglycoprotein receptor 1,15918,-0.0218058445650447,0.0101958096451864,-0.0417896314696101,-0.00182205766047923,0.0324746313422377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK5,Serine protease inhibitor Kazal-type 5,16074,0.0247014960345765,0.0115612903642341,0.00204136692067767,0.0473616251484753,0.032648121689871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",13965,-0.0396112825757915,0.0185410120824003,-0.075951666257296,-0.00327089889428687,0.0326630119867272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF8,SLAM family member 8,15725,-0.0398486641614162,0.0186568517687959,-0.0764160936282561,-0.00328123469457629,0.0327051877333804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,15609,0.0619707711162838,0.02911083749242,0.00491352963114064,0.119028012601427,0.0332875170074232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA6,Carbonic anhydrase 6,16023,0.0458099803133647,0.0215612797296819,0.00354987204318807,0.0880700885835413,0.0336318528783358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QPCT,Glutaminyl-peptide cyclotransferase,16086,-0.0193946922257168,0.00914826723851014,-0.0373252960131966,-0.00146408843823687,0.03401795455702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,13946,-0.0365444422556786,0.0172535745150908,-0.0703614483052567,-0.00272743620610054,0.0341859940474581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA2,Heat shock-related 70 kDa protein 2,13913,-0.0254073781455162,0.0119986792663522,-0.0489247895075666,-0.00188996678346581,0.0342339084537488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARF6,ADP-ribosylation factor 6,13936,-0.0777156427306474,0.0367058750800587,-0.149659157887562,-0.00577212757373236,0.0342560214761685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPO,Erythropoietin,16054,0.0546763853596077,0.0258358291569706,0.00403816021194541,0.10531461050727,0.0343345952675235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD274,Programmed cell death 1 ligand 1,15918,-0.0244383626364241,0.0115948776628411,-0.0471643228555926,-0.00171240241725562,0.0350737571579176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG3,Proteasome assembly chaperone 3,16054,-0.0374981567931474,0.0177952668290077,-0.0723768797780025,-0.00261943380829224,0.035115872451745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPSE,Heparanase,13790,-0.0679416063070459,0.0322509583541669,-0.131153484681213,-0.00472972793287868,0.0351656282950872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHS1,"Enoyl-CoA hydratase, mitochondrial",13643,-0.0698664359259247,0.0332712514432992,-0.135078088754791,-0.00465478309705832,0.0357556163415021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST3,Cystatin-C,16107,-0.020087062500241,0.00956635436346361,-0.0388371170526297,-0.00133700794785231,0.0357653565221545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD1,Sphingomyelin phosphodiesterase,16118,-0.0354079067931872,0.0168723899932974,-0.06847779118005,-0.00233802240632435,0.0358702772887749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YJU2,Splicing factor YJU2,13913,-0.0235872233852885,0.0112471508187258,-0.045631638989991,-0.00154280778058594,0.0359962650951692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THSD1,Thrombospondin type-1 domain-containing protein 1,13464,0.0245840743716354,0.011729912677088,0.00159344552454298,0.0475747032187278,0.0361146191885962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERC2,ERC protein 2,13605,-0.0555131817096415,0.0264952691736179,-0.107443909289933,-0.00358245412935033,0.0361706910265011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLMH,Bleomycin hydrolase,16254,-0.0226244910394323,0.010812532954186,-0.0438170556296369,-0.00143192644922779,0.0364153635786678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B4,Protein ATP1B4,13506,-0.0299553693723297,0.0143254217943289,-0.0580331960892144,-0.00187754265544495,0.0365410139440034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL16,C-C motif chemokine 16,16254,-0.0375115821993076,0.017953411435657,-0.0727002686131953,-0.00232289578541984,0.036688635427123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF3,Immunoglobulin superfamily member 3,15973,-0.0251062419845725,0.0120178398171734,-0.0486612080262324,-0.00155127594291263,0.0367162242114444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOT,Angiomotin,13703,0.0286483475731133,0.0137241663432026,0.00174898154043624,0.0555477136057904,0.0368669978716811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE2,Adhesion G protein-coupled receptor E2,16133,-0.0201328871518806,0.00964556179299133,-0.0390381882661436,-0.00122758603761755,0.0368794454292333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16076,-0.0243723125133344,0.0117066192801737,-0.0473172863024749,-0.00142733872419399,0.0373650415790653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAXX,Protein PAXX,13703,-0.0337053301313763,0.0161910165179905,-0.0654397225066378,-0.00197093775611483,0.0373856417710655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN3,Neuronal-specific septin-3,13946,-0.0544326388110395,0.0261617530295839,-0.105709674749024,-0.00315560287305507,0.037487025379967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LECT2,Leukocyte cell-derived chemotaxin-2,13965,-0.0472800260397935,0.0227489822052431,-0.0918680311620699,-0.00269202091751713,0.0376966690740967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRAID,All-trans retinoic acid-induced differentiation factor,13936,-0.0209903533395804,0.010111285153069,-0.0408084722395956,-0.00117223443956515,0.0379184315709879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL2,Angiopoietin-related protein 2,16077,-0.0284505293673523,0.0137410697171847,-0.0553830260130343,-0.00151803272167042,0.0384239051163287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAN,Neurocan core protein,16208,0.0265085008791223,0.0128151940962897,0.00139072045039447,0.0516262813078502,0.0386068724381268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA,Adenosine deaminase,16249,-0.0256194297382319,0.0123866018328565,-0.0498971693306307,-0.00134169014583314,0.0386259411907751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPD,Pulmonary surfactant-associated protein D,16063,-0.0473124743759407,0.022933370335472,-0.0922618802334658,-0.0023630685184156,0.0391248175854354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID1,Nidogen-1,16085,-0.0268897445005244,0.0130555942918568,-0.0524787093125638,-0.00130077968848498,0.0394496225604588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA7A,Semaphorin-7A,16203,-0.0195177750559829,0.00948000326314712,-0.0380985814517513,-0.000936968660214546,0.0395258827581614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM1,Neural cell adhesion molecule 1,16138,-0.0214190572716357,0.0104207793305848,-0.041843784759582,-0.000994329783689497,0.0398547189965822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF14,Tumor necrosis factor ligand superfamily member 14,15918,-0.0407337846299709,0.019823148330218,-0.0795871553571982,-0.00188041390274361,0.0399088761533152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",13946,-0.0646087079850594,0.0314508688264046,-0.126252410884813,-0.0029650050853063,0.0399677759717681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOR1AIP1,Torsin-1A-interacting protein 1,13643,-0.0379095876826454,0.0184637695105044,-0.074098575923234,-0.00172059944205674,0.0400734042305142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHLHE40,Class E basic helix-loop-helix protein 40,13528,0.0489082547814283,0.0238255891534716,0.00221010004062386,0.0956064095222327,0.0401149161110564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT1,Dynein light chain Tctex-type 1,13605,-0.0568930301190433,0.0277240009899079,-0.111232072059263,-0.00255398817882374,0.0401769286306837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHDC3L,KH domain-containing protein 3,13506,0.0476100511753919,0.0232283043868464,0.00208257457717285,0.0931375277736109,0.0404172275485704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,13946,-0.0223550114784685,0.0109239362175036,-0.0437659264647756,-0.000944096492161327,0.0407333445811638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSB,Arylsulfatase B,15973,-0.0391525221365376,0.0191384436924498,-0.0766638717737393,-0.00164117249933592,0.0407970690896726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK2,Serine protease inhibitor Kazal-type 2,13703,-0.0261564968689028,0.0128073382891021,-0.0512588799155429,-0.0010541138222626,0.0411403617128303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRF5,Adhesion G protein-coupled receptor F5,13965,-0.0201319814276805,0.0098585161144261,-0.0394546730119556,-0.000809289843405302,0.0411613263211326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPA2,Replication protein A 32 kDa subunit,13568,-0.0224123364523132,0.0109825453125203,-0.0439381252648531,-0.000886547639773357,0.0412976692089479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MASP1,Mannan-binding lectin serine protease 1,15900,-0.016410204634454,0.00804467537843629,-0.0321777683761891,-0.000642640892718899,0.0413783866275806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,15725,-0.0446153543239313,0.0218745201553315,-0.087489413828381,-0.00174129481948148,0.041406497643651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EZR,Ezrin,16208,-0.0170127117506657,0.00834639610291709,-0.0333716481123833,-0.000653775388948244,0.0415331270575186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16148,-0.0243236231718005,0.0119360964725438,-0.0477183722579864,-0.000928874085614633,0.0415841564584775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRB,Receptor-type tyrosine-protein phosphatase beta,13965,-0.0203886504146429,0.0100074716794668,-0.0400032949063979,-0.000774005922887948,0.0416345333904609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPI,Glucose-6-phosphate isomerase,13988,-0.0335889685637091,0.0164904213919324,-0.0659101944918965,-0.00126774263552167,0.041681125596989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP6,Bone morphogenetic protein 6,15797,-0.0287446386012612,0.0141234788072717,-0.0564266570635136,-0.00106262013900874,0.0418436192027013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSF,Cathepsin F,16091,0.0276374660263347,0.0136351335109763,0.000912604344821075,0.0543623277078483,0.0426860049785494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAAM1,Disheveled-associated activator of morphogenesis 1,13703,-0.0577411912857507,0.0285027648406949,-0.113606610373513,-0.00187577219798862,0.0428035985593168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO6,Unconventional myosin-VI,13946,-0.0259898750008254,0.0128369741092823,-0.0511503442550187,-0.000829405746632015,0.042926393572064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRF1,Killer cell lectin-like receptor subfamily F member 1,13568,-0.0309169506408595,0.0153137660252329,-0.0609319320503161,-0.000901969231402944,0.0435173436647031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASP,Vasodilator-stimulated phosphoprotein,13988,-0.050693697475798,0.0251141749468422,-0.0999174803716087,-0.00146991457998725,0.0435552331533466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP1,Syntaxin-binding protein 1,13946,-0.0539229259679029,0.0267207796702418,-0.106295654121577,-0.00155019781422903,0.0436088610628031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG4,Desmoglein-4,15922,0.0344821580432852,0.017088799703781,0.000988110623874494,0.0679762054626959,0.0436265462605603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL16,Pro-interleukin-16,16249,-0.0296121949472086,0.0147023481724095,-0.0584287973651312,-0.000795592529286005,0.0440141023789636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99L2,CD99 antigen-like protein 2,16074,-0.0166007832774551,0.00824427058667805,-0.0327595536273441,-0.000442012927566134,0.0440666646762108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAM,Integrin alpha-M,16074,-0.0216920307562095,0.0107905152558319,-0.0428414406576401,-0.000542620854778922,0.0444175272321132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,13568,-0.0236573309126186,0.0117706622249399,-0.0467278288735007,-0.000586832951736362,0.0444662577815665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALY,Neuron-specific vesicular protein calcyon,13501,-0.0268897504025961,0.0133807396373758,-0.0531160000918526,-0.00066350071333961,0.0444948790716018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4E,Eukaryotic translation initiation factor 4E,13568,-0.0623718015583277,0.0311177597040287,-0.123362610578224,-0.00138099253843151,0.0450492734222099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNG,Uracil-DNA glycosylase,13913,-0.0237084124128753,0.0118301577125566,-0.0468955215294863,-0.000521303296264319,0.0450823989132741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT8,"Alpha-(1,6)-fucosyltransferase",15918,-0.0401180205091281,0.0200298097689949,-0.0793764476563582,-0.000859593361898052,0.0452032771490501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB44,Ras-related protein Rab-44,13913,-0.0318524685617617,0.0159104919304471,-0.063037032745438,-0.000667904378085494,0.0453064010924025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL28,C-C motif chemokine 28,15992,-0.0402183621471618,0.0200998519217754,-0.0796140719138415,-0.000822652380482077,0.0454170042892933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,13605,-0.028647022329845,0.0143237476365956,-0.0567215676975725,-0.000572476962117555,0.0455236932929696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3B1,AP-3 complex subunit beta-1,13936,-0.0527367227890981,0.026373129583317,-0.104428056772399,-0.00104538880579677,0.0455587197744128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDA2R,Tumor necrosis factor receptor superfamily member 27,16195,-0.0257377513881209,0.0128839009791467,-0.0509901973072484,-0.000485305468993457,0.0457694215406121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACYP1,Acylphosphatase-1,13654,-0.045782670036791,0.0229185285268029,-0.0907029859493247,-0.000862354124257413,0.0457769451021275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHL1,Neural cell adhesion molecule L1-like protein,16110,-0.021026387312521,0.0105278518994274,-0.0416609770353988,-0.000391797589643226,0.0458186000056766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18,Interleukin-18,15984,-0.0319794323784124,0.0160172731035545,-0.0633732876613792,-0.000585577095445655,0.0458900445530396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCP1,Plastin-2,13983,-0.0326051460360504,0.0163409452989562,-0.0646333988220046,-0.000576893250096251,0.0460291730658289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGLAP,Osteocalcin,13983,-0.0615937601302017,0.0308721013602994,-0.122103078796389,-0.00108444146401487,0.0460484319078333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,13965,-0.0530822550372888,0.026609362554763,-0.105236605644624,-0.000927904429953254,0.0460763329077209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD7B,OTU domain-containing protein 7B,13946,-0.04323749388549,0.0217373183813713,-0.0858426379129777,-0.000632349858002292,0.0467107367502866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN2,Prorelaxin H2,13685,-0.0780502216820549,0.0392584264058397,-0.154996737437501,-0.00110370592660912,0.0468190088397098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIRBP,Cold-inducible RNA-binding protein,13936,-0.0656344879556148,0.0330259198783033,-0.130365290917089,-0.000903684994140286,0.046901756818542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLGA3,Golgin subfamily A member 3,13946,-0.0525283250250879,0.0264355706765154,-0.104342043551058,-0.000714606499117788,0.0469384016461417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR1,Complement receptor type 1,13938,-0.0242621591160661,0.0122126394392871,-0.0481989324170688,-0.000325385815063337,0.0469814998718212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVALB,Parvalbumin alpha,16113,-0.0777672121829636,0.0391609916682722,-0.154522755852777,-0.00101166851315007,0.0470687395304169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XCL1,Lymphotactin,16195,-0.0375997704332868,0.0189363804368986,-0.074715076089608,-0.000484464776965558,0.0470964060159493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPYL1,Testis-specific Y-encoded-like protein 1,13568,-0.0279382483778622,0.0140762311505643,-0.0555276614329683,-0.000348835322756164,0.0471888729770397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC5A,C-type lectin domain family 5 member A,16012,-0.0200943858121281,0.0101274788095331,-0.039944244278813,-0.000244527345443214,0.0472567446212118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB1,Nuclear factor NF-kappa-B p105 subunit,13501,-0.0508307097447004,0.0256261751682913,-0.101058013074551,-0.000603406414849593,0.0473266641402468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC1,Hamartin,13568,0.0516476264191458,0.0260775376044839,0.000535652714357342,0.102759600123934,0.0476629819149085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIP2,Cysteine-rich protein 2,15918,-0.0247630652425976,0.0125044966707139,-0.0492718787171968,-0.000254251767998401,0.0476833472839681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",13703,-0.0607328005711215,0.0306853985498933,-0.120876181728912,-0.00058941941333069,0.0478125440692706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLI2,Zinc finger protein GLI2,13568,0.022838588070751,0.0115448377499887,0.000210706080773074,0.0454664700607288,0.0479206017417547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,13703,-0.0410289103389147,0.0207567330395478,-0.0817121070964283,-0.000345713581401036,0.0481006230388978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200,OX-2 membrane glycoprotein,16054,0.0175215234670308,0.00886467747596882,0.00014675561413189,0.0348962913199296,0.0481090438050564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEL1L,Protein sel-1 homolog 1,13643,-0.0211826503728367,0.0107226808454933,-0.0421991048300035,-0.000166195915669885,0.0482316358253717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF8,Tumor necrosis factor ligand superfamily member 8,13983,-0.0243310497338962,0.0123265782482375,-0.0484911431004417,-0.000170956367350816,0.0484163218151355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB2,Plexin-B2,16172,-0.0161620581143806,0.00819299758665744,-0.0322203333842292,-0.000103782844532049,0.0485505051024378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZU1,Azurocidin,15610,-0.0533722521029812,0.0270651062993939,-0.106419860449793,-0.000324643756169168,0.0486278285965566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF1,Rho guanine nucleotide exchange factor 1,13938,-0.0607843841423239,0.0309326129259462,-0.121412305477179,-0.000156462807469324,0.0494273540771925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBPL,FK506-binding protein-like,13936,-0.0401027517439293,0.0204094042003854,-0.0801051839766847,-0.000100319511173827,0.0494438899065657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP2,Fibroblast growth factor-binding protein 2,13983,-0.0339270088713234,0.0172799425682781,-0.0677956963051484,-5.83214374983293e-05,0.0496224133991964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT2,Omega-amidase NIT2,13925,-0.0501039301823212,0.0255418514148169,-0.100165958955362,-4.19014092799957e-05,0.0498242662170099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFP,Alpha-fetoprotein,15863,0.0457303586674317,0.0233132220697928,3.64434106378056e-05,0.0914242739242255,0.049830837863377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD5,Programmed cell death protein 5,16208,-0.0393633946076545,0.0200812605733663,-0.0787226653314525,-4.12388385660073e-06,0.0499889133682811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACSL1,Long-chain-fatty-acid--CoA ligase 1,13501,-0.024882759308395,0.0127132772329061,-0.0498007826848909,3.52640681009347e-05,0.050341476272986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO1,R-spondin-1,15918,-0.0234178778522172,0.0119656542327381,-0.046870560148384,3.48044439494877e-05,0.050354202532538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",13891,-0.0739344501648473,0.0378022573323418,-0.148026874536237,0.000157974206542538,0.0505062754051864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPK2,Death-associated protein kinase 2,13568,-0.0381562020100199,0.0195098135856203,-0.0763954366378358,8.30326177959778e-05,0.050515825918533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",13568,0.0302816301766352,0.0154928994344996,-8.44527149840568e-05,0.0606477130682544,0.0506568626500751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LATS1,Serine/threonine-protein kinase LATS1,13568,-0.0573081044327457,0.0293791961371251,-0.114891328861511,0.000275119996019389,0.0511209953422533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM1,Dynamin-1,13936,-0.0765595605618285,0.0392558218591009,-0.153500971405666,0.000381850282009155,0.0511636568200722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNRPB2,U2 small nuclear ribonucleoprotein B'',13938,-0.0313231776290175,0.0160626458940677,-0.0628059635813902,0.000159608323355077,0.0511886052084834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANGAP1,Ran GTPase-activating protein 1,15725,0.0322292705626794,0.0165360210846578,-0.000181330763249818,0.0646398718886086,0.051309113546626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN3,Calsyntenin-3,13938,-0.0203905994111696,0.010469064162117,-0.0409099651689189,0.00012876634657967,0.0514709042715277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FEN1,Flap endonuclease 1,15725,-0.0443777589474085,0.02280029789637,-0.0890663428242937,0.000310824929476622,0.0516284118981788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH1,Acid ceramidase,13861,-0.0310849351882538,0.0159869554521466,-0.0624193678744612,0.000249497497953517,0.0518682181256528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_E,,16054,-0.0191392143934806,0.00984450572426896,-0.0384344456130478,0.000156016826086521,0.0518945982806171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGBP1,Immunoglobulin-binding protein 1,13946,-0.0412584570892303,0.021222817894521,-0.0828551801624915,0.000338265984030958,0.0519081737072881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBC,Inhibin beta C chain,16074,-0.027788534861523,0.014295552111273,-0.0558078169996181,0.000230747276571984,0.0519299220709109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CARHSP1,Calcium-regulated heat-stable protein 1,15667,-0.0351953981475766,0.0181325849051199,-0.0707352645616116,0.000344468266458328,0.0522758642434693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGF,Placenta growth factor,16249,-0.0166878388619161,0.00860965808610338,-0.0335627687106787,0.000187090986846539,0.0526076477550062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC1,Stanniocalcin-1,16208,-0.0287007333350404,0.014816329223563,-0.057740738613224,0.000339271943143184,0.0527503084720765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",13643,-0.0329827869278851,0.0170271094167546,-0.0663559213847242,0.000390347528953942,0.0527568222151205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPGN,Epigen,13913,-0.0313677633487646,0.0161958706686612,-0.0631116698593406,0.000376143161811449,0.05279304971209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,13936,-0.0933532441951165,0.0482063131652483,-0.187837617999003,0.00113112960877014,0.0528223409960403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY1,Aminoacylase-1,16063,-0.0407948975722155,0.021114107083411,-0.0821785474557011,0.000588752311270056,0.0533628070680964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCLN,Nicalin,15797,0.0347523932152294,0.0179994245886775,-0.000526478978578458,0.0700312654090373,0.0535318372633688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL25,C-C motif chemokine 25,16249,-0.0325108971728387,0.0168551598441549,-0.0655470104673823,0.000525216121704933,0.0537682085852923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL6,Fc receptor-like protein 6,16054,-0.0447967853467786,0.0232360736143887,-0.0903394896309803,0.000745918937423165,0.0538854180457067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB2,Interleukin-12 receptor subunit beta-2,13568,0.0276988753110021,0.0143707298142381,-0.00046775512490467,0.0558655057469088,0.053944341077422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPF,Centromere protein F,13751,-0.0373676102163521,0.0194040988533556,-0.0753996439689291,0.000664423536224847,0.054155138344263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA2A,Chymotrypsin-like elastase family member 2A,13983,0.0404970003590521,0.0210674498883286,-0.000795201422071956,0.0817892021401761,0.0545940565119864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NADK,NAD kinase,16063,-0.0375484923759759,0.0195391698822096,-0.0758452653451067,0.000748280593154849,0.0546607559221541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL28,"39S ribosomal protein L28, mitochondrial",13946,0.0252813610299842,0.0131685984673251,-0.000529091965973099,0.0510918140259415,0.0549008226931673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,13913,-0.0490892410245059,0.0255969968854896,-0.0992593549200656,0.00108087287105381,0.0551602134856761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5A,Eukaryotic translation initiation factor 5A-1,15797,0.0197602368551601,0.0103049556194859,-0.000437476159032162,0.0399579498693524,0.0551865031357146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP5,Vesicle-associated membrane protein 5,15821,-0.0359126014550844,0.0187419972259502,-0.0726469160179468,0.000821713107778038,0.0553631829171043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG2,Secretogranin-2,16121,0.0210774593142907,0.0110002650397726,-0.000483060163663538,0.042637978792245,0.0553717674864647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIGR,Polymeric immunoglobulin receptor,15870,-0.023790132842191,0.0124467392230098,-0.0481857417192901,0.00060547603490816,0.0559770301620317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53I3,Quinone oxidoreductase PIG3,13396,-0.035218057653994,0.0184442768871919,-0.0713688403528901,0.000932725044902043,0.0562279915703165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGFAC,Hepatocyte growth factor activator,13849,-0.01860359629667,0.00974376120413044,-0.0377013682567657,0.000494175663425651,0.0562462759097937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,15725,-0.0444875100122353,0.0233023492494855,-0.0901601145412269,0.00118509451675632,0.0562618835725321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP28,Ubiquitin carboxyl-terminal hydrolase 28,13938,-0.0238672881293233,0.0125303361194826,-0.0484267469235092,0.000692170664862587,0.0568318068975293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI2B,Protein EVI2B,13506,-0.0255239129948406,0.013413913843349,-0.0518151841278046,0.000767358138123401,0.0570887142962634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABRAXAS2,BRISC complex subunit Abraxas 2,13501,-0.0441423959936356,0.0231998614537149,-0.0896141244429168,0.00132933245564565,0.0571008671043168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS2,Protein MTSS 2,13913,-0.0648870730980643,0.0341630886977046,-0.131846726945565,0.00207258074943671,0.0575414230192007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR3,Transforming growth factor beta receptor type 3,16254,0.0204672555658112,0.0107957443464915,-0.000692403353312131,0.0416269144849346,0.0579958573342912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFM,Afamin,14020,-0.0126814253186874,0.00670363111521999,-0.0258205423045186,0.000457691667143748,0.058548265529476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L1,Mortality factor 4-like protein 1,13751,-0.026098547744196,0.0138229525783052,-0.0531915347976742,0.000994439309282211,0.0590391071283659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROD,Uroporphyrinogen decarboxylase,13703,-0.0453946982816388,0.0240869382485832,-0.0926050972488619,0.0018157006855844,0.0595024801931347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,15973,-0.0202952241973112,0.0107747887062522,-0.0414138100615656,0.000823361666943166,0.0596393762192623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL18,C-C motif chemokine 18,15852,-0.0453946991839264,0.0241119558835343,-0.0926541327156536,0.00186473434780091,0.059764298994733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1B,Protein phosphatase 1B,13568,0.0408165015271897,0.0216838114114143,-0.0016837688391824,0.0833167718935618,0.0598100438995674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR2,Cadherin-related family member 2,15973,-0.0470056840405127,0.0249904150325989,-0.0959868975044065,0.00197552942338118,0.059997113865265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRP14,Signal recognition particle 14 kDa protein,15973,-0.0395733039684736,0.0210492296543017,-0.0808297940909049,0.00168318615395776,0.0601214074368851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BECN1,Beclin-1,13643,-0.0392914380788674,0.020902721762741,-0.0802607727338398,0.00167789657610497,0.0601664283442745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNAR1,Interferon alpha/beta receptor 1,13936,-0.0168459416831403,0.00896193029567092,-0.0344113250626553,0.000719441696374713,0.0601667786533326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHACTR2,Phosphatase and actin regulator 2,13946,-0.0738174542446659,0.0392875627231814,-0.150821077182101,0.00318616869276959,0.0602788258040717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDNRB,Endothelin receptor type B,13568,0.0289053365131072,0.0153969858523393,-0.00127275575747786,0.0590834287836922,0.0604933321485449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALLD,Palladin,13568,0.027114322323003,0.0144492432950199,-0.00120619453523601,0.0554348391812421,0.060605110407612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL6A3,Collagen alpha-3(VI) chain,16254,-0.021931306001843,0.0117054393720779,-0.0448739671711157,0.00101135516742961,0.0610035834592993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FTCD,Formimidoyltransferase-cyclodeaminase,13912,-0.0551051245899494,0.0294127237140983,-0.112754063069582,0.00254381388968322,0.061018527754033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAM,Cytotoxic and regulatory T-cell molecule,15918,-0.0326282349200497,0.0174161791792268,-0.0667639461113342,0.0015074762712349,0.0610254351402834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP6,Lysophosphatidic acid phosphatase type 6,16173,-0.0429416938247037,0.0229390677878431,-0.0879022666888762,0.00201887903946878,0.0612261062333994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL2,Fc receptor-like protein 2,16169,-0.0314232189085353,0.0167874445910907,-0.0643266103070731,0.00148017249000256,0.0612483748426269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIAE,Sialate O-acetylesterase,16067,-0.0301922605215257,0.0161303323419518,-0.0618077119117513,0.00142319086869981,0.061256700292533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2AP,CD2-associated protein,16063,-0.0410111095548531,0.0219241640191543,-0.0839824710323956,0.0019602519226893,0.0614201956389213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNC4,Potassium voltage-gated channel subfamily C member 4,13528,-0.0364516596977361,0.0195189013057392,-0.0747087062569849,0.00180538686151278,0.0618526298892676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2R,Proteinase-activated receptor 1,16103,-0.0367465482997539,0.0197022465557053,-0.0753629515489363,0.00186985494942852,0.0621863735232681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRSK2,Serine/threonine-protein kinase BRSK2,13946,-0.0247466785122967,0.0132713824069068,-0.0507585880298341,0.00126523100524066,0.0622494261941663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEFL,Neurofilament light polypeptide,15620,-0.0282595876811062,0.0151610848559968,-0.05797531399886,0.00145613863664758,0.06234671573083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,13936,-0.0142043301432842,0.00762811106048725,-0.0291554278218392,0.000746767535270804,0.0626095951786446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLA,Alpha-galactosidase A,13677,-0.0238428483870276,0.0128323955300925,-0.0489943436260089,0.00130864685195368,0.0631876592279752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBP,Lipopolysaccharide-binding protein,16138,-0.0370222909200545,0.0199327251288585,-0.0760904321726172,0.00204585033250818,0.0632778548604325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE2,Glia-derived nexin,13965,-0.0411379418526952,0.0221656580176528,-0.0845826315672946,0.00230674786190421,0.0634844012573108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RP2,Protein XRP2,15973,-0.0271426931652739,0.0146320346050254,-0.0558214809911237,0.00153609466057582,0.0636120302371274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIE1,Tyrosine-protein kinase receptor Tie-1,16254,0.0262067953775492,0.0141322859720351,-0.00149248512763958,0.053906075882738,0.0637012407440666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD72,B-cell differentiation antigen CD72,13703,-0.0271108436252317,0.014639978821077,-0.0558052021145427,0.00158351486407931,0.0640708564377157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,13643,-0.0303984240967803,0.0164154490727365,-0.0625727042793439,0.0017758560857833,0.0640735740396334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT1,NAD-dependent protein deacetylase sirtuin-1,13568,0.0560675302421367,0.0302863468013664,-0.00329370948854141,0.115428769972815,0.0641556622583916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDHB15,Protocadherin beta-15,13913,-0.0255631655399073,0.0138285830567888,-0.0526671883312134,0.00154085725139884,0.0645405075055715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53BP1,TP53-binding protein 1,13568,0.0553939764386473,0.0299957064276526,-0.00339760815955171,0.114185561036846,0.0648080389220501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP3R1,Calcineurin subunit B type 1,15918,-0.0262173695305244,0.014204798435168,-0.0540587744634537,0.00162403540240491,0.0649587182622886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16227,-0.0238304290145318,0.0129198268589759,-0.0491532896581246,0.00149243162906104,0.0651306958271107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP29,Dual specificity phosphatase 29,13605,-0.042856613921006,0.0232567753133597,-0.0884398935351909,0.00272666569317893,0.0653860840128335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN8,Septin-8,13904,-0.0210719410334907,0.0114366286915652,-0.0434877332689586,0.00134385120197712,0.0654239502667858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CWC15,Spliceosome-associated protein CWC15 homolog,13854,-0.0402045942014152,0.0218239984909872,-0.08297963124375,0.0025704428409196,0.065464437114826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L1CAM,Neural cell adhesion molecule L1,16091,-0.018345301305009,0.00996500845247275,-0.0378767178718556,0.00118611526183757,0.0656440799599094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",13965,-0.0562019848147872,0.0305305680844024,-0.116041898260216,0.00363792863064156,0.0656657804181957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHIT1,Chitotriosidase-1,16120,-0.0955806740160512,0.0519359640343223,-0.197375163523323,0.00621381549122056,0.0657343442302485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPS,Calcyphosin,13938,0.0599469941258353,0.0325737737986039,-0.00389760251942828,0.123791590771099,0.0657388148468988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR37,Prosaposin receptor GPR37,15821,-0.0416112120535241,0.0226138662499191,-0.0859343899033655,0.00271196579631734,0.0657759500346994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFIC,Nuclear factor 1 C-type,13946,-0.0280742227591138,0.0152583513334217,-0.0579805913726203,0.00183214585439263,0.0658005023504423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16054,-0.0393696600154591,0.0214294363459849,-0.0813713552535895,0.00263203522267127,0.0662023108816305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANPEP,Aminopeptidase N,16109,-0.0177030812806459,0.00966375269999747,-0.0366440365726409,0.00123787401134917,0.0669839771714266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSRC1,Proline/serine-rich coiled-coil protein 1,15725,-0.03726254463451,0.0203443377744083,-0.0771374466723502,0.00261235740333016,0.0670310187424852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSB,Lupus La protein,15667,-0.0360497381963229,0.0197073046532435,-0.0746760553166802,0.00257657892403446,0.0673800298830453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPP1,Osteopontin,16230,-0.028646476475013,0.0156659305365872,-0.0593517003267239,0.00205874737669795,0.0674802472048595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,13703,-0.0319633590880304,0.017490830225571,-0.0662453863301496,0.00231866815408875,0.067656117178667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G10,Group 10 secretory phospholipase A2,15918,0.0368464989341997,0.0201747818812907,-0.00269607355313002,0.0763890714215294,0.0678141607856369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA1,BolA-like protein 1,13528,-0.0346428957929881,0.0189810341983453,-0.0718457228217448,0.00255993123576866,0.0680031517374307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD163,Scavenger receptor cysteine-rich type 1 protein M130,16138,-0.0268625933811826,0.0147465047643163,-0.0557657427192424,0.00204055595687731,0.0685305101587946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16076,0.0210528863707283,0.0115605153345261,-0.00160572368494286,0.0437114964263995,0.0686098327633246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA4H,Leukotriene A-4 hydrolase,16195,-0.0363355776081994,0.0199528207993205,-0.0754431063748677,0.00277195115846883,0.068613957292955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX1B,Syntaxin-1B,13605,0.0267151653105603,0.0146755966925364,-0.0020490042068111,0.0554793348279317,0.0687231113605171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP29,Endoplasmic reticulum resident protein 29,13703,-0.0744385746842771,0.0409434500309737,-0.154687736744986,0.00581058737643138,0.069073353078908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,13501,-0.0247988284341702,0.0136710534488206,-0.0515940931938586,0.00199643632551821,0.0697051464840064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FN1,Fibronectin,14020,-0.0168254662761566,0.00927713551796269,-0.0350086518913635,0.0013577193390503,0.0697531943537474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13506,0.0272415673557729,0.0150207488264008,-0.00219910034397258,0.0566822350555185,0.0697621808185266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L1,Bcl-2-like protein 1,13938,-0.06178472591572,0.0341199002346739,-0.128659730375681,0.00509027854424082,0.0701914959205323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSIP1,PC4 and SFRS1-interacting protein,16054,-0.0407121015113817,0.0225452133996997,-0.0849007197747931,0.0034765167520296,0.0709686355755564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFC,Vascular endothelial growth factor C,16091,-0.0345792738575289,0.0191957689893328,-0.0722029810766212,0.00304443336156341,0.0716584572905761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC1,Glypican-1,16195,0.0179390005847039,0.00996388263375133,-0.00159020937744865,0.0374682105468565,0.071815700620706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD3,Sphingomyelin phosphodiesterase 3,13568,0.0364177321409565,0.0202347384270706,-0.00324235517610194,0.0760778194580149,0.0719203093725444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC1,Syndecan-1,16063,-0.0245615348861917,0.013655529415956,-0.0513263725414654,0.00220330276908205,0.0720926490927263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAMR1,Inactive serine protease PAMR1,16074,-0.0169915515623101,0.00944696424725905,-0.0355076014869378,0.00152449836231768,0.0720966974906839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,13936,-0.0401770204029214,0.0223427769231201,-0.0839688631722368,0.0036148223663939,0.0721652810104543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC4,Apical endosomal glycoprotein,13913,-0.0343156425339719,0.0191096941472271,-0.0717706430625371,0.00313935799459333,0.0725609171321843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,13501,-0.0348242806565101,0.0193991069184555,-0.0728465302166829,0.00319796890366265,0.0726523995198183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRL,Appetite-regulating hormone,16063,0.0500287654685802,0.0278741755867442,-0.0046046186814384,0.104662149618599,0.0727032655249632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,15725,-0.04734458030776,0.0264446343341826,-0.0991760636027579,0.00448690298723789,0.0734203787745715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN1,CCN family member 1,15945,-0.046938341013666,0.0262315486556484,-0.0983521763787369,0.00447549435140485,0.0735718143782306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,13501,-0.0194921244568533,0.0109001307805373,-0.0408563807867065,0.00187213187299978,0.0737586316825618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGCC,Regulator of cell cycle RGCC,13946,-0.0464150703067887,0.0259700486338796,-0.0973163656291928,0.00448622501561537,0.0739181949466311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMM2,Phosphomannomutase 2,13501,-0.0373835406907338,0.0209312974667324,-0.0784088837255293,0.00364180234406166,0.074119833888884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBN,Nibrin,15797,-0.0336696427780546,0.0188529083955808,-0.0706213432333929,0.00328205767728364,0.0741326360320995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT1,Kunitz-type protease inhibitor 1,16021,-0.0156732829542891,0.0087797026288892,-0.032881500106912,0.0015349341983337,0.0742522835876767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,15918,-0.0204879418168845,0.0114921889647213,-0.0430126321877383,0.00203674855396922,0.0746426481573347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300E,CMRF35-like molecule 2,16145,-0.0249414327099737,0.0139963208940135,-0.0523742216622402,0.00249135624229287,0.0747681667538316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST13,Hsc70-interacting protein,13703,-0.0345165529043592,0.0193828611444895,-0.0725069607475587,0.00347385493884031,0.0749710618330409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD83,CD83 antigen,16054,-0.0203146070968292,0.011411539588572,-0.0426812246904303,0.00205201049677189,0.075065252155308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUS,RNA-binding protein FUS,15693,-0.0244526145916765,0.0137409779435067,-0.0513849313609496,0.00247970217759653,0.0751707011710631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4D,C-type lectin domain family 4 member D,16054,-0.0376325103936426,0.0211556628480355,-0.0790976095757923,0.00383258878850708,0.0752851552261157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTYMK,Thymidylate kinase,13965,-0.0422199677978054,0.0237354384933599,-0.0887414272447909,0.00430149164918012,0.0752986813610052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML1,Trem-like transcript 1 protein,13988,-0.0324392281596174,0.0182388269854272,-0.0681873290510546,0.00330887273181987,0.0753302434447171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGRN,Neugrin,13938,-0.0138160909606781,0.00777266020679419,-0.0290505049659947,0.00141832304463852,0.0755038683073367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH7,Protocadherin-7,13936,-0.0221796398084379,0.0124995566766225,-0.046678770894618,0.00231949127774217,0.0760132197549892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA80,N-alpha-acetyltransferase 80,13605,-0.073902756063763,0.0417061791713567,-0.155646867239622,0.00784135511209613,0.0764193196046419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE1,Ribonuclease pancreatic,13988,-0.0150444840230558,0.00849341444500843,-0.0316915763352723,0.00160260828916073,0.0765306814939418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELB,Transcription factor RelB,13568,0.0310450941312933,0.0175272506285105,-0.00330831710058725,0.0653985053631738,0.0765420657541287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OCLN,Occludin,13946,-0.026789971566409,0.0151285151012183,-0.0564418611647969,0.00286191803197896,0.0766114614539539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,15725,-0.0356665332692926,0.0201509412646436,-0.075162378147994,0.00382931160940887,0.0767517633615196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYDGF,Myeloid-derived growth factor,13965,-0.0610749119920505,0.034510610016435,-0.128715707624263,0.00656588364016207,0.0767917954674362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL12,Stromal cell-derived factor 1,15797,-0.0244228754233354,0.0138066072948055,-0.0514838257211542,0.00263807487448331,0.0769254281081341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRB1,Killer cell lectin-like receptor subfamily B member 1,16249,-0.0227946569028718,0.0129074372908718,-0.0480932339929805,0.00250392018723686,0.0774130459565424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNB2,Ephrin-B2,13605,-0.0358849389381851,0.0203200670915808,-0.0757122704376835,0.00394239256131327,0.0774207691133123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TALDO1,Transaldolase,13943,-0.0275316043332444,0.0156069747582998,-0.0581212748595121,0.0030580661930233,0.0777441783253535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS4B,Vacuolar protein sorting-associated protein 4B,13913,-0.0577134184064315,0.0327469370665434,-0.121897415056857,0.00647057824399357,0.0780225986302085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE6,Ribonuclease K6,13887,-0.0183588263569117,0.0104268074304996,-0.0387953689206908,0.00207771620686744,0.0783055949727284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECAP2,Adaptin ear-binding coat-associated protein 2,13501,-0.0405990544623189,0.0230684460620998,-0.0858132087440346,0.00461509981939665,0.0784408414244447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN1,Neuroligin-1,13605,-0.0415774865898121,0.0236265983175449,-0.0878856192922002,0.00473064611257594,0.0784685327525816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA4,Protein disulfide-isomerase A4,13983,-0.0369776383058963,0.0210157065534069,-0.0781684231505739,0.00421314653878125,0.0785104488944088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORT1,Sortilin,16043,-0.0225095480555009,0.012814112178242,-0.0476252079248552,0.0026061118138534,0.0790013971856327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARFIP1,Arfaptin-1,13946,-0.0416191502445952,0.0237121603277879,-0.0880949844870595,0.00485668399786911,0.0792502071210821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC51B,Organic solute transporter subunit beta,13501,0.0462134477247089,0.0263331081070772,-0.00539944416516241,0.0978263396145802,0.0792895269757864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,13946,-0.0509313282395912,0.029056983713041,-0.107883016317152,0.00602035983796913,0.0796568760218791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C4BPB,C4b-binding protein beta chain,16091,-0.0241588219006466,0.0137967717335345,-0.0512004944983742,0.00288285069708094,0.0799565579693504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,13751,0.0314088312928531,0.0179456498045765,-0.00376464232411698,0.0665823049098231,0.0801027208144789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",13501,-0.0301526750775682,0.0172285663730186,-0.0639206651686846,0.00361531501354817,0.0801141747511276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRPEL1,"GrpE protein homolog 1, mitochondrial",15973,-0.036523802668909,0.0208839581903689,-0.077456360722032,0.00440875538421404,0.0803287874182916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,15725,-0.0294694840406804,0.0168793810680931,-0.0625530709341429,0.00361410285278198,0.0808502168404129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDRG1,Protein NDRG1,15667,-0.0403023607405028,0.023092409968124,-0.0855634842780258,0.00495876279702029,0.0809584800058495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB7,Integrin beta-7,16195,-0.0277326866578016,0.0159045828025425,-0.0589056689507849,0.00344029563518158,0.0812318804212212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,13946,-0.0392218552452687,0.0225125279137592,-0.0833464099562366,0.00490269946569928,0.081491409481051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOH,Beta-2-glycoprotein 1,16074,-0.0212695599728782,0.0122165436919109,-0.0452139856090236,0.00267486566326711,0.0816947305505978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASSF2,Ras association domain-containing protein 2,15725,-0.0346386797683117,0.0199127792196009,-0.0736677270387295,0.00439036750210617,0.0819629031343018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUMB,Protein numb homolog,13568,-0.0500734986188997,0.0287860424635255,-0.10649414184741,0.00634714460961025,0.0819684676437657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD302,CD302 antigen,15973,-0.0180923276404255,0.0104015615416305,-0.0384793882620212,0.00229473298117026,0.0819862182374239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3BP,Galectin-3-binding protein,14020,-0.0184874421112697,0.0106288504501842,-0.0393199889936308,0.00234510477109141,0.0819926876903595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN2,Transcobalamin-2,16230,-0.0177935483016961,0.010232994951721,-0.0378502184070693,0.00226312180367718,0.0820817618583141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPI,Intestinal-type alkaline phosphatase,13568,-0.0733267024592706,0.0421998335602017,-0.156038376237266,0.00938497131872471,0.0823028982613783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZI2,5-azacytidine-induced protein 2,13946,-0.0334558394053815,0.0192577526216437,-0.0712010345438031,0.00428935573304014,0.0823623245287834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,15918,-0.0441013133545307,0.0254541383908212,-0.0939914246005403,0.00578879789147878,0.0831898564547424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL3,Angiopoietin-related protein 3,16085,-0.0211666254986382,0.0122235401540094,-0.0451247642004967,0.00279151320322024,0.0833589911275096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL3,C-C motif chemokine 3,16054,-0.0356446272263316,0.0205953182284354,-0.0760114509540649,0.00472219650140178,0.0835218314278372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH9,Protocadherin-9,13936,-0.0205622447187947,0.0118815142923218,-0.0438500127317454,0.00272552329415593,0.083543846716661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRN,Agrin,16133,-0.0200624111576508,0.0115965566868321,-0.0427916622638417,0.00266683994854007,0.0836437456696917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CINP,Cyclin-dependent kinase 2-interacting protein,13751,-0.0267664543342596,0.0154738279357829,-0.057095157088394,0.00356224841987484,0.0836904773425196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STEAP4,Metalloreductase STEAP4,13528,-0.0443426587335064,0.0256551424225721,-0.0946267378817477,0.00594142041473498,0.0839372082868768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGP1,SURP and G-patch domain-containing protein 1,13936,-0.02438087903375,0.0141127384253711,-0.0520418463474774,0.00328008827997745,0.0840857998418646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP3,Fibroblast growth factor-binding protein 3,13938,-0.0221327232227251,0.0128126060550583,-0.0472454310906394,0.00297998464518925,0.0841148389364758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16054,-0.0567369564917662,0.0328524947921847,-0.121127846284448,0.00765393330091574,0.0841830999034918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC5,Sialic acid-binding Ig-like lectin 5,16074,-0.0686162941308886,0.0397335126299037,-0.1464939788855,0.00926139062372268,0.0842026326412603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,13643,0.0368687001295002,0.0213715669300037,-0.00501957105330716,0.0787569713123075,0.0845269793194648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD2,Polycystin-2,13501,-0.0352458916954282,0.0204491771522797,-0.0753262789138965,0.00483449552304006,0.0848057357258776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB14,DnaJ homolog subfamily B member 14,13936,-0.038916640041228,0.0226000870735712,-0.0832128107054275,0.00537953062297155,0.0850974207102571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",13643,-0.054429942890218,0.0316121672096425,-0.116389790621117,0.00752990484068134,0.0851277950781767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXN,"Frataxin, mitochondrial",16195,-0.043220368316954,0.0251224000546604,-0.0924602724240884,0.00601953579018048,0.0853803854349054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA1,GDNF family receptor alpha-1,16173,-0.0164603963028877,0.0095704270015821,-0.0352184332259886,0.0022976406202132,0.0854656098038691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XG,Glycoprotein Xg,16180,-0.018658486333088,0.0108589331457528,-0.0399419952987634,0.00262502263258742,0.0857680833039632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD5,Sushi domain-containing protein 5,13616,0.0203660338812431,0.0118611441532767,-0.00288180865917919,0.0436138764216654,0.085995014558533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX1,Heme oxygenase 1,15887,-0.0281707420178273,0.0164115659444425,-0.0603374112689346,0.00399592723327988,0.08608685721988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPEP,Aspartyl aminopeptidase,13938,0.0335296118325357,0.0195409188428524,-0.00477058909945496,0.0718298127645264,0.0862086887167417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PQBP1,Polyglutamine-binding protein 1,15725,-0.0338030189870624,0.0197058670084062,-0.0724265183235386,0.00482048034941387,0.0862955869090224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH1,Protocadherin-1,16202,0.0127149772512408,0.00742606542763661,-0.00184011098692693,0.0272700654894086,0.0868772820344471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16112,-0.0285830736155126,0.0166962890876923,-0.0613078002273896,0.0041416529963643,0.0869266724273208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK2,"Adenylate kinase 2, mitochondrial",13938,-0.0626869219403682,0.0366182901446969,-0.134458770623974,0.00908492674323771,0.0869370090675343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAP,Gamma-aminobutyric acid receptor-associated protein,13913,-0.0286240809052936,0.0167210662738679,-0.0613973708020747,0.00414920899148758,0.0869452606507436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IST1,IST1 homolog,13833,-0.0582359480967953,0.0340409423992515,-0.124956195199328,0.00848429900573772,0.0871475149321849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFA,Platelet-derived growth factor subunit A,16254,-0.042017599666142,0.024564207582047,-0.0901634465269542,0.00612824719467016,0.0871886218304216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMA1,Proteasome subunit alpha type-1,15725,0.0268090426918757,0.0156849839926081,-0.0039335259336361,0.0575516113173875,0.0874304930542039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT5,Glutathione hydrolase 5 proenzyme,15918,-0.0137322059318041,0.00804051730986161,-0.0294916198591328,0.00202720799552467,0.0876788829225319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5PO,"ATP synthase subunit O, mitochondrial",15667,0.0248549883712945,0.0145762124393641,-0.00371438800985904,0.0534243647524481,0.0881816927310973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBX2,Chromobox protein homolog 2,13501,-0.0237966795884871,0.013965127141354,-0.051168328785541,0.00357496960856684,0.0884027451027385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK11,Serine/threonine-protein kinase STK11,15821,-0.0423362287636205,0.024849079975005,-0.0910404255146303,0.00636796798738932,0.0884504008592072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIAP1,TP53-regulated inhibitor of apoptosis 1,16195,-0.0368834265522377,0.0216653294993429,-0.0793474723709498,0.00558061926647445,0.0886964214550304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAP,Prosaposin,13851,-0.0164404856981141,0.00965873411826158,-0.0353716045699068,0.00249063317367857,0.0887522103753438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,15821,-0.0207184120106515,0.012172711806572,-0.0445769271515326,0.00314010313022969,0.0887680016644632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,13913,-0.031325352092007,0.0184264114873359,-0.0674411186071855,0.00479041442317144,0.0891486794084799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF1,Signaling lymphocytic activation molecule,15797,-0.034798014404337,0.0204838073268569,-0.0749462767649765,0.00535024795630254,0.0893754548711441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC1A4,Neutral amino acid transporter A,13605,-0.0305577783496253,0.017998835900887,-0.0658354967153638,0.00471994001611317,0.0895751773685833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1GALT1C1,C1GALT1-specific chaperone 1,13501,-0.0188901787663364,0.0111311095764255,-0.0407071535361305,0.00292679600345764,0.0897080858895473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIT2,Slit homolog 2 protein,15667,-0.0299654004731578,0.0176611721231824,-0.0645812978345953,0.00465049688827975,0.0897765979192171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNR,Tenascin-R,15918,0.0244092163401608,0.0143868970684253,-0.00378910191395279,0.0526075345942743,0.0897865294835365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH2,Cadherin-2,16063,-0.020637245456416,0.0121661931026306,-0.044482983937572,0.00320849302474001,0.0898526420394492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC1,Sialoadhesin,16133,-0.0246378449249813,0.0145248074661615,-0.0531064675586578,0.00383077770869512,0.0898560263413232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG4,BAG family molecular chaperone regulator 4,13568,-0.0294541321489273,0.0173665315577049,-0.0634925340020288,0.00458426970417419,0.0899034509367331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC6,Putative tyrosine-protein phosphatase auxilin,13643,-0.0492091174105556,0.0290465279226558,-0.106140312138961,0.00772207731784979,0.0902600097768491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THOP1,Thimet oligopeptidase,15982,-0.018524573818249,0.0109432073222599,-0.0399732601698784,0.0029241125333805,0.0905145731485465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD1,26S proteasome non-ATPase regulatory subunit 1,13946,-0.0291388252509339,0.0172216485154167,-0.0628932563411506,0.00461560583928279,0.0906705947484915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCA,Alpha-synuclein,13703,-0.0672246549791188,0.0397435495046094,-0.145122012008153,0.0106727020499156,0.0907715954073703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13391,-0.0299584679483447,0.0177247594532988,-0.0646989964768104,0.00478206058012098,0.0910121395644927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCLS1,Hematopoietic lineage cell-specific protein,16249,-0.03201148249636,0.0189668980369137,-0.0691866026487108,0.00516363765599087,0.0914774213852549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,15918,-0.0254941182076838,0.0151161127096084,-0.0551216991185163,0.00413346270314868,0.0917090381980869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",13936,-0.0851231934122789,0.0504746713401777,-0.184053549239027,0.0138071624144694,0.0917308620289929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN7,Tetraspanin-7,13528,-0.0552906327679632,0.0327991870778127,-0.119577039440476,0.00899577390454977,0.0918705539304998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC5,Thioredoxin domain-containing protein 5,16208,-0.0390579685901775,0.0231884629388085,-0.0845073559502423,0.00639141876988723,0.0921293116534557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKN3,Serine/threonine-protein kinase N3,13751,-0.0426023887549873,0.0253063384959841,-0.0922028122071162,0.00699803469714164,0.0923074212594228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C8B,Complement component C8 beta chain,14020,-0.0173932902039385,0.0103339478298957,-0.037647827950534,0.00286124754265706,0.0923738520700907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",13643,-0.0150424687112781,0.00894511208479593,-0.0325748883974781,0.00248995097492191,0.092661353627472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLRAP1,Low density lipoprotein receptor adapter protein 1,13946,-0.056453757264742,0.0335846527744115,-0.122279676702588,0.0093721621731045,0.0927971525487424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM24,Transcription intermediary factor 1-alpha,13720,-0.0383145379599354,0.0228154012963329,-0.0830327245007479,0.00640364858087707,0.0931109660914988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPAG1,Sperm-associated antigen 1,13946,-0.0336508007875274,0.0200735590721075,-0.072994976568858,0.00569337499380326,0.093687314105422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBP2,Poly(rC)-binding protein 2,13946,-0.0415000150495261,0.0247560473791714,-0.0900218679127021,0.00702183781364984,0.0936903926683424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,13913,-0.0507675686772339,0.0302980261806284,-0.110151699991266,0.00861656263679766,0.0938377938926612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",13643,-0.0442765727645416,0.0264258168738097,-0.0960711738372086,0.00751802830812547,0.0938582453152028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD48,CD48 antigen,16103,-0.017239835798785,0.0103079042544649,-0.0374433281375361,0.00296365653996616,0.0944477737502155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPD52L2,Tumor protein D54,13703,-0.0621815770266281,0.0372041044440174,-0.135101621736902,0.010738467683646,0.0946727854692377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP2,Methionine aminopeptidase 2,16173,-0.0327111759525977,0.019585469123477,-0.0710986954346127,0.00567634352941725,0.0949039603161712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASS1,Argininosuccinate synthase,13501,-0.0456255014605049,0.027352188631219,-0.0992357911776941,0.00798478825668436,0.0953240574242516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLR,Low-density lipoprotein receptor,16077,-0.0300738136765051,0.0180403604340548,-0.0654329201272525,0.00528529277424226,0.095528026934109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA2,DnaJ homolog subfamily A member 2,16200,-0.0467386477289232,0.0281068907247833,-0.101828153549499,0.00835085809165212,0.0963539587242182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,15642,-0.0330357545483449,0.019876697015092,-0.0719940806979252,0.00592257160123531,0.0965259293735315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRD2,Protein ZNRD2,13936,-0.0399693486884892,0.0240620943056411,-0.0871310535275457,0.00719235615056729,0.0967175184907872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XPNPEP2,Xaa-Pro aminopeptidase 2,16091,0.0561139894676753,0.0337828860679513,-0.0101004672255093,0.12232844616086,0.0967292853811795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP10,Caspase-10,15667,-0.0408368213961477,0.0246089709110852,-0.0890704043818747,0.00739676158957916,0.0970495614734529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES3,Carboxylesterase 3,15973,0.0391617390737062,0.0236112355508685,-0.00711628260599607,0.0854397607534085,0.0972148452191696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",15725,-0.0444284755737795,0.0268275667047456,-0.0970105063150809,0.00815355516752184,0.0977265030961568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCTD5,BTB/POZ domain-containing protein KCTD5,13685,-0.0258334155273927,0.0156018273456127,-0.0564129971247936,0.00474616607000814,0.0977864500258849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL13B,ADP-ribosylation factor-like protein 13B,13501,-0.0397531542973689,0.0240249342254532,-0.0868420253792571,0.00733571678451926,0.0980162754657814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFL7,Epidermal growth factor-like protein 7,15725,-0.0229389868429086,0.0138815795783216,-0.0501468828164189,0.00426890913060179,0.098457392629747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGEA3,Melanoma-associated antigen 3,13751,0.0498289175694955,0.0301646100772026,-0.00929371818182164,0.108951553320813,0.0985778058106829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5E,5'-nucleotidase,16091,-0.0315655199529495,0.019109070677569,-0.0690192984809847,0.00588825857508567,0.0985825112624412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL32,Interleukin-32,16054,-0.024827301205389,0.0150299280846549,-0.0542859602513125,0.00463135784053448,0.0985831536569646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF43,E3 ubiquitin-protein ligase RNF43,13751,-0.0341165492223212,0.0206646998403584,-0.0746193609094236,0.00638626246478118,0.0987700328520405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL8,C-C motif chemokine 8,16170,-0.0344358007986556,0.0208620674372038,-0.075325452975575,0.0064538513782639,0.0988311730896311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLO1,Lactoylglutathione lyase,15821,-0.0332831846440139,0.0201718391138832,-0.072819989307225,0.00625362001919718,0.098966352303486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPACT,Protein IMPACT,13938,-0.0319351758747837,0.0193711465634496,-0.0699026231391449,0.00603227138957755,0.0992531886535783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL11,Eotaxin,16249,-0.0212930490760259,0.0129593257891194,-0.0466933276227,0.00410722947064809,0.100388300511627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASET2,Ribonuclease T2,16174,-0.014846211999742,0.00904102864747401,-0.032566628148791,0.00287420414930711,0.100590140627304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA1,Glutathione S-transferase A1,16041,-0.0478467415562983,0.0291514055831467,-0.104983496499266,0.00929001338666918,0.100750937162415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAEA,E3 ubiquitin-protein transferase MAEA,15725,-0.0219970772814708,0.013425400361681,-0.0483108619903655,0.00431670742742392,0.101344308180621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB27B,Ras-related protein Rab-27B,13965,-0.0460630732970993,0.0281624086017728,-0.101261394156574,0.00913524756237544,0.101941146507899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,13965,-0.0504258907389151,0.0308648882355057,-0.110921071680506,0.0100692902026761,0.10233133601808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEAR1,Platelet endothelial aggregation receptor 1,16254,-0.0127567825987741,0.00781288637603474,-0.0280700398958022,0.002556474698254,0.10253309999823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FARSA,Phenylalanine--tRNA ligase alpha subunit,13605,-0.0392978958229484,0.0240866605147474,-0.0865077504318533,0.00791195878595645,0.102803571730108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",15973,-0.0250756711465822,0.0154005213109296,-0.0552606929160041,0.00510935062283977,0.10349475936746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRRT3,Proline-rich transmembrane protein 3,13643,0.0213836942958667,0.0131392013142758,-0.00436914028011391,0.0471365288718473,0.103659811821394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP2,Latent-transforming growth factor beta-binding protein 2,16254,-0.0175501828431019,0.0107853033900836,-0.0386893774876658,0.00358901180146194,0.103707390542529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,13936,-0.0171267233920843,0.0105353298413625,-0.0377759698811548,0.00352252309698623,0.104047485033907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CERT,Ceramide transfer protein,15667,-0.0337748288675848,0.0207767271658567,-0.0744972141126638,0.00694755637749427,0.104053050242944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPKOW,G-patch domain and KOW motifs-containing protein,15667,-0.0165045768144926,0.0101731331988629,-0.0364439178842638,0.00343476425527867,0.10474448302999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPB1,Signal-regulatory protein beta-1,16014,-0.025434393052295,0.0156893688437596,-0.0561855559860638,0.0053167698814739,0.105011016766239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,13938,-0.0347980146954451,0.0214760635608516,-0.0768910992747142,0.00729506988382403,0.105187005490739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPIND1,Heparin cofactor 2,13994,-0.0158227450435226,0.00977443811344112,-0.0349806437458672,0.00333515365882197,0.105515400436567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR2,GMP reductase 2,13703,-0.0376463455477354,0.0232656820311802,-0.0832470823288486,0.00795439123337779,0.105662740377101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB1,Calbindin,15973,0.0243740857239826,0.015063547057887,-0.005150466509476,0.0538986379574412,0.105664240297856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPM3,Tropomyosin alpha-3 chain,13501,-0.0250807531660864,0.0155038847645682,-0.0554683673046401,0.00530686097246725,0.10574899909931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGCT,Gamma-glutamylcyclotransferase,13948,-0.0271053548596717,0.016758798779475,-0.0599526004674427,0.00574189074809924,0.105818801336343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,13946,-0.0320967360923836,0.019867728258801,-0.0710374834796335,0.00684401129486633,0.106220517446867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH2,Growth hormone variant,15725,-0.0923593917539951,0.0572114120684684,-0.204493759408193,0.0197749759002029,0.106471048709511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNAS,Neuroendocrine secretory protein 55,13946,-0.0485449368251051,0.0300793762495056,-0.107500514274136,0.0104106406239259,0.106572980842888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B1,Aldo-keto reductase family 1 member B1,15725,-0.0414106173865197,0.0256641408484048,-0.0917123334493931,0.00889109867635384,0.106643098218679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16249,-0.0546657871139055,0.0338844638290993,-0.12107933621894,0.0117477619911292,0.106698899830131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,15725,0.0685116658462268,0.0424695555980357,-0.0147286631259232,0.151751994818377,0.106722278792094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS8,Prostasin,15996,-0.0225574275053657,0.0139836496426279,-0.0499653808049164,0.00485052579418511,0.106736278685999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHD3,EH domain-containing protein 3,13643,-0.0649666279835518,0.0403176939088384,-0.143989308044875,0.0140560520777716,0.107122768227636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTNL10,Butyrophilin-like protein 10,13506,0.0215846666873129,0.0134123286650359,-0.00470349749615742,0.0478728308707833,0.107570795217288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3G,Regenerating islet-derived protein 3-gamma,13913,-0.0225848027057288,0.0140508607764253,-0.0501244898275224,0.00495488441606489,0.107997960213548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RB,Interleukin-10 receptor subunit beta,16133,-0.0156765864558637,0.00977058715093949,-0.0348269372717051,0.00347376435997766,0.108630703231443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO4,Roundabout homolog 4,13643,-0.00983250593503501,0.00613131425389164,-0.0218498818726626,0.0021848700025926,0.108813537424918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA3,Protein disulfide-isomerase A3,13703,-0.0139193121045298,0.00868117563211967,-0.0309344163434844,0.00309579213442476,0.108871599663609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM106A,Transmembrane protein 106A,13913,-0.0391692637099706,0.0244377494395819,-0.0870672526115512,0.00872872519161,0.108997573599207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6R,Interleukin-6 receptor subunit alpha,15996,-0.0187085180764655,0.011672428494848,-0.0415864779263676,0.00416944177343659,0.108999530494828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB11FIP3,Rab11 family-interacting protein 3,13965,-0.0593236310322839,0.0370148880145526,-0.131872811540807,0.0132255494762392,0.109024317965789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT8,"Keratin, type II cytoskeletal 8",13528,-0.0405531084399672,0.0253099663128178,-0.0901606424130901,0.00905442553315575,0.109121832104374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF21,Fibroblast growth factor 21,16173,-0.0654049681734871,0.0408269025315973,-0.145425697135418,0.0146157607884436,0.109173691790941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,13501,-0.0367789858703204,0.0229823216794224,-0.0818243363619884,0.0082663646213476,0.109551836491009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP20,Centrosomal protein 20,15725,-0.0413936467502073,0.0258946517991212,-0.0921471642764848,0.00935987077607025,0.109942873424544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIB,Peptidyl-prolyl cis-trans isomerase B,16065,-0.0522828513759098,0.0327146638802069,-0.116403592581115,0.0118378898292957,0.110029885282293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBN2,Fibrillin-2,13605,-0.0330902002531973,0.0207159528102651,-0.0736934677613168,0.00751306725492223,0.110215550848953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPBP,Platelet basic protein,13924,-0.0464814315766596,0.0291664373043256,-0.103647648693138,0.0106847855398184,0.111034566461509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB2,Receptor tyrosine-protein kinase erbB-2,16091,-0.0136016104166198,0.00854203671913696,-0.0303440023861282,0.00314078155288868,0.111333677082717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT2,NAD-dependent protein deacetylase sirtuin-2,15973,-0.0483882328350378,0.0303935746917176,-0.107959639230804,0.0111831735607288,0.111392224285199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCA,Tubulin-specific chaperone A,13703,-0.047104589297887,0.0296006883362461,-0.105121938436929,0.0109127598411555,0.111557462475014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREG1,Protein CREG1,15864,-0.0209317508499456,0.0131559737644719,-0.0467174594283105,0.00485395772841928,0.111619313534664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,15649,-0.0253077556685726,0.015924035000187,-0.0565188642689391,0.00590335293179377,0.112017335813245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMC1,COX assembly mitochondrial protein homolog,13965,-0.0496772993659632,0.0312638719513729,-0.110954488390654,0.0115998896587277,0.112090225123293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRK5,G protein-coupled receptor kinase 5,15821,-0.0284042418059363,0.0178800147080229,-0.0634490706336613,0.00664058702178862,0.112170090914396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG4A,Cysteine protease ATG4A,15725,-0.0329610283609878,0.0207711363111571,-0.0736724555308557,0.00775039880888022,0.112562920722994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4B,Eukaryotic translation initiation factor 4B,15918,-0.0313430501526298,0.0197519033692234,-0.0700567807563077,0.00737068045104806,0.11256945719367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,15918,-0.0215159735030458,0.0135768651082801,-0.0481266291152748,0.00509468210918308,0.113042417450011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VGF,Neurosecretory protein VGF,13946,0.0164775677891717,0.0104013432642734,-0.00390906500880425,0.0368642005871476,0.113176164190309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5,T-cell surface glycoprotein CD5,16170,-0.0183933821544548,0.0116176415956892,-0.0411639596820056,0.00437719537309592,0.113388949147146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F12,Coagulation factor XII,14020,-0.0227703955541104,0.0144661090380475,-0.0511239692686835,0.00558317816046266,0.11549821159601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNLY,Granulysin,16074,-0.028225807205903,0.0179428792189479,-0.0633938504750409,0.00694223606323485,0.115717119541313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2R,Cation-independent mannose-6-phosphate receptor,16074,-0.0126372181005136,0.00804105268344812,-0.0283976813600719,0.00312324515904473,0.116065940520866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR158,Probable G-protein coupled receptor 158,13946,0.0192336406794373,0.0122444389164406,-0.0047654595967862,0.0432327409556609,0.116250378249391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTP4A3,Protein tyrosine phosphatase type IVA 3,13568,-0.0286264821397435,0.0182287925792794,-0.0643549155951311,0.00710195131564409,0.116345600031213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSR1,Macrophage scavenger receptor types I and II,16208,-0.0243861193523267,0.0155295125545131,-0.0548239639591724,0.00605172525451907,0.116362987883519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP6,Dipeptidyl aminopeptidase-like protein 6,15973,0.0179803914989012,0.0114578323822318,-0.00447695997027312,0.0404377429680756,0.116605700893326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX5,"Peroxiredoxin-5, mitochondrial",16249,-0.0362902148997574,0.0231347245575122,-0.0816342750324812,0.00905384523296652,0.116749717032119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6A,Ras-related protein Rab-6A,16054,0.0252654724264293,0.0161141256363531,-0.00631821382082274,0.0568491586736814,0.116922244613418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAST,Gastrin,13938,-0.0698000501076173,0.0445529016803024,-0.15712373740101,0.0175236371857753,0.117212704066403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD86,T-lymphocyte activation antigen CD86,13936,-0.0161130664189658,0.0102881286001079,-0.0362777984751773,0.00405166563724572,0.117329093718665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR1,Folate receptor alpha,16010,0.0151842876308228,0.00969550818062537,-0.00381890840320288,0.0341874836648486,0.117341313027705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIA1,Nucleolysin TIA-1 isoform p40,15633,-0.0656130921375808,0.0419026062816397,-0.147742200449595,0.0165160161744329,0.117404576839224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFRC,Transferrin receptor protein 1,16133,-0.0207055710594484,0.0132247449330431,-0.0466260711282129,0.00521492900931615,0.117445794950493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIT,Citron Rho-interacting kinase,13605,-0.0257885767019726,0.0164753787713605,-0.0580803190938392,0.00650316568989396,0.117540611714963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14020,-0.0140589360406166,0.00898542986151342,-0.0316703785691829,0.00355250648794973,0.117690639779901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCAR2,Cell cycle and apoptosis regulator protein 2,13938,-0.0303398568490124,0.0193935446055354,-0.0683512042758618,0.00767149057783705,0.11773917753259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRDT,Bromodomain testis-specific protein,13501,-0.0198580081783013,0.0127045824915806,-0.0447589898617993,0.00504297350519671,0.118062251018522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBKS,Ribokinase,15649,-0.0274632870870814,0.0175910948262196,-0.0619418329464718,0.00701525877230896,0.118495871847743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS8,Galectin-8,16208,-0.0323990749330559,0.0207587292110695,-0.073086184186752,0.00828803432064019,0.118603559632378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,13751,-0.0271696710408394,0.0174194917611188,-0.0613118748926322,0.0069725328109534,0.118847181419094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THTPA,Thiamine-triphosphatase,13886,-0.0472628539907895,0.0303122211559868,-0.106674807456524,0.0121490994749446,0.118971560307881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDUA,Alpha-L-iduronidase,16195,-0.0247667209541367,0.0158919047902518,-0.0559148543430302,0.00638141243475671,0.119146438105842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD177,CD177 antigen,16046,0.0677868895370677,0.0435048445777562,-0.0174826058353344,0.15305638490947,0.119218435737857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL1,Fc receptor-like protein 1,16063,-0.0241386984169651,0.0154952105755494,-0.0545093111450419,0.00623191431111176,0.119296414585148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAM1,Vascular cell adhesion protein 1,16115,-0.0145404467322334,0.00934435438944271,-0.0328553813355411,0.0037744878710743,0.119711682440921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,13913,-0.036717599792777,0.0236131547708546,-0.0829993831436521,0.00956418355809811,0.119977470171205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUK1,Guanylate kinase,13501,-0.0212249108981572,0.0136632171221255,-0.0480048164575232,0.00555499466120874,0.120342864121073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESM1,Endothelial cell-specific molecule 1,16044,-0.0182948135579651,0.0117808722210449,-0.0413853231112131,0.00479569599528281,0.12046074292232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG1,Adhesion G-protein coupled receptor G1,15973,-0.0368044069707573,0.0237121295369818,-0.0832801808632416,0.00967136692172706,0.120649948012179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPN,Asporin,13965,-0.014553469108266,0.00938617964476545,-0.0329503812120063,0.00384344299547429,0.121039188577152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN1,Prorelaxin H1,13946,-0.0359834840061645,0.0232205337096659,-0.0814957300771096,0.00952876206478067,0.121250493599044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBI,Acyl-CoA-binding protein,16001,-0.0418411412346822,0.0270064796755264,-0.094773841398714,0.0110915589293496,0.121329393837654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCC1,GRIP and coiled-coil domain-containing protein 1,13938,-0.0574503517784117,0.0370981371344615,-0.130162700561956,0.0152619970051328,0.121499487705247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1B,Lithostathine-1-beta,16254,-0.029831716289359,0.0192767327671388,-0.0676141125129511,0.00795067993423317,0.121750056919818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C19orf12,Protein C19orf12,15667,-0.0339100601788132,0.0219363418065337,-0.0769052901196192,0.00908516976199287,0.122163588951179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFAP,Glial fibrillary acidic protein,15704,-0.0245546496836948,0.0158967927197183,-0.0557123634143426,0.00660306404695299,0.122456155130169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGN,Cingulin,13605,-0.0212781984649796,0.0137769801891949,-0.0482810796358015,0.0057246827058424,0.122496638603682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPN1,Epsin-1,13751,-0.0224150935306071,0.0145224242065168,-0.05087904497538,0.00604885791416588,0.122737020271234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMFG,Glia maturation factor gamma,13965,-0.0381580027590646,0.0247677822580789,-0.0867028559848993,0.01038685046677,0.123429400976053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL24,C-C motif chemokine 24,16103,-0.0439055052488548,0.0285186368217268,-0.0998020334194393,0.0119910229217297,0.123692843903031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,13965,-0.0182422410705991,0.0118620924299376,-0.0414919422332768,0.00500746009207861,0.12410545365259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRL,Chymotrypsin-like protease CTRL-1,13938,0.0357354855624491,0.0232482085067233,-0.00983100311072848,0.0813019742356267,0.124284549370422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16091,-0.0505238254983569,0.0328948917549033,-0.114997813337967,0.0139501623412537,0.124578401553835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT,Linker for activation of T-cells family member 1,16249,-0.0400226953834452,0.0260657688065953,-0.091111602244372,0.0110662114774816,0.124692716269713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFASC,Neurofascin,16249,-0.0148972173086641,0.00970393425924585,-0.033916928456786,0.00412249383945772,0.124760839435952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB2,Carboxypeptidase B2,13994,-0.0120735261893382,0.00787580308416704,-0.0275101002343056,0.00336304785562916,0.125300983990939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST1,Cystatin-SN,12138,0.0548108097963947,0.0357656767614026,-0.0152899166559544,0.124911536248744,0.125425808737291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,13983,0.0135943397629331,0.00887871473634872,-0.00380794112031036,0.0309966206461766,0.125763438251857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,13946,-0.0526011658285015,0.0343634661734143,-0.119953559528393,0.0147512278713905,0.125859004115059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH17,Protocadherin-17,16063,0.0188437578726735,0.0123113119366912,-0.00528641352324128,0.0429739292685882,0.125886709089473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,15918,-0.0496890983215405,0.032470919675097,-0.113332100884731,0.0139539042416496,0.125971140168848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP15,Matrix metalloproteinase-15,13965,-0.0263188399837975,0.0172141859856409,-0.0600586445156536,0.00742096454805856,0.126310884921133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPRC5C,G-protein coupled receptor family C group 5 member C,13913,-0.0297423145966992,0.0194598712494498,-0.0678836622456208,0.00839903305222242,0.126437956976753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEO1,RNA polymerase-associated protein LEO1,13946,-0.0166692010830804,0.0109067624465853,-0.0380464554783876,0.00470805331222674,0.126451760981094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN3,Centrin-3,13936,-0.0411480676056802,0.0269306950813769,-0.0939322299651789,0.0116360947538185,0.126554013642908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",13946,-0.0422477470038193,0.0276850671658577,-0.0965104786489004,0.0120149846412617,0.127029555201571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,15821,-0.0141420042477695,0.00926969621494006,-0.032310608829052,0.00402660033351306,0.127125333312937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1S,Complement C1s subcomponent,14020,-0.0111581287800985,0.00731979833134181,-0.0255049335095284,0.00318867594933149,0.127437257646682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCOF1,Treacle protein,13965,-0.0169977508801872,0.0111771505738883,-0.0389049660050082,0.00490946424463387,0.128343022124272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16074,-0.0151570769052733,0.0099691969444485,-0.0346967029163924,0.00438254910584576,0.128432431714427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRB3,Adhesion G protein-coupled receptor B3,15888,0.0174993939457858,0.0115134988345703,-0.00506706376997192,0.0400658516615436,0.128555436046015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,15725,-0.0230014060152676,0.0151608583146195,-0.0527166883119219,0.00671387628138663,0.129247108232606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLA2,Src-like-adapter 2,13946,-0.0546481742050231,0.0360411301298939,-0.125288789259615,0.0159924408495689,0.129473152018694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTNB,Dystrobrevin beta,13887,-0.0231448802868707,0.0152714630296866,-0.0530769478250564,0.00678718725131495,0.129652407572768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSBPL2,Oxysterol-binding protein-related protein 2,13938,-0.021036343294268,0.0138903747963444,-0.0482614778951031,0.00618879130656709,0.129933254838712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN4,CCN family member 4,16195,-0.0208418496565186,0.013762285931545,-0.0478159300823468,0.00613223076930947,0.129939460368473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A1,Collagen alpha-1(IX) chain,16054,-0.0242429542572482,0.0160147969607095,-0.0556319563002389,0.0071460477857425,0.130100162959383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTS,6-pyruvoyl tetrahydrobiopterin synthase,15589,-0.028949602399372,0.0191317299798559,-0.0664477931598896,0.00854858836114561,0.130256208103727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD109,CD109 antigen,16074,0.0172350030767951,0.0113909708734743,-0.00509129983521461,0.0395613059888047,0.130288986483919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA1,Alpha-1-antitrypsin,13767,-0.00442836527303793,0.00292715100867921,-0.0101655812500492,0.00130885070397332,0.130338584224011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOT13,Acyl-coenzyme A thioesterase 13,13936,-0.0590311403895469,0.0390449407210679,-0.13555922420284,0.0174969434237463,0.130587902180083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNDC1,Fibronectin type III domain-containing protein 1,13938,-0.0243638113156331,0.0161189707176496,-0.0559569939222263,0.00722937129096005,0.130684006329827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB1,Interleukin-12 receptor subunit beta-1,15797,-0.0194569427778987,0.012880602960997,-0.0447029245814529,0.00578903902565545,0.13092023158527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,13908,-0.0423269936504916,0.0280327100245145,-0.09727110529854,0.0126171179975568,0.131087997662537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK6,SLIT and NTRK-like protein 6,15821,0.0178863730019945,0.0118584735925526,-0.0053562352394087,0.0411289812433977,0.13149263007092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKG1,cGMP-dependent protein kinase 1,13703,-0.0654394029341645,0.0434064379050138,-0.150516021227991,0.0196372153596625,0.131680852093677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILP,Rab-interacting lysosomal protein,16148,-0.0312416133040408,0.0207274332562917,-0.0718673824863725,0.00938415587829104,0.131763824541237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SF3B4,Splicing factor 3B subunit 4,15973,-0.0384182515423714,0.0254931306381551,-0.0883847875931555,0.0115482845084126,0.131829408106183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTF1,Cardiotrophin-1,15821,-0.0435879050900267,0.0289484408721822,-0.100326849199504,0.0131510390194503,0.132162076984874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC1,WAP four-disulfide core domain protein 1,13619,-0.0285475322742449,0.0189757043993594,-0.0657399128969893,0.00864484834849951,0.132495073361689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRD1,Adhesion G-protein coupled receptor D1,13703,-0.0203244654497031,0.0135131783615278,-0.0468102950382975,0.00616136413889124,0.132592143467366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,13936,0.0423432741109811,0.0281905327914821,-0.0129101701603239,0.0975967183822861,0.133109768107477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTD1,D-aminoacyl-tRNA deacylase 1,13703,-0.0451774537983057,0.0301195278855744,-0.104211728454031,0.0138568208574201,0.133653272550582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOG,Myelin-oligodendrocyte glycoprotein,16195,0.0168269369525903,0.011229352677947,-0.00518259429618586,0.0388364682013664,0.134028634746326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI5,Ecotropic viral integration site 5 protein homolog,13568,-0.0467471235215765,0.0312090998746141,-0.10791695927582,0.0144227122326671,0.134190740379013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR2,Asialoglycoprotein receptor 2,13988,-0.0135143779554179,0.00902521948059956,-0.0312038081373931,0.00417505222655719,0.134311382287986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIF,Macrophage migration inhibitory factor,16045,-0.0348100707200261,0.0232576276099261,-0.0803950208354812,0.0107748793954291,0.134486775720984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNW1,Interferon omega-1,13501,-0.0186732129240034,0.0124775113423242,-0.0431291351549588,0.00578270930695199,0.134533927668737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A16,Protein S100-A16,15645,0.0314445227302993,0.0210213649844115,-0.00975735263914724,0.0726463980997459,0.134716484501904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1L,Allograft inflammatory factor 1-like,13643,-0.02963855924106,0.019825355471751,-0.0684962559656919,0.00921913748357187,0.134942165136664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH1,Neurogenic locus notch homolog protein 1,16254,-0.00814735735991132,0.00545163129154061,-0.0188325546913309,0.00253783997150827,0.135069470573557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPE4,NXPE family member 4,13501,-0.0174721685218185,0.0117042305846384,-0.0404124604677097,0.00546812342407279,0.135510855615446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",13913,-0.0189122370892611,0.012676827370641,-0.0437588187357174,0.00593434455719522,0.135754711420358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAP1L4,Nucleosome assembly protein 1-like 4,13910,-0.021261099007697,0.0142585248894869,-0.0492078077910913,0.00668560977569728,0.135954028089857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16024,-0.0341906233289151,0.0229336536354906,-0.0791405844544767,0.0107593377966465,0.136020744670324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUCB2,Nucleobindin-2,16168,-0.0190281615517331,0.0127680006906915,-0.0440534429054885,0.00599711980202228,0.136164688440824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUP50,Nuclear pore complex protein Nup50,13501,-0.0169075339755456,0.0113464776456295,-0.0391466301609795,0.0053315622098882,0.136217908145525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOF,Apolipoprotein F,13988,0.0129259987011299,0.0086804240216853,-0.00408763238137332,0.029939629783633,0.13648423318082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSTB,Cystatin-B,15824,-0.0222602175003569,0.014951655439643,-0.0515654621620571,0.0070450271613434,0.136556590243055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM1,Probable carboxypeptidase X1,16091,-0.0351146453071282,0.023593308204523,-0.0813575293879934,0.0111282387737369,0.136683311802408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN1,Transcobalamin-1,13709,-0.0172345028518511,0.0115948273237442,-0.0399603644063897,0.00549135870268755,0.137197475259395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40,Tumor necrosis factor receptor superfamily member 5,16054,-0.0254574953122318,0.0171415202883093,-0.0590548750773182,0.00813988445285449,0.137527353765789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHPK,Sedoheptulokinase,13751,-0.0208472213631277,0.0140527830924017,-0.048390676224235,0.00669623349797949,0.137966114364455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRK1,NKG2-D type II integral membrane protein,13938,-0.0236098499714522,0.0159340772087065,-0.054840641300517,0.00762094135761264,0.138437290488105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16074,-0.0235522353869077,0.0159163712333412,-0.0547483230042566,0.00764385223044113,0.138959842106125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11R,Junctional adhesion molecule A,16074,-0.0285201784640521,0.0192750173283333,-0.0662992124275853,0.00925885549948119,0.138987688165839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA6C,Semaphorin-6C,13568,0.0137095858595976,0.00926685870496692,-0.00445345720213759,0.0318726289213328,0.13905105724218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL3,Myosin light chain 3,13643,-0.0375686600121502,0.0253998101816401,-0.0873522879681648,0.0122149679438643,0.139138797749374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF174,Zinc finger protein 174,13568,0.0193254138516677,0.0130722469749424,-0.00629619021921946,0.0449470179225548,0.139336180806176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAMBP,STAM-binding protein,15900,-0.0325094864559393,0.0220097286215461,-0.0756485545541697,0.0106295816422911,0.139681853231799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK1,Adenylate kinase isoenzyme 1,16063,-0.0324586702788176,0.0219800013948649,-0.0755394730127528,0.0106221324551177,0.1397659053739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",15973,-0.0353201182505854,0.0239328882636427,-0.0822285792473251,0.0115883427461543,0.140017748892688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG16L1,Autophagy-related protein 16-1,13936,-0.0433740776278948,0.0293904711991939,-0.100979401178315,0.0142312459225252,0.14002367616469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16208,-0.0360495886940732,0.0244472425431346,-0.083966184078617,0.0118670066904707,0.140343022425634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC12A,C-type lectin domain family 12 member A,13568,-0.0104223496670473,0.00706794353689648,-0.0242755189993644,0.00343081966526983,0.140344858391921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPY,Pancreatic prohormone,16027,-0.0515784734214132,0.0349921480591731,-0.120163083617392,0.017006136774566,0.140500885897042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TWF2,Twinfilin-2,13983,-0.0427334820220797,0.028997177199362,-0.0995679493328291,0.0141009852886698,0.140581739344787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFD,Complement factor D,14020,-0.00990490318028718,0.00672231620509377,-0.023080642942271,0.00327083658169662,0.140655962758624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XRCC4,DNA repair protein XRCC4,15667,-0.0186854762035222,0.0126836793046587,-0.0435454876406533,0.0061745352336089,0.140719776274463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPART,Spartin,13703,-0.0393192417681803,0.0266907803143962,-0.0916331711843969,0.0129946876480363,0.140736426896131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN1,Pantetheinase,13988,-0.0370448062616467,0.025165321011078,-0.0863688354433596,0.0122792229200663,0.141027798869182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX18,Sorting nexin-18,13936,-0.0224648507415407,0.0152736526164424,-0.0524012098697678,0.00747150838668641,0.14136139307625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBH,Dopamine beta-hydroxylase,13965,0.0547923529683,0.0372556357339455,-0.0182286930702331,0.127813399006833,0.141391264540908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2,Complement C2,16115,-0.0116539558749211,0.00794168572428841,-0.0272196598945264,0.00391174814468415,0.142275638858283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,15918,-0.0377965450592473,0.0257610246379531,-0.0882881533496352,0.0126950632311407,0.14234175044049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXJ3,Forkhead box protein J3,13568,-0.0231540490464352,0.0157821603731189,-0.0540870833777482,0.00777898528487773,0.142371339589405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AARSD1,Alanyl-tRNA editing protein Aarsd1,15973,-0.0285578542642217,0.0194719901240667,-0.0667229549073924,0.00960724637894899,0.142501339299556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP47,Ubiquitin carboxyl-terminal hydrolase 47,13501,0.0433511351450729,0.029591933043276,-0.014649053619748,0.101351323909894,0.142953878582146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A5,Zinc transporter ZIP5,16054,-0.02632616104647,0.0179963466880458,-0.0615990005550397,0.00894667846209972,0.14352489937841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRAS,GTPase Hras,13732,-0.0502527319141312,0.034390567335286,-0.117658243891292,0.0171527800630293,0.143973615828158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRC,Chymotrypsin-C,16050,0.0318115764529913,0.0217790941578122,-0.0108754480963206,0.0744986010023032,0.144131832811695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP3,Stromelysin-1,16074,-0.0243216373267518,0.0166675688524879,-0.0569900722776282,0.00834679762412448,0.144524330012477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDT,D-dopachrome decarboxylase,13983,-0.021080193536078,0.0144492463575525,-0.0494007163968809,0.00724032932472495,0.144611535489686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPLA2,Acyl-protein thioesterase 2,13528,-0.0543381240773521,0.0373983874382039,-0.127638963456232,0.0189627153015275,0.146259838109471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTA2,"Actin, aortic smooth muscle",15821,0.0216936595029969,0.0149356422054637,-0.00758019921971193,0.0509675182257058,0.146389190295173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,13703,-0.0320658720724617,0.022083006213673,-0.0753485642512607,0.0112168201063373,0.146507563282006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,13703,-0.0293792967607941,0.0202579448791208,-0.0690848687238708,0.0103262752022827,0.147008807856976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YWHAQ,14-3-3 protein theta,13703,-0.0368687049407743,0.0254299048997614,-0.0867113185443066,0.012973908662758,0.147132505346697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFYA,Nuclear transcription factor Y subunit alpha,13501,-0.0200383052559675,0.0138228753903694,-0.0471311410210916,0.00705453050915653,0.14717992316212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2A,Sodium channel protein type 2 subunit alpha,13528,0.024981613099179,0.0172359149807273,-0.00880078026304659,0.0587640064614045,0.147251089877702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMNL1,Formin-like protein 1,15667,-0.0320044657841171,0.0220921731358048,-0.0753051251302945,0.0112961935620604,0.147447297724591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPR,Nucleoprotein TPR,13501,-0.0256288363855757,0.0177058982013878,-0.0603323968602959,0.00907472408914449,0.147787312516895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX39A,ATP-dependent RNA helicase DDX39A,13568,0.0116158201983627,0.00802584840998932,-0.00411484268521635,0.0273464830819418,0.147835704846213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSHB,Thyrotropin subunit beta,16063,-0.0383846587524737,0.0265347262139292,-0.090392722131775,0.0136234046268276,0.148033544866055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN3,CCN family member 3,16231,-0.0166159995833676,0.0114994955191271,-0.0391550108008567,0.00592301163412146,0.148496051163049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB1,Scavenger receptor class B member 1,15667,-0.0285413372209259,0.019756237768115,-0.0672635632464313,0.0101808888045795,0.148569291173905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16138,-0.0212304089868518,0.0146969444273392,-0.0500364200644366,0.00757560209073299,0.148604944542758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD2,Mothers against decapentaplegic homolog 2,13913,-0.0346985592644922,0.0240281248250826,-0.0817936839216542,0.0123965653926697,0.148738723416816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBR,Delta(14)-sterol reductase LBR,16208,-0.0340847678472329,0.0236410032853765,-0.0804211342865709,0.0122515985921052,0.149388055971843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1A,5-hydroxytryptamine receptor 1A,13528,-0.0375843853050846,0.026093509521718,-0.0887276639676519,0.0135588933574826,0.149785078312893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16195,0.0128010621268539,0.00889270703530819,-0.00462864366235019,0.0302307679160579,0.150027925088174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL19,C-C motif chemokine 19,16208,-0.0603837563924314,0.0419776247022331,-0.142659900808808,0.0218923880239455,0.150318700459419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16254,-0.0113615464110992,0.0079087944561124,-0.0268627835450795,0.00413969072288115,0.150859132704655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL5A1,Collagen alpha-1(V) chain,13703,-0.019687396524511,0.0137058280368632,-0.046550819476763,0.00717602642774094,0.150904244411928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP1,"Fatty acid-binding protein, liver",16044,-0.046347572989501,0.0322713718060099,-0.10959946172928,0.0169043157502784,0.150969988388343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEP1,Rab GTPase-binding effector protein 1,13703,-0.0385540325784002,0.0268478831915018,-0.0911758836337437,0.0140678184769432,0.151020185999346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT5,"Keratin, type II cytoskeletal 5",15667,-0.0244854610495929,0.0170560521877998,-0.0579153233376804,0.00894440123849467,0.15113963991405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE1,Plasminogen activator inhibitor 1,16254,-0.0328549637686348,0.0228863638816255,-0.0777122369766207,0.0120023094393512,0.151144165475265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD6B,Deubiquitinase OTUD6B,13936,-0.0290150834058766,0.0202458719066029,-0.0686969923428183,0.0106668255310651,0.151841493463956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMI,N-myc-interactor,13854,-0.0351235363327504,0.0245317992037915,-0.0832058627721816,0.0129587901066809,0.152236413114596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC12,WAP four-disulfide core domain protein 12,16166,-0.0313831678106219,0.0219343689343573,-0.0743745309219623,0.0116081953007185,0.15251378009049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELN,Elastin,13965,-0.0171347480601713,0.0119800140367252,-0.0406155755721528,0.00634607945181013,0.152659700548817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC1,Amiloride-sensitive amine oxidase [copper-containing],15797,0.0284759155451167,0.01991340082914,-0.0105543500799976,0.067506181170231,0.152740382959643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL7,Angiopoietin-related protein 7,16195,0.0180915845886742,0.012656071239492,-0.0067143150407301,0.0428974842180784,0.152885991004906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2,T-cell surface antigen CD2,13501,-0.0189837721082939,0.013285562065033,-0.0450234737557585,0.00705592953917063,0.153055433946998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAGR1,PAXIP1-associated glutamate-rich protein 1,13643,-0.0218767048413701,0.0153177938911071,-0.0518995808679399,0.0081461711851998,0.153260378356595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK1,Serine protease inhibitor Kazal-type 1,16074,-0.0206934822941815,0.0144920901196174,-0.0490979789286316,0.00771101434026866,0.153335583025598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B2M,Beta-2-microglobulin,14020,-0.0162582509173307,0.011397163109367,-0.03859669061169,0.0060801887770287,0.153741352042191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18BP,Interleukin-18-binding protein,16138,-0.0150053317248048,0.0105191620407531,-0.035622889324681,0.00561222587507134,0.153750364183992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BID,BH3-interacting domain death agonist,16054,-0.0328945289091274,0.0230639237895754,-0.0780998195366952,0.0123107617184404,0.153820562908515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STIP1,Stress-induced-phosphoprotein 1,16045,-0.0318817864397724,0.0223672579539204,-0.0757216120294564,0.0119580391499116,0.154067574983574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDAN1,Codanin-1,13938,0.0114138923524555,0.00801033516535247,-0.00428636457163529,0.0271141492765464,0.154209757960938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPHOSPH8,M-phase phosphoprotein 8,15821,-0.0371011040065571,0.0260873368984406,-0.0882322843275007,0.0140300763143865,0.154991340371538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6AP2,Renin receptor,15725,-0.019111837588682,0.0134437039567936,-0.0454614973439975,0.00723782216663343,0.155156462952208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POF1B,Protein POF1B,13568,-0.0228347893132213,0.0160699283672244,-0.054331848912981,0.00866227028653842,0.1553502372386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13506,-0.0288719186440811,0.0203213401482199,-0.0687017453345922,0.01095790804643,0.15540719950133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,15918,-0.0382711711212321,0.0269792837408367,-0.0911505672532721,0.0146082250108079,0.156053002336791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD1,Superoxide dismutase [Cu-Zn],15724,-0.024018353604097,0.0169327145112714,-0.0572064740461889,0.00916976683799493,0.156076769804719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRH,Receptor-type tyrosine-protein phosphatase H,13936,-0.0238698751374141,0.0168310941854009,-0.0568588197407999,0.00911906946597175,0.156154463648087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD8,Frizzled-8,13528,-0.0211544202539924,0.0149178050876299,-0.050393318225747,0.00808447771776226,0.15619478803129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP5,Fatty acid-binding protein 5,16156,-0.0335082179851238,0.0236310212263236,-0.079825019588718,0.0128085836184704,0.156217112099768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNA4,Plexin-A4,16054,-0.0395015254449853,0.0278657661083177,-0.0941184270172879,0.0151153761273173,0.156337326535576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG2,"Arginase-2, mitochondrial",13913,-0.0208075177186063,0.0146990537334297,-0.0496176630361285,0.00800262759891589,0.156924280239544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBXN1,UBX domain-containing protein 1,13703,-0.0337922710362589,0.0239004165879928,-0.0806370875487249,0.013052545476207,0.157420494050611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB8,Serpin B8,16249,-0.0285917243687434,0.0202227339019427,-0.0682282828165512,0.0110448340790644,0.15742785336077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YTHDF3,YTH domain-containing family protein 3,15797,-0.0412632070193966,0.0291978792302534,-0.0984910503106932,0.0159646362719,0.157608955084667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC3,PDZ domain-containing protein GIPC3,13936,-0.0478333031124168,0.033865459315733,-0.114209603371253,0.0185429971464199,0.157839550826776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPP,"Alkaline phosphatase, placental type",15973,-0.0507698284939557,0.0359796834136152,-0.121290007984641,0.01975035099673,0.158243659617509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESYT2,Extended synaptotagmin-2,13938,-0.0399880726580506,0.0284221678600403,-0.0956955216637297,0.0157193763476284,0.159469714684486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROK1,Prokineticin-1,16054,-0.029625983984444,0.021068335661737,-0.0709199218814485,0.0116679539125606,0.159688478520192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRIB,Protein scribble homolog,13643,-0.0441330632628001,0.0314025868817673,-0.105682133551064,0.0174160070254639,0.159926413128105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT19,"Keratin, type I cytoskeletal 19",16024,-0.0322601398103094,0.0229810348407924,-0.0773029680982624,0.0127826884776437,0.160406065282244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAO1,Hydroxyacid oxidase 1,16195,-0.0616177027950318,0.0438978010287034,-0.14765739281129,0.0244219872212269,0.160438526414361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGES2,Prostaglandin E synthase 2,13470,-0.0267192558026061,0.0190465285403211,-0.0640504517416355,0.0106119401364233,0.160687256863097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5IF1,"ATPase inhibitor, mitochondrial",16133,-0.0531890824597585,0.0379228590397884,-0.127517886177744,0.0211397212582268,0.160767367147604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAP,Prolyl endopeptidase FAP,16254,-0.0130963698126563,0.00933866220501237,-0.0314001477344806,0.0052074081091679,0.160820383046982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JPT2,Jupiter microtubule associated homolog 2,13936,-0.0421884653469311,0.0300919142837954,-0.10116861734317,0.0167916866493078,0.160941495917821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG2,Adhesion G-protein coupled receptor G2,16063,0.0131000512307989,0.00934977952621399,-0.00522551664058049,0.0314256191021784,0.161201104630179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLN,Promotilin,16054,-0.0424969303993301,0.030337974435202,-0.101959360292326,0.0169654994936659,0.161298204803936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORBS1,Sorbin and SH3 domain-containing protein 1,13946,-0.0186415995060566,0.0133080337161637,-0.0447253455897375,0.00744214657762423,0.161302771594659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRN,Progranulin,15996,-0.0117406523344797,0.00838534993257546,-0.0281759382023276,0.00469463353336818,0.161491222160405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPY,Pro-neuropeptide Y,16195,-0.0314342015078421,0.0224625621039707,-0.0754608232316247,0.0125924202159404,0.161711007615567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA1,Annexin A1,13630,-0.0219846003021051,0.0157122608243127,-0.0527806315177579,0.00881143091354778,0.161775701475896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK6,Serine protease inhibitor Kazal-type 6,16195,-0.0256334896016693,0.0183215528699851,-0.0615437332268402,0.0102767540235016,0.16180535721041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR1,Toll-like receptor 1,13568,-0.0128416966212341,0.00917877026580355,-0.030832086342209,0.00514869309974089,0.161816361922103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN8,Tetraspanin-8,13936,0.0485139238368649,0.034727569849513,-0.0195521130681806,0.11657996074191,0.162440090729846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA2,Ephrin type-A receptor 2,15472,-0.0150139333753732,0.0107535626994989,-0.036090916266391,0.00606304951564458,0.162679669213196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11,Coagulation factor XI,13809,0.014429705264488,0.0103411620857603,-0.00583897242360222,0.0346983829525782,0.162927980475344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FURIN,Furin,16091,-0.0161338928329355,0.0115636449986947,-0.0387986370303772,0.00653085136450613,0.162967109947688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN2,Neuroligin-2,13528,-0.0228911375720544,0.0164098198590523,-0.055054384495797,0.00927210935168818,0.163049077044473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171A2,Protein FAM171A2,13946,-0.0771626807101666,0.0553268912866631,-0.185603387632026,0.0312780262116931,0.163138019202221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC6,Sialic acid-binding Ig-like lectin 6,16195,-0.0159778819199946,0.0114595250089446,-0.0384385509375261,0.00648278709753687,0.163249698826289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTUS1,Microtubule-associated tumor suppressor 1,13751,-0.0270574869279554,0.0194135406891561,-0.0651080266787015,0.0109930528227906,0.163417764687855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN4B,Sodium channel subunit beta-4,13643,0.0205779310384541,0.0147807257799288,-0.00839229149020634,0.0495481535671146,0.163880367334244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL15A1,Collagen alpha-1(XV) chain,13983,-0.0125188659277162,0.009000983039011,-0.0301607926841778,0.00512306082874534,0.164298170817129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAAA,N-acylethanolamine-hydrolyzing acid amidase,15836,0.0283342467003988,0.0203921463479067,-0.0116343601414983,0.0683028535422959,0.164709859751265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",13568,0.0296959003162977,0.0213799807389885,-0.0122088619321197,0.0716006625647152,0.164868270754061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP2,Metalloproteinase inhibitor 2,13965,-0.0123540174565321,0.00889448652993372,-0.0297872110552021,0.00507917614213804,0.164869428528026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16133,0.0199796045134089,0.0143856675570143,-0.00821630389833901,0.0481755129251568,0.164896073198018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR1,TGF-beta receptor type-1,13568,-0.0106992332366462,0.00771534759616775,-0.025821314525135,0.00442284805184263,0.165541804567264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLB1,Beta-galactosidase,15918,-0.0199581489176664,0.0144110644970183,-0.0482038353318223,0.0082875374964894,0.166096834982325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO3,R-spondin-3,16195,-0.0131331424451469,0.00949117235234036,-0.031735840255734,0.00546955536544019,0.166462731445359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAS,Tumor necrosis factor receptor superfamily member 6,16203,-0.0158267593722396,0.0114431789410271,-0.0382553900966527,0.00660187135217353,0.16666135548279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BB,Platelet glycoprotein Ib beta chain,13501,-0.0323567699922457,0.0233958364466051,-0.0782126094275916,0.0134990694431003,0.166683459709693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAP1A,Ras-related protein Rap-1A,13568,-0.0329424214450447,0.0238379615645814,-0.0796648261116243,0.0137799832215348,0.167015619424176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDAP1,28 kDa heat- and acid-stable phosphoprotein,13965,-0.0463783526603485,0.0335634750390729,-0.112162763736931,0.0194060584162344,0.167052107472636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT5,ADP-sugar pyrophosphatase,16074,-0.0244241847112225,0.0176788068079174,-0.0590746460547405,0.0102262766322955,0.167128627296457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTPBP2,GTP-binding protein 2,13605,-0.0383699761046469,0.0278196348236172,-0.0928964603589365,0.0161565081496427,0.167843209118636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16071,-0.0107486568956886,0.00779475308762863,-0.0260263729474407,0.00452905915606351,0.167926129551333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,13605,-0.0258522310308338,0.018760051677368,-0.0626219323184751,0.0109174702568074,0.168211495427114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,13643,-0.0365375544073832,0.0265217304702055,-0.0885201461289859,0.0154450373142195,0.168335249185056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYMP,Thymidine phosphorylase,15960,-0.0316282942685978,0.0229723893277544,-0.0766541773509964,0.0133975888138007,0.168594649656022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH12,Protocadherin-12,13946,-0.0119940566962166,0.0087288039418205,-0.0291025124221848,0.0051143990297516,0.169439600646831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACYBP,Calcyclin-binding protein,13677,-0.0485837629496786,0.0353843660495375,-0.117937120406772,0.020769594507415,0.169765844751397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD1,Polycystin-1,13965,-0.0124678202915429,0.00909348327007851,-0.0302910475008967,0.00535540691781102,0.170374566854482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS2,"Nitric oxide synthase, inducible",13501,-0.0188312121477979,0.0137425710872074,-0.0457666514787245,0.00810422718312862,0.17062137124384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC44A4,Choline transporter-like protein 4,13605,-0.0328224629728423,0.0239546020821877,-0.0797734830539302,0.0141285571082455,0.170648840710907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QL2,Complement C1q-like protein 2,13568,-0.0208481961824757,0.0152157160144184,-0.0506709995707358,0.0089746072057845,0.170654923124241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD84,SLAM family member 5,16054,-0.0147393847503091,0.0107611123915439,-0.0358311650377351,0.00635239553711696,0.170802960642946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",15973,-0.0163568985029123,0.0119487370495957,-0.0397764231201198,0.00706262611429529,0.171042676386108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPB1,Beta-ureidopropionase,13965,-0.0434289943251317,0.0317279264439739,-0.10561573015532,0.0187577415050571,0.171085725665008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MET,Hepatocyte growth factor receptor,16073,0.00925697538626111,0.00676976639176275,-0.00401176674159388,0.0225257175141161,0.171519246724726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,15973,0.0178228585628516,0.0130404261684704,-0.00773637672735037,0.0433820938530536,0.171726393099697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A11,Protein S100-A11,15929,-0.022739436941113,0.0166407349414087,-0.0553552774262741,0.00987640354404806,0.171803786310919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSO,Cathepsin O,16249,-0.0145214843993755,0.0106337810816936,-0.0353636953194949,0.00632072652074402,0.172083673670429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKA,Diacylglycerol kinase alpha,13568,-0.0257288283339056,0.0188633526824779,-0.0627009995915624,0.0112433429237511,0.172603308178222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOB,Apolipoprotein B-100,13988,-0.0106794935759396,0.00784194640153238,-0.026049708522943,0.00469072137106392,0.173269642394308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD8A,T-cell surface glycoprotein CD8 alpha chain,16208,-0.0233013260124791,0.0171116124747084,-0.0568400864629076,0.0102374344379494,0.173303345357938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPA,Inosine triphosphate pyrophosphatase,13501,-0.0319823971420561,0.0234975031979551,-0.0780375034100482,0.014072709125936,0.173505562550948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB37,Ras-related protein Rab-37,15797,-0.0386449292436567,0.0284285140198309,-0.0943648167225253,0.0170749582352119,0.174048123937334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF2,Cyclic AMP-dependent transcription factor ATF-2,15667,-0.0317327352829349,0.0233649564173612,-0.0775280498609629,0.014062579295093,0.174440830414193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL4,Angiopoietin-related protein 4,16103,-0.0208637454628191,0.0153764554053844,-0.0510015980573726,0.00927410713173433,0.174843738909834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1F,Protein phosphatase 1F,13965,-0.0246826945369009,0.0182031546633041,-0.0603608776769769,0.0109954886031751,0.175134804458966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD3,Mothers against decapentaplegic homolog 3,13913,-0.0238838182846145,0.0176154820022523,-0.058410163009029,0.0106425264397999,0.175171329373605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,13501,-0.0189931280122938,0.0140084209054669,-0.0464496329870089,0.00846337696242122,0.175173904073005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",13965,-0.0344173225085924,0.0254051376582003,-0.0842113923186649,0.0153767473014801,0.17552276907075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,13965,-0.0288136432658033,0.0212730197535111,-0.0705087619826852,0.0128814754510785,0.175608770547006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIP,Pancreatic triacylglycerol lipase,13988,0.02912245421297,0.0215055246168992,-0.0130283740361524,0.0712732824620925,0.175699329573798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL1,Kin of IRRE-like protein 1,13528,-0.0274370118835383,0.0202714533903351,-0.0671690605285951,0.0122950367615185,0.175924891417139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARK7,Parkinson disease protein 7,16074,-0.0243745675823013,0.0180272032234508,-0.0597078859002649,0.0109587507356623,0.176362613569509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPB,CCAAT/enhancer-binding protein beta,15821,-0.0178876780915865,0.0132442897331012,-0.0438464859684648,0.00807112978529183,0.176844378030139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB6,DnaJ homolog subfamily B member 6,13580,-0.0393255266210023,0.0291277719281257,-0.0964159596001288,0.0177649063581241,0.177005092273549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GART,Trifunctional purine biosynthetic protein adenosine-3,13946,0.0123337762491916,0.00913703803488048,-0.00557481829917415,0.0302423707975573,0.177080926138191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA5,Protein disulfide-isomerase A5,13506,0.0288902969470897,0.0214178276846716,-0.0130886453148667,0.0708692392090461,0.177394888611306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF21,Immunoglobulin superfamily member 21,13643,-0.0185922864061263,0.0137965078724143,-0.0456334418360583,0.0084488690238057,0.177806849630285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC2,MAM domain-containing protein 2,13965,-0.0162271378506979,0.0120561834689526,-0.039857257449845,0.00740298174844927,0.178337364205044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL3,Follistatin-related protein 3,16021,-0.014310260715346,0.0106342652907263,-0.0351534206851695,0.00653289925447758,0.178426540524962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL14,C-C motif chemokine 14,16035,-0.0184659323678976,0.0137465109022463,-0.0454090937363004,0.00847722900050518,0.179188127779528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,15582,-0.0396383499048938,0.0295283340952022,-0.0975138847314902,0.0182371849217025,0.179491240428062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB4,Receptor tyrosine-protein kinase erbB-4,16091,0.0109395029808222,0.00815030140061488,-0.005035087764383,0.0269140937260273,0.179543410842305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN3,Contactin-3,16074,0.014893729205754,0.0110997645896212,-0.00686180938990345,0.0366492678014115,0.179677921342332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON2,Spondin-2,15997,-0.0158086291887975,0.0117933074067627,-0.0389235117060525,0.00730625332845745,0.180110145181222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSG,Alpha-2-HS-glycoprotein,13988,-0.0126025897857721,0.00941408466692868,-0.0310541957329524,0.00584901616140806,0.180691703239953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRTN,Neurturin,15797,-0.0232953321369401,0.0174125361517164,-0.0574239029943043,0.010833238720424,0.180965164362235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO1A,Coronin-1A,15752,-0.0415560111888565,0.0310668513778615,-0.102447039889465,0.0193350175117521,0.181035792182301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP1,Neuropilin-1,16157,-0.0126827962944162,0.00948329807382118,-0.0312700605191057,0.00590446793027331,0.181116676790049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRY2,Protein sprouty homolog 2,15797,-0.0428887419811198,0.0320972735182434,-0.105799398076877,0.0200219141146374,0.181499458195918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4C,Semaphorin-4C,15973,-0.0128438405978435,0.00961618111230584,-0.031691555577963,0.00600387438227594,0.181683144878473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD2,Sushi domain-containing protein 2,16074,-0.0130210051722102,0.00976004698651073,-0.0321506972657712,0.00610868692135084,0.182185756154191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16063,-0.0301969474058533,0.0226411090138732,-0.0745735210730448,0.0141796262613382,0.182313877145112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FASLG,Tumor necrosis factor ligand superfamily member 6,16249,0.0168678801217099,0.0126566349787144,-0.00793912443657022,0.0416748846799901,0.18263905041317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR3,Folate receptor gamma,16038,-0.0846676033170164,0.0636344332271553,-0.209391092442241,0.0400558858082078,0.183362224076255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1B,C-type lectin domain family 1 member B,16208,-0.0438301287487085,0.0329764464213471,-0.108463963734549,0.0208037062371317,0.183822363698417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MVK,Mevalonate kinase,15797,-0.036579691392621,0.0275383832622532,-0.0905549225866371,0.0173955398013952,0.184092747428461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS2,Thrombospondin-2,16074,-0.0169434029544196,0.0127620257052385,-0.0419569733366871,0.00807016742784794,0.184315230957931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARCL1,SPARC-like protein 1,16075,0.0125270999105182,0.00943876171912303,-0.00597287305896294,0.0310270728799993,0.184462261796692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA10,Ephrin type-A receptor 10,15667,-0.0297204236184912,0.0223945803205926,-0.0736138010468527,0.0141729538098702,0.184486454452342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC37A2,Leucine-rich repeat-containing protein 37A2,13936,-0.0195729606849072,0.0147488496661288,-0.0484807060305197,0.00933478466070532,0.184502699664934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABCA2,ATP-binding cassette sub-family A member 2,13501,-0.0168739401709122,0.0127326880708138,-0.0418300087897073,0.00808212844788289,0.185112120332896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN15,Tetraspanin-15,13501,-0.0223343532558705,0.0168604202282738,-0.0553807769032872,0.0107120703915463,0.185305819366496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LXN,Latexin,15834,0.0313778714010188,0.0236910570511221,-0.0150566004191805,0.0778123432212181,0.185369256238247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NSFL1C,NSFL1 cofactor p47,16208,-0.0299173744341585,0.0225932796699675,-0.0742002025872948,0.0143654537189778,0.185464820863167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP45,Rho GTPase-activating protein 45,13703,-0.0375934791011656,0.0283899938657881,-0.0932378670781103,0.018050908875779,0.185465181271161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARBP2,RISC-loading complex subunit TARBP2,15667,-0.0356592501353274,0.0269500647818526,-0.0884813771077585,0.0171628768371037,0.185801472298702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RYR1,Ryanodine receptor 1,13501,-0.0157274038778179,0.0118988891718762,-0.0390492266546952,0.00759441889905936,0.1862725125541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,13501,0.023393454737519,0.0177441194498149,-0.0113850193841182,0.0581719288591562,0.187399567172662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,13913,-0.0219743867738766,0.016675179100204,-0.0546577378102764,0.0107089642625233,0.187595625548693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1A,Lithostathine-1-alpha,15990,-0.0222544468321125,0.0169042890281458,-0.0553868533272782,0.0108779596630532,0.188026149995432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDNF,Glial cell line-derived neurotrophic factor,15667,-0.0172312234589234,0.0130909340018866,-0.0428894541026212,0.00842700718477435,0.188102203690022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A12,Protein S100-A12,15819,-0.0341592160291333,0.0259564461788619,-0.0850338505397026,0.0167154184814361,0.188186239032847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA3,Alpha-1-antichymotrypsin,13972,-0.00691288032673466,0.00525555095947924,-0.017213760207314,0.00338799955384465,0.188414459005027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,13946,0.0109608937697698,0.00834848122034669,-0.00540212942210976,0.0273239169616493,0.189231297427732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK13,Kallikrein-13,15686,-0.0197450504002583,0.0150438549335664,-0.0492310060700485,0.00974090526953193,0.189370913001399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR5,Cadherin-related family member 5,16063,0.0174590959918546,0.0133153857014462,-0.00863905998297996,0.0435572519666892,0.189809918815361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,13946,-0.048147499653038,0.0367331587369754,-0.12014449077751,0.0238494914714338,0.189968336828403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYN,Tyrosine-protein kinase Lyn,15973,-0.0381921974263037,0.0291511472169872,-0.0953284459715986,0.0189440511189913,0.190166019596327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE4,Ribonuclease 4,13489,-0.0122983320490131,0.00940486796378794,-0.0307318732580374,0.00613520916001131,0.191012321898301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTKN2,Rhotekin-2,13501,-0.0238428013417347,0.0182395270379996,-0.0595922743362139,0.0119066716527444,0.191165375625939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL33,Interleukin-33,15797,0.0175018678969245,0.0133994245767207,-0.0087610042734481,0.0437647400672971,0.191515271809669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APRT,Adenine phosphoribosyltransferase,15889,-0.0212789262665788,0.0163047083392931,-0.0532361546115934,0.0106783020784357,0.191884993825592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP8,Neutrophil collagenase,16188,-0.033053139481763,0.0253293055038728,-0.0826985782693537,0.0165922993058278,0.191932979713873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD9,26S proteasome non-ATPase regulatory subunit 9,15973,-0.0253670252635267,0.0195010507602288,-0.0635890847535752,0.0128550342265218,0.193344677782595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1B,5-hydroxytryptamine receptor 1B,13528,0.0195141029239431,0.015006129653673,-0.00989791119725595,0.0489261170451422,0.193483074371194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF3,Neurotrophin-3,16054,-0.0155955458042202,0.0120076879090824,-0.0391306141060217,0.00793952249758121,0.194032367340674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,13751,-0.0163584070426292,0.0125950581769822,-0.0410447210695142,0.00832790698425584,0.194035861103425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHB,Lutropin subunit beta,15725,-0.0387692529259816,0.0298688704011722,-0.0973122389122791,0.019773733060316,0.194312612056215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,13936,-0.0178230100512368,0.0137353918848673,-0.0447443781455767,0.00909835804310311,0.194447184277083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP350,Centrosome-associated protein 350,13506,-0.0166980260876921,0.0128715004565156,-0.0419261669824627,0.00853011480707849,0.194554747646824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGMN,Legumain,16133,-0.0158369185574046,0.0122241822780169,-0.0397963158223176,0.00812247870750845,0.195152523465209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR2,Complement factor H-related protein 2,13919,0.0256906082860789,0.0198809490262607,-0.0132760518053921,0.06465726837755,0.196301600142119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RWDD1,RWD domain-containing protein 1,16208,-0.0280052680924073,0.0217067894083037,-0.0705505753326826,0.014540039147868,0.197012946676542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTNNA1,Catenin alpha-1,13528,0.0155870937693742,0.0120857381979452,-0.00810095309859847,0.0392751406373468,0.19717354159511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTRA2,"Serine protease HTRA2, mitochondrial",16091,-0.0272100481965979,0.0211233670106582,-0.068611847537488,0.0141917511442922,0.19771257256046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPB2,Coatomer subunit beta',13501,-0.019430482121376,0.0150980820036502,-0.0490227228485303,0.0101617586057783,0.198133676515206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH17,Cadherin-17,16063,0.0301234458546617,0.0234100801280396,-0.0157603111962959,0.0760072029056193,0.198192176372014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16054,-0.0532395456657934,0.0413837546088229,-0.134351704699086,0.0278726133674993,0.198292703668596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN1,Perilipin-1,15667,0.0153018713072518,0.0119110593782678,-0.00804380507415314,0.0386475476886567,0.198923975992131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEB,Nebulin,13501,-0.0172688750658716,0.0134714036737906,-0.0436728262665011,0.00913507613475787,0.199902818247288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSH,Pro-cathepsin H,15766,-0.0325670542087795,0.0254064978394792,-0.0823637899741588,0.0172296815565997,0.199917797238176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALMS1,Alstrom syndrome protein 1,13751,0.0197377933750303,0.015408025218135,-0.0104619360525143,0.0499375228025749,0.200212713830522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FYB1,FYN-binding protein 1,16047,-0.0402794103512812,0.0314463801129624,-0.101914315372688,0.0213554946701251,0.200250201762958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX33,Testis-expressed protein 33,13751,-0.017970690851236,0.0140344548729303,-0.0454782224021794,0.00953684069970746,0.20040169871217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,15764,-0.0344621289485056,0.0269269411660829,-0.0872389336340281,0.0183146757370169,0.200620883562803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGL1,Fibrinogen-like protein 1,13988,-0.0283994166615253,0.0221959205953463,-0.071903421028404,0.0151045877053534,0.200746464627988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC2,Plexin domain-containing protein 2,13938,-0.012332096693987,0.00964064313475948,-0.0312277572381156,0.00656356385014158,0.200855767427598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIT,Bis(5'-adenosyl)-triphosphatase,15667,-0.0320914141360041,0.0250909942459528,-0.0812697628580717,0.0170869345860634,0.200915560196644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUOX2,Dual oxidase 2,15821,0.0315433089963025,0.0247308869357999,-0.0169292293978653,0.0800158473904704,0.202164474433121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEBP1,Phosphatidylethanolamine-binding protein 1,16074,-0.0257685814840033,0.0202091250710182,-0.0653784666231989,0.0138413036551924,0.202293588933793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,13936,-0.0132945956298405,0.0104270800421552,-0.0337316725124647,0.00714248125278383,0.202328191374717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G2,V-type proton ATPase subunit G 2,13501,0.0423709082095489,0.033244941971341,-0.0227891780542795,0.107530994473377,0.202505784081207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1MT,"DNA topoisomerase I, mitochondrial",13506,-0.0213812885580302,0.0167837630328656,-0.0542774641024467,0.0115148869863863,0.202711239454826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GL3,Endophilin-A3,13670,-0.0369906335078533,0.0290432264128011,-0.0939153572769435,0.0199340902612369,0.202812479456809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NENF,Neudesin,13913,-0.0494924546555432,0.0388592865569999,-0.125656656307263,0.0266717469961766,0.202814947058137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG3,Secretogranin-3,16076,0.0144561064628514,0.0113595320002417,-0.0078085762576223,0.0367207891833252,0.203179500983164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC15,Thioredoxin domain-containing protein 15,16091,-0.0119690774711749,0.00940577111900288,-0.0304043888644205,0.00646623392207078,0.203205104108758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2B,V-set and transmembrane domain-containing protein 2B,13751,0.0187278221095357,0.0147364438202676,-0.0101556077781888,0.0476112519972602,0.20380323605912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC2,SPARC-related modular calcium-binding protein 2,16133,-0.016663484855379,0.0131254898650789,-0.0423894449909336,0.0090624752801756,0.204262776721743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5R2,NADH-cytochrome b5 reductase 2,13765,-0.0247631761891715,0.0195240285425377,-0.0630302721325453,0.0135039197542024,0.20469675376721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDC,Aromatic-L-amino-acid decarboxylase,16043,0.0210126897321665,0.0165788062429798,-0.0114817705040739,0.0535071499684069,0.20501539225272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MESD,LRP chaperone MESD,16074,-0.0528294622917776,0.0417053767866692,-0.134572000793649,0.028913076210094,0.205270130729154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB2,Lamin-B2,13938,-0.0124148802970753,0.009821208364756,-0.0316644486919971,0.00683468809784644,0.206219287422247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4D,Semaphorin-4D,16208,-0.0129313868199937,0.010231167099191,-0.0329844743344081,0.00712170069442072,0.206276581006756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL8,Interleukin-8,15920,-0.0298792462603198,0.0236566621709911,-0.0762463041154623,0.0164878115948227,0.206594296174637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR2,Toll-like receptor 2,13751,0.0103161811876661,0.00816774378448898,-0.00569259662993226,0.0263249590052645,0.206596502774695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3D,Protein FAM3D,13936,-0.0368829920070681,0.0292118900142441,-0.0941382964349866,0.0203723124208503,0.206753381203438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS9,Galectin-9,16054,-0.0138247066317098,0.0109516438380475,-0.035289928554283,0.00764051529086337,0.206844541393177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNLR1,Interferon lambda receptor 1,16054,-0.0163119121096628,0.0129433842840019,-0.0416809453063065,0.0090571210869809,0.207597188320082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON3,Serum paraoxonase/lactonase 3,16133,0.0124410170845175,0.0098740256189528,-0.00691207312862997,0.031794107297665,0.207696927039782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTM4,Glutathione S-transferase Mu 4,13501,-0.0310156902636294,0.0246262338114942,-0.079283108534158,0.0172517280068991,0.207886994592185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF3,Fibroblast growth factor 3,13568,-0.0131925202803839,0.010478437206364,-0.0337302572048573,0.00734521664408944,0.208046229092283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM2,Junctional adhesion molecule B,16208,0.0111884163052913,0.008893276475104,-0.00624240558591252,0.0286192381964952,0.208382467711471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,15918,0.0121618714307499,0.00966907675228684,-0.00678951900373233,0.0311132618652321,0.208478571595561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16208,-0.0226612254778392,0.0180264178000759,-0.0579930043659879,0.0126705534103095,0.208731225879454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZFYVE19,Abscission/NoCut checkpoint regulator,13936,-0.0390292044844264,0.0310465489936178,-0.0998804405119173,0.0218220315430645,0.208731662067943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",13938,-0.0423596561989678,0.0337205551599412,-0.108451944312453,0.023732631914517,0.209065673525465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCG,Gamma-synuclein,15918,-0.0284799223460262,0.0226793963966389,-0.0729315392834384,0.015971694591386,0.209220750097023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA7,Thyroxine-binding globulin,14020,0.00816364836383242,0.00650229767445448,-0.00458085507809836,0.0209081518057632,0.209317492548485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),P4HB,Protein disulfide-isomerase,15968,-0.0167768260149702,0.0133639716066066,-0.0429702103639191,0.00941655833397869,0.209360228090454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL1,Interferon lambda-1,15667,-0.0191537886447262,0.0152733732996537,-0.0490896003120476,0.0107820230225951,0.209837446943408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL3,Fc receptor-like protein 3,15797,-0.0232138141395274,0.0185164342974548,-0.0595060253625387,0.013078397083484,0.209974341375013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,15725,0.054610110258001,0.0435702027455965,-0.0307874871233681,0.14000770763937,0.210085350628984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16054,-0.0355871043966265,0.028435453798112,-0.091320593840926,0.020146385047673,0.21076864709966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GORASP2,Golgi reassembly-stacking protein 2,13936,-0.0204467474956491,0.0163379874178903,-0.0524692028347141,0.0115757078434159,0.210778581228422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK4,Kallikrein-4,16195,-0.0269445635884701,0.0215407514478992,-0.0691644364263525,0.0152753092494124,0.211001964870345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN2,Matrilin-2,16076,-0.0127203524228003,0.0101841320923877,-0.0326812513238802,0.00724054647827945,0.21166993684043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK1,Cyclin-dependent kinase 1,13506,0.0160634966898132,0.0128636796468784,-0.00914931541806847,0.0412763087976949,0.211778855240863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF9,Multiple epidermal growth factor-like domains protein 9,16203,-0.00865778249782419,0.00693388244604714,-0.0222481920920766,0.0049326270964282,0.211822244659866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFR,Epidermal growth factor receptor,16254,0.00696304751815969,0.00557843610216932,-0.00397068724209218,0.0178967822784116,0.211972959316128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CANT1,Soluble calcium-activated nucleotidase 1,16013,-0.00852352259833536,0.00684220801867232,-0.0219342503149331,0.00488720511826239,0.212882915940787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,15821,-0.0359800728807194,0.0288913459317586,-0.0926071109069662,0.0206469651455275,0.213018592687754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERVV_1,,13501,-0.0192658006415378,0.0154794855633568,-0.049605592345717,0.0110739910626415,0.213299665388086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR1,Natural cytotoxicity triggering receptor 1,16028,0.0155523493624587,0.0125023481641999,-0.00895225303937313,0.0400569517642906,0.213534602480005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP29,Synaptosomal-associated protein 29,16091,-0.0390230095979713,0.0313912424660639,-0.100549844831457,0.022503825635514,0.213842587205873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,13965,-0.017193532739936,0.0138341389896051,-0.0443084451595621,0.00992137967969004,0.213950046501215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK1,Kallikrein-1,15870,0.0543184250515791,0.0437312271439614,-0.0313947801505852,0.140031630253743,0.214219154622161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCND2,G1/S-specific cyclin-D2,13751,0.016401460826898,0.01323920622108,-0.00954738336641877,0.0423503050202148,0.215420256629745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB1,Carboxypeptidase B,16254,0.0248792737284708,0.0200870335485282,-0.0144913120266445,0.064249859483586,0.215521273371292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,13938,-0.0173535446727286,0.0140341798721652,-0.0448605372221724,0.0101534478767152,0.21628617737236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LELP1,Late cornified envelope-like proline-rich protein 1,13528,-0.0311086751748752,0.0251740122788963,-0.0804497392415118,0.0182323888917615,0.216574617834356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN1,Nectin-1,13568,-0.0137823738802477,0.0111552979017945,-0.035646757767765,0.00808201000726953,0.216665779425911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA3,Annexin A3,16188,-0.0295670044197032,0.0239320002415027,-0.0764737248930484,0.017339716053642,0.216677681384606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARAF,Serine/threonine-protein kinase A-Raf,13751,-0.0286259706779429,0.023197733778416,-0.0740935288836382,0.0168415875277524,0.217224542126875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF10,Tumor necrosis factor ligand superfamily member 10,16249,-0.0111696988061107,0.00905312441364635,-0.0289138226568576,0.0065744250446361,0.217297197951228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCR,Breakpoint cluster region protein,16054,-0.0385370479663905,0.0312431074461786,-0.0997735385609006,0.0226994426281196,0.217423165175877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFB,Platelet-derived growth factor subunit B,16133,-0.0362600761616718,0.0294005428353642,-0.0938851401189855,0.0213649877956419,0.217476937242439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRNN,Cornulin,15575,0.0284393745640385,0.0230662163732805,-0.0167704095275912,0.0736491586556682,0.217614935937023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACSTD2,Tumor-associated calcium signal transducer 2,14210,0.0129640572011832,0.0105266556882777,-0.00766818794784104,0.0335963023502074,0.218139248195103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,13751,-0.0288859003927647,0.0234682460511611,-0.0748836626530403,0.017111861867511,0.218399889661323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSH3,Protein phosphatase Slingshot homolog 3,13506,0.0125122824705113,0.0101717560524557,-0.00742435939230196,0.0324489243333245,0.21868091068119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16208,-0.0191368335986718,0.0155574992791308,-0.0496295321857681,0.0113558649884246,0.218688269339095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF11,Multiple epidermal growth factor-like domains protein 11,13501,0.014138767609694,0.0114960327006336,-0.0083934564835479,0.0366709917029359,0.218762620795759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLFM4,Olfactomedin-4,13220,-0.0522160151193112,0.0424591825487532,-0.135436012914868,0.0310039826762451,0.218796453435371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDK,Midkine,16038,-0.0214660122584848,0.0174566765872344,-0.0556810983694641,0.0127490738524946,0.218837455692587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APP,Amyloid-beta precursor protein,16047,-0.0279006406098638,0.0227049940755139,-0.0724024289978711,0.0166011477781434,0.219152550396638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,15821,-0.00904486626249187,0.00737013887427464,-0.0234903384560702,0.00540060593108643,0.219753886589204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",13528,-0.0191809064325266,0.0156433284518401,-0.0498418301981332,0.01148001733308,0.220167464026244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM26,Tripartite motif-containing protein 26,13506,-0.0243060619790822,0.0198391662101547,-0.0631908277509854,0.0145787037928209,0.220538055702368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR2,Anterior gradient protein 2 homolog,15532,0.0421104410913196,0.0343856678052978,-0.0252854678070641,0.109506349989703,0.220725348508865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,13751,0.0259668979085822,0.0212073671151311,-0.0155995416370748,0.0675333374542392,0.220811741752775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1F,V-type proton ATPase subunit F,15649,-0.0282919085733495,0.0231132926688948,-0.0735939622043832,0.0170101450576843,0.220950461362139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP6,Charged multivesicular body protein 6,13965,-0.0238520278784951,0.0194861440181218,-0.0620448701540138,0.0143408143970236,0.22095377975012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL14,C-X-C motif chemokine 14,15797,-0.0254997120777645,0.0208346134944481,-0.0663355545268828,0.0153361303713538,0.221004083736809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOBR,Apolipoprotein B receptor,13643,-0.0179312344065106,0.0146550707545744,-0.0466551730854765,0.0107927042724553,0.22114260282002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBA,Lysosomal acid glucosylceramidase,13605,-0.0231356322822904,0.0189194526641249,-0.0602177595039752,0.0139464949393943,0.221407967695252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCAT,Phosphatidylcholine-sterol acyltransferase,13988,-0.0093806172003928,0.00767206192327957,-0.0244178585700207,0.00565662416923515,0.221464283777519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHEK2,Serine/threonine-protein kinase Chk2,15821,0.0141045771502266,0.0115387354193818,-0.00851134427176172,0.036720498572215,0.221586844998609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMA,Repulsive guidance molecule A,16208,0.0130149094619847,0.0106635061944956,-0.00788556267922664,0.0339153816031961,0.222289602898916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",15725,-0.0346003975258652,0.0283549645164538,-0.0901761279781147,0.0209753329263843,0.222385063968426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18RAP,Interleukin-18 receptor accessory protein,15811,-0.0723425829524098,0.0593024813044545,-0.188575446309141,0.043890280404321,0.222524283530019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF7,Fibroblast growth factor 7,13506,-0.0338324229681394,0.0277370963468037,-0.0881971318078746,0.0205322858715958,0.222579619085209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA2,Annexin A2,13439,-0.0305808478900461,0.025074087387311,-0.0797260591691757,0.0185643633890835,0.222630546863741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPCAL1,Hippocalcin-like protein 1,16249,-0.0309325075917649,0.0253706465429866,-0.0806589748160187,0.0187939596324889,0.22277680239821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,13913,-0.034935703247856,0.0286622652224365,-0.0911137430838316,0.0212423365881195,0.222912528281599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA1,Paraneoplastic antigen Ma1,13643,-0.0240132431457159,0.0197064493246952,-0.0626378838221184,0.0146113975306867,0.223037105001205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGR1,Prostaglandin reductase 1,13965,-0.0341570660449975,0.0280362488326704,-0.0891081137570315,0.0207939816670364,0.223123762510059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13506,-0.0225016984328187,0.0184833663132438,-0.0587290964067765,0.0137256995411391,0.223472361627386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCYT2,Ethanolamine-phosphate cytidylyltransferase,13936,-0.032016484563509,0.0263115410190682,-0.0835871049608827,0.0195541358338646,0.223692248186809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP8,Vesicle-associated membrane protein 8,13568,-0.0370901948779224,0.0304864419315619,-0.0968436210637837,0.0226632313079389,0.223772762638625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT14,"Keratin, type I cytoskeletal 14",15155,-0.011999949469503,0.00986440279130315,-0.0313341789404572,0.00733428000145115,0.22381719936691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP7,GTPase IMAP family member 7,13703,-0.0141150822477772,0.0116072567619845,-0.0368653055012668,0.00863514100571244,0.223984296087884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDA1,DET1- and DDB1-associated protein 1,13501,-0.0164271458427169,0.0135307757427513,-0.0429474662985094,0.0100931746130757,0.224746854393974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLURP1,Secreted Ly-6/uPAR-related protein 1,13888,-0.0156620048147957,0.0129218144092176,-0.0409887610568622,0.00966475142727083,0.225510337654206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS22,Brain-specific serine protease 4,13568,0.0149530041129663,0.0123398083663634,-0.00923302028510592,0.0391390285110386,0.22562172908977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR4,Complement factor H-related protein 4,13995,-0.0303307727745053,0.0250447569557724,-0.0794184964078191,0.0187569508588086,0.225891818456412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASN,Vasorin,15834,0.0115063042146368,0.00950230240176053,-0.00711820849281381,0.0301308169220875,0.225953183702071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA2,Apolipoprotein A-II,13988,-0.0201735498406038,0.0166718338390525,-0.0528503441651468,0.0125032444839391,0.226284840660826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRA,Platelet-derived growth factor receptor alpha,16063,0.0117750673950506,0.00973921950170915,-0.00731380282829935,0.0308639376184005,0.226666810194628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHK,Ketohexokinase,13643,-0.0268332721186087,0.0222200910287694,-0.0703846505349968,0.0167181062977794,0.227217089106417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XIAP,E3 ubiquitin-protein ligase XIAP,13568,-0.0243255919411105,0.0201582781239847,-0.0638358170641206,0.0151846331818996,0.227557336313749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DFFA,DNA fragmentation factor subunit alpha,16249,-0.0280394709238322,0.023247301608501,-0.0736041820764942,0.0175252402288297,0.227781578492215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G15,Phospholipase A2 group XV,16091,-0.0109609795587437,0.00909440831190332,-0.0287860198500742,0.00686406073258682,0.228126923824118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMCH,Pro-MCH,13501,-0.034135981707101,0.0283426101441949,-0.0896874975897231,0.021415534175521,0.228454211117071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,13983,-0.0162967904558496,0.0135450876642197,-0.0428451622777202,0.010251581366021,0.228938149179474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP3,"Fatty acid-binding protein, heart",13965,-0.0208231809842572,0.0173231616467013,-0.0547765778117918,0.0131302158432773,0.229367365620238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH3,Cadherin-3,16208,-0.0146503583385624,0.012195179087001,-0.0385529093490843,0.00925219267195946,0.229643208223147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3,"TNF receptor-associated factor 3, Isoform 2",13568,0.015500326124086,0.0129063271085228,-0.00979607500861873,0.0407967272567907,0.229777379790675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI2,Tissue factor pathway inhibitor 2,16050,-0.0156440895499334,0.0130298226963241,-0.0411825420347287,0.00989436293486179,0.229909707740244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBFOX3,RNA binding protein fox-1 homolog 3,13946,-0.0159535248108037,0.0132931192064208,-0.0420080384553885,0.010100988833781,0.23010769531184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA11,Annexin A11,16034,-0.0273468938170608,0.0227878007489469,-0.0720109832849967,0.0173171956508751,0.230130962276371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",13946,-0.0304068481479603,0.0253457413449305,-0.080084501184024,0.0192708048881034,0.230282984101879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTL1,Cytokine-like protein 1,13983,-0.00997812805906257,0.00831782974079493,-0.0262810743510206,0.00632481823289548,0.2303122930625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,15973,-0.0190545641930957,0.0158854730599262,-0.0501900913905511,0.0120809630043596,0.230352878526232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC42BPB,Serine/threonine-protein kinase MRCK beta,13936,-0.0423935273518056,0.0353780597070937,-0.111734524377709,0.026947469674098,0.230820662382554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F9,Coagulation factor IX,16115,-0.00737634741838239,0.00615693666445559,-0.0194439432807153,0.00469124844395056,0.230913325516273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3LG,Fms-related tyrosine kinase 3 ligand,16249,0.0138428526543757,0.0115572764744148,-0.0088094092354773,0.0364951145442286,0.231027640333125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTF2,Transcription termination factor 2,13605,-0.0207084687910604,0.0173007006957422,-0.0546178421547151,0.0132009045725942,0.231338020116777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD4,T-cell surface glycoprotein CD4,16022,-0.0122973366551905,0.0102744075988313,-0.0324351755488998,0.00784050223851877,0.23136712120673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP9,Fatty acid-binding protein 9,16054,0.0231208515167478,0.01931790553744,-0.0147422433366346,0.0609839463701303,0.231378350171019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYM,Ketimine reductase mu-crystallin,13528,0.0315203583841327,0.0263417804049469,-0.0201095312095633,0.0831502479778286,0.231486690582715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNMBP,Dynamin-binding protein,15918,-0.0253068373945137,0.0211534199331451,-0.066767540463478,0.0161538656744506,0.231578881654736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPCDC,Phosphopantothenoylcysteine decarboxylase,16208,-0.0194786233722786,0.0162841334010541,-0.0513955248383446,0.0124382780937874,0.231646983396029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,13501,-0.0107392364895083,0.00898215743678396,-0.0283442650656048,0.00686579208658831,0.23186636417351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPSCR1,Tether containing UBX domain for GLUT4,13946,-0.0278108621325026,0.0233285966189198,-0.0735349115055854,0.0179131872405801,0.233228190099906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHBG,Sex hormone-binding globulin,13988,0.0211533022582676,0.0177547248984228,-0.0136459585426412,0.0559525630591764,0.23350968917943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA3,GDNF family receptor alpha-3,15867,0.0116372615986701,0.00977141484985973,-0.00751471150705499,0.0307892347043952,0.233691242960801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH4,Cadherin-4,13528,-0.0192829815040729,0.0162025317870027,-0.0510399438065982,0.0124739807984524,0.234019545790347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA2_BOLA2B,BolA-like protein 2,13643,-0.0227442189625117,0.0191461955050755,-0.0602707621524596,0.0147823242274363,0.234884181653486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME2,Proteasome activator complex subunit 2,15845,-0.0150752947249938,0.0126992511265179,-0.0399658269329689,0.00981523748298133,0.235205564814921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCLRE1C,Protein artemis,13506,-0.0128656649528984,0.010839516802646,-0.0341111178860845,0.00837978798028767,0.23527914126105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP10,Inactive dipeptidyl peptidase 10,16054,-0.0142413475630376,0.0120059997129115,-0.0377731070003441,0.00929041187426898,0.235566463565197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13225,-0.0440389931553642,0.0371732536943024,-0.116898570396197,0.0288205840854686,0.236159101959695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,13983,-0.0104424672802148,0.00882822408637761,-0.0277457864895149,0.00686085192908533,0.23688862323084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",15973,-0.0143002778983686,0.0121035365589944,-0.0380232095539978,0.00942265375726046,0.237423417077243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINH1,Serpin H1,13751,-0.0527521954905464,0.0446600961109557,-0.14028598386802,0.0347815928869268,0.237546487726765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP3,Caspase-3,16254,-0.0355249531946874,0.0300756903630584,-0.0944733063062818,0.023423399916907,0.237546551145816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,15725,-0.0264585274088005,0.0224294755049255,-0.0704202993984544,0.0175032445808535,0.238164465319399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDM1,Nuclear protein MDM1,13605,-0.0127546306772584,0.0108126122148244,-0.0339473506183142,0.0084380892637974,0.238177292678622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",13643,-0.0279273965151615,0.0236800997858122,-0.0743403920953535,0.0184855990650305,0.238274870468567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF3,Wiskott-Aldrich syndrome protein family member 3,15667,-0.034403192268734,0.0292191303134142,-0.0916726876830259,0.0228663031455578,0.239045760319745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CADPS,Calcium-dependent secretion activator 1,13605,0.0173475747504684,0.0147483723399011,-0.0115592350357377,0.0462543845366745,0.239520960423625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL1,Chordin-like protein 1,16103,-0.0125633575272372,0.0106858204079532,-0.0335075655268254,0.00838085047235097,0.239730736446307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF8,Immunoglobulin superfamily member 8,16063,-0.0122972663710976,0.010464396564516,-0.0328074836375489,0.00821295089535374,0.239950968583713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX15,Sorting nexin-15,13703,-0.0222956605396819,0.0189955566730772,-0.0595269516189132,0.0149356305395494,0.240523487795787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5A,Cytochrome b5,13506,-0.0294416290949063,0.0250937775390735,-0.0786254330714904,0.0197421748816778,0.240710613679843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESPL1,Separin,13506,-0.0225556005149207,0.0192347790699507,-0.060255767492024,0.0151445664621827,0.240958210759373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP4,Insulin-like growth factor-binding protein 4,15872,-0.0168782658346579,0.0144008443620055,-0.0451039207841887,0.0113473891148728,0.241201386534039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECE1,Endothelin-converting enzyme 1,15667,-0.0140807778435001,0.0120173878574613,-0.0376348580441243,0.00947330235712406,0.241335207009408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,15918,-0.0379296901342681,0.0324006368726166,-0.101434938404597,0.0255755581360604,0.241758463379619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX2,Heme oxygenase 2,15667,-0.0185599760578731,0.0158657829482423,-0.049656910636428,0.0125369585206819,0.242094628205581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIP,Gastric inhibitory polypeptide,13643,-0.0208229437395231,0.0178011390659723,-0.0557131763088287,0.0140672888297826,0.242120659481522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF11,Tumor necrosis factor ligand superfamily member 11,16054,-0.0245858895662033,0.0210219487166569,-0.0657889090508508,0.0166171299184441,0.242205818469147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP1,Lysosome-associated membrane glycoprotein 1,13587,-0.0109776881728595,0.00938689565633712,-0.0293760036592803,0.00742062731356122,0.242235058746778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HARS1,"Histidine--tRNA ligase, cytoplasmic",16074,-0.0308585736103215,0.0263909713046277,-0.0825848773673918,0.0208677301467487,0.242306075822946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2,Interleukin-2,15797,-0.01247459505836,0.0106724288013213,-0.0333925555089497,0.00844336539222965,0.24247694267901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31,Interleukin-31,13568,-0.0230132249723965,0.019688520634524,-0.0616027254160636,0.0155762754712705,0.242478536422768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13528,-0.0128234651320109,0.0109850004152051,-0.0343540659458129,0.00870713568179116,0.243085061151226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,13751,-0.0455925119204601,0.039068847026635,-0.122167452092665,0.0309824282517445,0.243239232426665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA11,Integrin alpha-11,16054,-0.013709153080633,0.0117675233625155,-0.0367734988711634,0.0093551927098974,0.244036718289193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS1BP3,HCLS1-binding protein 3,13643,-0.0361953310022616,0.0311048493039201,-0.097160835637945,0.0247701736334218,0.244583994798318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD207,C-type lectin domain family 4 member K,15686,-0.0154807442591398,0.0133041015725895,-0.0415567833414153,0.0105952948231356,0.244601072926197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP4,Zona pellucida sperm-binding protein 4,13506,-0.012853909946902,0.0110485814048356,-0.0345091295003798,0.00880130960657589,0.244688178600158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",13568,-0.0142134043789693,0.0122231250552796,-0.0381707294873172,0.00974392072937871,0.244919357828854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIP2,CAP-Gly domain-containing linker protein 2,16054,-0.0448718452064387,0.0386188332162848,-0.120564758310357,0.0308210678974796,0.245286823404291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOMO1,Nodal modulator 1,16074,-0.00937406060176756,0.00807398134755951,-0.0251990640429842,0.00645094283944908,0.2456506812283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEPE,Matrix extracellular phosphoglycoprotein,16044,0.0100067244291876,0.00861960327088641,-0.0068876979817498,0.0269011468401249,0.245689145996189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GYS1,"Glycogen [starch] synthase, muscle",15821,-0.0363498375847424,0.0313302813729185,-0.0977571890756626,0.0250575139061779,0.245979126666293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNG,Interferon gamma,15797,-0.0454218077628748,0.0391783971267845,-0.122211466131372,0.0313678506056227,0.246327624157097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADD1,Alpha-adducin,13703,-0.0281757094103335,0.024307606568425,-0.0758186182844464,0.0194671994637794,0.246422857818923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNDA,Myeloid cell nuclear differentiation antigen,16041,-0.0406642785086191,0.0350964018442776,-0.109453226123403,0.028124669106165,0.246618088925047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN1,Calsyntenin-1,15667,-0.0202935731855216,0.017515197970042,-0.0546233612068039,0.0140362148357607,0.246626122638828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,13605,-0.0214190683274259,0.0185188528354476,-0.0577160198849032,0.0148778832300514,0.247452550503137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB2,DnaJ homolog subfamily B member 2,13703,-0.0218442116851972,0.0188888633624557,-0.0588663838756104,0.0151779605052159,0.247513303289807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL4,Early placenta insulin-like peptide,13913,-0.0198898137134513,0.0172013940767614,-0.0536045461039036,0.013824918677001,0.247582104398261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFLAM,Pikachurin,13936,-0.0126845042550846,0.0109717957181661,-0.0341892238626901,0.00882021535252087,0.24765967626484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BANK1,B-cell scaffold protein with ankyrin repeats,16054,-0.0416732958110733,0.0360677461525538,-0.112366078270079,0.0290194866479322,0.247936815131964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC28A,Coiled-coil domain-containing protein 28A,13605,-0.0118487003294262,0.010271568027498,-0.0319809736633223,0.00828357300446988,0.248707667172412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16044,-0.011680088238111,0.0101283507046376,-0.0315316556192006,0.00817147914297862,0.248842491976262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMT,Catechol O-methyltransferase,15638,-0.0333492444671036,0.0289361596217479,-0.0900641173257295,0.0233656283915223,0.249128753988823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDNF,Cerebral dopamine neurotrophic factor,15973,0.0128195153373874,0.0111250658933066,-0.0089856138134935,0.0346246444882683,0.249211314608596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPA,CCAAT/enhancer-binding protein alpha,13568,0.0146846382531574,0.0127546283643957,-0.0103144333410582,0.039683709847373,0.249621581193341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAP1,Antigen peptide transporter 1,13751,-0.0229849154500823,0.019983353026404,-0.0621522873818342,0.0161824564816695,0.25008023471735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC2L,C-type lectin domain family 2 member L,13605,0.0202313182833844,0.0176136877670357,-0.0142915097400056,0.0547541463067744,0.2507356323782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHPS,Deoxyhypusine synthase,13913,-0.0164793281500136,0.0143473926159905,-0.044600217677355,0.0116415613773279,0.2507432253889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGA,Protein O-GlcNAcase,13936,-0.0280276839243953,0.0244295110787117,-0.0759095256386703,0.0198541577898797,0.251282343970657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRD54,Ankyrin repeat domain-containing protein 54,15725,-0.0231115400472622,0.0201559724727961,-0.0626172460939425,0.0163941659994182,0.251550037963204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA11,Serpin A11,16254,-0.0159947927102922,0.0139605121163516,-0.0433573964583414,0.011367811037757,0.251929249216545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",15946,-0.0413400893111435,0.0360877089873458,-0.112071998926341,0.0293918203040542,0.252000732943283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,13703,-0.0337130084043411,0.029439114079453,-0.0914136720000689,0.0239876551913868,0.252155694957283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR,GMP reductase 1,16249,-0.0198071590977513,0.0172992293512887,-0.0537136486262771,0.0140993304307745,0.252237015503522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL11,Interleukin-11,15797,-0.0252242439117026,0.0220352444454283,-0.0684133230247422,0.0179648352013369,0.252341415279363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAG1,Dystroglycan,16133,-0.0186935134687072,0.0163607411669748,-0.0507605661559779,0.0133735392185635,0.253228515895225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM1,U6 snRNA-associated Sm-like protein LSm1,15725,-0.021845985300956,0.019121570993985,-0.0593242644491666,0.0156322938472546,0.253272554284082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP6,Platelet glycoprotein VI,16047,-0.0344567011136795,0.0301669474069069,-0.0935839180312171,0.0246705158038581,0.253387763173761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC4,MANSC domain-containing protein 4,13501,-0.0261041536912966,0.0228549403224666,-0.0708998367233312,0.018691529340738,0.253404976245992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXN,Thioredoxin,13750,-0.0173707860277225,0.0152137540473814,-0.0471897439605899,0.012448171905145,0.253564672371002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH2,"Aldehyde dehydrogenase, mitochondrial",13913,0.0196265421512084,0.0171979472957403,-0.0140814345484425,0.0533345188508594,0.253800446633563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FETUB,Fetuin-B,16115,-0.0128216405922372,0.0112594269842997,-0.0348901174814647,0.00924683629699025,0.254825565629951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAG,Myelin-associated glycoprotein,13605,-0.0184041239229429,0.016167912053728,-0.0500932315482499,0.013284983702364,0.255010403027037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL2,C-C motif chemokine 2,15888,0.0205643444925674,0.0180747154533126,-0.0148620977959252,0.05599078678106,0.255245827741487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR1,Cadherin-related family member 1,15667,0.0166814925791743,0.0146727775574957,-0.0120771514335174,0.0454401365918659,0.255597160400013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP7,Caspase-7,13938,-0.0329086952902355,0.0289458688611463,-0.0896425982580822,0.0238252076776112,0.255597678466358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC38,Leucine-rich repeat-containing protein 38,13605,-0.0188513355959555,0.0165812859314397,-0.0513506560215774,0.0136479848296664,0.255598330486365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL1A1,Collagen alpha-1(I) chain,16254,-0.00974941141684267,0.00857691362870879,-0.0265601621291119,0.00706133929542656,0.255678848753514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF4,E3 ubiquitin-protein ligase RNF4,13751,-0.0256203457029078,0.022551914659019,-0.0698220984345851,0.0185814070287695,0.255950947673714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLMAP,Sarcolemmal membrane-associated protein,13936,-0.0327775238300972,0.0288839586592902,-0.089390082802306,0.0238350351421115,0.256478554176281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT1,Diamine acetyltransferase 1,13501,-0.019257812714191,0.0169859521294654,-0.0525502788879432,0.0140346534595611,0.256919841255635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BACH1,Transcription regulator protein BACH1,16054,-0.0284594640503926,0.0251033227122839,-0.0776619765664691,0.0207430484656838,0.256940243608397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT2,Kunitz-type protease inhibitor 2,16133,-0.0157131520301602,0.0138682010266138,-0.0428948260423233,0.0114685219820029,0.257216563087066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARD3,Partitioning defective 3 homolog,13751,0.0289409601041987,0.0255772072268609,-0.0211903660604487,0.0790722862688461,0.257858697371453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSRA,Mitochondrial peptide methionine sulfoxide reductase,16091,-0.0282847956000604,0.025008670852426,-0.0773017904708155,0.0207321992706946,0.258072149748069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO2,Roundabout homolog 2,16208,-0.00890872428849216,0.00787861868287338,-0.024350816906924,0.00653336832993967,0.258178347078236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPC,C-type natriuretic peptide,16054,-0.0184817078866219,0.0163530545319688,-0.0505336947692808,0.013570278996037,0.258422109583253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1R,Macrophage colony-stimulating factor 1 receptor,13988,-0.0156969763072737,0.0138972044410786,-0.0429354970117878,0.0115415443972403,0.258703812707837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN2,CCN family member 2,16049,-0.0222651685054857,0.0197197478375809,-0.0609158742671443,0.0163855372561729,0.258881072034171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA7,Carbonic anhydrase 7,13751,-0.0136277170391468,0.0120913468198237,-0.0373267568060012,0.0100713227277077,0.259735272713488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK2B,Divergent protein kinase domain 2B,13703,0.0106802996079544,0.00948421313881164,-0.00790875814411641,0.0292693573600252,0.260137259632431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP13,Collagenase 3,15667,-0.012501687010707,0.0111097064194439,-0.034276711592817,0.009273337571403,0.260481685760991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY75,Lymphocyte antigen 75,16054,-0.0149173327477492,0.0132635284680773,-0.0409138485451807,0.0110791830496823,0.260738052237778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D17,TBC1 domain family member 17,15667,-0.017472216956446,0.015560921181216,-0.0479716224716294,0.0130271885587374,0.261528347330319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAB2,Disabled homolog 2,16195,-0.0430478986122869,0.0383524558194015,-0.118218712018314,0.0321229147937402,0.261696845476554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRADD,Death domain-containing protein CRADD,15900,-0.0291684347307178,0.0260087565365638,-0.0801455975423829,0.0218087280809473,0.26209835245495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB1A1,Uteroglobin,16079,0.0208722081043815,0.0186376350501122,-0.0156575565938384,0.0574019728026014,0.262774936043746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRGN,Neurogranin,13988,-0.0353606595898738,0.0315768856252341,-0.0972513554153326,0.0265300362355849,0.262806596107492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YOD1,Ubiquitin thioesterase OTU1,13501,-0.0245432079981877,0.0219227442651646,-0.0675117867579103,0.0184253707615349,0.262933295597417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO2,Amphoterin-induced protein 2,15973,-0.00882510219192193,0.00788676216625756,-0.0242831560377868,0.00663295165394289,0.263166970250288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILPL2,RILP-like protein 2,13965,-0.0377049226999819,0.0337505350632088,-0.103855971423871,0.0284461260239074,0.263942942905215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCS1,Neuronal calcium sensor 1,16195,-0.0108993063275835,0.00975748116386284,-0.0300239694087546,0.0082253567535877,0.264002152754835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCHE,Cholinesterase,13720,-0.0108270217263493,0.00969426401911467,-0.029827779203814,0.00817373575111549,0.264078795935869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX5,Syntaxin-5,13568,-0.0154753570592992,0.0138568658478209,-0.0426348141210281,0.0116841000024298,0.264099359209829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16148,-0.0281138609179262,0.0251745829385818,-0.0774560434775466,0.0212283216416942,0.264115392746945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACTB2,Endoribonuclease LACTB2,16063,-0.0252878917085906,0.0226831455959996,-0.0697468570767499,0.0191710736595687,0.264939206433457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCA,Calcitonin,15900,-0.0242117039770719,0.0217207379433947,-0.0667843503461256,0.0183609423919817,0.265003809818872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL2,Kin of IRRE-like protein 2,15667,-0.0149039882097981,0.0133757009325325,-0.0411203620375619,0.0113123856179657,0.265185421481676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHMT1,"Serine hydroxymethyltransferase, cytosolic",16103,-0.032938161777298,0.0295741554039568,-0.0909035063690534,0.0250271828144574,0.265403871446538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM1,V-set and transmembrane domain-containing protein 1,15667,-0.0190396720783046,0.0170957219343962,-0.0525472870697212,0.0144679429131119,0.265420829367085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLKB1,Plasma kallikrein,13745,0.00965423699722304,0.00866871907035734,-0.00733645238067734,0.0266449263751234,0.265433118277224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,15725,-0.0259384344954767,0.023314073124716,-0.0716340178199201,0.0197571488289666,0.265912087496278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTproBNP,N-terminal prohormone of brain natriuretic peptide,16063,-0.0393803747165405,0.0354123810054284,-0.10878864148718,0.0300278920540992,0.26613286837695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THPO,Thrombopoietin,15821,-0.0147087925690199,0.013227201290231,-0.0406341070978726,0.0112165219598327,0.26615035775895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD1C,T-cell surface glycoprotein CD1c,16091,-0.009281394028032,0.00834744540330015,-0.0256423870185003,0.0070795989624363,0.266204498552614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMC3,Structural maintenance of chromosomes protein 3,13506,-0.0210577270406771,0.0189422036318501,-0.0581844461591033,0.016068992077749,0.266294251347611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGH,Gamma-glutamyl hydrolase,15773,-0.0130735702256802,0.0117617083506455,-0.0361265185929454,0.00997937814158496,0.266354368913897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16103,-0.0198931125621964,0.0179044618403413,-0.0549858577692653,0.0151996326448725,0.266554771677447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DARS1,"Aspartate--tRNA ligase, cytoplasmic",15900,-0.0276587814337992,0.0249035876794342,-0.0764698132854903,0.0211522504178919,0.266742554544891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16063,0.0119400058610259,0.0107727441029282,-0.00917457258071344,0.0330545843027653,0.267725898951885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549L,UPF0606 protein KIAA1549L,13751,-0.0108670828904245,0.00981641761716743,-0.0301072614200727,0.00837309563922366,0.268299721617323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB3,Plexin-B3,16013,-0.0180895285139694,0.0163434754290048,-0.0501227403548189,0.01394368332688,0.268381970014552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,13703,-0.0162528558903154,0.0147045823025461,-0.0450738372033057,0.0125681254226749,0.269052546922986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",15863,0.0155894364296169,0.0141253655145114,-0.0120962799788255,0.0432751528380592,0.269762462453707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD1,COMM domain-containing protein 1,13643,-0.0234740802200625,0.0212821240868381,-0.0651870434302651,0.0182388829901401,0.270048735151364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRZB,Secreted frizzled-related protein 3,15861,-0.00980033584572968,0.00888987377618778,-0.0272244884470577,0.00762381675559837,0.270297759141155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCAM,Cell surface glycoprotein MUC18,16138,0.0125040778483092,0.0113429813131783,-0.00972816552552026,0.0347363212221386,0.270320537850908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM13A,Protein FAM13A,13936,-0.0256626897286404,0.0232993693135132,-0.0713294535831263,0.0200040741258455,0.270727375599806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMN,Protein amnionless,15797,0.0178542874073608,0.0162171898115911,-0.0139314046233578,0.0496399794380793,0.270935952884669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP2,Dipeptidase 2,15973,-0.0109591641367458,0.00995936528865581,-0.0304795201025112,0.00856119182901957,0.271179785776105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK1,Docking protein 1,13938,-0.0514102639669034,0.0467218134619015,-0.14298501835223,0.0401644904184236,0.271199455320682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFP,Properdin,14020,-0.00867645581482867,0.00790169424719524,-0.0241637765393313,0.00681086490967399,0.272201508106098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS10,Regulator of G-protein signaling 10,13946,-0.0226427688878258,0.0206371703881127,-0.0630916228485268,0.0178060850728752,0.272580019390452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGN,Secretagogin,15797,0.0166361659021629,0.0151791165297218,-0.0131149024960918,0.0463872343004176,0.273099701334413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA4,Laminin subunit alpha-4,16133,-0.0125448904719297,0.0114501605993035,-0.0349872052465646,0.00989742430270516,0.273266616906678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2L,von Willebrand factor C domain-containing protein 2-like,13946,0.0173335655301179,0.0158210288113393,-0.0136756509401071,0.048342782000343,0.273271517404954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMSB10,Thymosin beta-10,16074,-0.0285244080162234,0.0260564077769344,-0.0795949672590147,0.022546151226568,0.273656795926233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN5,CCN family member 5,16074,0.0144205064631324,0.013174883405466,-0.011402265011581,0.0402432779378458,0.273732314372542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD9,Enhancer of filamentation 1,13568,-0.0129045577293962,0.0117898734848264,-0.036012709759656,0.0102035943008636,0.273735076465102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL1,Delta-like protein 1,16091,-0.0111223213389854,0.0101647645524664,-0.0310452598618195,0.00880061718384865,0.273882113268272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA1,DnaJ homolog subfamily A member 1,13506,-0.0178578162636352,0.0163342156790321,-0.0498728789945381,0.0141572464672677,0.27429188002994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLYR1,Putative oxidoreductase GLYR1,13913,-0.022543923981171,0.020633237225578,-0.0629850689433038,0.0178972209809619,0.274587357106513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT2,Signal transducer and activator of transcription 2,13568,-0.0292213535616281,0.0267644915267988,-0.0816797569541537,0.0232370498308974,0.274942368524938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFA2,BPI fold-containing family A member 2,13156,0.0415017486395418,0.0380376411667953,-0.0330520280473771,0.116055525326461,0.275261859724776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUCA1,Tissue alpha-L-fucosidase,16157,-0.0304853294274322,0.0279542363653695,-0.0852756327035564,0.024304973848692,0.275489785871766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR2,Fibroblast growth factor receptor 2,16091,-0.00828282770545719,0.00759609338002646,-0.0231711707303091,0.00660551531939467,0.275550571796484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD1,Sushi domain-containing protein 1,15821,-0.0180336632929335,0.0165432884533583,-0.0504585086615157,0.0143911820756487,0.275690384719133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL21R,Interleukin-21 receptor,13568,-0.0206756225663857,0.0189816649227716,-0.0578796858150181,0.0165284406822467,0.276066643059247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLSCR3,Phospholipid scramblase 3,13911,-0.0220416402130657,0.0202592880712718,-0.0617498448327584,0.0176665644066271,0.276624112856061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM3,Dynamin-3,13946,-0.0206161390005944,0.0189555102191471,-0.0577689390301227,0.0165366610289339,0.27678760787345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP43,Centrosomal protein 43,15680,-0.0259708071953854,0.0239023438341457,-0.0728194011103109,0.0208777867195402,0.277257712749117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPG,Macrophage-capping protein,15925,-0.0219490549081833,0.0202086554009215,-0.0615580194939895,0.017659909677623,0.277441700420612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,13501,0.0192823267448835,0.0177967083626722,-0.015599221645954,0.054163875135721,0.27861605951858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX58,Antiviral innate immune response receptor RIG-I,15725,-0.0216284023323826,0.0199623489642559,-0.0607546063023241,0.0174978016375588,0.278621018194444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK1C,Divergent protein kinase domain 1C,13605,-0.0161871367577767,0.0149477112091791,-0.0454846507277678,0.0131103772122144,0.278864293714112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QSOX1,Sulfhydryl oxidase 1,13736,-0.0166130668484739,0.0153456287497325,-0.0466904991979497,0.0134643655010019,0.27900823774865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI2,Protein-arginine deiminase type-2,15797,0.0209897559579733,0.0194076191434836,-0.0170491775632545,0.0590286894792012,0.27948175872318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",13751,-0.0184609017005488,0.0170992805695615,-0.0519754916168893,0.0150536882157918,0.280325790613234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIAPIN1,Anamorsin,16091,-0.0232829727828113,0.0215816202002191,-0.0655829483752406,0.0190170028096181,0.280678186207671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",15797,-0.0267083235394562,0.0247646937901122,-0.0752471233680762,0.0218304762891638,0.280834344885443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRELP,Prolargin,16044,0.0084709589910651,0.00785690442758414,-0.00692857368699982,0.02387049166913,0.280980916048748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,15797,-0.0160607195711929,0.014898340269309,-0.0452614664990385,0.0131400273566527,0.281040983041024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSCAR,Osteoclast-associated immunoglobulin-like receptor,16076,-0.0123443462330932,0.0114689909146746,-0.0348235684258555,0.0101348759596691,0.28179869850479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAMT,Guanidinoacetate N-methyltransferase,13501,-0.0134170725036092,0.0124843247963098,-0.0378863491043763,0.011052204097158,0.282522240002687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRO3,Tyrosine-protein kinase receptor TYRO3,16063,-0.0104268730612804,0.00972355247813076,-0.0294850359184167,0.00863128979585586,0.283587220391698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS5,Transmembrane protease serine 5,15835,0.0140342340337026,0.0130909201398964,-0.0116239694404944,0.0396924375078996,0.283710047295061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN3,Ataxin-3,13938,-0.0233451650100443,0.0217799365471895,-0.0660338406425358,0.0193435106224472,0.283798975260188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPT1,Translationally-controlled tumor protein,15797,-0.023866766188806,0.022308711902304,-0.0675918415173218,0.0198583091397097,0.284707415341643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLI1,Friend leukemia integration 1 transcription factor,15725,-0.0406476746745587,0.038038455938947,-0.115203048314895,0.0339076989657773,0.28526896600441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGK,N-acetyl-D-glucosamine kinase,13616,-0.0211989393162523,0.0198495821348928,-0.0601041203006421,0.0177062416681376,0.285548882759477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF1R,Insulin-like growth factor 1 receptor,15973,-0.00778782597256966,0.00729707613697501,-0.0220900952010407,0.00651444325590135,0.285873775869715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGFL2,Hepatoma-derived growth factor-related protein 2,13938,-0.0235570218635821,0.022078103509437,-0.0668301047420786,0.0197160610149144,0.285996769394219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEPD,Xaa-Pro dipeptidase,13988,0.00966404015040235,0.0090626553162515,-0.00809876426945058,0.0274268445702553,0.286280006104314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,15876,0.0118325715499661,0.0111145113566977,-0.00995187070916146,0.0336170138090936,0.287070628954132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD28,T-cell-specific surface glycoprotein CD28,15725,-0.0133467008014837,0.0125389322304987,-0.0379230079732611,0.0112296063702938,0.287154454881113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,13568,-0.0115848317287591,0.0108867242733683,-0.0329228113045609,0.00975314784704268,0.287291189459459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTD,Deoxycytidylate deaminase,13703,-0.0348471430033438,0.032770162160884,-0.0990766608386765,0.0293823748319889,0.287628306482787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGBL1,Integrin beta-like protein 1,13983,-0.0135508145761808,0.0127684208054982,-0.0385769193549573,0.0114752902025957,0.288582978999503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK2A1,Casein kinase II subunit alpha,13946,-0.0164976118024359,0.0155503867065524,-0.0469763697472786,0.0139811461424068,0.288747703205354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROS,Uroporphyrinogen-III synthase,13605,-0.0251439563796521,0.023717991485594,-0.0716312196914163,0.0213433069321122,0.289108096446414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC16A1,Monocarboxylate transporter 1,15667,-0.0205913333360716,0.0194295210297596,-0.0586731945544004,0.0174905278822572,0.289253660365784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP1,Caspase-1,15667,-0.0252585859612173,0.0238526083679806,-0.0720096983624593,0.0214925264400247,0.289641444120389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16068,-0.0216669836873201,0.020474331236563,-0.0617966729109836,0.0184627055363434,0.289956899642436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDHD2,Phospholipase DDHD2,13946,-0.0239485997416211,0.0226448418294586,-0.0683324897273599,0.0204352902441178,0.290267961511439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RB,Interleukin-17 receptor B,15864,0.0193790616185433,0.0183432701128672,-0.0165737478026764,0.0553318710397629,0.290770960142762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPEP,Glutamyl aminopeptidase,13501,-0.0162806793993295,0.015411068563252,-0.0464863737833035,0.0139250149846445,0.290791788024437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,15973,-0.010205863298451,0.00966168071858972,-0.0291427575068869,0.00873103090998482,0.290836295641946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD63,CD63 antigen,15888,-0.0185893256548869,0.0176002376994332,-0.0530857915457759,0.0159071402360021,0.290894102836007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16103,-0.0235675454029191,0.0223209942835959,-0.0673166941987671,0.0201816033929289,0.291054168814298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEND1,Cell cycle exit and neuronal differentiation protein 1,13528,-0.0217603261740462,0.0206336827855645,-0.0622023444337526,0.0186816920856602,0.291626175148357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLGAP5,Disks large-associated protein 5,13946,-0.0188012463363787,0.0178344969383742,-0.0537568603355921,0.0161543676628346,0.29180657054785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF12,Tumor necrosis factor ligand superfamily member 12,16249,0.0103651524489232,0.00983972525772162,-0.00892070905621115,0.0296510139540576,0.292174039546294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THY1,Thy-1 membrane glycoprotein,16208,0.0100948155823555,0.00958370301021717,-0.00868924231767012,0.0288788734823812,0.292204835384614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SGSH,N-sulphoglucosamine sulphohydrolase,13763,-0.0204964683074871,0.0194774708348506,-0.0586723111437944,0.0176793745288201,0.292672754847921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB17,Zinc finger and BTB domain-containing protein 17,15821,-0.0155362996428063,0.0147775324674588,-0.0445002632790255,0.0134276639934129,0.293115779528137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP152,Centrosomal protein of 152 kDa,13506,-0.0152985125142633,0.0145541365472393,-0.0438246201468523,0.0132275951183256,0.293210678507748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC59,Leucine-rich repeat-containing protein 59,13965,-0.0173714738408957,0.0165384617137614,-0.049786858799868,0.0150439111180766,0.293567066069285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANF,Mesencephalic astrocyte-derived neurotrophic factor,16133,-0.0432184004827322,0.0411934782751486,-0.123957617902023,0.037520816936559,0.294121881467128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPDC1,Neural proliferation differentiation and control protein 1,16063,-0.0112219995433816,0.0107010645480871,-0.0321960860576324,0.00975208697086913,0.294340905266573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK1,Dickkopf-related protein 1,16208,-0.0213841195451109,0.0204170952047836,-0.0614016261464867,0.0186333870562649,0.294947607803812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16044,-0.0138129887381912,0.0132193224677881,-0.0397228607750559,0.0120968832986735,0.296080796029842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2,Granulocyte-macrophage colony-stimulating factor,13501,-0.0131563385330168,0.0125992520439606,-0.0378508725391795,0.0115381954731459,0.296404256251585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTG,Protogenin,16195,0.00900334849994651,0.00862406633550643,-0.00789982151764609,0.0259065185175391,0.296510468322682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL25,Interleukin-25,13452,-0.0123858550221795,0.0118818816165121,-0.0356743429905431,0.0109026329461842,0.297237935287309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCB,Tubulin-folding cofactor B,15918,-0.0359134600800399,0.0344632669028425,-0.103461463209611,0.0316345430495315,0.297390714221202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPHN1,Oligophrenin-1,13938,-0.038453168497187,0.0369395344859283,-0.110854656089606,0.0339483190952325,0.297904765805842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOC2B,Double C2-like domain-containing protein beta,13605,-0.0125618580340693,0.0120714282140765,-0.0362218573336592,0.0110981412655207,0.298067056193701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPPED1,Serine/threonine-protein phosphatase CPPED1,16208,-0.0238257865643967,0.0228963915896902,-0.0687027140801896,0.0210511409513962,0.29808079230369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGR,Tyrosine-protein kinase Fgr,15667,-0.0213124337811715,0.020517680895676,-0.0615270883366965,0.0189022207743535,0.298944031746022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP4,Metalloproteinase inhibitor 4,16074,-0.0143521324628819,0.013832950035305,-0.0414647145320797,0.0127604496063158,0.299503471428706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB2B,Ras-related protein Rab-2B,13913,-0.0216918186014763,0.020918872673613,-0.0626928090417578,0.0193091718388053,0.299777342611152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX1,"Adrenodoxin, mitochondrial",13501,-0.0232486756569981,0.0224551764993483,-0.0672608215957208,0.0207634702817245,0.30053010691675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,15821,-0.0118618488200058,0.0114754162051497,-0.0343536645820992,0.0106299669420876,0.301304020767805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXYD5,FXYD domain-containing ion transport regulator 5,15797,0.0232439686489904,0.0224920307590895,-0.020840411638825,0.0673283489368059,0.301417938228676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3B,Protein FAM3B,15973,0.0125913427142991,0.0121947229274173,-0.0113103142234388,0.0364929996520371,0.30184241011926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,13643,-0.00960484327281941,0.00930419815038949,-0.0278410716475828,0.00863138510194399,0.30194390290847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEC31A,Protein transport protein Sec31A,13643,-0.0274426646833397,0.026586455544181,-0.0795521175499344,0.024666788183255,0.301994544147018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAPGEF2,Rap guanine nucleotide exchange factor 2,13751,-0.0187467726549231,0.0181659663361978,-0.0543520666738707,0.0168585213640246,0.302103298302341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLON5,IgLON family member 5,13506,-0.0321959919439619,0.0312423661325731,-0.0934310295638053,0.0290390456758814,0.302782807560095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNIP1,TNFAIP3-interacting protein 1,13938,-0.0314086243987463,0.0304937494464532,-0.0911763733137945,0.028359124516302,0.303026934792663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GM2A,Ganglioside GM2 activator,13641,-0.0135780605143905,0.0131826251688707,-0.039416005845377,0.012259884816596,0.303029832081219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTLA,B- and T-lymphocyte attenuator,13506,-0.0317103786998871,0.0308198078492571,-0.0921172020844311,0.0286964446846569,0.303546967060298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH2,Neurogenic locus notch homolog protein 2,13983,-0.00749541832151753,0.00728726151849117,-0.0217784508977602,0.00678761425472516,0.303702187618093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALB,Ras-related protein Ral-B,13568,0.0105350756458331,0.0102461801436096,-0.00954743743564181,0.030617588727308,0.303876253536308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT2,Linker for activation of T-cells family member 2,15973,-0.0439928122759826,0.0428087075677642,-0.1278978791088,0.0399122545568352,0.304125190653725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDI2,Isopentenyl-diphosphate delta-isomerase 2,15667,-0.0166978400804148,0.0162512544629263,-0.0485502988277504,0.0151546186669208,0.304210342023663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO3,Beta-enolase,13643,-0.021132077532007,0.0205741250073141,-0.0614573625463426,0.0191932074823285,0.304382596751064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUSB,Beta-glucuronidase,16132,-0.0210296460765126,0.020478174152988,-0.0611668674163691,0.0191075752633438,0.304468959618498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEXN,Nexilin,13988,-0.0244644950156768,0.0238254093883803,-0.0711622974169021,0.0222333073855486,0.304521261029595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,13643,-0.00739484949919787,0.00721593944703396,-0.0215380908153844,0.00674839181698869,0.30547871397387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP25,Ubiquitin carboxyl-terminal hydrolase 25,13913,-0.0254070800804621,0.0248207225413967,-0.0740556962615996,0.0232415361006754,0.306030857242514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMD,Dystrophin,13643,-0.0183385628015542,0.0179263011999233,-0.0534741131534038,0.0167969875502954,0.306327145786973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,13528,0.011647493723866,0.0113899277955437,-0.0106767647553995,0.0339717522031316,0.306508937564561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINK1,Misshapen-like kinase 1,13938,-0.0325005136285763,0.0317972889549005,-0.0948231999801812,0.0298221727230286,0.306743820912668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIL1,Nucleotide exchange factor SIL1,13643,-0.0115400898497025,0.0112956826333261,-0.0336796278110217,0.0105994481116166,0.306970766432214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD33,Myeloid cell surface antigen CD33,16091,-0.0279047900923612,0.0273607464294646,-0.0815318530941119,0.0257222729093895,0.307798780584363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDHB,Succinate dehydrogenase,13936,-0.0236802906573419,0.023227056827098,-0.069205322038454,0.0218447407237703,0.307977113282121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME1,Proteasome activator complex subunit 1,15889,-0.0132265438206483,0.0129792667881549,-0.0386659067254318,0.0122128190841352,0.308193954638645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN2,Alpha-actinin-2,13501,-0.0207220229648369,0.0203592188578676,-0.0606260919262575,0.0191820459965837,0.308781697061375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,13568,-0.017041053977127,0.0167498835766162,-0.0498708257872948,0.0157887178330408,0.3089892218675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA2,Integrin alpha-2,13703,0.0118485536578787,0.0116507541355957,-0.0109869244478889,0.0346840317636464,0.309182153781318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTLC1,Serine palmitoyltransferase 1,13938,-0.0131982099167133,0.012978473131196,-0.0386360172538575,0.0122395974204309,0.309203988126929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36A,Interleukin-36 alpha,13568,0.0199070748946512,0.0195949763724966,-0.0184990787954421,0.0583132285847446,0.309682057569465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL2,Podocalyxin-like protein 2,16091,-0.00970873390361347,0.00956081222991698,-0.0284479258742508,0.00903045806702382,0.309896328728609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG4,Regenerating islet-derived protein 4,16076,-0.0169924320263937,0.0167479700624637,-0.0498184533488225,0.0158335892960351,0.310313485008176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDSN,Corneodesmosin,16204,0.0150741172512088,0.0148875288685553,-0.0141054393311596,0.0442536738335772,0.31129831232051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSTN,Osteocrin,13605,-0.0149307758669505,0.014746519301303,-0.0438339536975044,0.0139724019636033,0.311319499280828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",15900,-0.033378754989052,0.0330406831535854,-0.0981384939700794,0.0313809839919755,0.312399544150163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDRG1,p53 and DNA damage-regulated protein 1,13605,-0.0184599739688986,0.0182789109280335,-0.0542866393878444,0.0173666914500471,0.312558512465937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP4,Secreted frizzled-related protein 4,13703,0.0144685976159287,0.0143339594681982,-0.0136259629417398,0.0425631581735972,0.312804059958473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAX1BP1,Tax1-binding protein 1,13938,-0.0219484950999373,0.021745722891914,-0.0645701119680887,0.0206731217682141,0.31283647997294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NINJ1,Ninjurin-1,15725,0.0191773980104468,0.0190386981070961,-0.0181384502794616,0.0564932463003552,0.313813273484817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLPBP,Pyridoxal phosphate homeostasis protein,16063,-0.0234916677036859,0.0233464952406125,-0.0692507983752863,0.0222674629679146,0.314325804044804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRN1,Neuritin,13946,-0.0123538921650861,0.0122845122028807,-0.0364315360827323,0.0117237517525602,0.314602506894465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PF4,Platelet factor 4,13928,-0.0337020168589695,0.0335361429248714,-0.0994328569917175,0.0320288232737785,0.314940268783333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7,Interleukin-7,16054,-0.0223232478652358,0.0222279279963426,-0.0658899867380673,0.0212434910075958,0.315254824583679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKZF2,Zinc finger protein Helios,15725,0.0315901571566307,0.0314607027067042,-0.0300728201485095,0.0932531344617708,0.315338747635619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED8,Protein TMED8,13936,-0.0355211887137063,0.0353804714442304,-0.104866912744398,0.0338245353169852,0.315407024531091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADM,Pro-adrenomedullin,16195,-0.00909269696334897,0.00905972548754295,-0.0268497589189332,0.00866436499223521,0.315567490431487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD1,Mothers against decapentaplegic homolog 1,15725,-0.0284960824086084,0.0284014447732041,-0.0841629141640885,0.0271707493468717,0.315716085413461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3F,Semaphorin-3F,16063,-0.00902673621697896,0.00900836429296477,-0.0266831302311899,0.00862965779723198,0.316339657288471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,13539,0.0132521634274965,0.0132299223754391,-0.0126784844283642,0.0391828112833571,0.316515549688527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFB,Complement factor B,13764,-0.0113799378913867,0.0113608969905298,-0.0336472959928251,0.0108874202100516,0.316517727108551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT2,Thialysine N-epsilon-acetyltransferase,13751,-0.0238788685792641,0.0238488231589474,-0.070622561970801,0.0228648248122728,0.316718845199391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF23,Fibroblast growth factor 23,16163,-0.0197839300699491,0.0197636315281544,-0.0585206478651317,0.0189527877252335,0.316828722383042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF9,Fibroblast growth factor 9,13478,-0.0141028838349516,0.0140898996036342,-0.0417190870580746,0.0135133193881714,0.316882735848594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GJA8,Gap junction alpha-8 protein,13506,-0.0216878552194453,0.0217068585746646,-0.0642332980257879,0.0208575875868972,0.317752280115937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZHX2,Zinc fingers and homeoboxes protein 2,13938,-0.0120391020939109,0.0120498723305847,-0.0356568518618569,0.011578647674035,0.317760612588308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16054,-0.0289467960966879,0.0289858534237784,-0.0857590688072935,0.0278654766139178,0.317978104642572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT1,Deaminated glutathione amidase,13643,-0.0161856307037173,0.0162255792361021,-0.0479877660064774,0.0156165045990427,0.318521182990817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1B,Meprin A subunit beta,16063,0.0399294686878149,0.0400717783810359,-0.0386112169390155,0.118470154314645,0.319047237692804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK3,Dickkopf-related protein 3,16254,0.0101376141605352,0.0101778247090073,-0.00981092226911905,0.0300861505901894,0.319241081007304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX6,Peroxiredoxin-6,16195,0.0204898220121968,0.0205777947431399,-0.0198426556843575,0.060822299708751,0.319398732204836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRN1,Leucine-rich repeat neuronal protein 1,15797,0.01348491547946,0.0135604451978743,-0.0130935571083736,0.0400633880672935,0.320028743656848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPNMB,Transmembrane glycoprotein NMB,15640,-0.0096925155345542,0.00976006463298616,-0.0288222422152071,0.00943721114609867,0.320686818923837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PITHD1,PITH domain-containing protein 1,13478,-0.0273650556858388,0.0275585283813804,-0.0813797713133443,0.0266496599416668,0.320737755029284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC80,Coiled-coil domain-containing protein 80,16063,-0.0118991288804312,0.0119917033785245,-0.0354028675023392,0.0116046097414767,0.321075857652633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIABLO,"Diablo homolog, mitochondrial",16012,-0.0375238318646618,0.0378769891479591,-0.111762730594662,0.036715066865338,0.321858696870803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP2,Integrin beta-1-binding protein 2,15821,-0.0380557722437037,0.0384688978298441,-0.113454811990198,0.0373432675027907,0.322550705306312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBN,Ameloblastin,15797,0.00933481914946443,0.00944463166324164,-0.00917665891048917,0.027846297209418,0.322985145935606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX,Glutaredoxin-1,15963,-0.0194399186962692,0.0196895767882307,-0.0580314892012014,0.019151651808663,0.323500623840263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP3,Dual specificity protein phosphatase 3,15667,0.029474282103594,0.0298536569663956,-0.0290388855505413,0.0879874497577293,0.323514683086548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA2,Carbonic anhydrase 2,16025,-0.0238914039547306,0.0242046209319229,-0.0713324609812995,0.0235496530718382,0.323628327234807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLC,Galectin-10,16041,-0.0229682487875984,0.0233188747075361,-0.0686732432143691,0.0227367456391723,0.324656693191184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FIS1,Mitochondrial fission 1 protein,16054,-0.0262322113080058,0.0266435969978648,-0.0784536614238208,0.0259892388078092,0.324855254087931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM58,E3 ubiquitin-protein ligase TRIM58,13913,-0.0294560097701637,0.0299248134873351,-0.0881086442053405,0.0291966246650131,0.324968477671551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP3,Insulin-like growth factor-binding protein 3,16138,-0.00998083824591649,0.0101586083757718,-0.0298917106624293,0.00993003417059633,0.325868057337894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BEX3,Protein BEX3,13506,-0.0157216705945901,0.016005222964865,-0.0470919076057256,0.0156485664165453,0.325977686466839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLG4,Disks large homolog 4,13938,-0.0240753275178991,0.0245170573354449,-0.0721287598953712,0.0239781048595729,0.326125405636364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLEKHO1,Pleckstrin homology domain-containing family O member 1,13938,-0.0234436500453079,0.0238783903232056,-0.0702452950787908,0.0233579949881751,0.326218615758008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG3,Proteoglycan 3,13983,-0.0169024245504189,0.0172175778124012,-0.0506488770627251,0.0168440279618874,0.32626671617628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,15900,-0.0376745426250739,0.0383857524564289,-0.112910617439675,0.0375615321895267,0.32637496446358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLP1R,Glucagon-like peptide 1 receptor,13528,0.0124682933276527,0.0127259440781532,-0.0124745570655275,0.0374111437208329,0.327225152271127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DXO,Decapping and exoribonuclease protein,13938,-0.0154199196610341,0.0157505028022246,-0.0462909051533944,0.0154510658313261,0.327591423036848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB1,Lamin-B1,13904,-0.0211345994167931,0.0215993603703048,-0.0634693457425905,0.0212001469090044,0.32785270872641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP11,Low-density lipoprotein receptor-related protein 11,16063,0.011879634837299,0.0121678633239113,-0.0119693772775671,0.0357286469521651,0.328924433476951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD1,Leiomodin-1,13946,-0.0117148541579887,0.0120084206532927,-0.0352513586384423,0.0118216503224649,0.329302824374561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G7,Platelet-activating factor acetylhydrolase,16074,-0.0106330184626017,0.01090640529308,-0.0320095728370386,0.0107435359118352,0.329607996408212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1,Macrophage colony-stimulating factor 1,16133,-0.0089757155162923,0.00920735493166238,-0.0270221311823506,0.00907070014976596,0.329653310989711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK13,Mitogen-activated protein kinase 13,13506,-0.0147311920128745,0.0151173566526143,-0.0443612110519986,0.0148988270262496,0.329847872102271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13535,-0.00948211110162062,0.00974375895803202,-0.0285798786593634,0.00961565645612213,0.330497590015533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRN,"Attractin, Isoform 2",14020,-0.00564188160280035,0.00580583603571,-0.0170213202327919,0.00573755702719125,0.33118653738307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTPP1,dCTP pyrophosphatase 1,16063,0.0105955091139061,0.0109126372626451,-0.0107932599208784,0.0319842781486905,0.331593105597513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD5,Mothers against decapentaplegic homolog 5,15973,-0.00671613061881042,0.00691743202488809,-0.0202742973875911,0.00684203614997023,0.331613090215703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS28,Vacuolar protein sorting-associated protein 28 homolog,13751,-0.0223607096841697,0.0230677247548301,-0.0675734502036366,0.0228520308352972,0.332387425417777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD8,Ly6/PLAUR domain-containing protein 8,15725,0.0170244250222392,0.0175751444944563,-0.0174228581868952,0.0514717082313735,0.332727337948085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMB1,Laminin subunit beta-1,13643,-0.0101490598476751,0.0104824793702169,-0.0306947194133003,0.0103965997179501,0.332965327952066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBB,Inhibin beta B chain,13703,-0.0175002743786535,0.0180756009457121,-0.0529284522322492,0.0179279034749422,0.33297603241693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF2,Trefoil factor 2,16103,-0.0189485570957261,0.0195871774025492,-0.0573394248047226,0.0194423106132703,0.333360649576292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX9,Sorting nexin-9,16063,-0.0225745169194753,0.0233733580313334,-0.0683862986608888,0.0232372648219382,0.334147521556215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAN,Versican core protein,16208,-0.00997106410499973,0.0103247102299564,-0.0302074961557143,0.0102653679457149,0.334184917233588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3G,T-cell surface glycoprotein CD3 gamma chain,13568,-0.0288839646609166,0.029973266392555,-0.0876315667903244,0.0298636374684912,0.335234832106148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLK1,Protein delta homolog 1,16254,0.0184022253073243,0.0191007416078737,-0.0190352282441081,0.0558396788587567,0.335346179513412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSCA,Prostate stem cell antigen,13936,-0.0863078857744577,0.0898277705640387,-0.262370316079974,0.0897545445310582,0.336661789782004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL9,Interleukin-9,13751,-0.0183869835766593,0.0191392875710691,-0.0558999872159548,0.0191260200626361,0.33672335621538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB1,BPI fold-containing family B member 1,16031,-0.0206223683158322,0.0214872057944659,-0.0627372916729854,0.0214925550413211,0.337195011062954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR2,Complement receptor type 2,16138,-0.0153740433114299,0.0160322180459578,-0.0467971906815071,0.0160491040586473,0.337599952824724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1,Integrin beta-1,16060,-0.007116391450061,0.00742251978517084,-0.0216645302289958,0.00743174732887384,0.337695713300494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKD2,Serine/threonine-protein kinase D2,13501,-0.0157143721439973,0.0164024964886176,-0.0478632652616878,0.0164345209736931,0.338055937440474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL5,Insulin-like peptide INSL5,13936,-0.0321553387536683,0.0335789573692534,-0.0979700951974049,0.0336594176900683,0.338279187153281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16249,-0.0115654650901772,0.0120822161946025,-0.0352466088315981,0.0121156786512437,0.338465211183189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP1,Dipeptidase 1,15900,0.0161526356527259,0.0168803441316927,-0.0169328388453919,0.0492381101508436,0.338637246213849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPT1,Palmitoyl-protein thioesterase 1,13605,-0.0250592443575324,0.0261981886959467,-0.0764076942015879,0.0262892054865232,0.33882365121824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,13528,-0.0162970996575664,0.0170884645312185,-0.0497904901387548,0.017196290823622,0.340257584349834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATOX1,Copper transport protein ATOX1,16091,-0.0232965847055379,0.0244556304061454,-0.071229620301583,0.0246364508905071,0.340803965282378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX7,Syntaxin-7,13568,0.0164238623958647,0.0172445658523208,-0.0173754866746841,0.0502232114664135,0.340907089602552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APPL2,DCC-interacting protein 13-beta,13703,-0.0366530269847376,0.0384919643220021,-0.112097277055862,0.0387912230863866,0.340999483238725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK15,Kallikrein-15,13897,-0.0168297428767245,0.0176845695239775,-0.0514914991437203,0.0178320133902714,0.341284705496459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYAL1,Hyaluronidase-1,15994,-0.00749552316084484,0.007879884391068,-0.0229400965673381,0.00794905024564844,0.34150583630453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN2B2,Epididymis-specific alpha-mannosidase,13965,-0.0194936462679384,0.0204972438121658,-0.0596682441397834,0.0206809516039066,0.341601846085598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COCH,Cochlin,13965,-0.015186930816807,0.0159756967038687,-0.0464992963563896,0.0161254347227756,0.341810155914217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA8,Carbonic anhydrase-related protein,13568,0.00839506049381392,0.00883154100730749,-0.00891475988050877,0.0257048808681366,0.34183605577339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM2,Neural cell adhesion molecule 2,16074,-0.00870752629986302,0.00916792841704217,-0.0266766659972657,0.00926161339753964,0.342237718861031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG4,V-set and immunoglobulin domain-containing protein 4,16049,-0.0130607420186992,0.013752318696263,-0.0400152866633748,0.0138938026259763,0.342272926719632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAPIN,SNARE-associated protein Snapin,13946,-0.0189140076999465,0.0199565057731479,-0.0580287590153165,0.0202007436154234,0.343267326443334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKBIE,NF-kappa-B inhibitor epsilon,15725,-0.0159862110111838,0.016871349275897,-0.0490540555919419,0.0170816335695743,0.343380288129595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL2A1,Collagen alpha-1(II) chain,13643,-0.0260643114088957,0.0275142233133331,-0.0799921891030286,0.0278635662852371,0.343501103073881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAVL4,ELAV-like protein 4,13528,-0.0275378742412159,0.0291096437593017,-0.0845927760094473,0.0295170275270155,0.344162850065101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPP,Lipoma-preferred partner,13501,-0.0217161963947698,0.0229574558909571,-0.0667128099410458,0.0232804171515061,0.344200123060363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRBP,Acrosin-binding protein,13913,-0.0124902265949837,0.0132293792276561,-0.0384198098811896,0.0134393566912221,0.345120682830557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJAP1,Tight junction-associated protein 1,16091,-0.0268366031160092,0.0284261496659171,-0.0825518564612067,0.0288786502291883,0.345142169651128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT6C,"Keratin, type II cytoskeletal 6C",13501,-0.012527666652572,0.0132747042874548,-0.0385460870559835,0.0134907537508395,0.345327240635848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCAMP3,Secretory carrier-associated membrane protein 3,15973,-0.0275099338890294,0.029168909522104,-0.0846809965523532,0.0296611287742944,0.345631139647626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,13568,-0.0187265844805708,0.0198566803273018,-0.0576456779220822,0.0201925089609407,0.345653023309645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP1,Rho GTPase-activating protein 1,15725,-0.015002385871734,0.0159287338534744,-0.0462227042245439,0.0162179324810758,0.346286884450587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS2,RNA-binding protein with multiple splicing 2,13643,-0.0335174394756183,0.0356443746328094,-0.103380413755925,0.036345534804688,0.347065489366552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RB,Interleukin-2 receptor subunit beta,15797,0.0124984938006396,0.0133016226696712,-0.0135726866319159,0.0385696742331951,0.347426001797807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOL1,Apolipoprotein L1,13988,-0.0194943053380165,0.0207703149962617,-0.0602041227306895,0.0212155120546565,0.347969989320206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,13965,-0.010483139299219,0.0111870315209232,-0.0324097210802284,0.0114434424817904,0.34873382269226
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22RA1,Interleukin-22 receptor subunit alpha-1,15797,-0.0138717890156678,0.0148196495784202,-0.0429183021893714,0.0151747241580358,0.349266768153351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOSB,Protein fosB,15667,0.0126809693109655,0.013557564710107,-0.0138918575208441,0.0392537961427752,0.34962614064017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GAT1,"Beta-1,4-glucuronyltransferase 1",16074,0.0078317047801386,0.00838492765038713,-0.00860275341462018,0.0242661629748974,0.350306717284314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO1,Amphoterin-induced protein 1,13605,-0.0167909470465292,0.0179828736462687,-0.0520373793932158,0.0184554853001573,0.350465556917395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PER3,Period circadian protein homolog 3,13568,-0.0384809282061184,0.0412315940488771,-0.119294852541917,0.0423329961296807,0.350688211373395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP2,Src kinase-associated phosphoprotein 2,16133,-0.0333895138129446,0.0358197953072989,-0.103596312615251,0.0368172849893613,0.351271650938812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPI,Mannose-6-phosphate isomerase,15973,-0.0273579631119286,0.0293612463869412,-0.0849060060303333,0.0301900798064761,0.351468888421359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CILP,Cartilage intermediate layer protein 1,13983,-0.0170814612498216,0.0183403220334432,-0.0530284924353703,0.0188655699357271,0.35168293696586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L,Seizure 6-like protein,16091,0.00868420879212198,0.00932746115475777,-0.00959761507120324,0.0269660326554472,0.35184855271846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGBL2,Cytosolic carboxypeptidase 2,13528,-0.0293870366319629,0.0315911531529519,-0.0913056968117485,0.0325316235478227,0.352268657256993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIRC2,Baculoviral IAP repeat-containing protein 2,15725,-0.0202452727446148,0.0217687911191092,-0.0629121033380688,0.0224215578488393,0.352378309511061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSLP,Thymic stromal lymphopoietin,15821,-0.0193047129731426,0.0207877595972984,-0.0600487217838475,0.0214392958375622,0.35308069032062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,13913,-0.0345779729858944,0.0372546170010762,-0.107597022308004,0.0384410763362149,0.353344488783186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SETMAR,Histone-lysine N-methyltransferase SETMAR,15863,-0.00987709269303592,0.0106432929723169,-0.030737946918777,0.0109837615327051,0.353416008660161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAC1,Zinc phosphodiesterase ELAC protein 1,13946,-0.0270709528688601,0.029171884341372,-0.0842478461779492,0.030105940440229,0.353433528937448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),M6PR,Cation-dependent mannose-6-phosphate receptor,13643,-0.0129869135634083,0.013999176413833,-0.040425299334521,0.0144514722077044,0.353584173130918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP2,Pancreatic lipase-related protein 2,16044,0.0931141515589925,0.100471062847994,-0.103809131623076,0.290037434741061,0.354056895197563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12A_IL12B,Interleukin-12,15973,-0.0246510035103623,0.026623949985815,-0.0768339454825597,0.027531938461835,0.354514134199483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKAP4,Cytoskeleton-associated protein 4,16178,-0.00854044249100302,0.00922860474781719,-0.0266285077967247,0.00954762281471868,0.354755261766971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD2,"Superoxide dismutase [Mn], mitochondrial",16074,-0.0121942948616619,0.0131869531185698,-0.0380407229740587,0.0136521332507349,0.355123274515509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",15797,0.0191007399008973,0.0206805252932003,-0.0214330896737753,0.0596345694755699,0.35570352669807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA6,Corticosteroid-binding globulin,14020,0.00548836362685251,0.00594475566106792,-0.00616335746884061,0.0171400847225456,0.355904413840423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMTOR5,Ragulator complex protein LAMTOR5,13913,0.0130242213290632,0.0141113907921711,-0.0146341046235923,0.0406825472817186,0.356045103184044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,15973,-0.0298435309766553,0.0323617859647808,-0.0932726314676256,0.0335855695143151,0.356446391161824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFER,FAD-linked sulfhydryl oxidase ALR,15725,-0.0203220670718043,0.0220868909517617,-0.0636123733372573,0.0229682391936487,0.357536554207849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIK2,"Glutamate receptor ionotropic, kainate 2",13946,-0.0132778746506544,0.0144457560730723,-0.041591556553876,0.0150358072525673,0.358030934408601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP1,Ran-specific GTPase-activating protein,13643,-0.0168090466826776,0.0182895752598766,-0.0526566141920358,0.0190385208266807,0.358085326323661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMIP,C-Maf-inducing protein,13913,-0.0264090008828624,0.0287481638466059,-0.08275540202221,0.0299374002564852,0.358303708534859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL13,C-C motif chemokine 13,16220,-0.0217396452478736,0.0236699070662931,-0.0681326630978081,0.0246533726020609,0.358396570810577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUOM,Fucose mutarotase,13703,-0.0201952215692806,0.0220145445584786,-0.0633437289038986,0.0229532857653374,0.358971163822331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G1,V-type proton ATPase subunit G 1,13643,-0.0230139825205613,0.0250894908518349,-0.0721893845901578,0.0261614195490351,0.359014372005996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KITLG,Kit ligand,16063,0.011678662807895,0.0127353859059445,-0.0132826935677563,0.0366400191835463,0.3591435027681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L2,Seizure 6-like protein 2,15973,-0.00747561307296259,0.00815433199948389,-0.023458103791951,0.00850687764602584,0.359279206638598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL6,C-X-C motif chemokine 6,16249,-0.0242077324994525,0.0264084773430167,-0.0759683480917653,0.0275528830928603,0.359331716551671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARA5,Scavenger receptor class A member 5,16208,-0.00933363812987995,0.0101857219585183,-0.0292976531685759,0.010630376908816,0.359499477002593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RB,Cytokine receptor common subunit beta,13568,-0.0137028784032539,0.0149582078080075,-0.0430209657069486,0.0156152089004409,0.359642518359315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARS1,"Methionine--tRNA ligase, cytoplasmic",13677,-0.0270115110241328,0.0294969259018698,-0.0848254857917975,0.030802463743532,0.359819510890638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX3,Syntaxin-3,13938,-0.0120350749489854,0.0131495351224402,-0.0378081637889682,0.0137380138909975,0.360077730540984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF1,Trefoil factor 1,16000,-0.0245494315110663,0.02684454076474,-0.0771647314099568,0.0280658683878241,0.360466034431304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L15,Bcl-2-like protein 15,13568,-0.0185826875305674,0.0203506022881416,-0.058469868015325,0.0213044929541902,0.361191912734733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENSA,Alpha-endosulfine,13913,-0.0166636497865851,0.018300584507766,-0.0525327954218065,0.0192054958486363,0.362546802029177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCC,Tubulin-specific chaperone C,15918,-0.0253561081362616,0.0278721463211626,-0.0799855149257403,0.029273298653217,0.362979074929327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFA,Vascular endothelial growth factor A,16194,-0.0181478389445285,0.0199589580598044,-0.0572673967417452,0.0209717188526882,0.36322758696199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APCS,Serum amyloid P-component,13898,-0.0109910388688603,0.0120937108016564,-0.0346947120401068,0.0127126343023862,0.363459498889903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRAS,Ras-related protein R-Ras,13605,-0.0407883911304341,0.0449217340863513,-0.128834989939683,0.0472582076788145,0.363900712252401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP25,Synaptosomal-associated protein 25,13528,-0.0147456170418531,0.0162694467123648,-0.0466337325980881,0.0171424985143818,0.364773161821973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC10,Sialic acid-binding Ig-like lectin 10,16054,-0.0104787576396564,0.0115854789749611,-0.0331862964305803,0.0122287811512674,0.365758013433267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSBP1,Heat shock factor-binding protein 1,13643,-0.0297005064616917,0.0328897003451194,-0.0941643191381257,0.0347633062147423,0.366523990703906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX8,Syntaxin-8,16054,-0.015081360787398,0.0167156565932498,-0.0478440477101676,0.0176813261353717,0.36694844184909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX2,Transcription factor SOX-2,13921,-0.00743604433836715,0.00825791671599801,-0.0236215611017232,0.00874947242498894,0.367883323570643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSL,Cathepsin L1,16063,-0.0074290192943133,0.00826216188987419,-0.0236228565984667,0.00876481800984011,0.368580042934698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEXIM1,Protein HEXIM1,16054,-0.0249568642232368,0.0277568578066072,-0.079360305524187,0.0294465770777134,0.368599974726524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP1,Low molecular weight phosphotyrosine protein phosphatase,13568,0.0139907205137144,0.0155665613364633,-0.0165197397057536,0.0445011807331825,0.368792442824221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZPR1,Zinc finger protein ZPR1,13528,-0.0300257771506225,0.0334192594535242,-0.0955275256795298,0.0354759713782849,0.368957814493939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD3,Extracellular superoxide dismutase,13988,0.0181698739739481,0.0202293381132939,-0.0214796287281079,0.0578193766760041,0.369097505207508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGT1,Protein SGT1 homolog,15725,-0.0248550986264676,0.0276843867922889,-0.0791164967393539,0.0294062994864188,0.369304860698512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYAT1,Kynurenine--oxoglutarate transaminase 1,16038,-0.0177061535369473,0.0197230320274182,-0.056363296310687,0.0209509892367923,0.369337700424369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN4,Prefoldin subunit 4,13506,-0.0169280502652568,0.0188577111543049,-0.0538891641276945,0.0200330635971809,0.369376148771436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1,Methionine aminopeptidase 1,15667,0.00920441440754803,0.0102539999001683,-0.0108934253967819,0.0293022542118779,0.369390587862568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI2,Serpin I2,13936,0.0177340344175678,0.0197629548188804,-0.0210013570274378,0.0564694258625734,0.369554532242704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC79,Protein unc-79 homolog,13506,-0.0175525258013228,0.0195615903317394,-0.055893242851532,0.0207881912488864,0.369577299800565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRLB,Fc receptor-like B,15725,-0.0185084057842934,0.0206587777126693,-0.0589996101011252,0.0219827985325385,0.370314552831822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK1D,Casein kinase I isoform delta,13568,0.0198431854558951,0.0221794393114167,-0.0236285155944816,0.0633148865062718,0.370981661239703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD51,DNA repair protein RAD51 homolog 1,13751,-0.0165303592101472,0.0184791662740074,-0.0527495251072018,0.0196888066869074,0.3710485424207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP2B4,Plasma membrane calcium-transporting ATPase 4,13501,-0.0194515664987246,0.0217610963703255,-0.0621033153845625,0.0232001823871134,0.371408008454886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB103A_DEFB103B,Beta-defensin 103,13461,-0.0126519032082112,0.0141543963751573,-0.0403945201035195,0.0150907136870971,0.371418300909969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLF4,Krueppel-like factor 4,13528,-0.0127888355912776,0.0143100420316013,-0.0408365179732161,0.0152588467906609,0.371500171754194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP85,Centrosomal protein of 85 kDa,15725,-0.0196768336270672,0.022018492847238,-0.0628330796076536,0.0234794123535192,0.37152269170503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1A,Meprin A subunit alpha,13936,-0.0221889248521013,0.0248312555388168,-0.0708581857081821,0.0264803360039795,0.371557538025438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPA,Apolipoprotein(a),13697,0.055353489809007,0.0619470675553724,-0.0660627625995228,0.176769742217537,0.37157248314109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ORM1,Alpha-1-acid glycoprotein 1,13973,-0.00620462240501335,0.00694636157391372,-0.0198194910898842,0.00741024627985753,0.371755283103245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP8,Caspase-8,16148,-0.0190462469397333,0.0213316711277766,-0.0608563223501755,0.0227638284707088,0.371944185231655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN1,Tetraspanin-1,15821,0.017203496830678,0.0192940745958681,-0.0206128893772235,0.0550198830385795,0.372595933721578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PACS2,Phosphofurin acidic cluster sorting protein 2,13501,-0.0190402044622475,0.0213679109967674,-0.0609213100159117,0.0228409010914166,0.372910023784708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDP1,Tyrosyl-DNA phosphodiesterase 1,13913,-0.0219553363427091,0.0246672597804575,-0.0703031655124058,0.0263924928269877,0.373449181583039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP2,Lysosome-associated membrane glycoprotein 2,15521,-0.00599933557673032,0.00674608760345863,-0.0192216672795092,0.0072229961260486,0.373852491143065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGHMBP2,DNA-binding protein SMUBP-2,13501,-0.0176196582003015,0.0198134740715405,-0.0564540673805209,0.0212147509799179,0.373870322680323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,13936,-0.0362398606355995,0.0407605294444014,-0.116130498346626,0.0436507770754274,0.373968999765212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH1B,All-trans-retinol dehydrogenase,13703,-0.0232797636088451,0.0262223397365257,-0.0746755494924354,0.0281160222747452,0.374672755288811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB1,Leukocyte elastase inhibitor,16023,-0.027376198506581,0.0308388880397669,-0.0878204190645242,0.0330680220513622,0.374706451858809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL5,C-X-C motif chemokine 5,16007,-0.0350297147530908,0.0394626744619282,-0.11237655669847,0.0423171271922885,0.374733238638279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHBP,Corticotropin-releasing factor-binding protein,16044,-0.00854353528077929,0.00964366322539042,-0.0274451152025445,0.0103580446409859,0.375672745268197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2B,Ubiquitin-conjugating enzyme E2 B,13913,-0.00884673511581104,0.00999260451372145,-0.0284322399627051,0.010738769731083,0.375994930973467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAGE2A,G antigen 2A,13506,0.0195099836391971,0.0220446865874169,-0.02369760207214,0.0627175693505342,0.376161735900061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD14,Monocyte differentiation antigen CD14,15736,-0.0126603268936938,0.014306266570977,-0.0407006093728087,0.0153799555854211,0.376197272504258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16076,-0.00815038804993144,0.00921065541190286,-0.026203272657261,0.00990249655739816,0.376230895668152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC3,Membrane primary amine oxidase,16138,-0.00908062828319571,0.0102632764222503,-0.0291966500708063,0.0110353935044149,0.376294453572032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDF1,Endothelial differentiation-related factor 1,13946,-0.0217942062322499,0.0246556889102638,-0.070119356496367,0.0265309440318671,0.376742617455908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLN,Mesothelin,15950,-0.0168821012750391,0.0191283680410319,-0.0543737026354616,0.0206095000853833,0.377482591891459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA1,Carboxypeptidase A1,16254,0.0181825803801004,0.0206283892420193,-0.0222490625342575,0.0586142232944583,0.378095567800305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MELTF,Melanotransferrin,13965,0.00903930313603357,0.0102565313675395,-0.0110634983443439,0.0291421046164111,0.378158934897351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT3,RAC-gamma serine/threonine-protein kinase,15655,-0.017480936282855,0.0198450496117996,-0.0563772335219821,0.0214153609562722,0.378400973377489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA5,Plasma serine protease inhibitor,13825,-0.00977441135191762,0.0111019922060334,-0.031534316075743,0.0119854933719078,0.378647371226271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1A,T-cell leukemia/lymphoma protein 1A,15892,-0.0299272829533661,0.0340187084880045,-0.096603951589855,0.0367493856831227,0.37901883519213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,13913,-0.0108560079906679,0.0123473017698067,-0.0350567194594889,0.0133447034781532,0.379296617128032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16076,-0.00900453424348797,0.0102471676571242,-0.0290889828514514,0.0110799143644754,0.379558684322607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,13643,0.0105186400566174,0.0119727097038823,-0.012947870962992,0.0339851510762267,0.379660081814246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16054,-0.0304815958132854,0.0347051542875514,-0.0985036982168861,0.0375405065903152,0.379793172543492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ID4,DNA-binding protein inhibitor ID-4,13751,-0.0135087516075243,0.0154056698866437,-0.043703864585346,0.0166863613702974,0.380573226387543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G4A,Cytosolic phospholipase A2,16133,-0.0263722204732724,0.0300921514747548,-0.0853528373637918,0.032608396417247,0.380835449952208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXDNL,Peroxidasin-like protein,13913,-0.0168124780257994,0.0191998530194236,-0.0544441899438697,0.0208192338922708,0.381231877600647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRAXIN,Draxin,15918,0.0129110672216151,0.0147515962055519,-0.0160020613412667,0.0418241957844968,0.381460969874406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRC1,Protein regulator of cytokinesis 1,13913,-0.0139648023498172,0.0159863466193237,-0.0452980417236916,0.0173684370240572,0.382380868359548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLNL,Mesothelin-like protein,13605,0.0110232950691543,0.0126466572236483,-0.0137641530891964,0.0358107432275049,0.383421805386745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,15521,-0.0190604540441578,0.0218789186987297,-0.061943134693668,0.0238222266053524,0.383669922636918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP170,Centrosomal protein of 170 kDa,13643,-0.0232371846077879,0.0267037680295271,-0.075576569945661,0.0291022007300852,0.384215328603296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT5B,Signal transducer and activator of transcription 5B,15973,-0.0410176150541796,0.0471458688257026,-0.133423517952557,0.0513882878441975,0.384305269199834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL1,Follistatin-related protein 1,13643,-0.00694514062176295,0.00798415398641705,-0.0225940824351404,0.00870380119161446,0.384389194925894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA3,Glutathione S-transferase A3,15725,-0.0231119862021002,0.0265946416154663,-0.0752374837684141,0.0290135113642137,0.384834849826638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSMR,Oncostatin-M-specific receptor subunit beta,16157,-0.00599841472391379,0.00691281978646197,-0.0195475415053793,0.00755071205755168,0.385558731665573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUCL3,Mucin-like protein 3,13506,-0.0129154803092374,0.014892481241,-0.0421047435415974,0.0162737829231225,0.3858213539276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4,Interleukin-4,15797,-0.0272382166664778,0.0314156832152962,-0.0888129557684584,0.0343365224355028,0.385940901262329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR2,Hepatitis A virus cellular receptor 2,16074,-0.0102827911556505,0.0118603980542196,-0.0335291713419209,0.01296358903062,0.385962999017399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MITD1,MIT domain-containing protein 1,15918,-0.0288316248922484,0.033278989379435,-0.094058444075941,0.0363951942914441,0.386305188687896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16063,-0.0248641329105222,0.0287145544189386,-0.0811446595716418,0.0314163937505975,0.386554122639767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WNT9A,Protein Wnt-9a,15797,-0.00843604836410823,0.00974330402706401,-0.0275329242571537,0.0106608275289372,0.3865963621857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,13703,-0.00859797133477635,0.00993810968263904,-0.0280766663127489,0.0108807236431962,0.386970755995886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,15956,-0.00772370970051373,0.00893432283458464,-0.0252349824562996,0.00978756305527217,0.387327049223136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16091,-0.0104249662662309,0.012065591819002,-0.0340735262314748,0.013223593699013,0.387587352841629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1A,C-type lectin domain family 1 member A,15821,-0.00979758196743662,0.0113472607685606,-0.0320382130738154,0.0124430491389421,0.387913387359926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB8,DnaJ homolog subfamily B member 8,15821,0.0166421458459448,0.0192878021291197,-0.0211619463271298,0.0544462380190194,0.388242563343155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC25,Leucine-rich repeat-containing protein 25,15973,-0.0115348532261896,0.0133697316237716,-0.0377395272087819,0.0146698207564026,0.388283076239244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",13703,-0.0308016535959681,0.0357250402712432,-0.100822732527605,0.0392194253356685,0.388599905731104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCXR,L-xylulose reductase,16091,-0.0158814346041583,0.0184260982781907,-0.0519965872294122,0.0202337180210955,0.388755986657434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT2,RAC-beta serine/threonine-protein kinase,13946,-0.0374544481817731,0.0434657606631942,-0.122647339081634,0.0477384427180876,0.388867428071693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS6,Growth arrest-specific protein 6,16158,-0.00749766468218456,0.00870214445058808,-0.0245538678053372,0.00955853844096808,0.388926981808025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCTN3,Tectonic-3,13965,-0.00889505777432798,0.0103361370859536,-0.029153886462797,0.011363770914141,0.3894849978303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ULBP2,UL16-binding protein 2,15918,-0.0111422639255713,0.0129508608164655,-0.0365259511258436,0.014241423274701,0.389609498376347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT4,Vascular endothelial growth factor receptor 3,16091,0.0100060478523778,0.0116322769783682,-0.0127932150252238,0.0328053107299794,0.389693375497854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD6,T-cell differentiation antigen CD6,16227,-0.0154868210737978,0.0180059707017554,-0.0507785236492385,0.0198048815016429,0.389750138656051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16074,-0.0107906936145922,0.0125525872284355,-0.0353937645823258,0.0138123773531413,0.390000897490411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",13946,-0.0229328280810512,0.0267107214890044,-0.0752858421994999,0.0294201860373974,0.390596617221551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA3A,Chymotrypsin-like elastase family member 3A,16232,0.016924463011576,0.0197132591720539,-0.0217135249656495,0.0555624509888016,0.390611479287055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD160,CD160 antigen,16249,-0.0138165019884602,0.0160952593222962,-0.0453632102601608,0.0177302062832403,0.390672935676416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD2,Glutamate decarboxylase 2,13568,-0.0135969554240375,0.0158494783034882,-0.0446619328988744,0.0174680220507994,0.390973724655074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2BP,LRP2-binding protein,13605,0.0243074417715098,0.0284409063857457,-0.0314367347445518,0.0800516182875715,0.392751803499648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP7,Dipeptidyl peptidase 2,15927,-0.0177991376823701,0.020836007110624,-0.0586377116191933,0.023039436254453,0.392979912912844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFH,Complement factor H,13185,-0.00694425219429984,0.00813077845893056,-0.0228805779738037,0.00899207358520406,0.393081858329407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5,Eukaryotic translation initiation factor 5,13501,0.0129993764332287,0.0152278713376596,-0.0168472513885841,0.0428460042550415,0.393310319063305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAL,Integrin alpha-L,13568,-0.0128857522926579,0.0151026148814511,-0.042486877460302,0.0167153728749863,0.393556091340843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM1,Myomesin-1,13528,-0.0142354183746634,0.0166876089455192,-0.046943131907881,0.0184722951585543,0.39364491604717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICOSLG,ICOS ligand,15973,0.00550836482873696,0.00645746952839557,-0.00714827544691835,0.0181650051043923,0.393659798249703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",13501,-0.0195235871893722,0.0228974102004518,-0.0644025111822577,0.0253553368035134,0.393865893137077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME1,Nucleoside diphosphate kinase A,13568,-0.00626345524521909,0.00735027059017922,-0.0206699856019704,0.00814307511153218,0.39415177673681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA1,Ephrin type-A receptor 1,16103,0.00964072055491956,0.0113140393688644,-0.0125347966080546,0.0318162377178937,0.394169921000605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP2B1,AP-2 complex subunit beta,13605,-0.0145494842739895,0.0170815855957906,-0.048029392041739,0.0189304234937601,0.394359949201868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SARG,Specifically androgen-regulated gene protein,13915,-0.0320455069951033,0.0376486608203705,-0.105836882203029,0.0417458682128228,0.394688165184389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZN,Kazrin,13936,-0.0303985960090964,0.0357214632441541,-0.100412663967638,0.0396154719494456,0.394789730428831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC9,Thioredoxin domain-containing protein 9,13938,-0.0155770081242472,0.0183148184927104,-0.0514740523699596,0.0203200361214652,0.395054047885097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16254,-0.00788676915813837,0.00927558653678572,-0.0260669187702384,0.0102933804539616,0.395186556465072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDC,Nuclear migration protein nudC,16249,-0.0184513353434031,0.0217406281129866,-0.0610629664448569,0.0241602957580506,0.396059114254261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",13501,0.0119982773212785,0.0141520157860331,-0.0157396736193463,0.0397362282619034,0.39655660195794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",13643,-0.00948865875857683,0.0111968704464064,-0.0314345248335334,0.0124572073163797,0.396765650577852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QDPR,Dihydropteridine reductase,15984,-0.012631832236657,0.0149279588634253,-0.0418906316089706,0.0166269671356566,0.397461578345096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF12,Rho guanine nucleotide exchange factor 12,16054,-0.0297867068151475,0.0352073281625003,-0.0987930700136482,0.0392196563833532,0.397544653146369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN2,Dynactin subunit 2,15973,0.0274282426611435,0.0324780042464636,-0.0362286456619253,0.0910851309842122,0.398392952991943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GC,Vitamin D-binding protein,14020,0.00755417300467095,0.00895319158074575,-0.00999408249359072,0.0251024285029326,0.398828674264812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS27,Serine protease 27,16012,0.0115393183872719,0.0136798768574176,-0.0152732402532666,0.0383518770278104,0.398947491286909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICALL2,MICAL-like protein 2,13605,-0.0200540050506932,0.0237790076508819,-0.0666608600464217,0.0265528499450354,0.399048063896685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3,Microfibril-associated glycoprotein 3,15821,-0.0140111334409781,0.0166303095478118,-0.0466065401546892,0.0185842732727329,0.399517601604067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFGE8,Lactadherin,16074,-0.0126127590934028,0.0149715218108458,-0.0419569418426605,0.0167314236558548,0.399548640834093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP6,Insulin-like growth factor-binding protein 6,16005,0.00853117507459625,0.0101305137698033,-0.0113246319142182,0.0283869820634107,0.399729689922762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG2,V-set and immunoglobulin domain-containing protein 2,13913,-0.0174250327011321,0.0207247937689872,-0.058045628488347,0.0231955630860827,0.400484559626728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIDA,"Axin interactor, dorsalization-associated protein",13605,-0.0248703957338093,0.0295847157177904,-0.0828564385406784,0.0331156470730599,0.400558743383344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCG,Pro-glucagon,15725,0.0358500085262002,0.0426498237145861,-0.0477436459543886,0.119443663006789,0.400603683869441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF5,Rho guanine nucleotide exchange factor 5,13528,-0.0216146151870603,0.0257331540148416,-0.0720515970561498,0.0288223666820291,0.400950137460871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2,Apoptosis regulator Bcl-2,13936,-0.0157533505653623,0.0187937276856949,-0.0525890568293244,0.0210823556985997,0.401919391442407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL2,Protein kinase C-binding protein NELL2,16133,-0.00829908191287032,0.00990951786231963,-0.0277217369230168,0.0111235730972762,0.402331891928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TANK,TRAF family member-associated NF-kappa-B activator,15797,-0.0200912159279368,0.0239923902736152,-0.0671163008642227,0.0269338690083491,0.402380719215859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12B,Interleukin-12 subunit beta,16249,-0.0156459352509451,0.0186867151274045,-0.0522718969006579,0.0209800263987676,0.402449856625995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",13946,-0.0121283090550715,0.0144915953407524,-0.0405318359229462,0.0162752178128032,0.402651773062544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RHOC,Rho-related GTP-binding protein RhoC,15816,-0.0337157315719842,0.0403292322510177,-0.112761026783979,0.0453295636400105,0.40316066122263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCDC2C,Doublecortin domain-containing protein 2C,13506,-0.017850599274488,0.0213523254953248,-0.0597011572453246,0.0239999586963485,0.403168254730187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSAP,Gamma-secretase-activating protein,15725,0.024180538857678,0.0289390419035666,-0.0325399832733126,0.0809010609886685,0.403410654793952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKIV2L,Helicase SKI2W,13501,-0.011617020230948,0.0139078585196336,-0.0388764229294298,0.0156423824675339,0.403572274583991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSG,Basigin,16227,-0.00560379763496925,0.00671889709712656,-0.0187728359453373,0.00756524067539881,0.404273356560279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG5,Chondroitin sulfate proteoglycan 5,13528,-0.0142967231030459,0.0171479226753954,-0.047906651546821,0.0193132053407291,0.404448360087107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPPK1,Epiplakin,13643,-0.0215371592641304,0.0259343625534479,-0.0723685098688882,0.0292941913406274,0.406299652732426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB9,Serpin B9,15918,-0.0093922603852837,0.0113106935988026,-0.0315612198389367,0.0127766990683693,0.406332105300978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNGB3,Cyclic nucleotide-gated cation channel beta-3,13528,-0.0151284872343194,0.0182767188889528,-0.0509508562566669,0.0206938817880282,0.407828784084487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBQLN3,Ubiquilin-3,13501,-0.0139807614416539,0.0169009705733536,-0.0471066637654269,0.0191451408821192,0.408129005925209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP290,Centrosomal protein of 290 kDa,13751,0.0149473068273152,0.0180735586320069,-0.0204768680914183,0.0503714817460487,0.408236567060646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD22,B-cell receptor CD22,16249,-0.0117912743029572,0.0142807337371306,-0.0397815124277332,0.0161989638218188,0.408999439028594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX1,ATP-dependent RNA helicase DDX1,13936,-0.0142408390054349,0.0172661798835535,-0.0480825515771998,0.01960087356633,0.409509346359895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F3,Tissue factor,16081,0.00768381480371515,0.0093209499585094,-0.0105852471149633,0.0259528767223936,0.409747486695865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,13677,-0.0136301395869072,0.016542587322022,-0.0460536107380703,0.0187933315642558,0.409986652673179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A14,Zinc transporter ZIP14,15667,-0.00935866616864175,0.0113600250618883,-0.0316243152899429,0.0129069829526594,0.410051876230147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD226,CD226 antigen,13568,-0.0119367419083565,0.014533437912205,-0.0404222802162784,0.0165487963995653,0.411473030563117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIN2,Bridging integrator 2,16074,-0.0253589234475561,0.0309299183730503,-0.0859815634587347,0.0352637165636226,0.412294807171793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTLA4,Cytotoxic T-lymphocyte protein 4,13983,-0.00823657416915277,0.0100519438160581,-0.0279383840486267,0.0114652357103212,0.412571567288498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC13,Mucin-13,15667,-0.0142278245279885,0.0173743277434699,-0.0482815069051895,0.0198258578492126,0.412856346120843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D23,TBC1 domain family member 23,15973,-0.0253815922715102,0.0309957202910819,-0.0861332040420307,0.0353700194990104,0.412870481035741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX2,"Ferredoxin-2, mitochondrial",13501,-0.015856275973368,0.01936671872053,-0.0538150446656068,0.0221024927188708,0.412950158327573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA4,Annexin A4,15982,-0.0204220425159442,0.0249484191341985,-0.0693209440189731,0.0284768589870848,0.413043659843718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1C4,Aldo-keto reductase family 1 member C4,15821,0.014835342567036,0.0181290108821513,-0.0206975187619806,0.0503682038960525,0.413186497572243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1R,Complement C1r subcomponent,14020,-0.0055834921772016,0.00682596802404173,-0.0189623895043234,0.00779540514992019,0.413383622521399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLG,Plasminogen,13662,-0.0061972293022321,0.00757984816817641,-0.0210537317118579,0.00865927310739367,0.413604011624971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3E,T-cell surface glycoprotein CD3 epsilon chain,13751,-0.00998432377842676,0.0122188662129798,-0.0339333015558672,0.0139646539990137,0.413871976221232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECSCR,Endothelial cell-specific chemotaxis regulator,13528,-0.014339885672128,0.0175582106919178,-0.048753978628287,0.020074207284031,0.4141111949599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPK2,SRSF protein kinase 2,16054,-0.02352088013643,0.02880591140608,-0.0799804664923467,0.0329387062194867,0.414209411240203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13506,-0.0161567097192802,0.0197921360470453,-0.054949296371489,0.0226358769329287,0.414331746447407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX3,Probable E3 ubiquitin-protein ligase DTX3,15973,-0.00679525676863595,0.0083316789847363,-0.0231253475787191,0.0095348340414472,0.414745283585931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH15,Cadherin-15,16190,0.0158477594767142,0.019449345601797,-0.0222729579028079,0.0539684768562364,0.415186060746002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXLNA,Alpha-taxilin,15918,-0.0247036887337627,0.0303674778207211,-0.084223945262376,0.0348165677948507,0.415948427229391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRA2,Ankyrin repeat family A protein 2,13506,0.0157207447954939,0.0193250324270789,-0.0221563187615808,0.0535978083525686,0.415950816218349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16168,0.00830131440350241,0.0102100137394607,-0.0117103125258406,0.0283129413328454,0.416197851800869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG6,Large proline-rich protein BAG6,15821,-0.0101936457251794,0.0125475615015077,-0.0347868662681344,0.0143995748177757,0.416574071623622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHP1,Calcineurin B homologous protein 1,13528,0.0208168700503215,0.025672110984195,-0.0295004674787007,0.0711342075793438,0.417451804106897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAMD9L,Sterile alpha motif domain-containing protein 9-like,16054,-0.0201723487202871,0.0248996776875888,-0.0689757169879611,0.028631019547387,0.417868877644206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP44,Endoplasmic reticulum resident protein 44,15945,-0.00722712513770469,0.00892844698143147,-0.0247268812213104,0.010272630945901,0.418268844998157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGN,Mimecan,16074,0.0114475283787123,0.0141479589606878,-0.0162824711842358,0.0391775279416603,0.418452752975512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16054,0.0109809432383345,0.0135897573955225,-0.0156549812568896,0.0376168677335586,0.41908480531125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG4,Proteasome assembly chaperone 4,13568,-0.0163465813035296,0.0202308900425878,-0.0559991257870016,0.0233059631799424,0.419104132253207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",13605,-0.0217210804107992,0.0269501152106112,-0.0745433062235972,0.0311011454019988,0.420272193523233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABGAP1L,Rab GTPase-activating protein 1-like,15797,-0.0169239119655633,0.0210034756304666,-0.0580907242012779,0.0242429002701512,0.420389227277533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",13946,-0.0131552413266192,0.0163311292546516,-0.0451642546657362,0.0188537720124979,0.420526703521332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLMP,CXADR-like membrane protein,16195,0.0057711982751234,0.00717353090225123,-0.00828892229328903,0.0198313188435358,0.421112632025076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTO1,Protein LTO1 homolog,15797,-0.0117235556546984,0.0146095252357314,-0.0403582251167319,0.0169111138073351,0.422299157398997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMOD4,Tropomodulin-4,13506,-0.0112394263119194,0.014041550963461,-0.038760866200303,0.0162820135764641,0.423469707902085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA6,Integrin alpha-6,16054,-0.0144219538286993,0.0180300663231312,-0.0497608838220365,0.0209169761646379,0.423790103148169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASHC3,WASH complex subunit 3,13938,-0.0210317989902614,0.0262967951401488,-0.0725735174649531,0.0305099194844303,0.423848651313535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF10,Multiple epidermal growth factor-like domains protein 10,16044,-0.0108412777427316,0.0135579559709817,-0.0374148714458558,0.0157323159603925,0.423940066762882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC13A1,Solute carrier family 13 member 1,13913,0.0166111378560362,0.0208243807113746,-0.024204648338258,0.0574269240503303,0.42507134956608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEK7,Serine/threonine-protein kinase Nek7,13751,-0.0210246217008043,0.0263672697827424,-0.0727044704749794,0.0306552270733707,0.425246616670511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIF,Leukemia inhibitory factor,15667,-0.0140732786868844,0.0176606357234564,-0.0486881247048589,0.0205415673310902,0.425537046738051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QA,Complement C1q subcomponent subunit A,16175,-0.00619023643714448,0.00777446548225952,-0.0214281887823731,0.00904771590808418,0.425912018530125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP1,Insulin-like growth factor-binding protein 1,16226,0.0329988198979166,0.041511128744652,-0.0483629924416012,0.114360632237434,0.426660557654237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO1,Alpha-enolase,16034,-0.0214685054118069,0.0270204934784606,-0.0744286726295897,0.0314916618059759,0.426900600547039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPA1,Inositol monophosphatase 1,15918,-0.0166273900981496,0.0209315246757861,-0.0576531784626902,0.0243983982663911,0.426991503953758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,13501,-0.0133759293642013,0.0168616331098285,-0.0464247302594651,0.0196728715310626,0.427630974461674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHCY,Adenosylhomocysteinase,16063,-0.0183970068470943,0.0232145699465662,-0.0638975639423639,0.0271035502481754,0.428094459522228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PZP,Pregnancy zone protein,14020,-0.014470108734814,0.0183057628532732,-0.0503494039272296,0.0214091864576015,0.429268238202199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FH,"Fumarate hydratase, mitochondrial",13528,-0.0231267118249467,0.0293324791775134,-0.080618371012873,0.0343649473629795,0.430456960171542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMARCA2,Probable global transcription activator SNF2L2,15667,0.0195224965038886,0.0247613882452209,-0.0290098244567444,0.0680548174645216,0.43046011645159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL2,Chordin-like protein 2,16063,0.0145671921099484,0.0184787146141458,-0.0216510885337774,0.0507854727536742,0.43051955611123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK12,Kallikrein-12,15725,-0.037342382015837,0.0474456028724173,-0.130335763645775,0.0556509996141009,0.431260518008009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH1,Neurexophilin-1,15667,0.00997262149613114,0.0126768615962323,-0.0148740272324841,0.0348192702247464,0.43148167799176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSC,Dipeptidyl peptidase 1,16019,0.0117103021156351,0.0148877427135224,-0.0174696736028688,0.0408902778341389,0.431543293056293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",13501,-0.017139973905524,0.0218389558535402,-0.0599443273784627,0.0256643795674147,0.432564182350577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD58,Lymphocyte function-associated antigen 3,16014,0.00470366113481654,0.0059933931995681,-0.00704338953633693,0.01645071180597,0.432577944201641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK9,Mitogen-activated protein kinase 9,16054,-0.011511377977199,0.0147021070312329,-0.0403275077584154,0.0173047518040174,0.433653523380998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP2,E3 SUMO-protein ligase RanBP2,13528,0.00885313679077698,0.0113161609174129,-0.0133265386073523,0.0310328121889063,0.434025820973577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF1,Wiskott-Aldrich syndrome protein family member 1,15821,-0.0251125433018306,0.0321174054093714,-0.0880626579041985,0.0378375713005374,0.434286081092154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,13568,-0.00963963551917702,0.0123368020326307,-0.0338197675031332,0.0145404964647792,0.434597198976262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA1A,Heat shock 70 kDa protein 1A,16103,-0.0191880234009051,0.0245686857989521,-0.0673426475668512,0.0289666007650411,0.434816863367893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BDNF,Brain-derived neurotrophic factor,13983,-0.0222537672991844,0.0285596800740451,-0.0782307402443129,0.033723205645944,0.435873778204113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN6,Dynactin subunit 6,15667,-0.0188948795510086,0.0242813236546709,-0.0664862739141636,0.0286965148121464,0.436483428469374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKZ,Diacylglycerol kinase zeta,15797,0.00959992403760111,0.0123452155658521,-0.0145966984714689,0.0337965465466712,0.436802930883827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL24,Interleukin-24,15797,0.0130398370339113,0.0167721529241158,-0.0198335826973557,0.0459132567651783,0.436893486365982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICA1,Islet cell autoantigen 1,15797,-0.0212567574403903,0.0273660640701146,-0.074894243017815,0.0323807281370344,0.437314317224246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDR1,Epithelial discoidin domain-containing receptor 1,16208,-0.00613446356001444,0.00789922223298896,-0.0216169391366728,0.00934801201664391,0.437411555264421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABL1,Tyrosine-protein kinase ABL1,15973,-0.0181509080076898,0.0233992692287469,-0.0640134756960338,0.0277116596806541,0.437935239991572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,13946,-0.0176206311103734,0.0227391664380018,-0.0621893973288569,0.0269481351081101,0.438410576951812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TF,Serotransferrin,14020,-0.00585115437778635,0.00755298615205446,-0.0206550072358131,0.00895269848024039,0.438541296398353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX1,Neuronal pentraxin-1,16074,-0.0107325653064051,0.0138665874579288,-0.0379110767239455,0.0164459461111354,0.438949578725427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD1,Ly6/PLAUR domain-containing protein 1,15667,0.0168626506035626,0.0218065007487267,-0.0258780908639418,0.059603392071067,0.439365118647579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTCN1,V-set domain-containing T-cell activation inhibitor 1,15725,0.00859335377571113,0.0111196821939838,-0.0132012233244972,0.0303879308759195,0.439649005624737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL4,ADAMTS-like protein 4,13643,-0.00628814127409764,0.00814432587584839,-0.0222510199907605,0.00967473744256521,0.440075333042141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLOD4,Glyoxalase domain-containing protein 4,16024,-0.00944350086268147,0.0122550211790833,-0.0334633423736846,0.0145763406483217,0.440966001454734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR3,Anterior gradient protein 3,15690,-0.0156013969244587,0.0202534069164267,-0.055298074480655,0.0240952806317376,0.441127779458301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JCHAIN,Immunoglobulin J chain,15797,-0.016367918002287,0.0212523266018438,-0.0580224781419008,0.0252866421373268,0.441210204187489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP4,Microfibril-associated glycoprotein 4,13703,0.00849031032940336,0.0110246595379969,-0.0131180223650705,0.0300986430238772,0.441242028349722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,13568,0.0120467341870333,0.0156457116318366,-0.0186188606113664,0.042712328985433,0.441330895160638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA0319,Dyslexia-associated protein KIAA0319,13938,0.00815576952668197,0.0106010285042779,-0.0126222463417027,0.0289337853950667,0.441705988465985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",15725,0.0135392134885829,0.017604470925839,-0.0209655495260615,0.0480439765032273,0.441858494642027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP1,Interstitial collagenase,15493,-0.0244324557328519,0.0317847043414153,-0.0867304762420258,0.0378655647763221,0.442091493724663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC37,Hsp90 co-chaperone Cdc37,16091,-0.0221379226679361,0.0288276958022566,-0.078640206440359,0.0343643611044868,0.442534482567946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC7A,C-type lectin domain family 7 member A,16249,-0.0156541415750077,0.0203965511162806,-0.0556313817629177,0.0243230986129022,0.442801614818335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A4,Protein S100-A4,16091,-0.0150167236600072,0.019569222305221,-0.0533723993782403,0.0233389520582259,0.442876184165347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP4,"Fatty acid-binding protein, adipocyte",16254,0.0129310834447649,0.0168808716983386,-0.0201554250839789,0.0460175919735086,0.443675602135504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR2,Interferon gamma receptor 2,15918,-0.0137439006748103,0.0179458873321552,-0.0489178398458345,0.0214300384962139,0.443775503972963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRXN3,Neurexin-3,13605,0.00932790503092214,0.0121805846128305,-0.0145460408102256,0.0332018508720699,0.443807961728787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHX2,Bifunctional epoxide hydrolase 2,15821,0.0164528596712066,0.0214999103716508,-0.0256869646572289,0.0585926839996421,0.444132641660215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXOSC10,Exosome component 10,13501,-0.0158156747547031,0.020687243128863,-0.0563626712872745,0.0247313217778683,0.444574724930452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F13B,Coagulation factor XIII B chain,13949,0.00677236502857304,0.008859191069352,-0.0105916494673569,0.024136379524503,0.444614997129871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMBS,Porphobilinogen deaminase,16195,-0.0114846388516699,0.0150253215686271,-0.040934269126179,0.0179649914228393,0.4446684820182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,13568,0.0119220473336235,0.0155981211942013,-0.0186502702070111,0.0424943648742581,0.44468638649961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LG,CMRF35-like molecule 9,16074,0.00967966148060407,0.0126661537587079,-0.0151459998864633,0.0345053228476715,0.444750507902466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK2,BDNF/NT-3 growth factors receptor,16063,0.00666941050780856,0.00873851733868595,-0.0104580834760159,0.023796904491633,0.445343468973138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAMPT,Nicotinamide phosphoribosyltransferase,15725,-0.0141998974399604,0.0186096526804237,-0.0506748166935909,0.0222750218136701,0.445451380307546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",13643,-0.00966718519697534,0.01268805638909,-0.0345357757195918,0.0152014053256411,0.446125581065829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL46,"39S ribosomal protein L46, mitochondrial",15667,-0.00711706752632854,0.00934552503927992,-0.0254342966033172,0.0112001615506601,0.446341189803763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRB1,Chymotrypsinogen B,16074,0.0144503106261909,0.0190485280392995,-0.0228848043308362,0.051785425583218,0.4480999500974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN1A,Cyclin-dependent kinase inhibitor 1,15973,-0.0277063452285762,0.0365923477996855,-0.0994273469159599,0.0440146564588075,0.448963828083581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],15973,0.0146260125058557,0.0193243900643788,-0.0232497920203267,0.052501817032038,0.449140120377939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MBL2,Mannose-binding protein C,13826,0.0280971348499833,0.0372291289163338,-0.0448719578260309,0.101066227525998,0.450436856544312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD209,CD209 antigen,16090,-0.0100423105730673,0.0133082871737886,-0.036126553433693,0.0160419322875584,0.450505621148031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YES1,Tyrosine-protein kinase Yes,15973,-0.0295842913572932,0.0392173297208999,-0.106450257610257,0.0472816748956706,0.450639522299478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY6D,Lymphocyte antigen 6D,15964,-0.00977651744520127,0.0129605760364003,-0.0351792464765459,0.0156262115861434,0.450663798035367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH,Parathyroid hormone,13605,-0.0209063289625416,0.0277235012257706,-0.0752443913650521,0.0334317334399688,0.450801447508408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7R,Interleukin-7 receptor subunit alpha,16074,0.0133424232521869,0.0176969004493572,-0.0213435016285532,0.0480283481329269,0.450895553155984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,13946,0.00688047274511749,0.00913598107585097,-0.0110260501635504,0.0247869956537854,0.451391672034657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD46,Membrane cofactor protein,15974,-0.00728306179692297,0.009689879655148,-0.026275225921013,0.0117091023271671,0.452293523124715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB33A,Ras-related protein Rab-33A,13501,-0.0172719870233078,0.0229814977904531,-0.0623157226925958,0.0277717486459802,0.45232849152828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK8,Serine protease inhibitor Kazal-type 8,13501,-0.00901436745229216,0.0119945721685172,-0.0325237289025858,0.0144949939980015,0.452342521801105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP1,Prolow-density lipoprotein receptor-related protein 1,15973,0.00683086635453335,0.00908931883624301,-0.0109841985645029,0.0246459312735696,0.452346783174492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN7,Septin-7,13751,-0.0136641069911882,0.0181980729096257,-0.0493323298940546,0.0220041159116782,0.452753019290185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPE,Ribulose-phosphate 3-epimerase,13751,-0.0184304394095798,0.0246143205913115,-0.0666745077685503,0.0298136289493907,0.45400928711512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4C,C-type lectin domain family 4 member C,16054,-0.0120087410694799,0.0160550063784062,-0.0434765535711561,0.0194590714321963,0.45448629049293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBR,Tumor necrosis factor receptor superfamily member 3,15965,-0.00719875293707044,0.00962462706487724,-0.0260630219842298,0.011665516110089,0.454500521231697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBL1,Neuroblastoma suppressor of tumorigenicity 1,16091,0.00677208130989702,0.0090608986074721,-0.0109872799607483,0.0245314425805423,0.454835361293642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP9,Caspase-9,13568,0.0157863321356027,0.0211359996269133,-0.0256402271331473,0.0572128914043527,0.455141051051679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCN,Decorin,15821,-0.00578331171378333,0.00775045650817344,-0.0209742064698033,0.00940758304223661,0.455563856190753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C3A,Cytosolic 5'-nucleotidase 3A,16034,-0.022307683251767,0.0299158457301061,-0.0809427408827749,0.0363273743792409,0.455870969087191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTBDN,Retbindin,15973,0.00749618878116647,0.0100557479908618,-0.0122130772809227,0.0272054548432557,0.456002806423871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLB1,"Phospholipase B1, membrane-associated",13938,0.0152123608690903,0.0204137728241314,-0.0247986338662072,0.0552233556043878,0.456162886997631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEFTY2,Left-right determination factor 2,16173,0.0133818840601839,0.0179848854962028,-0.0218684915123736,0.0486322596327414,0.456849309224519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAYN,Layilin,15900,0.00863083672447036,0.0116245605467825,-0.0141533019472234,0.0314149753961642,0.457816243408044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP2,Caspase-2,16054,-0.0172563747574582,0.0233151290583547,-0.0629540277118335,0.028441278196917,0.459228090969944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF16,Fibroblast growth factor 16,13568,-0.0121171671783115,0.01638093147018,-0.0442237928598643,0.0199894585032413,0.459487739468442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMRK2,Nicotinamide riboside kinase 2,13506,-0.010981357165044,0.0148844138573674,-0.0401548083254842,0.0181920939953961,0.460663662073473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE,Angiotensin-converting enzyme,13988,-0.00668613452208979,0.00907091347901551,-0.0244651249409602,0.0110928558967806,0.461076314489402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNST,Consortin,16063,-0.0273980649148768,0.0371747330874748,-0.100260541766327,0.0454644119365738,0.461128434252294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHM,Rab proteins geranylgeranyltransferase component A 1,13605,-0.0155935546572824,0.021171014216921,-0.0570887425224476,0.0259016332078827,0.461407495549837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NARS1,"Asparagine--tRNA ligase, cytoplasmic",13946,-0.0119169016430076,0.0161901124943039,-0.0436495221318432,0.0198157188458281,0.46170629684586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDRKH,Tudor and KH domain-containing protein,15667,-0.0212379723015444,0.028862175554645,-0.0778078363886486,0.0353318917855597,0.461838488657364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCP2,Non-specific lipid-transfer protein,15725,-0.019315017583515,0.0262692698836477,-0.0708027865554645,0.0321727513884345,0.46218578342864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGT,Angiotensinogen,13988,0.00560388690761763,0.00763264315039818,-0.00935609366716281,0.0205638674823981,0.462839147779499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,15821,0.0144020271659734,0.0196896780678431,-0.024189741846999,0.0529937961789459,0.464514800679002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC10A,C-type lectin domain family 10 member A,15918,-0.00904548870608216,0.0124083665249823,-0.0333658870950475,0.0152749096828832,0.466022773739518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTT2B,Glutathione S-transferase theta-2B,13938,-0.0596165846745647,0.081786272344361,-0.219917678469512,0.100684509120383,0.466055866181114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXK,Tyrosine-protein kinase TXK,13751,0.0194160840523764,0.0266374119552452,-0.0327932433799042,0.0716254114846571,0.46607355065351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4R,Interleukin-4 receptor subunit alpha,16054,-0.00907867605467759,0.012456432483888,-0.0334932837230981,0.0153359316137429,0.466113628918426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFA1_DEFA1B,Neutrophil defensin 1,15726,-0.0135487465449332,0.0185941705132406,-0.0499933207508848,0.0228958276610185,0.466223216349225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,13643,0.00929683057794149,0.0127604790666692,-0.0157137083927302,0.0343073695486132,0.466280689138354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16195,-0.00860570297488845,0.0118175897347761,-0.0317681788550496,0.0145567729052727,0.466494756821081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPS16,"28S ribosomal protein S16, mitochondrial",13568,-0.00750088569024696,0.010304568016617,-0.0276978390028164,0.0126960676223224,0.466676052229009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI,Tissue factor pathway inhibitor,16035,-0.00789511567299614,0.0108524627033536,-0.0291659425715691,0.0133757112255768,0.466933220790503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPRIP,Myosin phosphatase Rho-interacting protein,13885,-0.0112791968725157,0.0155152054684231,-0.0416889995906249,0.0191306058455935,0.467252339727402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM21,E3 ubiquitin-protein ligase TRIM21,16054,-0.0190000050807486,0.0261575511757243,-0.0702688053851683,0.0322687952236711,0.467623873570684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MN1,Transcriptional activator MN1,13605,-0.0148941857087878,0.0205266601575241,-0.055126439617535,0.0253380681999594,0.468095286988026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3BL1,Uroplakin-3b-like protein 1,13725,-0.0131824392861709,0.0181784338892633,-0.048812169709127,0.0224472911367852,0.468360647563763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB2,Beta-crystallin B2,13938,-0.0171355547297441,0.0236562895716932,-0.0635018822902627,0.0292307728307745,0.468859909157866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFHD1,EF-hand domain-containing protein D1,13946,0.00867520766493596,0.0119788477814146,-0.0148033339866366,0.0321537493165086,0.468948657388848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9orf40,Uncharacterized protein C9orf40,13936,-0.020576140195673,0.0284495514378097,-0.0763372610137801,0.0351849806224341,0.469538410163236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDH1,"Malate dehydrogenase, cytoplasmic",13908,-0.0101281842887929,0.0140159336228448,-0.0375994141895686,0.0173430456119828,0.469925963920186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENR,Density-regulated protein,13568,-0.0141833620888087,0.0196787999053732,-0.0527538099033402,0.0243870857257228,0.471079930786805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX16,Syntaxin-16,15725,-0.0143186029569992,0.0198666928914384,-0.0532573210242185,0.0246201151102202,0.471083853272222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2A,Pancreatic alpha-amylase,15425,0.0117150500858574,0.0162891246981396,-0.0202116343224961,0.043641734494211,0.472031947644422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD82,CD82 antigen,13751,0.0102728613524239,0.0142860129580096,-0.0177277240452749,0.0382734467501227,0.472100620027206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK9,Proprotein convertase subtilisin/kexin type 9,16254,0.00964706840121055,0.0134162777741421,-0.016648836036108,0.0359429728385291,0.472116148296835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOCK9,Dedicator of cytokinesis protein 9,13528,-0.0290381716044924,0.0404243023032069,-0.108269804118778,0.0501934609097932,0.472563471712782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIT,Mast/stem cell growth factor receptor Kit,16115,0.00728627347485696,0.010143576905158,-0.0125951372592526,0.0271676842089666,0.472574112113192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEMIP2,Cell surface hyaluronidase,13568,-0.00848517550201118,0.011826256466003,-0.031664638175377,0.0146942871713547,0.473086529398679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16054,-0.023799394928031,0.0332182373123738,-0.0889071400602837,0.0413083502042217,0.473720453165727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEMP1,Mast cell-expressed membrane protein 1,13568,-0.0224859640403549,0.0313856670584295,-0.0840018714748767,0.0390299433941669,0.473731718142755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16063,-0.0121147649090444,0.0169405593576238,-0.045318261249987,0.0210887314318981,0.474536834071094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM25,Transmembrane protein 25,13946,-0.0110325194398128,0.0154568303993773,-0.0413279070225923,0.0192628681429668,0.475385466870631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH4,Myosin-4,13501,-0.0114045898396724,0.0159823058191991,-0.0427299092453028,0.0199207295659579,0.475501750519082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSG1,Pregnancy-specific beta-1-glycoprotein 1,15918,-0.0277436884814171,0.0388807440834479,-0.103949946884975,0.0484625699221407,0.475510649083225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK4,Interleukin-1 receptor-associated kinase 4,16054,-0.0253878098807553,0.0355842166133674,-0.0951328744429555,0.0443572546814448,0.475573367284993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UXS1,UDP-glucuronic acid decarboxylase 1,15725,0.0131519768689331,0.0184498429072821,-0.0230097152293399,0.049313668967206,0.475948955718104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,13528,-0.0147055609070509,0.0206445796021696,-0.0551689369273033,0.0257578151132015,0.476278520618662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,15918,-0.0130949068245754,0.0183842792036422,-0.049128094063714,0.0229382804145633,0.476296721751244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USO1,General vesicular transport factor p115,15973,-0.0219140225709164,0.0307783538221844,-0.0822395960623978,0.038411550920565,0.476478510614441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALY,RNA-binding protein Raly,13913,0.0122019631030206,0.0171522604841892,-0.0214164674459902,0.0458203936520315,0.476853936077754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT3,Dynein light chain Tctex-type 3,13913,-0.0108391020654948,0.0152428721952005,-0.0407151315680878,0.0190369274370981,0.477038444782302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRC1,Macrophage mannose receptor 1,13988,-0.0070635665167255,0.00993370188224055,-0.026533622205917,0.012406489172466,0.47705215870604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16054,-0.0242579926683088,0.034200230980294,-0.0912904453896851,0.0427744600530676,0.478152831530314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,13568,-0.0196451416035332,0.0277304032648786,-0.0739967320026952,0.0347064487956288,0.478688390975415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MILR1,Allergin-1,15797,-0.0122633475889632,0.0173366889463727,-0.0462432579238538,0.0217165627459274,0.479350820343943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO3,Forkhead box protein O3,15725,0.023336832898728,0.0330046506198769,-0.0413522823162308,0.0880259481136867,0.479529048348563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",13643,-0.0109439239036348,0.0154788352043482,-0.0412824409041573,0.0193945930968876,0.479563012115472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F10,Coagulation factor X,13988,0.00641348857038605,0.00907756866431105,-0.0113785460116636,0.0242055231524357,0.479876273539156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLIF,Cobalamin binding intrinsic factor,16043,0.0177625393935354,0.0251492581073529,-0.0315300064968763,0.0670550852839471,0.480021293247633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100P,Protein S100-P,15821,-0.013475166249527,0.0190839032697471,-0.0508796166582313,0.0239292841591772,0.480135636508965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACRT,Extracellular glycoprotein lacritin,13887,0.0122773105682105,0.0173874982653847,-0.0218021860319436,0.0463568071683645,0.480137878969768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,13605,0.0251274595450921,0.0356422227077943,-0.0447312969621847,0.094986216052369,0.480827685654195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B10,Aldo-keto reductase family 1 member B10,13605,0.0151215725343472,0.0214983080761927,-0.0270151112949904,0.0572582563636848,0.481828332429252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,13936,-0.0260749561001259,0.037274781465004,-0.0991335277715338,0.0469836155712819,0.48423040983025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD93,Complement component C1q receptor,15457,0.00755357682509992,0.0108008968601346,-0.013616181020764,0.0287233346709638,0.484345618077384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMCN2,Hemicentin-2,13669,-0.0138858607008152,0.019895851178012,-0.0528817290097188,0.0251100076080884,0.485234449879106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,13643,-0.00982498048251297,0.0141099464548835,-0.0374804755340845,0.0178305145690586,0.486242873848069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPKAPK2,MAP kinase-activated protein kinase 2,13751,0.0177578791615468,0.0255243070771467,-0.0322697627096608,0.0677855210327544,0.486613311099025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,13913,-0.0112027987435262,0.0161216288797515,-0.0428011913478391,0.0203955938607868,0.487134299073571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CUZD1,CUB and zona pellucida-like domain-containing protein 1,13605,-0.00906885033969275,0.0130560568282839,-0.0346587217231292,0.0165210210437437,0.487312447570388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLVRB,Flavin reductase,16074,-0.0161111248977203,0.0232074104876102,-0.0615976494534362,0.0293753996579956,0.487552229745516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF41,E3 ubiquitin-protein ligase NRDP1,15725,-0.016039336793472,0.0231073836793105,-0.0613298088049206,0.0292511352179766,0.487616144508762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELPLG,P-selectin glycoprotein ligand 1,16054,-0.0065819585779046,0.00948474268773489,-0.025172054245865,0.0120081370900558,0.487722201037279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA10,N-alpha-acetyltransferase 10,13501,-0.0120755398043819,0.0174185831608495,-0.0462159627996469,0.022064883190883,0.488160757663623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPTP,Ceramide-1-phosphate transfer protein,13501,-0.00952376327560704,0.0137378442588534,-0.0364499380229598,0.0174024114717457,0.488164487608866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC2,Stanniocalcin-2,16049,0.00608913917347484,0.00879866149367164,-0.0111562373541216,0.0233345157010713,0.488914131399018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2B,Alpha-amylase 2B,14928,0.0115586962871586,0.016710841814215,-0.0211945536687028,0.04431194624302,0.489143768508621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPS10,40S ribosomal protein S10,13501,-0.0101598058098929,0.0146973158496585,-0.0389665448752235,0.0186469332554378,0.489408108877278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO2,Gamma-enolase,16208,-0.0154712206479254,0.0223921560576738,-0.0593598465209661,0.0284174052251152,0.489624816764971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBEGF,Proheparin-binding EGF-like growth factor,16148,-0.0172935920570313,0.0250549111490561,-0.0664012179091812,0.0318140337951186,0.490060976005907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRI1,Methylthioribose-1-phosphate isomerase,13605,-0.0162960780539009,0.0236119501347486,-0.0625755003180082,0.0299833442102064,0.490103906944015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRG1,Leucine-rich alpha-2-glycoprotein,14020,-0.00631506168404426,0.00915356824396862,-0.0242560554422227,0.0116259320741342,0.490267479113506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549,UPF0606 protein KIAA1549,13751,-0.0168368019702667,0.0244104489460259,-0.0646812819044775,0.0310076779639441,0.490370931640073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMS1,PMS1 protein homolog 1,13605,-0.0120045487253185,0.0174336717916431,-0.046174545436939,0.022165447986302,0.491096800188523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROS1,Vitamin K-dependent protein S,14020,-0.00605623394693263,0.00880148664265812,-0.0233071477665425,0.0111946798726773,0.491406143388162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABO,Histo-blood group ABO system transferase,13988,0.0343086932043787,0.0499233796369375,-0.0635411308840187,0.132158517292776,0.491951112620698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2orf69,UPF0565 protein C2orf69,13605,-0.0142127064297033,0.0206995738898877,-0.0547838712538832,0.0263584583944766,0.492335001570916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD69,Early activation antigen CD69,15990,-0.020754851941166,0.0302655696012371,-0.0800753683595908,0.0385656644772588,0.492875770703568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP1A,Charged multivesicular body protein 1a,15918,-0.0185630997177708,0.0271046700481622,-0.0716882530121688,0.0345620535766271,0.493437700565059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,13605,-0.0122949616512679,0.0179561964252575,-0.0474891066447725,0.0228991833422368,0.49353248374827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,13501,0.0120479647766479,0.0176006155164784,-0.0224492416356498,0.0465451711889455,0.493658933690335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES2,Cocaine esterase,15973,-0.0129857187212653,0.0189948062131956,-0.0502155388991287,0.0242441014565982,0.494208807353274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBZ,Hemoglobin subunit zeta,13965,-0.024820084815621,0.0363672311976824,-0.0960998579630784,0.0464596883318364,0.49494374232831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENND2B,DENN domain-containing protein 2B,13501,-0.0113069245458201,0.0165900445340661,-0.0438234118325897,0.0212095627409495,0.49553601708968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF20,Fibroblast growth factor 20,13568,-0.0104826250831063,0.015407067557916,-0.0406804774966216,0.019715227330409,0.496276962989426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,13913,-0.0228894098861099,0.0336999929892403,-0.0889413961450208,0.043162576372801,0.497015414406356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN1,Contactin-1,16254,-0.00631474816387867,0.00930833524748459,-0.0245590852489485,0.0119295889211911,0.497529577718808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGXT,Serine--pyruvate aminotransferase,16063,-0.0179009553836643,0.0263879423097855,-0.069621322310844,0.0338194115435154,0.497542895764203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP23,Synaptosomal-associated protein 23,16063,-0.0202046164437752,0.0298257390555235,-0.0786630649926014,0.0382538321050509,0.498147909846727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2A,DNA-directed RNA polymerase II subunit RPB1,13568,-0.00682840797574501,0.0100810443680316,-0.026587254937087,0.012930438985597,0.498194683801665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN9,Septin-9,15973,-0.00667541139209166,0.00985673205223483,-0.0259946062144719,0.0126437834302886,0.498261052297209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB2,Lysosome membrane protein 2,15607,-0.00709617015349505,0.0104783534846365,-0.0276337429833825,0.0134414026763924,0.498275239897929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",15973,-0.0225324079180662,0.0333029636588335,-0.0878062166893798,0.0427414008532474,0.498676774876428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECR,Peroxisomal trans-2-enoyl-CoA reductase,13643,-0.00663264350747217,0.00982731091558833,-0.0258941729020253,0.012628885887081,0.499738376626205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,13946,-0.00683833145502622,0.0101650620162672,-0.02676185300691,0.0130851900968575,0.501130906348471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PREB,Prolactin regulatory element-binding protein,15797,-0.0066425374566852,0.00988581531095469,-0.0260187354661564,0.012733660552786,0.50164057046577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB1,Heat shock protein beta-1,15813,-0.0159744105671209,0.0238107313680329,-0.0626434440484654,0.0306946229142236,0.502299638823152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM,Paralemmin-1,13852,0.00703174339222109,0.0105097846908179,-0.0135674346017819,0.0276309213862241,0.503464309123899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL34,Interleukin-34,15645,-0.00817695703654355,0.0122390152978536,-0.0321654270203367,0.0158115129472496,0.504075928173768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNF1A,Hepatocyte nuclear factor 1-alpha,13605,-0.016702345035957,0.0250248286749086,-0.0657510092387778,0.0323463191668638,0.504508237485232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGA4,Pepsin A-4,13988,0.0163441134391153,0.0245170538318094,-0.0317093120712311,0.0643975389494616,0.50501143326191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSRP3,Cysteine and glycine-rich protein 3,13501,-0.0225326119073462,0.0338158807328317,-0.0888117381436963,0.0437465143290039,0.505210153475292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MXRA8,Matrix remodeling-associated protein 8,13703,0.00695544868335359,0.0104389774106508,-0.013504947041522,0.0274158444082292,0.505233163067536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK4,Serine protease inhibitor Kazal-type 4,16054,-0.0147901770046524,0.0222241086327195,-0.0583494299247826,0.0287690759154779,0.505739371802204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID2,Nidogen-2,16074,-0.0168535637144772,0.0253298875222461,-0.0665001432580795,0.0327930158291251,0.50582805685783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,15973,0.00451998563686017,0.00680185505553868,-0.00881165027199564,0.017851621545716,0.506365562853641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB1,Transforming growth factor beta-1 proprotein,16227,-0.00883790382950779,0.0133087811903987,-0.0349231149626893,0.0172473073036737,0.506657766256223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",15667,-0.00689308673984604,0.0103901505979932,-0.0272577819119127,0.0134716084322206,0.507068102470224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDS,Iduronate 2-sulfatase,16249,-0.0019802302328861,0.00300236325970257,-0.00786486222190314,0.00390440175613094,0.509547398807296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGOLN2,Trans-Golgi network integral membrane protein 2,13988,0.00589737901908972,0.00895282906923372,-0.0116501659566084,0.0234449239947878,0.510088488395491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNER,Delta and Notch-like epidermal growth factor-related receptor,16015,-0.00574841333640616,0.00873996074983286,-0.0228787364060786,0.0113819097332662,0.510730004083806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRB,Platelet-derived growth factor receptor beta,16254,0.00782555971329176,0.0119269437029302,-0.0155512499444514,0.0312023693710349,0.511753331569593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TUBB3,Tubulin beta-3 chain,13528,-0.00628102998926956,0.00958345869360647,-0.0250646090287382,0.0125025490501991,0.512219314913502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2CD2L,Phospholipid transfer protein C2CD2L,15649,-0.00937093623609474,0.0143061942120726,-0.0374110768917569,0.0186692044195675,0.512460332795165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSR,Insulin receptor,13568,-0.00387901316921735,0.00593958741979227,-0.0155206045120102,0.00776257817357551,0.513717148097567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB6,Serpin B6,16142,-0.013309886865591,0.0203987005477384,-0.0532913399391583,0.0266715662079762,0.514096357848263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLB,Beta-klotho,15667,-0.0166574918412116,0.0256040428608453,-0.0668414158484683,0.0335264321660451,0.515326849289296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LUZP2,Leucine zipper protein 2,13913,-0.00991688032895641,0.0152545099438323,-0.0398157198188678,0.019981959160955,0.515641616508991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R2,Interleukin-1 receptor type 2,16018,0.00439606265034372,0.00679135856011068,-0.00891500012747321,0.0177071254281606,0.51744553717689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXIN1,Axin-1,16054,-0.0210097687567705,0.0325331625723224,-0.0847747673985224,0.0427552298849815,0.518421065496419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERMAP,Erythroid membrane-associated protein,13568,-0.0100622082632279,0.0156015423017448,-0.0406412311746477,0.0205168146481918,0.518970771771137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDGF1,Teratocarcinoma-derived growth factor 1,15667,-0.0318944328153159,0.049558118622417,-0.129028345315253,0.0652394796846214,0.519859622564497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCIN,Adseverin,13528,-0.0163668765475257,0.0254422004105526,-0.0662335893522088,0.0334998362571575,0.520042691426892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPN3,Calpain-3,13913,-0.0082606837833096,0.0128796865192657,-0.0335048693610703,0.0169835017944511,0.521290916238311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB6,Ephrin type-B receptor 6,15900,0.00692696741004022,0.0108021092713236,-0.014245166761754,0.0280991015818345,0.521362613957496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,15797,0.0119820433589793,0.0187122920208874,-0.02469404900196,0.0486581357199186,0.521967327659816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK8,Kallikrein-8,15498,-0.00788350246276371,0.0123569397521865,-0.0321031043770492,0.0163360994515218,0.523494972705438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C1A,Cytosolic 5'-nucleotidase 1A,13938,-0.00687719823286088,0.0107881237208844,-0.0280219207257944,0.0142675242600726,0.523823613033618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN4,Contactin-4,16074,-0.00522015686600549,0.00819063674259555,-0.0212738048814928,0.0108334911494818,0.523917539932611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML2,Trem-like transcript 2 protein,16074,-0.0073665765294229,0.0115617350058126,-0.0300275771408157,0.0152944240819699,0.524035263207925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPB41L5,Band 4.1-like protein 5,13605,0.0138710456423508,0.0217946541752375,-0.0288464765411147,0.0565885678258163,0.524498722133568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAP18,Histone deacetylase complex subunit SAP18,13751,-0.0162588516758294,0.0255782349324274,-0.0663921921433871,0.0338744887917283,0.525013972454349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA2,GDNF family receptor alpha-2,15973,0.00454041002542022,0.00715697865143887,-0.00948726813139997,0.0185680881822404,0.525826827461828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES1,Retinoic acid receptor responder protein 1,15725,0.00723742773732816,0.0114122673898907,-0.0151306163468577,0.029605471821514,0.525972820041159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA4,Ephrin type-A receptor 4,13703,0.00622838974963842,0.00983931406994249,-0.0130566658274489,0.0255134453267257,0.526737318583475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC134,Coiled-coil domain-containing protein 134,13913,-0.0106407291410835,0.0168138113580515,-0.0435957994028644,0.0223143411206973,0.526837794079929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16103,-0.0124279829243513,0.0196395196333353,-0.0509214414056884,0.0260654755569858,0.526870094327599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,13751,-0.0231190445204539,0.0365671602384613,-0.094790678587838,0.0485525895469302,0.527243745576974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3B,Sodium channel subunit beta-3,13528,-0.0102255989540934,0.016248237012692,-0.0420721434989697,0.0216209455907828,0.529139807833843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA4,Apolipoprotein A-IV,14020,0.0078238384191406,0.0124464822849197,-0.0165712668593019,0.0322189436975831,0.52962228130382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB1,Beta-crystallin B1,13965,-0.0141020805076453,0.0225313190422823,-0.0582634658305187,0.0300593048152281,0.531398694652913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALCAM,CD166 antigen,16254,-0.00413813746197842,0.00662859579576266,-0.0171301852216732,0.00885391029771638,0.532448753317336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TST,Thiosulfate sulfurtransferase,15647,-0.0160633774397123,0.0257376150539682,-0.06650910294549,0.0343823480660654,0.532557450241146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMTN,Smoothelin,13914,-0.020397689363131,0.032705862239844,-0.0845011793532252,0.0437058006269633,0.532854075641959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLLT1,Protein ENL,13506,0.0151059856960927,0.0242250881920404,-0.0323751871603065,0.0625871585524919,0.532921984012505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNU13,NHP2-like protein 1,13501,-0.0143952628441303,0.0230909120998622,-0.0596534505598601,0.0308629248715996,0.533021194200652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX2,Neuronal pentraxin-2,13983,-0.0071665240431768,0.0114988945686925,-0.0297043573978141,0.0153713093114605,0.533139680776058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16195,-0.00669160574479339,0.0107466819002581,-0.0277551022692993,0.0143718907797125,0.533512051644409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OBP2B,Odorant-binding protein 2b,15853,-0.0133625160672268,0.0215008882435322,-0.0555042570245499,0.0287792248900963,0.534288387434385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGF,Pro-epidermal growth factor,16018,-0.0220411815310961,0.0354904360116508,-0.0916024361139317,0.0475200730517395,0.534578420833513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2,Microtubule-associated protein 2,13938,-0.00973152389225354,0.0156728259233967,-0.040450262702111,0.0209872149176039,0.534664405530376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",13605,-0.0102900457646301,0.0165839601465257,-0.0427946076518205,0.0222145161225603,0.53495102387885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAMBI,BMP and activin membrane-bound inhibitor homolog,15725,-0.00625231590700101,0.0101035086628959,-0.0260551928862769,0.0135505610722749,0.536039830057395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG3,Desmoglein-3,16141,0.00722087763492706,0.0116814801481224,-0.0156748234553929,0.030116578725247,0.536486849321403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIF1A,Hypoxia-inducible factor 1-alpha,13568,0.0137452953796213,0.0222587333418179,-0.0298818219703419,0.0573724127295845,0.536899727825736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ODAM,Odontogenic ameloblast-associated protein,15645,0.0115324012177781,0.0187243202921003,-0.0251672665547385,0.0482320689902946,0.537966234319188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGACT,Gamma-glutamylaminecyclotransferase,13965,-0.0149932725735624,0.02440050589372,-0.0628182641252537,0.0328317189781289,0.53891768952975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP2,Cysteine-rich secretory protein 2,16195,0.0121491164021035,0.0197742474606024,-0.0266084086206772,0.0509066414248841,0.538965729209985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGA,Glycoprotein hormones alpha chain,16074,-0.0165543461804901,0.0270003858478649,-0.0694751024423053,0.0363664100813252,0.539808872015061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP1,Fibroblast growth factor-binding protein 1,16091,0.00676960691342279,0.0110452135041826,-0.014879011554775,0.0284182253816206,0.539951398821456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRAL,GDNF family receptor alpha-like,13538,0.0131150420687368,0.0214449671495016,-0.0289170935442864,0.05514717768176,0.540834314963708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYDC1,Pyrin domain-containing protein 1,13643,-0.008765741524858,0.0143552291405277,-0.0369019906402923,0.0193705075905763,0.541454372755543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM8,U6 snRNA-associated Sm-like protein LSm8,13751,-0.0184510966292073,0.0302514367944778,-0.0777439127463838,0.0408417194879691,0.541921819556511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMP,Olfactory marker protein,13528,0.0103009032560709,0.0169203339289856,-0.022862951244741,0.0434647577568827,0.542674927020227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A4,Collagen alpha-4(IV) chain,13727,0.0108999540111316,0.0179221451674728,-0.024227450517115,0.0460273585393782,0.543075811031186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,13605,-0.0102362142700184,0.016832407621684,-0.0432277332085191,0.0227553046684823,0.543114482770936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1A,Interleukin-1 alpha,15797,-0.0118982132572445,0.0195826956819422,-0.0502802967938511,0.0264838702793622,0.543469423441992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK2,Docking protein 2,16063,-0.0255534000706922,0.0420587523628167,-0.107988554701813,0.0568817545604284,0.543485023349442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF2,Scavenger receptor class F member 2,16208,-0.0060116973639468,0.00989645807676872,-0.0254087551944135,0.0133853604665199,0.543554537234035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM172A,Cotranscriptional regulator FAM172A,13643,-0.0128846735910385,0.0212349965559123,-0.0545052668406266,0.0287359196585496,0.544016332201903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4R,Reticulon-4 receptor,16195,0.00701574940420913,0.0115642174582736,-0.0156501168140071,0.0296816156224254,0.544073533490761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK14,Kallikrein-14,16195,-0.00956206907199563,0.015798785995668,-0.0405276896235049,0.0214035514795136,0.545027531867585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORN4,MORN repeat-containing protein 4,13506,-0.0164137668793433,0.0271337626229213,-0.069595941620269,0.0367684078615824,0.545242052784804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS1,Galectin-1,16063,-0.00708152186345199,0.0117406092241922,-0.0300931159428687,0.0159300722159647,0.546407605210982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHR,Growth hormone receptor,13703,-0.00595723925451708,0.00988014637822547,-0.025322326155839,0.0134078476468048,0.546551604475998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,15725,-0.0126246452930682,0.0209388669358432,-0.0536648244873209,0.0284155339011845,0.546564778482738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRAP2,GRB2-related adapter protein 2,16063,-0.0264086240614009,0.0441293020419057,-0.112902056063536,0.0600848079407343,0.549556573172949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTN,Pleiotrophin,15821,-0.0101896155681426,0.017076941855845,-0.0436604216055988,0.0232811904693137,0.550723888122887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPVL,Probable serine carboxypeptidase CPVL,16166,-0.00831227723136232,0.0139400347535004,-0.0356347453482231,0.0190101908854985,0.550991116835869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH1,Cadherin-1,15537,-0.00828716121762506,0.0139192421092654,-0.0355688757517852,0.0189945533165351,0.551601874747456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3D,T-cell surface glycoprotein CD3 delta chain,13528,-0.00713877979763585,0.0119920549422547,-0.030643207484455,0.0163656478891833,0.551657968084642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CX3CL1,Fractalkine,15918,0.00677904507858907,0.0114247820849821,-0.0156135278079758,0.029171617965154,0.552946559721933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX6,Syntaxin-6,15725,0.0137630134285256,0.0232228236146918,-0.0317537208562704,0.0592797477133216,0.553423737281632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP13,Dual specificity protein phosphatase 13 isoform A,13913,-0.00855004629593879,0.0144316619768528,-0.0368361037705703,0.0197360111786927,0.553558552467742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1,Huntingtin-interacting protein 1,13501,0.00692150529429159,0.0116925239166262,-0.0159958415822957,0.0298388521708789,0.553887363359603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOC1,Apolipoprotein C-I,13994,-0.00771055540173572,0.0130279813970644,-0.0332453989399819,0.0178242881365105,0.553963455776858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53INP1,Tumor protein p53-inducible nuclear protein 1,15821,0.00635599977197426,0.0107410710377095,-0.0146964994619363,0.0274084990058848,0.55402828127723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAA4,Serum amyloid A-4 protein,14020,-0.00674732698740517,0.0114145264395838,-0.0291197988089894,0.015625144834179,0.554451195731768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDK2,Protein sidekick-2,13703,-0.00775802956567167,0.0131398911610053,-0.0335122162412421,0.0179961571098988,0.554920125681825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRM1,Muscarinic acetylcholine receptor M1,13605,-0.00730261203554511,0.0123753024841237,-0.0315582049044276,0.0169529808333374,0.555136342442259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY4,Protein canopy homolog 4,15973,-0.015260381685128,0.0259249627688854,-0.0660733087121433,0.0355525453418874,0.556113413586561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TERF1,Telomeric repeat-binding factor 1,13568,-0.00601970738498216,0.0102307329426441,-0.0260719439525646,0.0140325291826002,0.556277307112334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK3,NT-3 growth factor receptor,16208,0.00429975125119161,0.00730847402912294,-0.0100248578458893,0.0186243603482726,0.556322991133688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC26,Anaphase-promoting complex subunit CDC26,13910,-0.0141207198113275,0.0240802924744357,-0.0613180930612215,0.0330766534385665,0.557615256445342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTOA,Otoancorin,13528,-0.0104895108762443,0.0179256325790121,-0.045623750731108,0.0246447289786194,0.558444367862268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL4,C-C motif chemokine 4,16084,-0.0133088964278546,0.0227466023219881,-0.0578922369789512,0.031274444123242,0.558492849572793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MENT,Protein MENT,13703,-0.00454214740438756,0.00778656739601761,-0.0198038195005821,0.010719524691807,0.559679998836962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAVS,Mitochondrial antiviral-signaling protein,15725,-0.0184009305618825,0.0315557385076919,-0.0802501780369586,0.0434483169131937,0.55981772665824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPG1,Interphotoreceptor matrix proteoglycan 1,13528,-0.00595619865796469,0.0102144169612175,-0.0259764559019509,0.0140640585860216,0.559824370555392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,15973,-0.00866490156195281,0.0149038983171426,-0.0378765422635523,0.0205467391396467,0.560989277203521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP3,Cysteine-rich secretory protein 3,13859,-0.00546272036129988,0.00941776402302875,-0.0239215378464362,0.0129960971238365,0.561894181767505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC50,Coiled-coil domain-containing protein 50,13946,-0.01527875849169,0.0263837573498943,-0.0669909228974829,0.0364334059141028,0.562532990406205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOM,Apolipoprotein M,16115,0.00548612244422647,0.00948205065111274,-0.0130986968319545,0.0240709417204074,0.562880868071069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",13501,-0.0172837762865702,0.0298751266101819,-0.0758390244425268,0.0412714718693864,0.562913314589016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",13946,-0.0134076040654875,0.0231767410502387,-0.0588340165239554,0.0320188083929804,0.562940043887109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSH1,Chorionic somatomammotropin hormone 1,13988,-0.00613854183816774,0.0106207238854508,-0.0269551606536513,0.0146780769773158,0.563288470755992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SATB1,DNA-binding protein SATB1,13946,-0.00625129188611405,0.0108173792145306,-0.0274533551465941,0.014950771374366,0.563345441659451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGFR,Opioid growth factor receptor,15973,-0.00659569259648604,0.0114191462311364,-0.0289772192095134,0.0157858340165413,0.56354272615893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,15725,-0.0169687096577798,0.0293838916028846,-0.0745611371994336,0.040623717883874,0.563621223887689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA2,Pulmonary surfactant-associated protein A2,15725,-0.00998363316932651,0.0173027610417865,-0.043897044811228,0.023929778472575,0.563950063319983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBNL,Drebrin-like protein,16133,-0.0182590890297568,0.0316893580521757,-0.0803702308120212,0.0438520527525076,0.56449485507074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF6,Fibroblast growth factor 6,13568,-0.00800231631850892,0.013891024603494,-0.0352287245413571,0.0192240919043393,0.564571897171531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,13501,-0.00747628259621341,0.0129868530586881,-0.032930514591242,0.0179779493988152,0.564840526934053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D5,TBC1 domain family member 5,16054,-0.0155489004569169,0.0270755761694936,-0.0686170297491243,0.0375192288352904,0.565787928979656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS53,Vacuolar protein sorting-associated protein 53 homolog,15973,-0.0152474232801251,0.0265511210464667,-0.0672876205311997,0.0367927739709496,0.565795468667086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16103,-0.0176131235826705,0.0307265714664322,-0.0778372036568776,0.0426109564915365,0.566502912071704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCTS1,Malignant T-cell-amplified sequence 1,13936,0.00506253789209712,0.00883799229743527,-0.012259927010876,0.0223850027950703,0.566778956902466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA1,Apolipoprotein A-I,14020,-0.00547189626971017,0.00956262334302402,-0.0242146380220372,0.0132708454826169,0.567184111330273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,13988,-0.00816344584024663,0.0143042415173573,-0.0361997592142669,0.0198728675337736,0.568211474695933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT2A1,Bile salt sulfotransferase,16054,-0.0111654384385987,0.0195668439688101,-0.0495164526174664,0.027185575740269,0.568258116033171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP2,"Fatty acid-binding protein, intestinal",16063,0.015400371732154,0.0269994555045256,-0.0375185610567162,0.0683193045210243,0.568417370512646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,13544,-0.0069401104372896,0.0121761873313682,-0.0308054376067712,0.016925216732192,0.568704783053204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRKL,Crk-like protein,16073,-0.0206589119512093,0.0362618391150253,-0.0917321166166589,0.0504142927142402,0.568879015957068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGM2,Phosphoglucomutase-2,13605,-0.0114342404465168,0.0201257785807668,-0.0508807664648198,0.0280122855717861,0.56994994903054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,13501,0.00917040236553395,0.0161851925262478,-0.0225525749859118,0.0408933797169797,0.57100076576049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMP,Cartilage oligomeric matrix protein,15915,-0.00651248044129939,0.0115097746890714,-0.0290716388318793,0.0160466779492805,0.571522968236693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPT,Dermatopontin,16254,-0.0050414074436397,0.0089385363281433,-0.0225609386468006,0.0124781237595212,0.572756365980684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM5,Tripartite motif-containing protein 5,16054,0.0166626735944145,0.0295661803628726,-0.0412870399168158,0.0746123871056448,0.573053274851674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15,Interleukin-15,16054,-0.00631394111169003,0.0112334400611361,-0.0283314836315167,0.0157036014081366,0.574078518747844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOPH1,Enolase-phosphatase E1,13913,-0.0104424460713745,0.0185790080265021,-0.0468573018033185,0.0259724096605695,0.57408681395713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3A,Sodium channel protein type 3 subunit alpha,13605,-0.00719872765510609,0.0128567817333534,-0.0323980198524787,0.0180005645422665,0.575545439806894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,13528,0.0123483528059034,0.022063854924291,-0.030896802845707,0.0555935084575138,0.575717685606699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED21,Mediator of RNA polymerase II transcription subunit 21,13501,-0.00978541439562832,0.0174956848429109,-0.0440769566877337,0.0245061278964771,0.575963245790576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3A,Regenerating islet-derived protein 3-alpha,16254,-0.0118685941886741,0.0212468453512341,-0.053512411077093,0.0297752226997448,0.576439023995445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERI1,3'-5' exoribonuclease 1,13751,-0.00677991548273529,0.0121548428213953,-0.0306034074126701,0.0170435764471995,0.576993189871734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG4,Chondroitin sulfate proteoglycan 4,13983,-0.00637489074456334,0.0114291717888335,-0.0287760674506769,0.0160262859615502,0.577007903473771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERCC1,DNA excision repair protein ERCC-1,13506,0.00638951949093896,0.0114590399462789,-0.0160701988037676,0.0288492377856455,0.577129261952505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNMT,Histamine N-methyltransferase,15844,-0.00895110219165254,0.0160599368139685,-0.0404285783470308,0.0225263739637257,0.577292099994973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIT1,ARF GTPase-activating protein GIT1,13568,-0.0186132378272384,0.0334322374543019,-0.0841404232376701,0.0469139475831932,0.5777107200042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16254,-0.0134038752165275,0.0240922449455148,-0.0606246753097364,0.0338169248766815,0.577974888232994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REST,RE1-silencing transcription factor,13506,0.00689909684454454,0.0124168467851615,-0.0174379228543719,0.031236116543461,0.578477201800132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITM2A,Integral membrane protein 2A,16054,-0.0114284686330651,0.0205775069938783,-0.0517603823410665,0.0289034450749364,0.57863810167898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX1,Peroxiredoxin-1,15582,0.0169868416487143,0.0306117980257791,-0.0430122824818128,0.0769859657792413,0.578963103309142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBIN,Erbin,15973,-0.0195554520499024,0.0352470312833849,-0.0886396333653368,0.049528729265532,0.579031496951308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPRE3,Microtubule-associated protein RP/EB family member 3,13506,-0.0276401451556686,0.0498497833297448,-0.125345720481968,0.0700654301706312,0.57926730310745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,13501,-0.00651064390625463,0.0117563921955148,-0.0295531726094636,0.0165318847969543,0.579727592632412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORD,Sorbitol dehydrogenase,16120,0.0129184641147177,0.0233751771911323,-0.0328968831799016,0.0587338114093371,0.580505714396355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROCR,Endothelial protein C receptor,13501,-0.00693733454685248,0.0125733630219997,-0.0315811260699719,0.017706456976267,0.58112979785108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNH2,Potassium voltage-gated channel subfamily H member 2,13605,-0.0148247682192051,0.0268711892583124,-0.0674922991654974,0.0378427627270873,0.581164686379906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),A1BG,Alpha-1B-glycoprotein,14020,-0.00324409302452647,0.00590151107850538,-0.014811054738397,0.00832286868934407,0.582530157264449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARTN,Artemin,15797,-0.00859202907700032,0.015636333768314,-0.0392392432628957,0.0220551851088951,0.582676120792153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC16,Mucin-16,15973,0.0355297141739636,0.0648410575581307,-0.0915587586399726,0.1626181869879,0.583733298805698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPGR,X-linked retinitis pigmentosa GTPase regulator,13605,-0.00771852031262912,0.0141131310431069,-0.0353802571571187,0.0199432165318604,0.584454031993688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,13680,0.00930128624717164,0.0170133420410604,-0.0240448641533067,0.04264743664765,0.58459005833185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYGD,Gamma-crystallin D,13938,-0.0182277198524813,0.0333563875977522,-0.0836062395440757,0.047150799839113,0.584762893947059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD1,Bromodomain-containing protein 1,13751,-0.00573467450907956,0.0104984310768779,-0.0263115994197602,0.014842250401601,0.584909090799347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1B,T-cell leukemia/lymphoma protein 1B,15821,-0.0149875266324397,0.0274959948534669,-0.0688796765452348,0.0389046232803554,0.585705943685899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COLEC12,Collectin-12,16044,-0.0047943153971069,0.00879597587699653,-0.0220344281160201,0.0124457973218063,0.585721337584362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5F1D,"ATP synthase subunit delta, mitochondrial",13501,0.00972488368523405,0.0178971247196859,-0.0253534807653502,0.0448032481358184,0.586879325469449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPM,Carboxypeptidase M,16125,-0.0064294309004571,0.0118359619908932,-0.0296279164026077,0.0167690546016935,0.586991691197022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZD2,PDZ domain-containing protein 2,13501,-0.0112072736729361,0.0207415476607035,-0.0518607070879151,0.0294461597420428,0.588978620170747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB2,Pleckstrin homology-like domain family B member 2,13506,-0.0175814854614411,0.0325485137658792,-0.0813765724425644,0.0462136015196822,0.589093910546398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGF,Beta-nerve growth factor,15918,0.00222460196665343,0.0041220319189117,-0.0058545805944135,0.0103037845277203,0.58942131146939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCC,Netrin receptor DCC,13605,-0.00418951732487576,0.00779591704009255,-0.0194695147234572,0.0110904800737056,0.591000893828572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNNI3,"Troponin I, cardiac muscle",15821,0.015655538443612,0.0291696832638419,-0.0415170407535181,0.0728281176407422,0.591478396556458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREM2,Triggering receptor expressed on myeloid cells 2,16044,-0.00943100253196723,0.0175783567863864,-0.0438845818332846,0.0250225767693502,0.591612065151875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP8,Ubiquitin carboxyl-terminal hydrolase 8,15821,-0.0175636836757131,0.0327694081385215,-0.0817917236272153,0.046664356275789,0.591981257995765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM2,Paralemmin-2,13938,-0.00701770372688864,0.0131073230593933,-0.0327080569232996,0.0186726494695223,0.592379574990796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS1,Protein MTSS 1,13936,-0.0205685670207084,0.0384974585907356,-0.0960235858585501,0.0548864518171333,0.593153755938698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPGDS,Hematopoietic prostaglandin D synthase,15725,0.00685856381100256,0.0128507591014332,-0.0183289240278064,0.0320460516498115,0.593550538420769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMVK,Phosphomevalonate kinase,15641,-0.0200813605291747,0.0376498967868783,-0.0938751582314562,0.0537124371731067,0.593784420800404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F7,Coagulation factor VII,16112,-0.0055404676773488,0.0103893334551457,-0.0259035612494344,0.0148226258947368,0.593844205577329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX2,Sorting nexin-2,13913,0.0149472203810522,0.0280311528109337,-0.0399938391283778,0.0698882798904822,0.593878735815505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB2,Transforming growth factor beta-2 proprotein,13913,0.00964632483538142,0.0181284083733684,-0.0258853555764206,0.0451780052471835,0.594657650131439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,13528,-0.0103007251496958,0.0193874249151614,-0.048300077983412,0.0276986276840205,0.595212980067441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRR,Receptor-type tyrosine-protein phosphatase R,13938,0.00664871987070874,0.0125358304649398,-0.0179215078405733,0.0312189475819908,0.595858821865671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRG,Histidine-rich glycoprotein,13949,0.00576475775944871,0.0108793121559743,-0.0155586940662609,0.0270882095851583,0.596201801821547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRG2,Developmentally-regulated GTP-binding protein 2,15973,-0.0103096473623929,0.019505173806252,-0.0485397880226467,0.027920493297861,0.59711832457397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZT1,Mitotic-spindle organizing protein 1,15725,-0.00951009824755798,0.0180148804590662,-0.0448192639473278,0.0257990674522118,0.59757454903233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASL,Neural Wiskott-Aldrich syndrome protein,13568,0.0108051735256442,0.0204743387879377,-0.0293245304987136,0.050934877550002,0.597686886524033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM5,PDZ and LIM domain protein 5,13946,-0.0214525865357284,0.0406530034395913,-0.101132473277327,0.0582273002058704,0.597716034640104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF10,Rho guanine nucleotide exchange factor 10,13946,-0.0168880095438785,0.0320106152017827,-0.0796288153393725,0.0458527962516155,0.597802549764678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH7B,Myosin-7B,13506,-0.00800881028532548,0.0151994314129703,-0.0377996958547472,0.0217820752840963,0.598261193631859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSCAM,Down syndrome cell adhesion molecule,13946,-0.00649352038963882,0.0123433084634618,-0.030686404978024,0.0176993641987464,0.598843661719414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOC,Brother of CDO,15821,0.00422198529385486,0.00805522203180467,-0.0115662498884823,0.020010220476192,0.600195319972192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMC3,26S proteasome regulatory subunit 6A,13506,0.00549658057474842,0.0105003055034727,-0.015084018212058,0.0260771793615549,0.600656770517152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC11A,C-type lectin domain family 11 member A,16056,-0.0086311407718312,0.0165267973912891,-0.0410236636587579,0.0237613821150955,0.601502610827594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKB,Creatine kinase B-type,13983,0.0106905980783496,0.0205026718258852,-0.0294946387003855,0.0508758348570847,0.602079263374796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN4,Alpha-actinin-4,15797,-0.00573042970590949,0.0110104044908595,-0.0273108225079941,0.0158499630961751,0.602753175063005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,15992,0.0332200703004367,0.0638389370886772,-0.0919042463933705,0.158344386994244,0.602810713919465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN4,Nectin-4,16091,-0.0055663098426182,0.0107044907419869,-0.0265471116969125,0.0154144920116761,0.603072384943633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDCCAG8,Serologically defined colon cancer antigen 8,13913,-0.0202882360474822,0.0390335205397176,-0.0967939363053288,0.0562174642103643,0.603236042455747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK1,Interleukin-1 receptor-associated kinase 1,15797,-0.0124043319029191,0.0238875783856816,-0.0592239855388551,0.0344153217330168,0.60357306575649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,15918,0.00524377164242923,0.0101107519799011,-0.014573302238177,0.0250608455230354,0.604023768991802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN2,Prefoldin subunit 2,15667,-0.00965130264891166,0.0186211571647173,-0.0461487706917576,0.0268461653939342,0.604257913830711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP112,Centrosomal protein of 112 kDa,13501,-0.0080218823719243,0.0154816841628591,-0.0383659833311282,0.0223222185872795,0.604359966186842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX5,Sorting nexin-5,13643,-0.00541153197788726,0.0104836694754873,-0.0259595241498424,0.0151364601940679,0.605732310998744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF149,E3 ubiquitin-protein ligase RNF149,13643,-0.00547180483239849,0.0106133021792768,-0.0262738771037809,0.015330267438984,0.606169407847106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBLN2,Fibulin-2,13983,-0.00561335914937747,0.0108894720265746,-0.0269567243214637,0.0157300060227088,0.606222328122806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,13501,-0.0036845083734606,0.00716384828450296,-0.0177256510110864,0.0103566342641652,0.607036910649071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UGDH,UDP-glucose 6-dehydrogenase,13501,-0.017864516265192,0.0347939051774897,-0.0860605704130718,0.0503315378826878,0.607653316513168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFD,Vascular endothelial growth factor D,16220,0.00633886938136835,0.0123471295641986,-0.0178615045644609,0.0305392433271976,0.607686867016705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBN1,Drebrin,13568,0.00917510959772801,0.0178800207231407,-0.0258697310196278,0.0442199502150838,0.60785566291255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC2,"Myosin-binding protein C, fast-type",13643,-0.0149461979643483,0.0291693637280888,-0.0721181508714025,0.0422257549427058,0.608383808395936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT3,Kunitz-type protease inhibitor 3,13936,-0.0262460049086205,0.0512591408325294,-0.126713920940378,0.0742219111231371,0.608641043289232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GKN1,Gastrokine-1,15357,0.00482193400452979,0.00941904423437002,-0.0136393926948355,0.023283260703895,0.60870419722768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCC1,Regulator of chromosome condensation,13913,0.00940049713241989,0.0183680010127333,-0.0266007848525375,0.0454017791173772,0.6088084873103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD5,26S proteasome non-ATPase regulatory subunit 5,13605,0.00968998009005555,0.0189527033587336,-0.0274573184930623,0.0468372786731734,0.609169152679996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD59,CD59 glycoprotein,15460,-0.00390761322518591,0.00764728690600961,-0.0188962955609647,0.0110810691105929,0.609372130032943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRC,Proto-oncogene tyrosine-protein kinase Src,16059,-0.0211647038864076,0.0414616837204114,-0.102429603978414,0.0601001962055987,0.609733334114907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP2,Guanylate-binding protein 2,15797,-0.010468197519992,0.0205505765642313,-0.0507473275858853,0.0298109325459013,0.610488075107437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15RA,Interleukin-15 receptor subunit alpha,15797,-0.00613222296841497,0.0120395001193056,-0.0297296432022539,0.017465197265424,0.610519650034932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABHD14B,Protein ABHD14B,15871,-0.0100162531556264,0.0196886247416589,-0.0486059576492778,0.0285734513380251,0.610946465042757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX9,Transcription factor SOX-9,13605,-0.00474258720971277,0.00933082503947662,-0.0230310042870869,0.0135458298676614,0.611271596440193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS4,Galectin-4,16044,-0.00943853878977894,0.0185742698107707,-0.0458441076188895,0.0269670300393316,0.611354254488435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GET3,ATPase GET3,13965,0.00977059352136146,0.0192292351506002,-0.0279187073738148,0.0474598944165378,0.611383257088546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANG,Angiogenin,16035,-0.00591532748310019,0.0116433152182758,-0.0287362253109208,0.0169055703447204,0.611428815688676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX4,Syntaxin-4,15973,-0.010553699871964,0.0207744834934905,-0.0512716875192055,0.0301642877752774,0.611451511254541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16146,-0.0178371707721313,0.0351156573661866,-0.0866638592098571,0.0509895176655945,0.611491906167668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPCAT2,Lysophosphatidylcholine acyltransferase 2,15973,-0.00730305036733107,0.0144730179945695,-0.0356701656366872,0.021064064902025,0.613848451924457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK10,Kallikrein-10,16048,-0.0068374721507452,0.0135549011547079,-0.0334050784139727,0.0197301341124823,0.61396755322683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP4,Dipeptidyl peptidase 4,15768,-0.00516928672640187,0.0102602993939793,-0.0252794735386012,0.0149409000857975,0.614398842666084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSPN,Claspin,15649,0.00589042722467487,0.0116937037878017,-0.0170292321994164,0.0288100866487662,0.614460756264787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYZL1,Quinone oxidoreductase-like protein 1,13643,-0.0158803491392272,0.0315860221049602,-0.0777889524649492,0.0460282541864947,0.615137566770873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBP1,Z-DNA-binding protein 1,13568,-0.00722496925699188,0.0144019643763127,-0.0354528194345648,0.021002880920581,0.615910955585602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MKI67,Proliferation marker protein Ki-67,13568,0.00709465668930799,0.0141543898700076,-0.0206479474559069,0.0348372608345228,0.616214825369681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCS,Copper chaperone for superoxide dismutase,15918,-0.00829299466991818,0.0165676223309121,-0.040765534438506,0.0241795450986696,0.616691755433628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFAP1,Actin filament-associated protein 1,13703,-0.0146449271341351,0.0292843384618641,-0.0720422305193887,0.0427523762511186,0.617016805082155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOCS2,Molybdopterin synthase catalytic subunit,13703,-0.0116543535921105,0.0233095172043909,-0.0573410073127166,0.0340323001284956,0.617095348721797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RA,Interleukin-10 receptor subunit alpha,15797,-0.0102151681529954,0.0204511571222817,-0.0502994361126676,0.0298690998066767,0.617440514628099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIPF,Gastric triacylglycerol lipase,13643,0.0105798080751263,0.0211888914016738,-0.0309504190721544,0.052110035222407,0.617569645776521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAP3,Cytosol aminopeptidase,15797,-0.00834173138372577,0.0167147730888416,-0.0411026866378553,0.0244192238704037,0.617741680698308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP4,Guanylate-binding protein 4,15667,0.00826249487230407,0.016572637457263,-0.0242198745439314,0.0407448642885395,0.61809466350819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK24,Serine/threonine-protein kinase 24,15667,-0.0105418828004606,0.0211556095352847,-0.0520068774896186,0.0309231118886974,0.618278191025417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1RL,Complement C1r subcomponent-like protein,13995,-0.00332927883189024,0.00668929517800418,-0.0164402973807784,0.00978173971699796,0.618701584076365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNXB,Tenascin-X,16074,-0.00439453243832893,0.00885076361912762,-0.0217420291318191,0.0129529642551612,0.619538258096654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_A,,13946,-0.0055559469125955,0.0111957804693259,-0.0274996766324743,0.0163877828072833,0.619723292852428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",13751,-0.0121277322094166,0.0244953300971073,-0.0601385791997468,0.0358831147809137,0.620534736026415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASH1,Tubulinyl-Tyr carboxypeptidase 1,16054,-0.0139650417794778,0.0282825934221125,-0.0693989248868183,0.0414688413278626,0.62147674125444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7orf50,Uncharacterized protein C7orf50,13938,-0.00410495726755404,0.00831947128460444,-0.0204111209853787,0.0122012064502707,0.621726713978798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNDP1,Beta-Ala-His dipeptidase,16138,-0.00781700910255143,0.0158734460762415,-0.0389289634119847,0.0232949452068818,0.622402151158171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN10,Ataxin-10,15667,-0.012175346526697,0.0247518767218588,-0.0606890249015402,0.0363383318481463,0.622799839068209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHBP1,EH domain-binding protein 1,13965,-0.012670589200659,0.0257652334744764,-0.0631704468106327,0.0378292684093147,0.622889125874584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE10,Inactive ribonuclease-like protein 10,13643,-0.00812839876526795,0.0165444294112891,-0.0405554804113946,0.0242986828808587,0.623217036568162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD9,COMM domain-containing protein 9,13913,0.00665586088960064,0.013570857405929,-0.0199430196260201,0.0332547414052214,0.62382147912397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP1,Inactive pancreatic lipase-related protein 1,13938,0.0133369050850786,0.0272389763642229,-0.0400514885887982,0.0667252987589554,0.624406442904756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD23B,UV excision repair protein RAD23 homolog B,15725,0.00787518304114615,0.0160856331669761,-0.0236526579661271,0.0394030240484194,0.624438901899426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA12,Serpin A12,15628,0.0190229050566254,0.0388711142866543,-0.057164478945217,0.0952102890584678,0.624576669398612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANK2,Ankyrin-2,13501,-0.0118625098376831,0.0242434125047385,-0.0593795983469706,0.0356545786716044,0.624631202354589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF5,E3 ubiquitin-protein ligase RNF5,13643,-0.0122871521830967,0.0251530405144015,-0.0615871115913236,0.0370128072251302,0.625206628850065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDI2,Protein DDI1 homolog 2,13703,-0.0133111130943879,0.0272718476758702,-0.0667639345390936,0.0401417083503178,0.625493990430554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSG1,Tryptase gamma,13568,0.00453712525880174,0.00929684545265471,-0.0136846918284015,0.022758942346005,0.62553757000506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFE2,Transcription factor NF-E2 45 kDa subunit,13643,-0.0125138760646046,0.0257556820353843,-0.0629950128539579,0.0379672607247487,0.627068174064118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST5,Cystatin-D,15746,0.00927241646268242,0.0190844801441921,-0.0281331646199342,0.046677997545299,0.627072047645668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP10,Stromelysin-2,16022,0.00975830250206206,0.0200882851635537,-0.0296147364185031,0.0491313414226272,0.627136322999211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSR,"Glutathione reductase, mitochondrial",13914,-0.00376872484635167,0.00776334915501265,-0.0189848891901765,0.0114474394974731,0.627364183970125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA2,Paraneoplastic antigen Ma2,13528,0.00749000933224367,0.0154577055015773,-0.0228070934508478,0.0377871121153351,0.62800444538993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS15,Enteropeptidase,15973,-0.014947892211754,0.0309060088470175,-0.0755236695519084,0.0456278851284003,0.628636302361804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL16,C-X-C motif chemokine 16,16229,0.00383290935838878,0.00794390936794113,-0.0117371530027758,0.0194029717195534,0.629459717597788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13,Interleukin-13,15797,-0.00811939731020941,0.0168298608901795,-0.0411059246549613,0.0248671300345425,0.629500135023001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCFD2,Multiple coagulation factor deficiency protein 2,15994,-0.0073418557263186,0.0152210591931975,-0.0371751317449858,0.0224914202923486,0.629564975215132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,15918,-0.0100370498733964,0.0210009750390451,-0.0511989609499248,0.0311248612031319,0.63270477099951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SBSN,Suprabasin,13954,0.00565812108357977,0.0118675798651687,-0.0176023354521509,0.0289185776193104,0.633532481891136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAPRT,Nicotinate phosphoribosyltransferase,13938,0.00541229044905913,0.0113529063019725,-0.016839405902807,0.0276639868009253,0.633560659922509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCLM,Glutamate--cysteine ligase regulatory subunit,13501,-0.00759251678765382,0.0159385261308634,-0.0388320280041462,0.0236469944288385,0.633823834304446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT1S1,Proline-rich AKT1 substrate 1,15667,-0.0108596803154923,0.0228043258081019,-0.0555561588993721,0.0338367982683875,0.633930412865098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB104A_DEFB104B,Beta-defensin 104,13528,-0.00910634573283295,0.0192068749413843,-0.0467518206179462,0.0285391291522803,0.635422658640446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC4A1,Band 3 anion transport protein,13983,0.0077885573577884,0.0164491302486671,-0.0244517379295991,0.0400288526451759,0.635868488686952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF2,Alpha-2-antiplasmin,13762,-0.00226437250438823,0.00478387054144476,-0.01164075876562,0.00711201375684351,0.635981838827644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,15667,-0.0179785558298749,0.0380018622504297,-0.0924622058407171,0.0565050941809672,0.63615078413994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YAP1,Transcriptional coactivator YAP1,13938,-0.00446456982744333,0.00945229592078746,-0.0229910698321868,0.0140619301773001,0.636701162032347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,13946,-0.00621552782775764,0.0131885075139705,-0.0320650025551397,0.0196339468996245,0.637445576399561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRH,Corticoliberin,15699,-0.0140960790571311,0.0299419262526068,-0.0727822545122405,0.0445900963979783,0.637803941395351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD2,Protein disulfide isomerase CRELD2,16103,-0.00833090463834641,0.0177019369370854,-0.0430267010350339,0.026364891758341,0.637917732864028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK4,Serine/threonine-protein kinase 4,16063,-0.0140756953474725,0.029909830194339,-0.0726989625283768,0.0445475718334319,0.637929716455073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS,RNA-binding protein with multiple splicing,13568,0.011041680858054,0.0235130156157,-0.0350438297487181,0.057127191464826,0.638649329471822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7A,B-cell CLL/lymphoma 7 protein family member A,13506,-0.0100474175055955,0.0215174710003515,-0.0522216606662844,0.0321268256550934,0.64054869695406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),H2AP,Huntingtin-interacting protein M,13506,-0.00787468526320709,0.0168826021872428,-0.040964585550203,0.0252152150237888,0.640909629678154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",15667,0.00796785381282814,0.017086910092533,-0.0255224899685366,0.0414581975941929,0.640997733331755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIT,Vitrin,13965,0.00593844564900543,0.0128104579948785,-0.0191700520209563,0.0310469433189672,0.64296858638689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC5D,Netrin receptor UNC5D,13568,0.00433383850685025,0.00935122489399078,-0.0139945622853717,0.0226622392990722,0.643048266498196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,15973,-0.00724149758974217,0.0156281893676973,-0.037872748750429,0.0233897535709446,0.643111757622868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF1C,Kinesin-like protein KIF1C,13501,-0.00592349880126767,0.0128074509782507,-0.031026102718639,0.0191791051161037,0.643727312139614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16091,0.00555555282017074,0.0120319824457231,-0.0180271327734465,0.029138238413788,0.644279678127281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCNA,Proliferating cell nuclear antigen,13506,-0.0105725584004714,0.0229106704901764,-0.0554774725612172,0.0343323557602744,0.644469778457058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN1,Cerebellin-1,13528,-0.0153221440432056,0.0332404402533109,-0.080473406939695,0.0498291188532838,0.644842692151032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10,Interleukin-10,15797,0.0128543026043352,0.0278959240175513,-0.0418217084700654,0.0675303136787358,0.644952030740822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA5A,"Carbonic anhydrase 5A, mitochondrial",15821,-0.0144560306602429,0.0314595162870996,-0.0761166825829581,0.0472046212624723,0.645872732548014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD248,Endosialin,13983,0.0063652237398343,0.0138630127441867,-0.0208062812387716,0.0335367287184402,0.646132487192463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPS,Colipase,16047,-0.0109784437726502,0.0239389923422365,-0.0578988687634338,0.0359419812181334,0.646526996234379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF75D,Zinc finger protein 75D,13751,0.00978423518849647,0.0214060096578883,-0.0321715437409646,0.0517400141179576,0.647621568831921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB6,Heat shock protein beta-6,16195,-0.00600740442545323,0.0131442382979831,-0.0317701114895001,0.0197553026385936,0.647650521885678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",13528,-0.00862283558438193,0.0188821676258726,-0.0456318841310922,0.0283862129623283,0.647918790950871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13478,-0.00847808482352076,0.0185936386105873,-0.0449216165002719,0.0279654468532303,0.648421093212902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASEH2A,Ribonuclease H2 subunit A,13946,0.00792435181175902,0.0173821538993601,-0.0261446698309867,0.0419933734545048,0.648476117299878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAK4,Serine/threonine-protein kinase PAK 4,15667,-0.00963533742059743,0.0211442252040594,-0.0510780188205538,0.031807343979359,0.648614968634498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C3,Complement C3,13274,-0.00713022028013833,0.0156747762758765,-0.0378527817808563,0.0235923412205796,0.649199436744492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREH,Trehalase,13983,-0.0117484039359607,0.0258624830875106,-0.0624388707874814,0.03894206291556,0.649645633675485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R2,Protein phosphatase inhibitor 2,16063,-0.0124204769135759,0.0275950365997122,-0.0665067486490118,0.04166579482186,0.652645698079733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIFR,Leukemia inhibitory factor receptor,16054,-0.00369219513797502,0.00821591770565822,-0.0197953938410651,0.0124110035651151,0.653152563743064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUOX,"Sulfite oxidase, mitochondrial",13946,-0.0097970867471455,0.0218171999630025,-0.0525587986746303,0.0329646251803393,0.653400155783558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14020,-0.0029653609820954,0.00660400298350896,-0.015909206829773,0.00997848486558216,0.653420728836669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTR,Methionine synthase,13501,0.00996035128604518,0.0222158607236689,-0.0335827357323458,0.0535034383044362,0.653912041351906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,13841,-0.00470995726801763,0.0105055823356361,-0.0253008986458644,0.0158809841098292,0.653922796053299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF20B,Kinesin-like protein KIF20B,13528,-0.0118526802020311,0.0265373823018713,-0.0638659495136988,0.0401605891096367,0.655141519804531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMD,Osteomodulin,16133,-0.00663935869999989,0.0148817841591251,-0.0358076556518851,0.0225289382518853,0.655502136693716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC1,"Myosin-binding protein C, slow-type",13965,-0.0108373972452831,0.0243274038185953,-0.0585191087297299,0.0368443142391638,0.655979068250906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD10,Frizzled-10,13605,-0.00932352628615699,0.0209754585571299,-0.0504354250581315,0.0317883724858175,0.656690447982196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BA,Platelet glycoprotein Ib alpha chain,16022,-0.00499920132642183,0.0112563714760647,-0.0270616894195087,0.0170632867666651,0.65696044173505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGN,Biglycan,15697,0.0180924262920034,0.0407733878060611,-0.0618234138078762,0.0980082663918831,0.657243021627223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100G,Protein S100-G,13946,0.00710297727991143,0.0160322178775536,-0.0243201697600936,0.0385261243199164,0.657740817922287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART5,Ecto-ADP-ribosyltransferase 5,13528,0.00968709501641239,0.0218675890766543,-0.0331733795738301,0.0525475696066549,0.657780993578466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFT20,Intraflagellar transport protein 20 homolog,13605,0.00668860847569241,0.0151095087045211,-0.0229260285851689,0.0363032455365537,0.65800755136381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA1,von Willebrand factor A domain-containing protein 1,16173,-0.00641369452510555,0.0144951245044572,-0.0348241385538416,0.0219967495036305,0.658153220783635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK3,Prostate-specific antigen,13983,-0.0135829412541839,0.0307407895942139,-0.0738348888588432,0.0466690063504754,0.658601689737713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,15821,-0.00757408987711602,0.0171479549747082,-0.0411840816275442,0.0260359018733121,0.65871918195721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16114,0.0047133863361186,0.0106723413944314,-0.0162044027969669,0.0256311754692041,0.65875203833468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF3,Trefoil factor 3,16035,0.00693079992764084,0.0157115610604464,-0.0238638597508342,0.0377254596061159,0.659126728013771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTK7,Inactive tyrosine-protein kinase 7,15667,-0.00568130508975191,0.0129074672390958,-0.0309799408783796,0.0196173306988758,0.659829869347418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRP,Gastrin-releasing peptide,13643,-0.00829113416579362,0.0188900041918763,-0.0453155423818711,0.0287332740502839,0.660729012131733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP1,Integrin beta-1-binding protein 1,15725,-0.00609923813469393,0.0139300355334628,-0.033402107780281,0.0212036315108931,0.661502495284129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164,Sialomucin core protein 24,16074,-0.0040556452370294,0.00929444217640024,-0.0222727519027739,0.0141614614287151,0.66258747421754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP4,Bone morphogenetic protein 4,15888,-0.00688310750380007,0.0157756021450668,-0.037803287708131,0.0240370727005309,0.662615253572882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPME1,Protein phosphatase methylesterase 1,15973,-0.00914466728816263,0.0209944704714486,-0.0502938294122019,0.0320044948358767,0.6631509753622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD70,CD70 antigen,16054,0.00639977932157877,0.0147020263955834,-0.0224161924137646,0.0352157510569221,0.663351172168995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KEL,Kell blood group glycoprotein,15667,-0.0053378500855025,0.0122701255780804,-0.0293872962185401,0.0187115960475351,0.66354798901594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FADD,FAS-associated death domain protein,16063,-0.0114030088520601,0.0262423842382064,-0.0628380819589446,0.0400320642548244,0.663912067299967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI16,Peptidase inhibitor 16,13988,-0.00369646854789805,0.00850778377592514,-0.0203717247487113,0.0129787876529152,0.663946056029602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD55,Complement decay-accelerating factor,15519,-0.00385521668752672,0.00888174598322392,-0.0212634388146456,0.0135530054395922,0.664250418263844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREBZF,CREB/ATF bZIP transcription factor,13506,-0.00394293993267797,0.00913535798082088,-0.0218482415750869,0.013962361709731,0.666029551798403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI4,Protein-arginine deiminase type-4,15645,-0.011058983539073,0.0256553660535835,-0.0613435010040968,0.0392255339259507,0.666431214184447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIFBP,KIF-binding protein,15973,-0.012244089525612,0.0284300082592708,-0.0679669057137827,0.0434787266625587,0.666710624814796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PENK,Proenkephalin-A,13703,-0.00451309978281152,0.0104995278980637,-0.0250921744630164,0.0160659748973934,0.667319997238634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF2,Growth/differentiation factor 2,16063,-0.00523321581547001,0.0121830722828927,-0.0291120374899398,0.0186456058589998,0.667530148205555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDDC2,5'-deoxynucleotidase HDDC2,13936,0.00654540677918951,0.0152410527542773,-0.0233270566191939,0.036417870177573,0.66759589467809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYT1,Synaptotagmin-1,13938,-0.00575573502062017,0.0134028426176355,-0.0320253065511856,0.0205138365099453,0.667608701399537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED1,Transmembrane emp24 domain-containing protein 1,13751,-0.0081557690791054,0.0190411700505854,-0.0454764623782528,0.029164924220042,0.668422767839788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHODH,Dihydroorotate dehydrogenase,13501,0.00714541986806224,0.0166873912926765,-0.0255618670655836,0.0398527068017081,0.668517636106308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR4,Toll-like receptor 4,13568,-0.00413156519995036,0.00965833549520488,-0.0230619027705519,0.0147987723706512,0.668823942415645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPL,Periplakin,13568,-0.00476594331011172,0.0111733321906668,-0.0266656744038186,0.0171337877835952,0.669716604889399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKBKG,NF-kappa-B essential modulator,16054,-0.0131564356604537,0.0310480098911095,-0.0740105350470283,0.0476976637261208,0.671757552483093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDDM3B,Epididymal secretory protein E3-beta,13913,-0.0076490229828069,0.0180611921062147,-0.0430489595109876,0.0277509135453738,0.671932684772265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,13568,0.00874876619882799,0.0206866844189712,-0.0317971352623555,0.0492946676600115,0.672361975358761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A13,Protein S100-A13,13568,0.00518398552053732,0.0122744299300074,-0.0188738971422772,0.0292418681833519,0.672783399312736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11B,Transmembrane protease serine 11B,13528,-0.0110938650979838,0.0263788457630373,-0.0627964027935369,0.0406086725975693,0.6740837115288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR5,Complement factor H-related protein 5,13779,-0.00603939400238035,0.0143639169355084,-0.0341926711959768,0.0221138831912161,0.674158983168049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP5,Rho GTPase-activating protein 5,13506,0.0111338459430868,0.0265811656721871,-0.0409652387743998,0.0632329306605734,0.67532350027511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSD1,Tryptase delta,13946,-0.0052914380594419,0.0127290824844258,-0.0302404397289164,0.0196575636100326,0.677638331281837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO9B,Unconventional myosin-IXb,15797,0.00943134978350444,0.0227651304531179,-0.0351883059046067,0.0540510054716156,0.678667884830449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK2,Protein AHNAK2,13643,0.00419575582612781,0.0101625113317863,-0.0157227663841734,0.024114278036429,0.679711256940528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D2,DCN1-like protein 2,13506,0.0117119428803137,0.0283757061369946,-0.0439044411481957,0.0673283269088231,0.67979969880116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD2,Leiomodin-2,13528,-0.00910051685842996,0.0220529219880837,-0.052324243955074,0.0341232102382141,0.679857029247182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17D,Interleukin-17D,15797,-0.0046923023730241,0.0113866297015547,-0.0270100965880713,0.0176254918420231,0.680279946729291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA2,Carboxypeptidase A2,16165,0.00925848100945451,0.0224748277654347,-0.0347921814107975,0.0533091434297065,0.680382330711965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRND,Prion-like protein doppel,13938,0.00731079633839396,0.0177627598044774,-0.0275042128783817,0.0421258055551696,0.680653642373889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINC1,Antithrombin-III,13994,0.00212692140796557,0.00516887198465019,-0.0080040676819488,0.0122579104978799,0.680722094350552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20,Interleukin-20,15797,0.00724849564924322,0.0176270171490417,-0.0273004579628786,0.041797449261365,0.680920398985317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16208,-0.0038455153429539,0.00935608467958013,-0.022183441314931,0.0144924106290232,0.681065077946357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCK2,Cytoplasmic protein NCK2,16133,-0.0148607067500657,0.0363426544825817,-0.0860923095359259,0.0563708960357946,0.682614537046792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL1,Growth-regulated alpha protein,16029,-0.0134070974525457,0.0327889091455326,-0.0776733593777896,0.0508591644726982,0.682624951473078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTP1,Glutathione S-transferase P,15569,-0.00958621650052261,0.0234740678850098,-0.0555953895551418,0.0364229565540966,0.683004192655666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF2,Fibroblast growth factor 2,16054,-0.0094313638530756,0.0231900198062558,-0.054883802673337,0.0360210749671858,0.684234311696469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC1,Plexin domain-containing protein 1,15725,0.00481671745406922,0.0118600708509169,-0.0184290214137279,0.0280624563218664,0.684653428008478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RG,Cytokine receptor common subunit gamma,13913,-0.0052331559199266,0.0129566280340233,-0.0306281468666122,0.020161835026759,0.686293954135917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF4,Neurotrophin-4,15725,-0.00554976424922305,0.0137472685636947,-0.0324944106340647,0.0213948821356186,0.686439265609426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBQ1,Hemoglobin subunit theta-1,16195,-0.00854678793292031,0.0212170909431228,-0.0501322861814411,0.0330387103156005,0.687081829946947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARC,SPARC,16091,0.00972895919585298,0.0241524830996131,-0.0376099076793888,0.0570678260710947,0.687090390791119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY2,Protein canopy homolog 2,15821,0.00837839654663213,0.0208516586036365,-0.0324908543164955,0.0492476474097597,0.687829590834522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEP,Leptin,16063,0.0092581585647084,0.0230815115272993,-0.0359816040287982,0.054497921158215,0.688346600586095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP164,Centrosomal protein of 164 kDa,15797,0.00894741833183695,0.0223619242015246,-0.0348819531031513,0.0527767897668252,0.689074694634606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS2,Growth arrest-specific protein 2,13751,-0.00708483485529599,0.0177924496227236,-0.0419580361158342,0.0277883664052422,0.690493866654148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD3,Ly6/PLAUR domain-containing protein 3,15959,0.00468726633133,0.0118161605721745,-0.0184724083901321,0.0278469410527921,0.69160677712892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STOML2,"Stomatin-like protein 2, mitochondrial",13506,0.0128368943620896,0.0324040906390664,-0.0506751232904805,0.0763489120146598,0.692000323582173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASRGL1,Isoaspartyl peptidase/L-asparaginase,13643,-0.0139047159600183,0.035164316475881,-0.082826776252745,0.0550173443327085,0.692538260156892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC5,Glypican-5,15918,-0.00762793974954089,0.0192991724594377,-0.0454543177700387,0.0301984382709569,0.692665920690362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC21,DnaJ homolog subfamily C member 21,13938,0.00528267399996135,0.0133659345456586,-0.0209145577095296,0.0314799057094523,0.692676134313748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSV,Cathepsin L2,16132,0.00568866734842506,0.0144091021012948,-0.0225531727701128,0.0339305074669629,0.692998083358584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIC5,Chloride intracellular channel protein 5,13605,-0.00440920209932559,0.0111706530051329,-0.026303681989386,0.0174852777907349,0.693060892144486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD7,T-cell antigen CD7,13540,-0.00587692257513782,0.0150243749399359,-0.0353246974574123,0.0235708523071366,0.695685720820819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16124,-0.0150650071204093,0.0385249025786173,-0.0905738161744991,0.0604438019336806,0.695768442906603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOS,Proto-oncogene c-Fos,13478,-0.00486844042866872,0.0124573312147857,-0.0292848096096487,0.0195479287523113,0.695944411112529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAN,Aggrecan core protein,15915,-0.00376430333797166,0.00963823153662143,-0.0226552371497497,0.0151266304738063,0.696128064469466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B3,Testosterone 17-beta-dehydrogenase 3,13501,-0.00660929756224125,0.0169290497639235,-0.0397902350995312,0.0265716399750487,0.696238370556161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSZ,Cathepsin Z,16080,-0.0042372959281303,0.0108801908989519,-0.0255624700900761,0.0170878782338155,0.696948073449071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAV,Integrin alpha-V,16195,-0.00218743297186124,0.00561728008319832,-0.0131973019349299,0.00882243599120745,0.696976955712079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17A,Interleukin-17A,15773,-0.00573725529736346,0.0147347338333542,-0.0346173336107378,0.0231428230160108,0.697008124656614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR5,Proline-rich protein 5,13568,-0.00622254721175869,0.0159823986057571,-0.0375480484790427,0.0251029540555253,0.6970326116419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAG,S-arrestin,13528,-0.00712160857685213,0.0183071838245787,-0.0430036888730264,0.0287604717193221,0.697277666124805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF1,Formylglycine-generating enzyme,13568,-0.00919492081786249,0.0237825482915075,-0.0558087154692171,0.0374188738334921,0.699040131843225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",13616,-0.0106202309653193,0.0275235249294095,-0.064566339826962,0.0433258778963234,0.699606292925112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",15945,-0.0101933869433626,0.0264543049836228,-0.0620438247112633,0.0416570508245382,0.700005093762918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL1,Angiopoietin-related protein 1,15823,0.0038492977075948,0.0100188208054984,-0.015787591071182,0.0234861864863716,0.700830447829758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,13946,0.015506296493022,0.0403778218346528,-0.0636342343028976,0.0946468272889416,0.700962044178929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,13751,-0.00934075939127739,0.0243269086615895,-0.0570215003679928,0.038339981585438,0.701007957935478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR101,Probable G-protein coupled receptor 101,13528,-0.0078094430245465,0.020360522878265,-0.0477160678659459,0.0320971818168529,0.7013120501709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,15667,-0.00611484814016488,0.0159746181437219,-0.0374250997018599,0.0251954034215301,0.701884199205081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN2,Centrin-2,15667,-0.00878039452993848,0.0230510833000979,-0.0539605177981304,0.0363997287382534,0.703274995601564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSTN,Growth/differentiation factor 8,15821,-0.00687954207283991,0.0180810067467264,-0.0423183152964236,0.0285592311507438,0.703590943123313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16208,0.0060140342348692,0.0158185140552614,-0.0249902533134432,0.0370183217831816,0.703809678754685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGA,Fibrinogen alpha chain,13676,-0.00404843625066016,0.0106646791802317,-0.0249512074439142,0.0168543349425939,0.704239626538759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRUNE2,Protein prune homolog 2,13751,-0.0036935146172705,0.0097298055813971,-0.0227639335568088,0.0153769043222678,0.70424209262363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,13936,-0.00454508488283889,0.0119803634633279,-0.0280265972709617,0.0189364275052839,0.704413060973913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MERTK,Tyrosine-protein kinase Mer,16249,0.00328435632582036,0.00867190236257658,-0.0137125723048297,0.0202812849564705,0.704889322608025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLASP1,CLIP-associating protein 1,13506,0.00960737535321341,0.025525599563823,-0.0404227997918797,0.0596375504983065,0.706638869283207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT1,Angiopoietin-1,15996,-0.0108224821036062,0.0287670700223514,-0.067205939347415,0.0455609751402026,0.706765189136764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RB,Interleukin-20 receptor subunit beta,13568,-0.00547342843122219,0.0145553628897538,-0.0340019396951396,0.0230550828326952,0.706891523924565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB2A2,Mammaglobin-A,13501,-0.00390183341799444,0.0104034143345879,-0.0242925255137868,0.0164888586777979,0.707626829103258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2,Prothrombin,14020,-0.00192069763832029,0.0051324564330507,-0.0119803122470997,0.00813891697045909,0.708241992271099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPB,Natriuretic peptides B,15821,-0.0169408731738014,0.0453173922133121,-0.105762961911893,0.0718812155642903,0.708537906293798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16208,-0.00734953622315915,0.0196639306328886,-0.0458908402636209,0.0311917678173026,0.708589836224806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDA,Cytidine deaminase,13942,0.00616577880646388,0.0165241560972227,-0.0262215671440925,0.0385531247570203,0.709051945569604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HK2,Hexokinase-2,15821,-0.00354944190180582,0.00951559766252391,-0.0222000133203527,0.015101129516741,0.709143748982616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMR1,Synaptic functional regulator FMR1,15725,-0.00453119921205273,0.0121507907163321,-0.0283467490160637,0.0192843505919582,0.709217529040177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN2,Neutrophil gelatinase-associated lipocalin,15607,-0.0049491948045816,0.013343381270147,-0.0311022220940697,0.0212038324849066,0.710709535210745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,13501,-0.00627640923695931,0.0169411999656803,-0.0394811611696927,0.0269283426957741,0.711029221924911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHD,SH2 domain-containing adapter protein D,13473,0.0108507668276117,0.0292964652837053,-0.0465703051284507,0.0682718387836741,0.711106676484446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN1,Dynactin subunit 1,16195,-0.00821355339747849,0.0222002777098534,-0.0517260977087911,0.0352989909138341,0.711405770330343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VMO1,Vitelline membrane outer layer protein 1 homolog,15973,0.00864891133065416,0.0234745691030809,-0.0373612441113844,0.0546590667726927,0.71255193406894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,15797,-0.00463872858557175,0.0126183631010122,-0.0293707202635557,0.0200932630924122,0.713163541893942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRX,Cone-rod homeobox protein,15821,-0.0133749766064778,0.03643870600207,-0.0847948403705349,0.0580448871575793,0.713583574138006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTPN,Myotrophin,15821,-0.00415849845519985,0.011354692925578,-0.0264136965893327,0.018096699678933,0.7141938080838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEPK,Rab9 effector protein with kelch motifs,15725,-0.00738444300003159,0.0201787742048136,-0.0469348404414663,0.0321659544414031,0.714406551756358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIPR1,Vasoactive intestinal polypeptide receptor 1,13643,-0.00303133186874864,0.00828548165091718,-0.0192708759045463,0.013208212167049,0.714474723705635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3,Galectin-3,16102,0.00372471712315296,0.0102175618429187,-0.0163017040889678,0.0237511383352737,0.715459080257171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID4B,AT-rich interactive domain-containing protein 4B,15667,-0.00537666905690349,0.0147884126213279,-0.0343619577947062,0.0236086196808992,0.716181725291743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP5,Microfibrillar-associated protein 5,16254,-0.00501594377563189,0.0138051827593687,-0.0320741019839945,0.0220422144327307,0.716357340558715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TADA3,Transcriptional adapter 3,13913,-0.0050208537538585,0.0138509607246063,-0.0321687367740868,0.0221270292663698,0.716990381602505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBK,Lymphokine-activated killer T-cell-originated protein kinase,13506,0.00391913766916604,0.010812761159754,-0.0172738742039519,0.025112149542284,0.717017838428513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA5,Annexin A5,15609,-0.00374710314915919,0.0103628124044884,-0.0240582154619564,0.016564009163638,0.717662341159506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSNAX,Translin-associated protein X,13501,-0.00502985815671019,0.0139674357479701,-0.0324060322227317,0.0223463159093113,0.718768111540023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON1,Serum paraoxonase/arylesterase 1,13988,-0.00329873367839718,0.00916123047326347,-0.0212547454059936,0.0146572780491992,0.718796194356889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLHL41,Kelch-like protein 41,13946,-0.00600931394576939,0.0166919511071689,-0.0387255381158204,0.0267069102242816,0.718843113121518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C5,Complement C5,14020,-0.00185633685789562,0.00516931858371125,-0.0119882012819697,0.00827552756617843,0.719520694432588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TINAGL1,Tubulointerstitial nephritis antigen-like,16011,-0.00272130964420328,0.00758094629636607,-0.0175799643850808,0.0121373450966742,0.719624504527607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",13568,0.00344298041509886,0.00961629442247731,-0.0154049566529567,0.0222909174831544,0.720321884064525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,13936,0.00895639826370052,0.0250419154078193,-0.0401257559356254,0.0580385524630264,0.720605978209522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCG22,Protein PBMUCL2,13501,0.00689732720462206,0.0192889008309428,-0.0309089184240258,0.0447035728332699,0.720663163621191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA1,Ephrin-A1,16050,0.00335623644930905,0.00941222618982446,-0.0150917268827469,0.021804199781365,0.721408968116903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPHA2,Glycoprotein hormone alpha-2,13936,-0.00582704479652593,0.0163501813779595,-0.0378734002973265,0.0262193107042746,0.721553750529872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OFD1,Oral-facial-digital syndrome 1 protein,13751,-0.00808520811073272,0.0227199716479261,-0.0526163525406679,0.0364459363192025,0.721948273201846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORC3,MORC family CW-type zinc finger protein 3,13938,-0.0034015257488281,0.00956058949517793,-0.0221402811593768,0.0153372296617206,0.722006078918554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG1,Arginase-1,15953,-0.00643847195952375,0.0181751352648964,-0.0420617370787207,0.0291847931596732,0.723159095502019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFC,Platelet-derived growth factor C,15725,-0.00351459420830446,0.00993297298671973,-0.0229832212622751,0.0159540328456662,0.723470254348827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD101,Immunoglobulin superfamily member 2,13936,-0.00516648032948814,0.0146457714496869,-0.0338721923708744,0.0235392317118981,0.724271769111548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16041,-0.00746998623654413,0.0211807286313908,-0.04898421435407,0.0340442418809818,0.724334165568026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13506,-0.00687379642557932,0.0195004868261368,-0.0450947506048074,0.0313471577536488,0.72447363780958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCT5,T-complex protein 1 subunit epsilon,15725,-0.00548023473925213,0.0155512294893928,-0.035960644538462,0.0250001750599577,0.724543922518057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYAR,Cell growth-regulating nucleolar protein,15725,0.00659571496728719,0.0188106979777527,-0.0302732530691082,0.0434646830036826,0.725865864034945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RA,Interleukin-17 receptor A,16074,0.00528012386543507,0.0150817934356315,-0.0242801912684028,0.0348404389992729,0.726268839944842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THRAP3,Thyroid hormone receptor-associated protein 3,13501,-0.0135934442489944,0.0389085803770185,-0.0898542617879507,0.0626673732899618,0.726817903755376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4G,C-type lectin domain family 4 member G,16054,-0.00395486706259364,0.0113337913313996,-0.0261690980721369,0.0182593639469496,0.727135363476206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13501,-0.00341068168590249,0.00977884532733898,-0.0225772185274869,0.0157558551556819,0.727258694418277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,15821,-0.00367380379312022,0.0105353612072817,-0.0243231117593923,0.0169755041731518,0.727310398587308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,15918,-0.00838858689906917,0.0241139856064227,-0.0556519986876577,0.0388748248895193,0.727940715720695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX53,Probable ATP-dependent RNA helicase DDX53,13605,-0.0042449913491681,0.0122503651449172,-0.0282557070332057,0.0197657243348695,0.728957638566903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLTA,Clathrin light chain A,15821,0.00565873504794089,0.0163584124379498,-0.0264037533304407,0.0377212234263224,0.729405924461551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMMR,Hyaluronan mediated motility receptor,13480,-0.00586816100957413,0.016970628588481,-0.0391305930429969,0.0273942710238487,0.729510931565398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA2,Interleukin-13 receptor subunit alpha-2,13528,0.00347338956635806,0.0100530171119419,-0.016230523973048,0.0231773031057642,0.729718493142218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP10,Bone morphogenetic protein 10,13703,-0.00335858421883857,0.00975306468156042,-0.022474590994697,0.0157574225570198,0.730579402026604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR1,Interferon gamma receptor 1,16133,0.00244599236886217,0.00710551049296215,-0.0114808081973436,0.016372792935068,0.73067119961923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES1,Liver carboxylesterase 1,16105,-0.00955208839121188,0.027808747146855,-0.0640572327990477,0.0449530560166239,0.731232677816862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECM1,Extracellular matrix protein 1,13640,0.00429004655559627,0.0125483854026901,-0.0203047888336764,0.0288848819448689,0.732446200683434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF19,Fibroblast growth factor 19,16133,0.00903896873368587,0.0264445187610277,-0.0427922880379284,0.0608702255053001,0.732499256514211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRP15,RRP15-like protein,13528,-0.0107250432347284,0.031401193929144,-0.0722713833358506,0.0508212968663939,0.732695709372798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM3,Paralemmin-3,13501,0.00894893528904765,0.0263103115415133,-0.0426192753323183,0.0605171459104136,0.733763669103209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC1,MANSC domain-containing protein 1,16091,-0.00322669041431275,0.00948998090674429,-0.0218270529915316,0.015373672162906,0.733853279916546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3,Granulocyte colony-stimulating factor,15797,-0.00569282292546097,0.0167682354118097,-0.0385585643326079,0.027172918481686,0.734237299769131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID3A,AT-rich interactive domain-containing protein 3A,13528,-0.00467178274330301,0.0137839257714276,-0.0316882772553012,0.0223447117686952,0.734667905811369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAM,Peptidyl-glycine alpha-amidating monooxygenase,16193,-0.0031793372689716,0.00938076563310906,-0.0215656379098654,0.0152069633719222,0.734673738900805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG3,BAG family molecular chaperone regulator 3,15888,0.00454792649985405,0.0134281011014067,-0.0217711516589031,0.0308670046586112,0.734849833811104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMS,Spermine synthase,13528,0.00736699306739071,0.0217587289788535,-0.0352801157311621,0.0500141018659435,0.734934091112108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17F,Interleukin-17F,15797,-0.00900724789868364,0.0267179014587323,-0.0613743347577989,0.0433598389604316,0.736027849847707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP6,Guanylate-binding protein 6,13501,-0.00522169557240665,0.0155228103059654,-0.0356464037720989,0.0252030126272856,0.736583119937942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL26,C-C motif chemokine 26,16054,-0.010500979935895,0.0312804596549225,-0.0718106808595432,0.0508087209877531,0.7370983711634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4A,C-type lectin domain family 4 member A,16054,-0.00405242610742581,0.0120767206951254,-0.0277227986698715,0.0196179464550199,0.737209471778718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG2,Bone marrow proteoglycan,13983,-0.00602386651750589,0.0179819308139408,-0.0412684509128299,0.0292207178778181,0.737633485090627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP2,Insulin-like growth factor-binding protein 2,16230,0.00711344239420611,0.0213218504423902,-0.0346773844728786,0.0489042692612908,0.738668986852427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL3A1,Collagen alpha-1(III) chain,13983,-0.00264177490739582,0.00791904422124982,-0.0181631015810455,0.0128795517662538,0.738688164212289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC9,Histone deacetylase 9,13528,-0.0075850020798632,0.022753793161524,-0.0521824366764502,0.0370124325167238,0.738874439002053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIGYF2,GRB10-interacting GYF protein 2,13946,-0.00878549613391876,0.0264323909315812,-0.0605929823598179,0.0430219900919804,0.73961025155743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFAT5,Nuclear factor of activated T-cells 5,13568,-0.00997015988389445,0.03014214098256,-0.0690487562097119,0.0491084364419231,0.740822235501261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTN,Titin,13501,-0.00777621882181118,0.0236135724379974,-0.0540588208002861,0.0385063831566638,0.741925434817496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16074,-0.00301868789643314,0.00918699184283874,-0.0210251919083971,0.0149878161155308,0.742475302172002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,13568,0.00381892093830307,0.0116337980606957,-0.0189833232606605,0.0266211651372667,0.742719481094861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD34,Hematopoietic progenitor cell antigen CD34,16158,-0.00270348809843177,0.00825613882335291,-0.0188855201922035,0.0134785439953399,0.743330385935311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOE,Apolipoprotein E,14020,0.00829582570690782,0.0253565546183828,-0.0414030213451224,0.0579946727589381,0.74354653372176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5,Interleukin-5,15797,-0.015800649096448,0.0484490008747977,-0.110760690811052,0.0791593926181555,0.744330691883444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS1,"Nitric oxide synthase, brain",15667,-0.00599718255595566,0.0185170683754091,-0.0422906365717574,0.0302962714598461,0.746038346729123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA4,DnaJ homolog subfamily A member 4,13938,-0.00807508649423541,0.0249818055338267,-0.0570394253405358,0.040889252352065,0.746519323831169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",15797,-0.0131382859467083,0.0409480888519026,-0.0933965400964375,0.0671199682030209,0.748326618412793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKAP12,A-kinase anchor protein 12,13703,-0.00232111489251157,0.00723435770625656,-0.0165004559967744,0.0118582262117513,0.748331978817472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",15649,-0.0052048761205195,0.0162544762763682,-0.0370636496222012,0.0266538973811622,0.748812010385911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPK1,Thiamin pyrophosphokinase 1,13965,-0.00302327269110566,0.00944964661767884,-0.0215445800617562,0.0154980346795449,0.749022396018636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16054,-0.0162588505320458,0.0508352430663874,-0.115895926942165,0.0833782258780736,0.749098167643663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THAP12,52 kDa repressor of the inhibitor of the protein kinase,13478,0.00975176427158298,0.0305875956225742,-0.0501999231486624,0.0697034516918283,0.749872245031803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOD,Apolipoprotein D,13376,-0.00483773809696081,0.0152213172976438,-0.0346715200003427,0.0249960438064211,0.750621509863194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3G,Semaphorin-3G,13703,-0.00482465358498347,0.0152022383347733,-0.0346210407211391,0.0249717335511722,0.750971740511654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENDOU,Poly(U)-specific endoribonuclease,12916,-0.0058765373697096,0.0186673383891323,-0.042464520612409,0.0307114458729898,0.752916192569687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RAP,Interleukin-1 receptor accessory protein,16074,0.00476020689111491,0.0151366447658319,-0.0249076168499156,0.0344280306321454,0.753158841225292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOST,Sclerostin,16043,0.00419461987629925,0.0133438091716946,-0.0219592461002221,0.0303484858528206,0.753259690104112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNL1,Thioredoxin-like protein 1,13496,0.010729291984302,0.0341374712670762,-0.0561801516991674,0.0776387356677713,0.75330062498043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16249,-0.00410036961638219,0.0130627257031593,-0.0297033119945744,0.02150257276181,0.75360218523948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADIPOQ,Adiponectin,14020,-0.00733971827383593,0.0235842297369569,-0.0535648085582715,0.0388853720105996,0.755643352345782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,13936,0.0184112603015502,0.059186061773172,-0.097593420773867,0.134415941376967,0.755748826817593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTB,Lymphotoxin-beta,13913,0.00378806618168804,0.0122113120345142,-0.0201461054059598,0.0277222377693358,0.756406224211886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7B,B-cell CLL/lymphoma 7 protein family member B,13913,0.00484274897398491,0.0156294997741741,-0.0257910705833963,0.0354765685313661,0.756682179473688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,13528,-0.00658159418866552,0.0213042613515388,-0.0483379464376816,0.0351747580603506,0.757377083809536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3,Interleukin-3,13506,0.00648849791820548,0.0210305819684132,-0.0347314427398843,0.0477084385762953,0.757686282706998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L2,Mortality factor 4-like protein 2,13506,-0.00402306581816577,0.0130466017003996,-0.029594405150949,0.0215482735146174,0.75781225928085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",13938,-0.00278113343536857,0.00907046694404868,-0.020559248645704,0.0149969817749668,0.75914167312585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB4,Ephrin type-B receptor 4,16254,-0.00259675347966898,0.00850325638452283,-0.0192631359933337,0.0140696290339958,0.760078065109645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK4,Dickkopf-related protein 4,15894,-0.0048445143406212,0.0158778850045388,-0.0359651689495173,0.0262761402682749,0.760285757766948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TG,Thyroglobulin,13913,-0.0117304509105688,0.0384652422306333,-0.08712232568261,0.0636614238614724,0.760399388999643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH22,Cadherin-22,13751,0.00301761881454019,0.00992121977678411,-0.0164279719479567,0.022463209577037,0.76101209349493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16103,-0.00791168598059682,0.0260299644233867,-0.0589304162504348,0.0431070442892412,0.761173476957939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELENOP,Selenoprotein P,14020,-0.00239345508959413,0.00787977234460912,-0.017837808885028,0.0130508987058397,0.761325364847484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAPL1,Proactivator polypeptide-like 1,13936,0.00530647873005726,0.0175022288604019,-0.0289978898363304,0.0396108472964449,0.761750559170881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZCCHC8,Zinc finger CCHC domain-containing protein 8,13501,-0.00655644229089059,0.0216823928175078,-0.0490539322132059,0.0359410476314247,0.762362831432132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM20A,Pseudokinase FAM20A,13965,-0.00296115573520078,0.00981981238318922,-0.0222079880062516,0.0162856765358501,0.763000297821275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA13,Carbonic anhydrase 13,15853,-0.0108416841234908,0.0361951212600987,-0.0817841217932843,0.0601007535463026,0.764536254981117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BABAM1,BRISC and BRCA1-A complex member 1,13568,0.00295159974750975,0.00986553999613374,-0.0163848586449124,0.0222880581399319,0.764805169537359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNLZ,DNL-type zinc finger protein,13528,0.00930164386665884,0.0311786084655202,-0.0518084287257607,0.0704117164590784,0.76545272386352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX101,Testis-expressed protein 101,13605,-0.00513693321347163,0.0173491315646362,-0.0391412310801585,0.0288673646532152,0.767164604661379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARMCX2,Armadillo repeat-containing X-linked protein 2,13528,-0.00635140317411878,0.0214694591873265,-0.0484315431812788,0.0357287368330413,0.767361146107034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEPR,Leptin receptor,16063,0.00314480924910394,0.0107050299231929,-0.0178370494003541,0.024126667898562,0.768937987048307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDAR,Tumor necrosis factor receptor superfamily member EDAR,16054,-0.00921789052387822,0.0314597223371942,-0.0708789463047788,0.0524431652570224,0.769521280040266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REEP4,Receptor expression-enhancing protein 4,13946,-0.00626540237339748,0.0214019032735425,-0.0482131327895408,0.0356823280427459,0.769717780322242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA4,Carboxypeptidase A4,13418,0.00440003287413293,0.0150377454534464,-0.025073948214622,0.0338740139628878,0.769833024573851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP3,Tubulin polymerization-promoting protein family member 3,15667,0.00392916198359615,0.013564998353888,-0.0226582347900243,0.0305165587572166,0.772084451789757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A1,Collagen alpha-1(IV) chain,16063,-0.00392165222133294,0.0135617684687571,-0.0305027184200969,0.022659413977431,0.772455269616998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD3,Bromodomain-containing protein 3,13501,-0.00469084782556297,0.0162528684234744,-0.0365464699355729,0.0271647742844469,0.772879216935651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA4,Carbonic anhydrase 4,16254,0.00234000033107225,0.00812402772488717,-0.0135830940097066,0.0182630946718511,0.773323999332723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EP300,Histone acetyltransferase p300,13568,-0.00304342248699424,0.0105734847500578,-0.0237674525971076,0.0176806076231191,0.773477191557824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX4,Probable ATP-dependent RNA helicase DDX4,13568,-0.00538782937657453,0.0187536519825456,-0.042144987262364,0.0313693285092149,0.773890886403992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHR1,Corticotropin-releasing factor receptor 1,15821,0.00603633983723353,0.0211012204973082,-0.0353220523374905,0.0473947320119576,0.774831389797505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIP2A,FHF complex subunit HOOK interacting protein 2A,13501,0.0047079263199907,0.0165013051870727,-0.0276346318466719,0.0370504844866533,0.77541386812327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBR1,T-box brain protein 1,13605,-0.00477996475335819,0.0167861095720246,-0.0376807395145264,0.02812081000781,0.775834540109733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLGN,Calmegin,13605,-0.00435293035843848,0.0152931826085631,-0.0343275682712221,0.0256217075543451,0.775930368572136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMB,RGM domain family member B,16208,-0.00256631139698559,0.00908629080577973,-0.0203754413763139,0.0152428185823427,0.777611493287382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM7,PDZ and LIM domain protein 7,16133,-0.0122108418831526,0.0432717272247747,-0.0970234272437109,0.0726017434774057,0.777801569561063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1B,Interleukin-1 beta,15718,-0.00552777571640715,0.0196151452168358,-0.0439734603414054,0.032917908908591,0.778091679046742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSND,Barttin,13506,0.00326631244053453,0.0116250668161399,-0.0195188185190996,0.0260514434001687,0.778736569114272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC14A,C-type lectin domain family 14 member A,16074,-0.00301330878076048,0.0107276638543117,-0.0240395299352114,0.0180129123736905,0.778797296698328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS7_LGALS7B,Galectin-7,15996,-0.00399870252715207,0.0142399307637639,-0.0319089668241293,0.0239115617698252,0.778860437740389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM25,RNA-binding protein 25,13506,0.00454610006246317,0.0162089426969778,-0.0272234276236133,0.0363156277485397,0.779122284620445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL3,C-X-C motif chemokine 3,16054,-0.00918225440695388,0.0327457511189553,-0.0733639266001063,0.0549994177861985,0.779166152550245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TET2,Methylcytosine dioxygenase TET2,13732,-0.00950305407098306,0.0339441927350993,-0.0760336718317777,0.0570275636898116,0.779511558729044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRM,Receptor-type tyrosine-protein phosphatase mu,16026,-0.00235775207587452,0.00844389180126109,-0.0189077800063463,0.0141922758545972,0.780075184886988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK11,Kallikrein-11,15935,-0.00289488671489713,0.0104063753929123,-0.0232913824850053,0.017501609055211,0.780874759726063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RA,Interleukin-20 receptor subunit alpha,15797,0.00411747926896913,0.0148221299718483,-0.0249338954758536,0.0331688540137918,0.781175146083466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4M,C-type lectin domain family 4 member M,13954,-0.00463550936307641,0.0167571056379413,-0.0374794364134414,0.0282084176872885,0.78206872978017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPACAM2,HEPACAM family member 2,13938,0.00399177249204494,0.0144507153977886,-0.0243316296876206,0.0323151746717105,0.782372785747995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAU,Urokinase-type plasminogen activator,16074,-0.00283634024241249,0.0102742143170213,-0.0229738003037742,0.0173011198189492,0.782502496860727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,15667,-0.00594416817166644,0.0215731403373867,-0.0482275232329443,0.0363391868896115,0.782908415909963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBS,Cystathionine beta-synthase,13643,-0.00491739791675997,0.0178662293537874,-0.0399352074501833,0.0301004116166633,0.783140461091624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVPL,Envoplakin,13751,-0.00310851484701555,0.0113280917986563,-0.0253115747723819,0.0190945450783508,0.783775504732055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLU,Clusterin,14020,0.00305690487820002,0.0112397064398497,-0.0189729197439055,0.0250867295003055,0.78564622791502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS4,Thrombospondin-4,16085,-0.00423051485562387,0.0155797433457819,-0.0347668118133565,0.0263057821021087,0.785979654237148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RETN,Resistin,16036,-0.00390154598950386,0.0144653132564677,-0.0322535599721805,0.0244504679931727,0.787381183565034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16054,0.00398197094972181,0.0148374678511856,-0.0250994660386021,0.0330634079380457,0.788415921062793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACC3,Transforming acidic coiled-coil-containing protein 3,15973,-0.0107659855082918,0.0402642184326093,-0.0896838536362062,0.0681518826196225,0.789177398319193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC27,Cell division cycle protein 27 homolog,15725,-0.00563539784171505,0.0211077650036921,-0.0470066172489515,0.0357358215655214,0.789486359186418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IQGAP2,Ras GTPase-activating-like protein IQGAP2,15973,-0.0050099254374873,0.0187812284417495,-0.0418211331833164,0.0318012823083418,0.789663757621272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBP,Protein AMBP,16170,-0.00179295694666779,0.00673080464804474,-0.0149853340568355,0.0113994201634999,0.789949370645789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPR1,Atrial natriuretic peptide receptor 1,13501,-0.0037635604720338,0.0142200586198118,-0.031634875366865,0.0241077544227974,0.791271117504111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPTC,Opticin,15973,0.00416817826169851,0.0157512048206443,-0.0267041831867643,0.0350405397101613,0.791301009406482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM1,Isthmin-1,16054,-0.00356744727297825,0.0134966553082785,-0.0300208916772041,0.0228859971312476,0.791536098833914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REXO2,"Oligoribonuclease, mitochondrial",13501,-0.00455638655686338,0.0172951478944012,-0.0384548764298898,0.029342103316163,0.792208679617369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKCQ,Protein kinase C theta type,15797,0.00389029147648526,0.0148477962902537,-0.0252113892524119,0.0329919722053825,0.793316094119102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP4,Caspase-4,13751,0.0152032371850039,0.0580439376602291,-0.0985628806290451,0.128969354999053,0.793382145419417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31RA,Interleukin-31 receptor subunit alpha,13512,0.0035751174944853,0.0138780716514386,-0.0236259029423344,0.030776137931305,0.796712535898637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI1,Neuroserpin,13677,-0.00270060755800878,0.0105795828093005,-0.0234365898642377,0.0180353747482201,0.798521517179288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADRA2A,Alpha-2A adrenergic receptor,13501,-0.00630544931275178,0.0248282301227045,-0.0549687803532527,0.0423578817277491,0.79952809186421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTN3,Myeloblastin,15684,-0.00424728755365397,0.0168997986956537,-0.0373708929971353,0.0288763178898273,0.801568630016826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13111,-0.00435810209827217,0.0174288735361525,-0.038518694229131,0.0298024900325867,0.802552059492298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYZL2,Lysozyme-like protein 2,13506,-0.00314770118292798,0.0126412002996066,-0.027924453770157,0.021629051404301,0.80336198276026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD4,Sushi domain-containing protein 4,13913,0.00359351913502256,0.0144612116875081,-0.0247504557724932,0.0319374940425384,0.803756161435061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6,Seizure protein 6 homolog,13605,-0.00264911511433846,0.010663939456134,-0.0235504364483611,0.0182522062196842,0.803814717599923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGLL,Monoglyceride lipase,16103,-0.00741342840813985,0.0299456895584741,-0.066106979942749,0.0512801231264694,0.804476122568334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB5,Serpin B5,15821,-0.00418013589874865,0.0168959774180045,-0.0372962516380374,0.0289359798405401,0.804598631710592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA2013,Uncharacterized protein KIAA2013,13913,-0.00468795201449879,0.0189839220036171,-0.0418964391415884,0.0325205351125908,0.80495576594679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT17,"Keratin, type I cytoskeletal 17",13501,0.00336019062861706,0.0136681580762688,-0.0234293992008699,0.030149780458104,0.805809229406645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXTL1,Exostosin-like 1,13501,-0.00399630107656519,0.0163422388237867,-0.0360270891711871,0.0280344870180567,0.806817768414514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGA,Chromogranin-A,13983,-0.00738595928063707,0.0303977564771104,-0.0669655619757734,0.0521936434144993,0.808026690607461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYY,Peptide YY,13501,0.00813210293094448,0.0334767203364263,-0.057482268928451,0.07374647479034,0.808072500003213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",15992,-0.00560193534916184,0.0232267408535201,-0.0511263474220612,0.0399224767237375,0.809415035822951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTN,Neuroplastin,15725,-0.00686658367814292,0.0286616606227268,-0.0630434384986874,0.0493102711424016,0.810663783451493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3R,Granulocyte colony-stimulating factor receptor,13568,-0.00254776878077946,0.0106470371831682,-0.0234159616597891,0.0183204240982302,0.810881478615946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16229,-0.00225988133666079,0.00944855289823277,-0.020779045017197,0.0162592823438754,0.810970965434315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNAT1,CDK-activating kinase assembly factor MAT1,13751,0.00364982277419301,0.0152651551537209,-0.0262698813271,0.033569526875486,0.811035460090775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO6,Coronin-6,13528,-0.00304325927907585,0.0128144116335678,-0.0281595060808688,0.0220729875227171,0.812282415495695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPQ,Carboxypeptidase Q,13966,-0.0029076637543042,0.0122764959013808,-0.0269695957210105,0.0211542682124021,0.812778173398842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJP3,Tight junction protein ZO-3,13528,-0.00347822720276502,0.0147035869694453,-0.0322972576628778,0.0253408032573478,0.813004554207272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP1,Secreted frizzled-related protein 1,15864,0.00350287097207445,0.0148094255691587,-0.0255236031434766,0.0325293450876255,0.813024616243003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD276,CD276 antigen,16044,-0.00286188589832435,0.012184050745267,-0.0267426253590476,0.0210188535623989,0.814298753850321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A2,Collagen alpha-2(IX) chain,13751,-0.00360250934417138,0.0153461296837514,-0.0336809235243241,0.0264759048359814,0.814406003146964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSE,Cathepsin E,13703,0.00417524580119377,0.0178414605087325,-0.0307940167959219,0.0391445083983095,0.814973507981886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPLAH,5-oxoprolinase,13643,-0.00553435589071912,0.0237884400341843,-0.0521596983577204,0.0410909865762822,0.816037497259968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB2,Dynein regulatory complex protein 8,13751,0.00283316306674292,0.0122087954002986,-0.0210960759178424,0.0267624020513282,0.816495504764765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAX,Integrin alpha-X,13751,0.00421994275143278,0.0182234505259579,-0.0314980202794446,0.0399379057823102,0.816878089170695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IZUMO1,Izumo sperm-egg fusion protein 1,13506,0.003679427008638,0.016021667573222,-0.027723041434877,0.035081895452153,0.818364755798001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCPKMT,Protein-lysine methyltransferase METTL21D,13506,-0.0069310151036542,0.0302957865333655,-0.0663107567090507,0.0524487265017422,0.819044789190442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99,CD99 antigen,16074,-0.00151515080188042,0.00663105023253433,-0.0145120092576477,0.0114817076538869,0.81926564385692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP2,Contactin-associated protein-like 2,16054,0.00322072257606441,0.0141867429719478,-0.0245852936489532,0.031026738801082,0.820408442449224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTTG1,Securin,13751,-0.00331600057504795,0.0146946569448192,-0.0321175281868936,0.0254855270367977,0.821469000966262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CABP2,Calcium-binding protein 2,13605,0.005052311853008,0.0224363528056757,-0.0389229396461164,0.0490275633521324,0.821839376532386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAL,Galanin peptides,16133,-0.00498960632042648,0.0221816669802751,-0.0484656736017657,0.0384864609609127,0.822026622774872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB1,Pleckstrin homology-like domain family B member 1,13936,0.00410001902145287,0.0182572699359492,-0.0316842300530075,0.0398842680959132,0.822317786540567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLR1,Oxidized low-density lipoprotein receptor 1,15909,-0.00466381103695123,0.0208198448626708,-0.0454707069677859,0.0361430848938835,0.822753986159525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR1B,Cornifin-B,13751,-0.00655531249528556,0.0292790834855697,-0.0639423161270022,0.0508316911364311,0.822845735060948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS53,Serine protease 53,13938,-0.00289873251741226,0.0129553742897244,-0.028291266125272,0.0224938010904475,0.822957071208065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IPCEF1,Interactor protein for cytohesin exchange factors 1,15888,-0.00684875869895185,0.0306674193671182,-0.0669569006585035,0.0532593832605998,0.823286529375771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS2,Podocin,13568,-0.0080703999335672,0.0361541267840108,-0.0789324884302283,0.0627916885630939,0.823366020120744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBPL1,Insulin-like growth factor-binding protein-like 1,16063,0.00256049107542664,0.0115352314935421,-0.0200485626519159,0.0251695448027692,0.824338999345486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRME1,Break repair meiotic recombinase recruitment factor 1,13528,0.00303059089324213,0.0136965913065789,-0.0238147280676525,0.0298759098541368,0.82488861255816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RN,Interleukin-1 receptor antagonist protein,16019,-0.00414202704545702,0.0187689277325045,-0.0409291254011658,0.0326450713102517,0.825340268320879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2B,Sodium channel subunit beta-2,13605,-0.0021862428084447,0.00992430526586312,-0.0216378811295364,0.017265395512647,0.825647235311267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAV3,Guanine nucleotide exchange factor VAV3,13528,-0.00752658548069682,0.0341776829756255,-0.0745148441129229,0.0594616731515292,0.825703691434008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASA1,Ras GTPase-activating protein 1,15667,-0.00248937621630563,0.0113170060902834,-0.024670708153261,0.0196919557206498,0.825899150147641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKL5,Cyclin-dependent kinase-like 5,13528,0.00411569361087838,0.0187284562876497,-0.032592080712915,0.0408234679346718,0.826064384452354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,13965,0.00558897012012954,0.0254491983271878,-0.0442914586011585,0.0554693988414176,0.826175922034868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53,Cellular tumor antigen p53,15725,-0.00323717359207707,0.0147524465727185,-0.0321519688746054,0.0256776216904512,0.826315617608896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R9B,Neurabin-2,16249,-0.00710067823476679,0.032491007266436,-0.0707830524769814,0.0565816960074478,0.827008900796171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCP11,T-complex protein 11 homolog,13751,0.00445586069663968,0.0204052927085494,-0.0355385130121171,0.0444502344053965,0.827145726315556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX2,Peroxiredoxin-2,13755,-0.00480622780565125,0.0220225386462746,-0.0479704035523495,0.038357947941047,0.82724433653835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TK1,"Thymidine kinase, cytosolic",13751,-0.00340306657300059,0.0156496804259287,-0.0340764402078209,0.0272703070618197,0.827858729274206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA1,Glucosamine-6-phosphate isomerase 1,13643,0.00258726933198334,0.0119017392796248,-0.0207401396560813,0.0259146783200479,0.827910936473989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAX,Protein max,15667,-0.00779915535183124,0.0360284719403459,-0.0784149603549093,0.0628166496512468,0.828622670002616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPBGL,Trophoblast glycoprotein-like,13605,-0.00311151291083975,0.0143849290157016,-0.0313059737816148,0.0250829479599353,0.828754296336982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK7,Proprotein convertase subtilisin/kexin type 7,13913,0.00334058574691197,0.0154548350472624,-0.0269508909457223,0.0336320624395462,0.828872830804415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA4,Kallistatin,13768,-0.00178496562210859,0.0082586336960163,-0.0179718876663005,0.0144019564220834,0.828887061103272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16043,-0.00843487733064863,0.0391840567437337,-0.0852356285483667,0.0683658738870694,0.829565019337957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS1,Nephrin,13568,-0.00258084789264494,0.01198973135234,-0.0260807213432313,0.0209190255579414,0.829571863167461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,13751,0.00286972985083131,0.0133417713570814,-0.0232801420090482,0.0290196017107108,0.829697523839444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRV1,Adhesion G-protein coupled receptor V1,13528,0.00511291052406329,0.0239348453147438,-0.0417993862928346,0.0520252073409612,0.83084829027474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOT1,"Aspartate aminotransferase, cytoplasmic",13983,-0.00309848993859312,0.0145768801750584,-0.0316691750817075,0.0254721952045213,0.831671761493809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2B3,SH2B adapter protein 3,15725,-0.00712146840967284,0.0336817618052141,-0.0731377215478925,0.0588947847285468,0.832551398798763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,13703,-0.00273345707103013,0.0129641669215611,-0.0281432242372898,0.0226763100952295,0.833009718214381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,13528,-0.0054931958523446,0.0261968771966761,-0.0568390751578297,0.0458526834531405,0.833913605954731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,15725,-0.00319954220827836,0.0152655673500791,-0.0331200542144334,0.0267209697978767,0.833988769188054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,13605,0.00226402628589986,0.0109662539024991,-0.0192298313629984,0.0237578839347981,0.836439435576094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSNL1,Visinin-like protein 1,13938,-0.0027262064913548,0.0132225388561835,-0.0286423826494745,0.0231899696667649,0.83665430318493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R1,Interleukin-1 receptor type 1,16050,-0.00159102472832621,0.00773235997046034,-0.0167464502704285,0.0135644008137761,0.836979551075307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVR,Poliovirus receptor,16208,0.00260229611662041,0.0126999270592704,-0.0222895609195496,0.0274941531527904,0.837647843480544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH6,Cadherin-6,16063,0.00265819360131057,0.0130597768457929,-0.0229389690164436,0.0282553562190647,0.838715168745593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAX,Apoptosis regulator BAX,15645,-0.00621724489050393,0.0305922800353545,-0.0661781137597988,0.0537436239787909,0.838958528612296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN2A1,Butyrophilin subfamily 2 member A1,16133,0.00177766539541523,0.00876845300514964,-0.0154085024946781,0.0189638332855085,0.839345341230253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXN,Paxillin,15667,-0.00369074241910922,0.0182216829084013,-0.0394052409195757,0.0320237560813573,0.839491956929696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB16,Zinc finger and BTB domain-containing protein 16,15725,0.00494371003479095,0.0245378355768911,-0.0431504476959156,0.0530378677654975,0.840331389540272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN3,Matrilin-3,15888,-0.00224746924252052,0.0111610990535803,-0.0241232233875379,0.0196282849024968,0.840414742706788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEBP1,Heme-binding protein 1,15821,0.00383130549586278,0.0191924315885846,-0.0337858604177631,0.0414484714094886,0.841775776035389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED18,Mediator of RNA polymerase II transcription subunit 18,15725,-0.00526766140624231,0.0264024516853188,-0.0570164667094672,0.0464811438969826,0.841863196248014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAME,Melanoma antigen preferentially expressed in tumors,13506,-0.00176749085276327,0.00886784888057331,-0.019148474658687,0.0156134929531604,0.842019742031272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLINT1,Clathrin interactor 1,13506,-0.00324856449996539,0.0163335997144756,-0.0352624199403377,0.0287652909404069,0.842352993327925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13506,0.0035238796871798,0.0178054257020606,-0.031374754688859,0.0384225140632186,0.843118115109732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAP,Cartilage-associated protein,13605,0.00334722588205057,0.0169857932728018,-0.0299449289326409,0.036639380696742,0.843783280160272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB2,Calretinin,15667,-0.00200098570454808,0.0101652449646396,-0.0219248658352418,0.0179228944261456,0.843950770266014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAT,Catalase,13796,0.00374923498200053,0.0190773615967999,-0.0336423937477272,0.0411408637117283,0.844199847145592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRING1,SREBP regulating gene protein,13506,0.0041425935771704,0.0210811349139513,-0.0371764308541741,0.0454616180085149,0.844216202647407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA3,Carbonic anhydrase 3,16226,0.00416187372362953,0.0211960041697632,-0.0373822944491064,0.0457060418963655,0.844337275361125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMP1,Dentin matrix acidic phosphoprotein 1,13643,0.00406184320207952,0.0208365644201787,-0.0367778230614708,0.0449015094656298,0.845444202716358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3L,Microfibrillar-associated protein 3-like,13605,-0.004521572050579,0.0233211661704873,-0.0502310577447341,0.0411879136435761,0.846270581041232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR3,Toll-like receptor 3,16249,-0.00407079121052677,0.0210090101504576,-0.0452484511054236,0.0371068686843701,0.846363049704635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELL,L-selectin,14020,0.00154990786272519,0.00800072203742243,-0.0141315073306228,0.0172313230560731,0.846397158031251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP1,Src kinase-associated phosphoprotein 1,15900,0.00483146753701261,0.0249684972802485,-0.0441067871322745,0.0537697222062997,0.84656789426402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A1,Secretoglobin family 3A member 1,13703,-0.00169277217243227,0.00874976096014636,-0.0188423036543191,0.0154567593094546,0.846597714220528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR2,TGF-beta receptor type-2,16091,0.00211664469085462,0.010951630375596,-0.0193485508453136,0.0235818402270228,0.846748310419135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,13605,-0.00317176889312511,0.0164238766015269,-0.0353625670321179,0.0290190292458677,0.846868359750049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,13643,-0.00281679990908063,0.0146764485930599,-0.031582639151478,0.0259490393333168,0.847802612012135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF2,TNF receptor-associated factor 2,16054,-0.00463317689274198,0.0241812027359369,-0.0520283342551784,0.0427619804696944,0.848056074283522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIT1,Signaling threshold-regulating transmembrane adapter 1,15797,-0.00363143400091448,0.0189540084303732,-0.040781290524446,0.033518422522617,0.848064372576145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,13501,-0.00375980670505818,0.0196391276575493,-0.0422524969138547,0.0347328835037384,0.848180091886504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM2,Intercellular adhesion molecule 2,16254,-0.00206587477920111,0.0108200030869067,-0.0232730808295383,0.019141331271136,0.848581983416172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D1,DCN1-like protein 1,13528,0.00492331877361532,0.0258120837220832,-0.0456683653216677,0.0555150028688984,0.848734533561999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE3,Eosinophil cationic protein,15990,-0.00742251309700276,0.0390960466178384,-0.0840507644679659,0.0692057382739604,0.849426507431419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FST,Follistatin,16103,-0.00329388791556693,0.0173672730555737,-0.0373337431044914,0.0307459672733576,0.849577467549236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLNS1A,Methylosome subunit pICln,13605,0.00224011486408394,0.0118573896152207,-0.0210003687817487,0.0254805985099166,0.850157227321411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP25,Rho GTPase-activating protein 25,15725,-0.0038847913715863,0.0207591835577169,-0.0445727911447114,0.0368032084015388,0.851556389111409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT1,Vascular endothelial growth factor receptor 1,15942,0.00142400575608943,0.00761055523000275,-0.013492682494716,0.0163406940068948,0.851577310022067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRS,Receptor-type tyrosine-protein phosphatase S,16254,-0.00157675723318311,0.00843164807835882,-0.0181027874667664,0.0149492730004002,0.851659338423085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPMT,Thiopurine S-methyltransferase,15725,0.00469501659884171,0.0251720967689491,-0.0446422930682985,0.0540323262659819,0.852041986579805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF12,Fibroblast growth factor 12,13568,-0.00307423229722118,0.0164931909763148,-0.0354008866107981,0.0292524220163558,0.852138565011406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP4,Contactin-associated protein-like 4,13605,-0.00665057910968143,0.0358169287833975,-0.0768517595251405,0.0635506013057776,0.852696474746026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKKL1,Dickkopf-like protein 1,15973,-0.00550950211811805,0.0296913179504622,-0.0637044853010239,0.0526854810647878,0.852792679921392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF31,E3 ubiquitin-protein ligase RNF31,13568,0.00229941964829589,0.0124159370006827,-0.0220358168730423,0.0266346561696341,0.853075690877836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER2,Low affinity immunoglobulin epsilon Fc receptor,16074,-0.00314664676702875,0.0170364484967487,-0.0365380858206562,0.0302447922865987,0.853466000166948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,15821,-0.00353837907002043,0.0192049776779608,-0.0411801353188236,0.0341033771787827,0.853825339519362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAFA5,Chemokine-like protein TAFA-5,15973,0.00223601141542049,0.0121692281818643,-0.0216156758210336,0.0260876986518746,0.854217349003826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,13946,0.00416704374844594,0.0227507944594765,-0.040424513392128,0.0487586008890198,0.854674860007751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSP,Alpha-hemoglobin-stabilizing protein,16047,0.00542079145974645,0.0296238179409467,-0.0526418917045091,0.063483474624002,0.854810058895995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,13528,-0.0038620843613506,0.0211851517070356,-0.0453849817071404,0.0376608129844392,0.855348877203052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNPO1,Transportin-1,13751,-0.00224281134034183,0.0123058299005636,-0.0263622379454465,0.0218766152647629,0.855384516155457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROC,Vitamin K-dependent protein C,16115,0.00160574856986996,0.00883046557009509,-0.0157019639475164,0.0189134610872563,0.855709096302083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCB,Calcitonin gene-related peptide 2,13938,-0.00245530104605833,0.0135256080704561,-0.0289654928641524,0.0240548907720357,0.855954380141483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15437,-0.00231143224359318,0.0128323492755331,-0.0274628368236381,0.0228399723364517,0.857056476824859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA9,Carbonic anhydrase 9,16195,0.00281492613062077,0.015646339811481,-0.0278518998998819,0.0334817521611235,0.857225821735972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPR,Gastric inhibitory polypeptide receptor,13568,0.00293841598966434,0.0163812954501637,-0.0291689230926565,0.0350457550719852,0.857644929195694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GID8,Glucose-induced degradation protein 8 homolog,13946,-0.00202643177163204,0.0114751506078178,-0.024517726962955,0.0204648634196909,0.859830625463126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM2,Myomesin-2,13501,0.00305030051018647,0.0175450422058173,-0.0313379822132155,0.0374385832335884,0.861981705610028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGM2,Protein-glutamine gamma-glutamyltransferase 2,16041,-0.00451605465693476,0.0261455550727091,-0.0557613425994446,0.0467292332855751,0.862867859214043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDN1,Endothelin-1,13643,-0.00175473904491139,0.0101659307373413,-0.0216799632901002,0.0181704852002775,0.862960728811544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REPS1,RalBP1-associated Eps domain-containing protein 1,13568,-0.0023593902889715,0.0137309350985888,-0.0292720230822056,0.0245532425042626,0.863573532496331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH1A1,Retinal dehydrogenase 1,16074,-0.00322057900555552,0.0187637701143818,-0.0399975684297438,0.0335564104186328,0.863724166589256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD6,Programmed cell death protein 6,16063,-0.00405773648093242,0.0236594352763927,-0.0504302296226621,0.0423147566607972,0.863828029626328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAGLN3,Transgelin-3,13506,0.00367552980959404,0.0214995838889987,-0.0384636546128435,0.0458147142320316,0.864259209744043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM132A,Transmembrane protein 132A,13643,0.00370325189148453,0.0218430172712193,-0.0391090619601053,0.0465155657430743,0.865374905825414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB2,Nuclear factor NF-kappa-B p100 subunit,13751,-0.00333843201964962,0.01971920636142,-0.0419880764880327,0.0353112124487335,0.865564350108098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14020,-0.00114769415052724,0.00679030954463174,-0.0144567008580055,0.012161312556951,0.865783810498379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPT,Microtubule-associated protein tau,15667,-0.00302002154941859,0.0178782752079732,-0.038061440957046,0.0320213978582089,0.865860725015889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN2,Ficolin-2,16011,0.00237408614996636,0.0140943081908268,-0.0252507579040541,0.0299989302039869,0.866236990144492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13,Tumor necrosis factor ligand superfamily member 13,16133,-0.00153981894501881,0.00919226533611364,-0.0195566590038016,0.0164770211137639,0.866968948742407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTC,Probetacellulin,15725,-0.00420953282104532,0.0257161042006019,-0.054613097054225,0.0461940314121344,0.869975344917429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164L2,CD164 sialomucin-like 2 protein,13605,-0.00203170102858817,0.0124686953145306,-0.0264703438450681,0.0224069417878918,0.870564826883894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENAH,Protein enabled homolog,15797,-0.00266239873474545,0.0163499482651445,-0.0347082973344286,0.0293834998649377,0.870647790465698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GALT1,"Beta-1,4-galactosyltransferase 1",16133,0.00151023615902846,0.00930511144841514,-0.0167277822798652,0.0197482545979221,0.871070246752231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXADR,Coxsackievirus and adenovirus receptor,16054,0.00285396086635755,0.0176173574185918,-0.0316760596740824,0.0373839814067975,0.871310175592472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF5,Fibroblast growth factor 5,15797,0.00182534114123482,0.0113234562915373,-0.0203686331901783,0.0240193154726479,0.871937945263078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF4,Cyclic AMP-dependent transcription factor ATF-4,13506,-0.00187777605873013,0.0117466825276716,-0.0249012738129665,0.0211457216955062,0.872997011453498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREB3,Cyclic AMP-responsive element-binding protein 3,13506,0.00303995366594187,0.0190489145872256,-0.0342959189250203,0.040375826256904,0.873209035134295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOTL2,Angiomotin-like protein 2,13860,0.00267130838268466,0.0167794520944745,-0.0302164177224854,0.0355590344878547,0.873512705171025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3A,Uroplakin-3a,13528,0.00272917641346976,0.0171571973508346,-0.0308989303941661,0.0363572832211056,0.873616971861004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP4,Peptidoglycan recognition protein 4,13501,-0.00339213133506019,0.0214862624150776,-0.0455052056686123,0.038720942998492,0.874558114278525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH3,Neurogenic locus notch homolog protein 3,16254,-0.00183142542824289,0.0116395623619658,-0.0246449676576959,0.0209821168012101,0.874975015476227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM4,Intercellular adhesion molecule 4,16054,-0.00284443588502583,0.0181640215075388,-0.0384459180398019,0.0327570462697502,0.875564237883637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTBS,Di-N-acetylchitobiase,13780,-0.00143909962315283,0.00926334393462161,-0.0195952537350112,0.0167170544887055,0.876544346418526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSB,Cathepsin B,16076,0.00275873965689463,0.0179972960955583,-0.0325159606903996,0.0380334400041889,0.87817439769036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13506,-0.00438165100261873,0.028689717690021,-0.0606134976750598,0.0518501956698224,0.878617047483697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX2,Probable E3 ubiquitin-protein ligase DTX2,13605,-0.00332941583116754,0.0220179543752595,-0.0464846064066761,0.0398257747443411,0.87980940626292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPL14,60S ribosomal protein L14,13643,-0.00214091532544526,0.0141773137806583,-0.0299284503355356,0.0256466196846451,0.879970108507602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBP1,"Fructose-1,6-bisphosphatase 1",16063,0.00380306306707381,0.0252959699886059,-0.0457770381105938,0.0533831642447414,0.880496177837975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP3,Syntaxin-binding protein 3,15725,0.00225249074132728,0.0149846850537142,-0.0271174919639525,0.031622473446607,0.880514458876013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED10,Transmembrane emp24 domain-containing protein 10,13501,0.0025135834068474,0.016793860128423,-0.0304023824448616,0.0354295492585565,0.881025037939023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPH,Hephaestin,13965,-0.00135581665513626,0.00905970440908415,-0.0191128372969412,0.0164012039866687,0.881040144025731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,13913,-0.00232370516602411,0.0155633050712058,-0.0328277831055874,0.0281803727735392,0.881313823087243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD2,Bromodomain-containing protein 2,13528,0.00178262325090618,0.0120281894337316,-0.0217926280392078,0.0253578745410202,0.882184152666781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36G,Interleukin-36 gamma,13516,-0.00341468135430339,0.0230553758905862,-0.0486032180998523,0.0417738553912455,0.882259893395408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9,Complement component C9,13988,-0.00271207846589588,0.0183711792958838,-0.038719589885828,0.0332954329540363,0.882639431030345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB5,Integrin beta-5,16091,-0.00193324553121135,0.0131241651266328,-0.0276566091794117,0.023790118116989,0.88289371133821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK7,Kallikrein-7,13334,0.00199595856508897,0.0135654251626443,-0.0245922747536938,0.0285841918838717,0.883027124992624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA2,Protein disulfide-isomerase A2,13506,-0.00207594059004741,0.0141378652604665,-0.0297861565005617,0.0256342753204669,0.883264053081607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH23,Cadherin-23,13938,-0.0013436233999011,0.00915487362493808,-0.0192871757047797,0.0165999289049775,0.883318914344725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC28A1,Sodium/nucleoside cotransporter 1,13506,-0.0029696241942362,0.0204881463428838,-0.0431263910262884,0.037187142637816,0.884757624684623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRCAM,Neuronal cell adhesion molecule,16063,-0.00138227354285685,0.00956609703981538,-0.020131823740895,0.0173672766551813,0.885109739016867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFAP2A,Transcription factor AP-2-alpha,13528,0.00297402273857567,0.0205864279324745,-0.0373753760090743,0.0433234214862256,0.885135276874809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MB,Myoglobin,16254,0.00257023253163447,0.0178830202392118,-0.0324804871372207,0.0376209522004897,0.885719613298815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN6,Prefoldin subunit 6,13605,-0.00319783275083072,0.0222557711439118,-0.0468191441928979,0.0404234786912364,0.885750911277351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTD,Biotinidase,14020,0.00102153669388933,0.00719156711359827,-0.0130739348487633,0.0151170082365419,0.887045346252671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB3,Receptor tyrosine-protein kinase erbB-3,15997,-0.00093757674885088,0.00670536651177698,-0.0140800951119338,0.012204941614232,0.888800154434859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME3,Nucleoside diphosphate kinase 3,16076,0.00115304717603032,0.00827054746362208,-0.015057225852669,0.0173633202047296,0.889123126894024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRN1,Secernin-1,16054,0.0026693511192303,0.0191602303739161,-0.0348847004136452,0.0402234026521058,0.889201187161905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16091,0.00211741950519372,0.0154600234854803,-0.0281842265263476,0.032419065536735,0.891063376483896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16138,0.0018055696016118,0.0132060448271503,-0.0240782782596028,0.0276894174628264,0.891251483717206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM40,E3 ubiquitin ligase TRIM40,13605,-0.00344832812444016,0.0252682324853171,-0.0529740637956617,0.0460774075467814,0.891452622735994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSDE1,Cold shock domain-containing protein E1,13501,-0.00562910349582511,0.0412937298857502,-0.0865648140718955,0.0753066070802453,0.891571454116033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRPV3,Transient receptor potential cation channel subfamily V member 3,13501,-0.00229049321281776,0.0169638196890852,-0.0355395798034248,0.0309585933777893,0.89259629224728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS2,Trypsin-2,16138,-0.00245827021294164,0.0182401091821271,-0.0382088842099107,0.0332923437840274,0.892793210464524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPOCK1,Testican-1,15918,0.00117009490478498,0.00875077923619396,-0.0159814323981552,0.0183216222077251,0.89363103961514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL4,Delta-like protein 4,13643,-0.00407747053486385,0.0308093063682871,-0.0644637110167065,0.0563087699469788,0.89471303849189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAEP,Glycodelin,15918,0.00589116568583159,0.0453538706560811,-0.0830024208000873,0.0947847521717505,0.896652457233633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL4,Myosin light chain 4,13643,-0.0024252625301634,0.0187898872479054,-0.0392534415360581,0.0344029164757313,0.897301983900493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED4,Transmembrane emp24 domain-containing protein 4,13501,-0.0025323129904839,0.019624136462768,-0.0409956204575092,0.0359309944765414,0.897327340664259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA1,Laminin subunit alpha-1,13501,0.00232723440132259,0.0181311740388955,-0.0332098667149127,0.0378643355175579,0.897869625246347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,13751,-0.00375648383881551,0.0293291735318952,-0.0612416639613301,0.0537286962836991,0.898087449384031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL2,Interferon lambda-2,13528,-0.00270923850042834,0.0213163031935376,-0.0444891927597621,0.0390707157589054,0.898865505168746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP3,Metalloproteinase inhibitor 3,16133,-0.00570101454581937,0.0450123389553381,-0.093925198898282,0.0825231698066432,0.899215452196073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,13528,-0.00140501884381445,0.0112723056310223,-0.0234987378806181,0.0206887001929892,0.900807697781412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXL,Tyrosine-protein kinase receptor UFO,16138,0.00117481890305768,0.00948779892545754,-0.0174212669908391,0.0197709047969544,0.90145603128611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA1,Carbonic anhydrase 1,15721,-0.00260412005204913,0.021153329959992,-0.0440646467736334,0.0388564066695351,0.90202405337791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1A,Protein phosphatase 1A,15725,0.00133810783710229,0.010876713599782,-0.0199802508184704,0.0226564664926749,0.902088864172314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP1,Inositol polyphosphate 1-phosphatase,15973,0.00228155896380191,0.0186774839313054,-0.0343263095415567,0.0388894274691605,0.902777339571282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO1,Forkhead box protein O1,16054,0.00356297119604011,0.0292220958427884,-0.0537123366558252,0.0608382790479054,0.902958123424081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLTP,Phospholipid transfer protein,16212,-0.0014600703197191,0.0121723289404948,-0.0253178350430889,0.0223976944036507,0.904524278657205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SV2A,Synaptic vesicle glycoprotein 2A,13605,-0.00259385829965935,0.0216444867633282,-0.0450170523557825,0.0398293357564638,0.904612288138495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLK,STE20-like serine/threonine-protein kinase,13751,0.00326140469287238,0.0272420567014705,-0.0501330264420098,0.0566558358277545,0.904707124190523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK2,SLIT and NTRK-like protein 2,16195,-0.00161284467793402,0.0135332209539112,-0.0281379577475999,0.0249122683917319,0.905136841477687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC3B,Tetranectin,13686,-0.000886280158810789,0.00749432828221461,-0.0155751635919514,0.0138026032743298,0.905863292875746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORCS2,VPS10 domain-containing receptor SorCS2,15725,0.00141652254701686,0.0121108558731859,-0.0223207549644275,0.0251538000584612,0.906890835468809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB39B,Ras-related protein Rab-39B,13501,0.00365779699265642,0.0313272126982572,-0.0577435398959278,0.0650591338812406,0.907051180441645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,13751,0.001745628213914,0.0151355045455115,-0.0279199606952885,0.0314112171231165,0.908182602992684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCT,Secretin,13605,0.00183773019121794,0.0159961339704822,-0.0295146923909272,0.0331901527733631,0.908537261207495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL3,Insulin-like 3,13938,-0.00295731804351968,0.0259956292594763,-0.0539087513920933,0.0479941153050539,0.909428003083538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTR,Transthyretin,13869,0.000995052422130762,0.00874804035567421,-0.0161511066749907,0.0181412115192522,0.90944099168519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16138,-0.00165541809015633,0.0147991677778903,-0.0306617869348213,0.0273509507545087,0.910936706290619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,13528,0.0021779654339819,0.0196539952049474,-0.0363438651677151,0.0406997960356789,0.911764374959257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPE,Coatomer subunit epsilon,15667,0.00172502680842128,0.0157743078354076,-0.0291926165489776,0.0326426701658201,0.912920949825942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD36,Platelet glycoprotein 4,13568,-0.001701274332294,0.015636222192698,-0.0323482698299821,0.0289457211653941,0.913360027765479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNIP4,Kv channel-interacting protein 4,15667,0.00185256235958986,0.0171703611152595,-0.0318013454263187,0.0355064701454984,0.914081925580841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN1A1,Butyrophilin subfamily 1 member A1,13886,-0.00147646488804739,0.0137637787046842,-0.0284534711492284,0.0255005413731337,0.914574931748665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC34A3,Sodium-dependent phosphate transport protein 2C,13506,-0.00177414322525824,0.0166513982118089,-0.0344108837204037,0.0308625972698872,0.915150584758693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMFR,E3 ubiquitin-protein ligase AMFR,15667,-0.00234068990511393,0.0219834156986207,-0.0454281846744105,0.0407468048641827,0.915206647828198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC22D1,TSC22 domain family protein 1,13946,-0.0024400507530685,0.0230424651795593,-0.0476032825050046,0.0427231809988676,0.915668256501074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPJ,Centromere protein J,13751,0.00266203513561056,0.025190292750334,-0.0467109386550441,0.0520350089262652,0.915840154568451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC27A4,Long-chain fatty acid transport protein 4,15667,-0.0023991851055806,0.0227253915378843,-0.0469409525198339,0.0421425823086727,0.915922593363916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FES,Tyrosine-protein kinase Fes/Fps,15725,-0.00168912335857761,0.0161928368943385,-0.0334270836714811,0.0300488369543259,0.916922294992922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC25A,M-phase inducer phosphatase 1,13506,-0.00146551204882069,0.0140525336298562,-0.0290084779633389,0.0260774538656975,0.916942270456271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRV1,Acrosomal protein SP-10,13568,0.00275794570006815,0.0265293999043859,-0.0492396781125283,0.0547555695126646,0.917204147028945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESAM,Endothelial cell-selective adhesion molecule,16254,-0.00111725595039792,0.0107611221307584,-0.0222090553266843,0.0199745434258885,0.917310803200501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF830,Zinc finger protein 830,13913,0.00282381438646148,0.0273093391913076,-0.0507024904285015,0.0563501192014245,0.91764616950772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_DRA,,16008,-0.00122631049522817,0.0123252002763441,-0.0253837030368626,0.0229310820464062,0.920745558073649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,13936,0.00166313907566983,0.0169086355558725,-0.0314777866138403,0.0348040647651799,0.921647585180189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,13703,-0.000740371460832821,0.0075475754814893,-0.0155336194045519,0.0140528764828862,0.921859131031369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHH,Sonic hedgehog protein,13568,-0.00142582829023568,0.0146295083511193,-0.0300996646584296,0.0272480080779582,0.922360563250126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS37A,Vacuolar protein sorting-associated protein 37A,15973,-0.00265247266338504,0.0274212585073828,-0.0563981393378553,0.0510931940110852,0.922941614662699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN5,Contactin-5,16097,0.00118257470800246,0.0127582695008816,-0.0238236335137255,0.0261887829297304,0.926150329368057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASQ2,Calsequestrin-2,13501,0.0015578323526552,0.0169094181083568,-0.0315846271397241,0.0347002918450345,0.926597640968148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAM,Signal transducing adapter molecule 1,13913,-0.00119436114537882,0.0130467136767769,-0.0267659199518615,0.0243771976611039,0.927060886480022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNT,Aryl hydrocarbon receptor nuclear translocator,15797,0.00116451026399672,0.0127906924012972,-0.0239052468425457,0.0262342673705392,0.927459128482375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP2,Tubulin polymerization-promoting protein family member 2,13751,-0.00246236982924653,0.0277727302987102,-0.0568969212147184,0.0519721815562254,0.92935228302741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,15725,-0.00104116642764184,0.0118551921236907,-0.0242773429900756,0.0221950101347919,0.930017947379945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAD,Chondroadherin,13703,0.00154990552600109,0.0178060169069876,-0.0333498876116945,0.0364496986636967,0.930637873931759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6ST,Interleukin-6 receptor subunit beta,16063,-0.000515298463242424,0.00598250497079698,-0.0122410082060045,0.0112104112795197,0.931360787070164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTH3,Cytohesin-3,13506,0.00210610231850477,0.0256959525944704,-0.0482579647666572,0.0524701694036668,0.934677817513218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC15,Sialic acid-binding Ig-like lectin 15,15667,0.00215565066671872,0.0269712923515863,-0.0507080823423904,0.0550193836758279,0.936298808982098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC2,PDZ domain-containing protein GIPC2,13938,-0.000822094291838555,0.0104076676304793,-0.0212211228475779,0.0195769342639008,0.937042275710738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUB1,NEDD8 ultimate buster 1,16054,-0.00227081622837511,0.0288363017742375,-0.0587899677058807,0.0542483352491304,0.937233630320545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",15667,-0.00144572410463849,0.0187449292316187,-0.0381857853986112,0.0352943371893342,0.938524181059992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP3,Zona pellucida sperm-binding protein 3,13643,0.00693355002313347,0.0908713319957161,-0.17117426068847,0.185041360734737,0.939180955787195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200R1,Cell surface glycoprotein CD200 receptor 1,15998,-0.000912690365959725,0.0120368107574107,-0.0245048394504848,0.0226794587185653,0.939559328726238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",15821,-0.00231155094329423,0.0306678647345775,-0.0624205658230662,0.0577974639364777,0.939918324709962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP1,Retinol-binding protein 1,13605,0.00180155364712127,0.0244224104572007,-0.0460663708489921,0.0496694781432346,0.941197337295352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGF,Hepatoma-derived growth factor,16171,0.00234289302010505,0.0319681290560833,-0.0603146399298181,0.0650004259700282,0.941577529787043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1D,V-type proton ATPase subunit D,15973,0.000655025250629847,0.00909512361260129,-0.0171714170300687,0.0184814675313284,0.94258737976098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR7L,Aflatoxin B1 aldehyde reductase member 4,13568,0.0017516230005443,0.0243605275439542,-0.0459950109856059,0.0494982569866945,0.942679249142032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC4,Syndecan-4,16063,-0.00112886762289607,0.0158333328709124,-0.0321622000498844,0.0299044648040922,0.943162347126194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST6,Cystatin-M,15630,0.00116532773849766,0.0165139623912641,-0.03120203854838,0.0335326940253754,0.943743907443492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGED1,Melanoma-associated antigen D1,15725,0.00115943901654754,0.0164503682381018,-0.031083282730132,0.033402160763227,0.943811690148306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WAS,Wiskott-Aldrich syndrome protein,15797,0.00161916904558577,0.0230423881884312,-0.0435439118037394,0.0467822498949109,0.943980326318612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP6,Gastrotropin,15789,-0.00135098298144801,0.0192750533940943,-0.0391300876338729,0.0364281216709769,0.944123141966208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF9,Protein turtle homolog A,13965,-0.00201202702242538,0.0287522450630883,-0.0583664273460785,0.0543423733012278,0.944212106216955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171B,Protein FAM171B,13913,0.000636843964444166,0.00910772238771564,-0.0172142919154785,0.0184879798443668,0.944255542485198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGDS,Prostaglandin-H2 D-isomerase,15954,0.000713512528628043,0.0102414453788202,-0.0193597204138596,0.0207867454711157,0.944457891411407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAFB2,Scaffold attachment factor B2,13946,0.000656352737819431,0.00946144393700846,-0.0178880773787172,0.019200782854356,0.944695062686155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPRKB,EKC/KEOPS complex subunit TPRKB,13506,0.00148447088189733,0.0214747726712635,-0.040606083553779,0.0435750253175737,0.944890136943098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1LG2,Programmed cell death 1 ligand 2,15973,0.00074304588961258,0.0107516325042407,-0.0203301538186991,0.0218162455979243,0.944902885071611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC9,Sialic acid-binding Ig-like lectin 9,16170,-0.000710177373238318,0.0102873199037108,-0.0208733243845115,0.0194529696380349,0.944963214474649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA1,Pulmonary surfactant-associated protein A1,15725,-0.00132756772590318,0.0195369012606933,-0.0396198941968621,0.0369647587450557,0.94582486344379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,15973,-0.000914728738740408,0.0134754756163655,-0.0273266609468168,0.025497203469336,0.945881215323599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIM1,Cysteine-rich motor neuron 1 protein,16133,0.000467633369540036,0.00695334699294843,-0.0131609267366389,0.014096193475719,0.946381135489018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF22,Kinesin-like protein KIF22,13501,-0.00282400778936395,0.0425610444211036,-0.0862436548547271,0.0805956392759992,0.947098617067403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RFC4,Replication factor C subunit 4,13913,0.000509040286734882,0.00767340606338411,-0.014530835597498,0.0155489161709677,0.947109489780646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LARP1,La-related protein 1,13913,0.00144833310326136,0.021946510282337,-0.0415668270501192,0.0444634932566419,0.947383729126626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC123,Cell division cycle protein 123 homolog,13506,-0.00144855035015918,0.0224405329955844,-0.0454319950215046,0.0425348943211863,0.948532757363507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRLF1,Cytokine receptor-like factor 1,16133,-0.000567587407613837,0.00885315152424078,-0.0179197643951258,0.0167845895798981,0.948882367385111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAND5,DAN domain family member 5,13568,-0.00127388769332794,0.0199895235509245,-0.04045335385314,0.0379055784664841,0.949187934805505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA5A,von Willebrand factor A domain-containing protein 5A,13506,-0.00176615455955548,0.0277261145992339,-0.0561093391740539,0.052577030054943,0.949210017981437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP73,Tumor protein p73,13605,-0.000764763278234104,0.01203982784047,-0.0243628258455553,0.0228332992890871,0.949353803417797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH2,Neutral ceramidase,15918,0.00114390210643747,0.0180761661884759,-0.0342853836229753,0.0365731878358503,0.94954247297074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB116,Beta-defensin 116,13528,0.00163410866127722,0.0259071561611933,-0.0491439174146617,0.0524121347372161,0.949707260128854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFX1,Transcriptional repressor NF-X1,13501,-0.00143320085467147,0.0230558652252338,-0.0466226966961298,0.0437562949867869,0.950434670054537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP30,Rho GTPase-activating protein 30,13751,-0.000831305067945762,0.0133923700363205,-0.0270803503391339,0.0254177402032424,0.950505572768944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD4B,FERM domain-containing protein 4B,13501,-0.00149864470333897,0.0241819904346892,-0.0488953459553297,0.0458980565486518,0.950584783903485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGREF1,Cell growth regulator with EF hand domain protein 1,16063,0.000868079869823341,0.0145504795303848,-0.0276508600097308,0.0293870197493775,0.952427268336539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKLR,Pyruvate kinase PKLR,16073,-0.0013557924726175,0.0229729068797339,-0.046382689956896,0.043671105011661,0.952939287181902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTF,Ciliary neurotrophic factor,13528,-0.000700440284767155,0.0119183617588725,-0.0240604293321572,0.0226595487626229,0.953136295312221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6B,Ras-related protein Rab-6B,15667,0.000936868257108697,0.0163046678664771,-0.0310202807611864,0.0328940172754038,0.954179402507259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYOU1,Hypoxia up-regulated protein 1,16254,0.000430092721978725,0.0075193089952723,-0.014307752908755,0.0151679383527124,0.95438782689607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT7,N-acetylgalactosaminyltransferase 7,15973,-0.000404314592425245,0.00712941376802151,-0.0143779655777474,0.0135693363928969,0.954776299200948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGB,Secretogranin-1,16166,0.000760916889593292,0.013714752378001,-0.0261199977712886,0.0276418315504752,0.95575544654829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD1,Glutamate decarboxylase 1,13506,-0.000496065753538545,0.00919771376976877,-0.0185235847422853,0.0175314532352083,0.956988870566883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA2,Glucosamine-6-phosphate isomerase 2,13703,0.000684605433124005,0.012704720797964,-0.0242166473308855,0.0255858581971335,0.957026849407734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL24,"39S ribosomal protein L24, mitochondrial",13501,0.000728871792915179,0.0137609117675333,-0.0262425152714502,0.0277002588572805,0.957759125594897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA9,Serpin A9,15892,-0.00131356303075016,0.0250367798082632,-0.050385651454946,0.0477585253934456,0.958158576240349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,13751,0.00119941032283424,0.0228924897350874,-0.0436698695579371,0.0460686902036056,0.958216170483947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM2,Isthmin-2,13983,0.000758475634005273,0.0147585898575315,-0.0281683604867565,0.0296853117547671,0.959013776325034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3C,Protein FAM3C,16043,0.000499465184105425,0.0100659320155677,-0.0192297615664072,0.020228691934618,0.960426330513174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCARE,Photoreceptor cilium actin regulator,13528,-0.0014848803674995,0.0300618748592408,-0.0604061550916115,0.0574363943566125,0.960605930352803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL2,Interleukin-1 receptor-like 2,15797,-0.000656213984223456,0.013450996704825,-0.0270201675256804,0.0257077395572335,0.961090832255565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,13938,0.00144475969483703,0.0297817521944934,-0.05692747460637,0.0598169939960441,0.9613092358382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,15918,-0.00173309800989516,0.0366455974313235,-0.0735584689752893,0.070092272955499,0.962279914368377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBLD,Phenazine biosynthesis-like domain-containing protein,15667,0.000826367436336647,0.0175394336283307,-0.0335509224751914,0.0352036573478647,0.962422308772479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",13568,-0.000731224850005772,0.0156590521516126,-0.0314229670671665,0.029960517367155,0.962755710079617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,15725,0.00155092673710357,0.0335716790501318,-0.0642495642011547,0.0673514176753618,0.963153443721237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,13703,-0.00108826460563932,0.0236012028972812,-0.0473466222843105,0.0451700930730319,0.963222804500515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIE,Peptidyl-prolyl cis-trans isomerase E,13751,0.000979918631892175,0.0215056070597436,-0.0411710712052052,0.0431309084689895,0.963657048572059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,13983,0.00218841249976021,0.048506550145456,-0.0928844257853335,0.0972612507848539,0.964015641298333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOC,Myocilin,16074,0.000692679403559448,0.0155278116676059,-0.029741831464948,0.0311271902720669,0.964419561798065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13506,-0.00103582088807005,0.0232400595023888,-0.0465863375127521,0.044514695736612,0.964450322778625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPD1,Glycerol-3-phosphate dehydrogenase,13913,0.00081282944271977,0.0182663502169051,-0.0349892169824142,0.0366148758678537,0.964507501078896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEK,Angiopoietin-1 receptor,16091,0.000330629261615474,0.00754322893375531,-0.0144540994485449,0.0151153579717759,0.96503945000181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,13501,0.000970198114800764,0.0228494461419577,-0.0438147163234364,0.0457551125530379,0.966132255982536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPING1,Plasma protease C1 inhibitor,13994,-0.000274567642344141,0.00651371542515171,-0.0130414498756415,0.0124923145909532,0.966377944173996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSHB,Follitropin subunit beta,13643,-0.000929903332938706,0.0221150822396786,-0.0442754645227087,0.0424156578568313,0.966460748242356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL52,"39S ribosomal protein L52, mitochondrial",13480,-0.000364908581645784,0.00877141561284498,-0.0175568831828219,0.0168270660195304,0.966816582058671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGMT,Methylated-DNA--protein-cysteine methyltransferase,16054,-0.00169574315157371,0.041705246555263,-0.0834380263998892,0.0800465400967418,0.967567307028619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2,Brorin,15870,0.000544654848718589,0.0135492054592653,-0.0260117878514413,0.0271010975488785,0.967935549465352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL5,ADAMTS-like protein 5,13965,-0.000544738140644803,0.0137199226758049,-0.0274357865852224,0.0263463103039328,0.968329545348824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",13938,-0.000699724603403537,0.0186870223636403,-0.0373262884361385,0.0359268392293314,0.970131196952656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP5,Platelet glycoprotein V,13703,-0.000468093197280508,0.0125021814438353,-0.0249723688271978,0.0240361824326367,0.970133990635652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POSTN,Periostin,13983,0.000486719998831894,0.0131172211009144,-0.0252230333589603,0.0261964733566241,0.9704014806402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A3,Protein S100-A3,13913,0.000556402728670078,0.015445060521722,-0.0297159158939051,0.0308287213512453,0.971263230008115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN2,Nectin-2,16043,-0.000359428240853303,0.0100263166658234,-0.0200110089058672,0.0192921524241606,0.971403620576351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RICTOR,Rapamycin-insensitive companion of mTOR,13568,0.000604103414080595,0.0169068978384065,-0.0325334163491962,0.0337416231773574,0.971497234356241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRF,Receptor-type tyrosine-protein phosphatase F,16254,0.00034059287681028,0.00980703067115394,-0.0188811872386514,0.019562372992272,0.972295896445766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA1,Interleukin-13 receptor subunit alpha-1,15869,-0.000268578917558808,0.00773509459312973,-0.0154293643200931,0.0148922064849755,0.97230175585245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSC2,Desmocollin-2,15899,-0.000395136461857361,0.0116518871579906,-0.023232835291519,0.0224425623678042,0.972947909987216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN3,Perilipin-3,16063,0.000499498809429698,0.0148038729416441,-0.0285160921561928,0.0295150897750522,0.973084032122306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX25,ATP-dependent RNA helicase DDX25,13605,0.000424277607386822,0.0129908865084368,-0.0250378599491494,0.025886415163923,0.973946493160706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNN,Tenascin-N,13983,-0.000483517922663306,0.0150259462561564,-0.0299343725847298,0.0289673367394032,0.974329869058716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,13913,0.000651162331222564,0.0213621886487252,-0.0412187274202788,0.0425210520827239,0.975683082675657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1,DNA topoisomerase 1,13936,-0.00118499290447721,0.0391668495698271,-0.0779520180613383,0.0755820322523839,0.975864121238318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRAP,BRCA1-associated protein,13806,0.00113189819039139,0.0376192323911887,-0.0726017972963384,0.0748655936771212,0.97599707897212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AAMDC,Mth938 domain-containing protein,13643,0.000502590696822801,0.0183281955994084,-0.0354206726780177,0.0364258540716633,0.978123774060113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMPD3,AMP deaminase 3,13938,0.000681939123752525,0.0251973051879674,-0.0487047790446636,0.0500686572921686,0.978409099469152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,13751,0.000592124969347102,0.0220244008015402,-0.0425757006016716,0.0437599505403658,0.978551885873619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM3,Myomesin-3,13703,0.000874603282275099,0.0325350270318602,-0.062894049700171,0.0646432562647212,0.97855432335231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCOR1,REST corepressor 1,15821,-0.000414978971233337,0.0155779050628534,-0.030947672894426,0.0301177149519593,0.978748046161133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN2,Contactin-2,16195,-0.000410251218451254,0.015402153648105,-0.0305984723687371,0.0297779699318346,0.978750416339722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA10,Annexin A10,15667,-0.000742413672877688,0.0280418519552449,-0.0557044435051577,0.0542196161594024,0.97887865072758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC12A2,Solute carrier family 12 member 2,13501,-0.000217473997412329,0.00920006505042122,-0.0182496014962379,0.0178146535014133,0.981141462751577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3RA,Interleukin-3 receptor subunit alpha,15797,-0.000259357773146023,0.0110072619386799,-0.0218335911729586,0.0213148756266666,0.981201942978813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCL2,Phosducin-like protein 2,13506,-0.00042674259534317,0.0188097385188572,-0.0372938300923033,0.0364403449016169,0.981900024279014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH5,Cadherin-5,16254,-0.000225043213807552,0.0103630560670069,-0.020536633105141,0.0200865466775259,0.982674837600701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR3,Small proline-rich protein 3,13938,-0.00050672485104401,0.0235962938559227,-0.0467554608086524,0.0457420111065644,0.982867241628598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP2,Retinol-binding protein 2,15973,-0.000560902760257007,0.0264058605966296,-0.0523163895296509,0.0511945840091369,0.983053194353396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR2,Folate receptor beta,16208,0.00020697598083597,0.0100572135732797,-0.0195051626227922,0.0199191145844642,0.983581065275976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWF,von Willebrand factor,16254,-0.000495705593191797,0.0251351608526659,-0.049760620864417,0.0487692096780334,0.98426570194527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACHE,Acetylcholinesterase,13703,-0.000219824826435518,0.0114279262675938,-0.0226185603109194,0.0221789106580484,0.984653312299946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSAB1,Tryptase alpha/beta-1,16222,0.000339316981516786,0.0181323291107312,-0.0352000480755164,0.03587868203855,0.985069992840636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOB,Elongin-B,13501,0.000245650248723427,0.013457223189201,-0.0261305072021105,0.0266218076995573,0.985436369757317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ING1,Inhibitor of growth protein 1,15649,0.000290470076572187,0.0160906255772788,-0.0312471560548943,0.0318280962080387,0.985597496202712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXT,Oxytocin-neurophysin 1,16208,0.000718137755711429,0.0478418336649405,-0.093051856227572,0.0944881317389949,0.988023856523496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGA1,ADP-ribosylation factor-binding protein GGA1,15667,-0.000338041359106546,0.0234635902082074,-0.046326678167193,0.0456505954489799,0.988505410277621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBL1X,F-box-like/WD repeat-containing protein TBL1X,15725,-0.000389480503323486,0.0291160089279024,-0.0574568580020121,0.0566778969953651,0.989327305535598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YY1,Transcriptional repressor protein YY1,13568,0.000121908077217189,0.00981472277399391,-0.0191149485598109,0.0193587647142452,0.990089961822042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSP90B1,Endoplasmin,15588,0.000277452173024871,0.0227569703380144,-0.0443262096894834,0.0448811140355331,0.990272616966083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3,Receptor-type tyrosine-protein kinase FLT3,15725,-0.000124816378864826,0.0106117047564672,-0.0209237577015406,0.0206741249438109,0.990615534182253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEF,Thyrotroph embryonic factor,13501,-0.000163841779201951,0.0145913155747587,-0.0287628203057289,0.028435136747325,0.991041132994844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEO1,Neogenin,13946,-8.66926482344947e-05,0.00772734376837027,-0.0152322864342402,0.0150589011377712,0.99104892504475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA11,Carbonic anhydrase-related protein 11,15725,0.000118763333295485,0.0107709470464174,-0.0209922928776827,0.0212298195442737,0.991202630409173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT1A1,Sulfotransferase 1A1,16208,0.000468505311766001,0.0441796644770619,-0.0861236370632753,0.0870606476868073,0.991539085186922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13506,9.7686405475548e-05,0.0093789131013854,-0.0182849832732398,0.0184803560841909,0.991689909015492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTHRC1,Collagen triple helix repeat-containing protein 1,13983,0.000100619377785129,0.00980911398127029,-0.0191252440255046,0.0193264827810749,0.991815794631666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL,Podocalyxin,15973,5.0876991303346e-05,0.00522671631193421,-0.0101934869800877,0.0102952409626944,0.992233615437057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH1,Somatotropin,16043,-0.000576599317004135,0.0611891188302183,-0.120507272224232,0.119354073590224,0.992481576506983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTX3,Pentraxin-related protein PTX3,16054,-0.000147940771384261,0.0170500446183873,-0.0335660282234234,0.0332701466806549,0.993077065833188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDR,Vascular endothelial growth factor receptor 2,16091,7.57367855175864e-05,0.0088472504486212,-0.01726487409378,0.0174163476648151,0.993169908048252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL6B,Myosin light chain 6B,13605,-0.000254246794257131,0.0316164293135268,-0.0622224482487696,0.0617139546602553,0.993583915761371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",15973,8.37648562737814e-05,0.0143423863460535,-0.0280273123819911,0.0281948420945387,0.99534015769697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RUVBL1,RuvB-like 1,15725,0.000193703171326759,0.0357082752077147,-0.069794516235794,0.0701819225784475,0.995671884134042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBAC1,Ubiquitin-associated domain-containing protein 1,15973,-6.3101838767376e-05,0.0120187661005492,-0.0236198833958439,0.0234936797183091,0.995810970737997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK,Neuroblast differentiation-associated protein AHNAK,13643,-5.73761954814151e-05,0.0111918775308087,-0.0219934561558664,0.0218787037649036,0.995909663939008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBD,Thrombomodulin,16063,4.30740711631708e-05,0.00962001888025594,-0.0188121629341385,0.0188983110764648,0.996427503253517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16179,-4.35815459393028e-05,0.0119387753106191,-0.0234435811547528,0.0233564180628742,0.997087437636977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLUL1,Clusterin-like protein 1,16044,-1.40316027203007e-05,0.0155380690050886,-0.0304686468526939,0.0304405836472533,0.999279484275301
